11.02.2014 Views

Trust Board papers November 2012 - Barking Havering and ...

Trust Board papers November 2012 - Barking Havering and ...

Trust Board papers November 2012 - Barking Havering and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

TRUST BOARD MEETING<br />

Wednesday, 7 <strong>November</strong> <strong>2012</strong> at 1.00 pm<br />

<strong>Board</strong> Room, <strong>Trust</strong> Headquarters<br />

Queen’s Hospital<br />

A G E N D A<br />

1. Apologies for Absence<br />

2. Minutes of the meeting held on 5 September <strong>2012</strong> (Attachment A)<br />

3. Matters Arising <strong>and</strong> Actions<br />

4. GOVERNANCE:<br />

4.1 Update on <strong>Trust</strong>-wide CQC action plan (MG) (Attachment B)<br />

4.2 Information Governance (IG) Strategy <strong>2012</strong>/13 (NM) (Attachment C)<br />

4.3 <strong>Board</strong> Assurance Framework <strong>2012</strong> – Quarter 2 (MG) (Attachment D)<br />

4.4 Risk Management Strategy <strong>and</strong> Policy (MG) (Attachment E)<br />

5. QUALITY AND PATIENT STANDARDS<br />

5.1 Quality & Patient St<strong>and</strong>ards Performance Report – (Attachment F)<br />

September <strong>2012</strong><br />

5.2 Emergency Care Report (DH) (Attachment G)<br />

5.3 Maternity Services Update (DH) (Attachment H)<br />

5.4 Complaints Annual Report 2011/12 (FP-C) (Attachment I)<br />

6. FINANCE, WORKFORCE AND ACTIVITY<br />

6.1 Single Operating Model - Self certification template (NM) (Attachment J)<br />

6.2 Finance Report – Month 6 (September) <strong>2012</strong>/13 (DG) (To Follow - Attachment K)<br />

6.3 Workforce Key Performance Indicators (DH) (Attachment L)<br />

6.4 Cost Improvement Update (DH) (Attachment M)<br />

7. INFORMATION<br />

Matters for Noting:<br />

7.1 Chairman <strong>and</strong> Chief Executive’s Report (Attachment N)<br />

7.2 Minutes of the Quality & Safety Committee meeting held on (Attachment O)<br />

14 August <strong>2012</strong><br />

8. Any Other Business<br />

Date of Next Meeting: The next public meeting will be held on Wednesday,<br />

9 January 2013 at 1.00 p.m. in the <strong>Board</strong> Room, <strong>Trust</strong> Headquarters, Queen’s Hospital<br />

9. Questions from the Public<br />

10. Exclusion of the Public <strong>and</strong> Press In accordance with the Public Bodies Admission to Meetings<br />

Act), to resolve to exclude members of the public <strong>and</strong> press from the remainder of the meeting.<br />

<strong>Trust</strong> <strong>Board</strong> Agenda – 7 <strong>November</strong> <strong>2012</strong> 1


1<br />

BARKING, HAVERING AND REDBRIDGE UNIVERSITY<br />

HOSPITALS NHS TRUST<br />

Minutes of the Part I <strong>Trust</strong> <strong>Board</strong> Meeting held on the 5 September <strong>2012</strong><br />

in the <strong>Board</strong> Room, <strong>Trust</strong> Headquarters, Queen’s Hospital<br />

Present: Mr George Wood Interim Chairman<br />

Mrs Averil Dongworth Chief Executive<br />

Mr Stephen Burgess Director of Clinical Strategy & Deputy Medical Director<br />

Dr Maureen Dalziel Associate Non-Executive Director<br />

Mr William Langley Non-Executive Director<br />

Mr Keith Mahoney Non-Executive Director<br />

Mr Neill Moloney<br />

Director of Planning & Performance<br />

Prof Anthony Warrens Non-Executive Director<br />

Ms Judith Douglas Acting Director of Nursing<br />

Mr David Gilburt<br />

Interim Director of Finance<br />

Mrs Dorothy Hosein Director of Transformation<br />

Ms Caroline Wright Non-Executive Director<br />

Mr Michael White<br />

Non-Executive Director<br />

In Attendance: Mr Nick Hulme Project Director, Integration<br />

Ms Imogen Shillito<br />

Director of Communications<br />

Mrs Sue Williams<br />

Executive Assistant/<strong>Trust</strong> <strong>Board</strong> Secretary<br />

Ms Heather Wright Team Leader for Palliative Care<br />

Dr Andrew Gage<br />

Palliative Care Consultant<br />

Dr Derek Hicks<br />

Clinical Director, Emergency Care<br />

<strong>2012</strong>/042 APOLOGIES FOR ABSENCE<br />

Mrs Cathy Geddes, Chief Operating Officer, Dr Mike Gill, Medical Director <strong>and</strong> Mrs Marie Gabriel, Chair of<br />

NELC.<br />

<strong>2012</strong>/043 MINUTES OF THE PART I MEETING HELD ON 4 JULY <strong>2012</strong><br />

The minutes of the Part I meeting held on the 4 July <strong>2012</strong> were noted as a true record <strong>and</strong> signed by the<br />

Interim Chairman.<br />

<strong>2012</strong>/044 MATTERS ARISING<br />

<strong>2012</strong>/011: Quality & Safety Committee continuing to review the Patient Stories paper <strong>and</strong> would make their<br />

recommendations to the <strong>Trust</strong> <strong>Board</strong> at a future meeting.<br />

<strong>2012</strong>/045 BOARD ASSURANCE FRAMEWORK<br />

Mr Burgess presented the <strong>Board</strong> Assurance Framework (BAF) for the first quarter of <strong>2012</strong>. He confirmed<br />

that following discussions at previous <strong>Trust</strong> <strong>Board</strong> meetings <strong>and</strong> at the <strong>Trust</strong> Executive Committee, there<br />

had been a progressive journey of improvement to the BAF <strong>and</strong> the comments at these meetings had been<br />

incorporated into the latest version.<br />

Mr Wood questioned when there would be a coordinated output from the Learning Lessons Group<br />

identified against Risk No 339. The <strong>Board</strong> was informed that this Group had been established by the<br />

previous Director of Nursing <strong>and</strong> responsibility for this area had now been moved to one of the Deputy<br />

Directors of Nursing, Gary Etheridge. Ms Douglas confirmed that one meeting had taken place to date <strong>and</strong><br />

another was scheduled for mid-September. The Group were amalgamating information/intelligence from<br />

different sources in the organisation, including clinical <strong>and</strong> non-clinical, complaints, compliments, claims<br />

<strong>and</strong> safeguarding <strong>and</strong> would be preparing an action plan to go out to the Directorates <strong>and</strong> the Corporate<br />

areas for them to prioritise the main areas for resolution <strong>and</strong> to learn from the issues identified. It was<br />

agreed that the action plan would feed into the Quality & Safety Committee.<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


2<br />

Following Mr White’s concerns raised around the ownership of risk management <strong>and</strong> the sequence of<br />

presenting <strong>papers</strong> to different <strong>Trust</strong> Committees, the Chief Executive confirmed that this was an area that<br />

would be picked up by the new appointment of a Director of Governance <strong>and</strong> Special Projects who would<br />

be starting with the <strong>Trust</strong> on the 10 September. The <strong>Board</strong> noted that the overall <strong>Board</strong> Assurance would<br />

report through the <strong>Trust</strong> Executive Committee <strong>and</strong> on to the <strong>Trust</strong> <strong>Board</strong>. The Clinical Governance Team<br />

was meeting with each Directorate <strong>and</strong> going through a rigorous training programme, in order to ensure<br />

that everyone understood the process. The <strong>Trust</strong>, through this new appointment, would be working<br />

towards Integrated Governance throughout the organisation.<br />

Dr Dalziel was concerned that the ‘Corporate Risks by Year’ chart did not provide a good comparison<br />

between 2011 <strong>and</strong> <strong>2012</strong> <strong>and</strong> she could not get a sense of whether the <strong>Trust</strong> had made improvements in<br />

going from quite a few risks, to less risks. The performance in 2011 looked to have doubled from the<br />

analysis in 2009 <strong>and</strong> 2010. It was agreed by the <strong>Board</strong> that when presenting this type of information, the<br />

report should include some narrative, in order to explain the trends. It was agreed that Mr Moloney,<br />

through the Performance/Information Department, would look at the quality control of information being<br />

presented to the <strong>Board</strong> to ensure it was meaningful for the members <strong>and</strong> complied with Information<br />

Governance. Dr Dalziel also felt that it was important to link these analyses to staffing <strong>and</strong> vacancy levels,<br />

as this information could not sit outside of this <strong>and</strong> needed to be linked to it in some way to ensure<br />

correlation of data.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the changes to the <strong>Board</strong> Assurance Framework.<br />

Action: Neill Moloney 7.11.12<br />

<strong>2012</strong>/046 QUALITY & PATIENT STANDARDS PERFORMANCE REPORT – JULY <strong>2012</strong><br />

Mr Moloney informed the <strong>Board</strong> that there had been three MRSA bacteraemias reported during the month,<br />

bringing the <strong>Trust</strong>’s total up to five. Unfortunately since the report had been finalised, another case had<br />

been reported, bringing the total to six, against a yearly target of seven. It was felt that the target would be<br />

breached by the end of the year.<br />

He also reported that the complaints performance had returned to ‘green’ <strong>and</strong> the <strong>Trust</strong> had achieved 87%<br />

for its response times during the month of July. Another area to note was that length of stay had improved<br />

on non-elective, but worryingly DTOCs had not reduced; increased from 4.39% in June to 4.69% in July.<br />

Mr Mahoney raised the performance for MRSA Screening <strong>and</strong> the <strong>Trust</strong>’s position compared with other<br />

<strong>Trust</strong>s. The <strong>Board</strong> noted that this area had been discussed in detail with the Directorates, both for elective<br />

<strong>and</strong> non-elective <strong>and</strong> there had been a considerable amount of work ongoing since August to ensure an<br />

improvement in performance over the next two to three months. The Emergency Department was also<br />

looking at the Emergency Medicine Decision Unit (EMDU) to capture all the patients going through there as<br />

well, so this would contribute to the improvement in performance. Mr Moloney informed the <strong>Board</strong> that it<br />

had been made very clear at the Directorate Performance Review meetings recently that the performance<br />

against this target had to improve. The Interim Deputy Director of Nursing, Gary Etheridge had taken on<br />

responsibility for patient experience <strong>and</strong> he was currently taking a different approach to the implementation<br />

of the h<strong>and</strong> held devices, in order to encourage both patients <strong>and</strong> their relatives to complete the<br />

questionnaires. The <strong>Board</strong> agreed that this had to be part of the discharge process, so the <strong>Trust</strong> had some<br />

good quality data to refer to.<br />

The Interim Chairman raised his concerns regarding the drop in performance for appraisals (72.69%, a<br />

drop of 3.71% on last month’s position) <strong>and</strong> whether this meant that the <strong>Trust</strong> had a large number of staff in<br />

the organisation who did not have their objectives set for the next year. The <strong>Board</strong> agreed that it was very<br />

important for staff to have their objectives set, in order to performance manage people appropriately. It had<br />

been agreed at a previous <strong>Board</strong> meeting that Clinical Directors would ensure appraisals <strong>and</strong> objectives<br />

were aligned <strong>and</strong> cascaded down through their Directorates. The Chief Executive would take this up with<br />

the two Executive Directors currently covering the Chief Operating Officer’s responsibilities, namely Mrs<br />

Hosein <strong>and</strong> Mr Hulme, to ensure that the Associate Directors <strong>and</strong> other senior management had their<br />

objectives. The Chief Executive would provide the appropriate evidence for the <strong>Board</strong>.<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


3<br />

Following Dr Dalziel’s comments regarding staff turnover <strong>and</strong> sickness absence, Mr Moloney confirmed<br />

that the <strong>Trust</strong>’s position was lower than the National average <strong>and</strong> it was the organisation’s ambition to<br />

reduce sickness absence down to the London average of 3.6%. The <strong>Trust</strong> had looked at other <strong>Trust</strong>s<br />

where they had been successful in addressing sickness absence <strong>and</strong> a Sickness Absence Plan paper had<br />

been prepared for the private <strong>Trust</strong> <strong>Board</strong> meeting later in the day. It was also agreed that Mrs Hosein<br />

<strong>and</strong> Mr Moloney would arrange for the staff turnover figure to be validated, as the trend indicated that this<br />

was going up.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the content of the report <strong>and</strong> supported the actions to bring the performance back in<br />

line with trajectory/target.<br />

Action: Averil Dongworth 7.11.12<br />

Dorothy Hosein/Neill Moloney 7.11.12<br />

<strong>2012</strong>/047 EMERGENCY CARE/RESET PROGRAMME UPDATE<br />

Dr Derek Hicks, Clinical Director for Emergency Care, attended the meeting to answer questions on the<br />

update report. He confirmed that the recent changes in the Department should allow the <strong>Trust</strong> to sustain<br />

<strong>and</strong> remain on the current trajectory. The Interim Chairman raised his concerns regarding patients being<br />

left to the last five minutes of the 4 hours, even when beds were available, leaving little room for<br />

unexpected events. It was agreed a cultural change was required by everyone, as there had in the past<br />

been no pressure to move patients as soon as a decision was made. This was happening in some areas<br />

more than others <strong>and</strong> the <strong>Trust</strong> was looking at Consultants <strong>and</strong> Senior Nurses performances to see if there<br />

were any patterns of behaviour that could be addressed, in order to make people accountable for these<br />

delays. Following a point raised by the Interim Chairman, it was noted that although it was not within the<br />

<strong>Trust</strong>’s remit to amend Health Needs Assessment Forms, it was pushing to have them changed/modified to<br />

reduce the time it took to complete them. The <strong>Trust</strong> was also undertaking a lot of work with the Wards, in<br />

order to alleviate what was an onerous task with the double entry of data. This was an area that would be<br />

rectified with the implementation of the new PAS, but in the meantime the <strong>Board</strong> asked the IT Department<br />

to look into a short term solution that would minimise the time involved.<br />

Mr Langley raised the issue of inappropriate admissions <strong>and</strong> if there was a periodic Audit to check these.<br />

Dr Hicks confirmed that there was an increase in senior presence in the Department now <strong>and</strong> patients<br />

would be filtered more effectively. He also informed the <strong>Board</strong> that there were better controls for<br />

managing patients in the Emergency Department <strong>and</strong> the Medical Assessment Unit <strong>and</strong> the recruitment<br />

programme was quite well advanced, which would enable the organisation to take out more bank <strong>and</strong><br />

agency staff. Mr White commented on the low number of discharges pre-11.00 a.m. <strong>and</strong> was concerned<br />

that the <strong>Trust</strong> had the right processes in place to deal with these. As the discharges remained low, Mr<br />

White questioned whether the Discharge Lounge was working as well as the <strong>Trust</strong> expected it to. Dr Hicks<br />

informed the <strong>Board</strong> that the organisation was trying to get flow throughout the day <strong>and</strong> there were a lot of<br />

initiatives around discharging patients pre-11.00 a.m. <strong>and</strong> for using the Discharge Lounge. Discharges<br />

were coming up late in the day, so the <strong>Trust</strong> would be looking at how many discharges were required by<br />

11.00 a.m. <strong>and</strong> would be holding people to account for this. The <strong>Board</strong> noted that the new Medical<br />

Director, Dr Mike Gill, would be undertaking two sessions in the Emergency Department around Care of<br />

the Elderly, in order to assist in turning these patients around much quicker <strong>and</strong> ensuring appropriate<br />

admissions were being made. From next week there would be a Care of the Elderly Consultant in the<br />

Emergency Department everyday. The <strong>Trust</strong> had undertaken an Audit last year, in conjunction with the<br />

local GPs, to look at the quality of admissions <strong>and</strong> this exercise was going to be repeated again this year.<br />

This would provide a healthy clinical challenge with GPs <strong>and</strong> the <strong>Trust</strong>’s clinicians looking at BHRUT’s<br />

practice <strong>and</strong> would provide the evidence that the <strong>Trust</strong> was not inappropriately admitting patients.<br />

Mr White referred to the next steps for the improvement in the emergency pathway; ‘create joint team with<br />

community <strong>and</strong> social care to completely redesign <strong>and</strong> manage complex frail patients’ <strong>and</strong> questioned the<br />

<strong>Trust</strong>’s confidence in having this process in place to prevent some of the problems experienced last Winter.<br />

It was confirmed that this was an ongoing process <strong>and</strong> there were daily Jonah meetings, monthly Cross<br />

Buffer Group meetings <strong>and</strong> the <strong>Trust</strong> was just about to commence weekly meetings with the Cluster to<br />

strengthen processes, in order to get the patients discharged as soon as possible. The <strong>Board</strong> noted that<br />

last week the <strong>Trust</strong> had eleven/twelve patients waiting for community beds <strong>and</strong> the problem was going to<br />

get significantly worse. The <strong>Board</strong> therefore asked for a document to be prepared that showed the <strong>Trust</strong>’s<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


4<br />

forecast in terms of community bed requirements, including the plans the Cluster was going to put in place<br />

to bridge the gap in available community beds. It was noted that the <strong>Trust</strong> was developing its own Winter<br />

Plan <strong>and</strong> it was agreed that the Director of Transformation would bring back the composite plan, based on<br />

credible data, to the next meeting, in order to provide the <strong>Board</strong> with the evidence it required. Executive<br />

Directors of BHRUT would be meeting with the Cluster for a Clinical Strategy Day on the 21 September, in<br />

order to share the work on their different Workstreams <strong>and</strong> use it as a good opportunity to highlight the<br />

issues; admission criteria into nursing homes <strong>and</strong> lack of community beds. This engagement would assist<br />

in bringing all of this to a conclusion before Winter arrived.<br />

Dr Dalziel raised the issue of how the organisation presented performance information <strong>and</strong> whether targets<br />

were right, as with the <strong>Trust</strong>’s previous experience, it should have more of a feel around realistic targets<br />

<strong>and</strong> should not be over estimating what is considered to be an achievable target/performance level. She<br />

felt that the <strong>Trust</strong> should be transparent about what was reasonable <strong>and</strong> how it presented this externally,<br />

otherwise it would always look like it had failed.<br />

The Chief Executive informed the <strong>Board</strong> that she would be attending a meeting tomorrow with the<br />

Consultant Physicians regarding seven day working. There was also a Surgery ‘Awayday’ planned for<br />

tomorrow where they would be looking at how the Surgeons would provide 7/7 working. The <strong>Board</strong> noted<br />

that by the end of the financial year, the Consultants should be working twelve hour shifts <strong>and</strong> have 7/7<br />

working in place.<br />

The Outline Business Case (OBC), which included the closure of the Emergency Department at King<br />

George Hospital, had not yet been completed, but Ernst & Young was working with the <strong>Trust</strong> to put<br />

together a plan for Queen’s <strong>and</strong> King George Hospitals, which would include the cost of moving A&E<br />

across from KGH to Queen’s. The OBC should be completed by the end of October/beginning of<br />

<strong>November</strong> <strong>and</strong> would be made available for the public to review.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the update.<br />

Action: Averil Dongworth 7.11.12<br />

Dorothy Hosein 7.11.12<br />

<strong>2012</strong>/048 MATERNITY SERVICES UPDATE<br />

The <strong>Trust</strong> <strong>Board</strong> noted the content of the Maternity Services Monthly Performance Report covering the<br />

period 1 July to 31 July <strong>2012</strong>. At previous <strong>Board</strong> meetings Ms Wright had raised the issue of data<br />

recorded for the ‘Out of Hours’ Obstetric Assessment Unit (OAU) not being robust <strong>and</strong> wanted to know<br />

when this would be addressed, as there did not appear to be any explanation for her to know that this was<br />

being h<strong>and</strong>led appropriately <strong>and</strong> the <strong>Board</strong> had reliable information to monitor performance against. In the<br />

current format it was difficult to assess whether there had been any improvement, or not.<br />

The timing of Caesarean Section (C/S) Deliveries according to acuity were discussed <strong>and</strong> it was noted by<br />

the <strong>Board</strong> that delays attributed to clinicians/anaesthetists required elsewhere, due to a busy Labour Ward<br />

<strong>and</strong> Theatres, was stated as being in the top three reasons for delays. The <strong>Board</strong> agreed that it would be<br />

helpful for them to underst<strong>and</strong> the proportion of these delays by Grade 1, Grade 2 <strong>and</strong> Grades 3 & 4 <strong>and</strong><br />

what took precedence over these C/S’s. The Chief Executive agreed to look into this <strong>and</strong> to report back to<br />

the <strong>Trust</strong> <strong>Board</strong>. Mrs Dongworth would also seek assurance from the Directorate that the clinical fellow<br />

pathway had been implemented on the 30 July <strong>2012</strong>.<br />

The transfer of some of the <strong>Trust</strong>’s midwives, due to the changes in boundaries, was discussed <strong>and</strong> the<br />

Chief Executive informed the <strong>Board</strong> that there would be further discussions regarding this later this week.<br />

Mr Mahoney highlighted to the <strong>Board</strong> that he had concerns around the TUPE across of midwives to other<br />

<strong>Trust</strong>s in the Cluster, when the births at BHRUT had increased for the second month <strong>and</strong> the organisation<br />

was still delivering over 9k, although the <strong>Trust</strong> had been assured by the Commissioners that this would not<br />

be the case by the end of the financial year.<br />

The <strong>Board</strong> agreed that it was important to have agreement on the Workforce Plan for the future, in order to<br />

ensure a safe service was operating, but the Directorate was not over resourced <strong>and</strong> left with str<strong>and</strong>ed<br />

costs. The <strong>Board</strong> noted that the Clinical Director for Maternity <strong>and</strong> the Director of Midwifery had been<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


5<br />

working with the Cluster over the last few months to ensure the <strong>Trust</strong> was confident that it would be<br />

operating a safe service by the time it opened the Midwifery Led Unit <strong>and</strong> closed Maternity Services on the<br />

King George Hospital site. A shift in the practice of women being referred from GPs to the different<br />

catchment areas was already evident, but it was agreed that it would be useful for members of the <strong>Board</strong> to<br />

receive a much more detailed briefing paper/visual schematic outlining all of this, in order that it could be<br />

explicitly understood <strong>and</strong> risk managed, as it was a very complex plan.<br />

The Commissioners had been informed that BHRUT felt that it was really important to get everything right<br />

before signing up to any plan that would put its patients at risk.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the content of the report.<br />

Action: Averil Dongworth 7.11.12<br />

<strong>2012</strong>/049 BARKING & DAGENHAM SAFEGUARDING CHILDREN BOARD (BDSCB) ANNUAL<br />

REPORT 2011/12<br />

Ms Douglas presented the <strong>Barking</strong> & Dagenham Safeguarding Children <strong>Board</strong> Annual Report for 2011/12.<br />

Several questions from the report were raised by members of the <strong>Board</strong>, including the Interim Chairman’s<br />

reference to the Child Death Overview Panel looking at trends <strong>and</strong> patterns <strong>and</strong> making recommendations,<br />

but it was not evident from the report what these recommendations, or trends, actually were. The <strong>Board</strong><br />

agreed it was important for the <strong>Trust</strong> to follow through on any actions required <strong>and</strong> to support the Local<br />

Authority in the identification of any trends.<br />

Mr White commented that this report only referred to one Safeguarding <strong>Board</strong> <strong>and</strong> he wanted assurance<br />

that the <strong>Trust</strong> was represented on the <strong>Board</strong>s of other Boroughs. He also referred to the <strong>Trust</strong>’s<br />

attendance on the Training Programme, as the report was indicating zero for BHRUT. Ms Douglas<br />

confirmed that the <strong>Trust</strong> had a very robust in-house Training Programme for Safeguarding Children <strong>and</strong><br />

Safeguarding Adults <strong>and</strong> reassured the <strong>Board</strong> members that BHRUT did have representation at each<br />

Borough’s Safeguarding <strong>Board</strong> meetings. The Director of Nursing was a member of each <strong>Board</strong> <strong>and</strong> Ms<br />

Douglas would ensure, when the new Director of Nursing arrived, that appropriate representation was<br />

timetabled for Executive Director attendance across all Boroughs. The <strong>Trust</strong> was committed to delivering<br />

its role in the Safeguarding agenda <strong>and</strong> apart from one meeting when Ms Wheeler was not available, the<br />

<strong>Trust</strong> now had much better representation at these meetings, <strong>and</strong> would be more of an active partner in the<br />

future.<br />

The <strong>Board</strong> agreed that once all the Local Borough reports had been received the Nursing Directorate<br />

would identify someone to sit down <strong>and</strong> cross reference them all to make sure the <strong>Trust</strong> was meeting its<br />

commitments in a timely way. It was also agreed that there would be a more comprehensive discussion<br />

around this subject at a future <strong>Board</strong> meeting, in order to pro-actively comment on these reports. The<br />

<strong>Board</strong> asked for a list of forthcoming reports to be prepared, so the <strong>Board</strong> was aware of the publication<br />

dates, prior to them being issued.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the Annual Report.<br />

Action: Judith Douglas 7.11.12<br />

<strong>2012</strong>/050 BHRUT TFA COMPOSITE PLAN<br />

Mr Moloney presented the revised TFA Composite Plan, which had now been signed off by the Cluster <strong>and</strong><br />

NHS London. The content was similar to what had been included in the Performance Report <strong>and</strong> what had<br />

been presented previously to the <strong>Board</strong>, although there were a number of key milestones that required a<br />

due date for delivery to be inserted in the plan. The <strong>Trust</strong> would now be reporting to NHS London on a<br />

monthly basis.<br />

Some milestones had been removed, as they had already been delivered <strong>and</strong> to a large extent the <strong>Trust</strong><br />

was now rated ‘amber’ or ‘green’. The <strong>Trust</strong> would be closely monitoring the timeframes for delivery<br />

through to the end of the financial year. Following a comment from Dr Dalziel, Mr Moloney would arrange<br />

for the TFA to indicate the trends on the key milestones, in order to make the current position much clearer.<br />

Mr Gilburt would ensure that the summary progress in the Financial Viability section was aligned to the<br />

Finance Report, as there was a discrepancy on the figure relating to the Cost Improvement Programme.<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


6<br />

The <strong>Trust</strong> <strong>Board</strong> noted the Plan for the period ending August <strong>2012</strong>.<br />

Action: Neill Moloney 30.9.12<br />

David Gilburt 30.9.12<br />

<strong>2012</strong>/051 FINANCE REPORT – MONTH 4 (JULY) <strong>2012</strong>/13<br />

Mr Gilburt highlighted the key points in the Finance Report for Month 4. The <strong>Trust</strong> was reporting a year to<br />

date deficit of £16.9m, excluding impairments <strong>and</strong> IFRS adjustment, against the year end control total of<br />

£40m. The deficit in month was £3.9m, which was ahead of where the <strong>Trust</strong> wanted to be <strong>and</strong> it was<br />

therefore taking measures to bring the in month expenditure down. Further short term actions were also<br />

being implemented to put a ‘cap’ on discretionary spending within the organisation, in order to get back on<br />

track. The <strong>Board</strong> noted that the agreed income re-profiling had been fully reflected in the position.<br />

Mr Gilburt reported that there was a credible plan for delivery of £17m CIPs <strong>and</strong> the <strong>Trust</strong> had identified<br />

other schemes to address the £6m gap. At present it was not clear that these schemes would deliver this<br />

year <strong>and</strong> it was therefore undertaking some further work on this with Ernst & Young. He also informed the<br />

<strong>Board</strong> that the <strong>Trust</strong> was doing a lot of work with the Commissioners around payment for the over<br />

performance in activity going through the <strong>Trust</strong>. Mr Gilburt confirmed that the Commissioners were being<br />

very cooperative in these discussions regarding the funding of the over performance <strong>and</strong> this would play a<br />

key part in the <strong>Trust</strong> delivering its financial target. The <strong>Trust</strong> was also talking to NHS London regarding PFI<br />

funding, which had been previously indicated <strong>and</strong> the <strong>Trust</strong> was doing everything they were being asked to<br />

do to get NHS London to release this funding, which could result in a lower control total at the end of the<br />

year.<br />

Following an issue raised by Mr Langley regarding procurement, Mr Gilburt confirmed that all purchases<br />

had to go through the central procurement route <strong>and</strong> had to have a purchase order. Suppliers had been<br />

informed that unless they had an official purchase order they would not be paid <strong>and</strong> there were<br />

arrangements in place to follow this process. As previously advised, the Capital Programme had been<br />

frozen, but there were ongoing schemes that the <strong>Trust</strong> had contractually signed up to, or were clinically<br />

essential, that were going ahead. Mr Gilburt <strong>and</strong> Mr Moloney were taking a rigorous look at the<br />

Programme <strong>and</strong> had arranged for a review meeting to take place next week to look at priority schemes, as<br />

the organisation was reluctant to sign-off any additional schemes until this review had taken place.<br />

Mr Gilburt highlighted that the <strong>Trust</strong> had recently received an injection of cash from the Commissioners <strong>and</strong><br />

would be monitoring cash flow carefully up to the end of the financial year.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the report.<br />

Action: David Gilburt/Neill Moloney 7.11.12<br />

<strong>2012</strong>/052 WORKFORCE KEY PERFORMANCE INDICATORS – JULY <strong>2012</strong><br />

Mrs Hosein informed the <strong>Board</strong> that the <strong>Trust</strong>’s sickness absence rate for the month of July had increased<br />

by 0.59% on the June position, increasing from 4% to 4.59%, but had decreased by 0.46% when compared<br />

to the same period last year. She reported that there was a lot of work ongoing with the Wards regarding<br />

short term sickness <strong>and</strong> the <strong>Trust</strong> was also strengthening the governance around vacancies <strong>and</strong><br />

scrutinising the recruitment of new staff. The <strong>Board</strong> acknowledged that there would continue to be a level<br />

of recruitment, in order to bring down the bank/agency staff numbers.<br />

In terms of workforce, Mrs Hosein reported that the <strong>Trust</strong> would be reviewing a lot of its policies, in<br />

conjunction with the Joint Staff Committee, now the new Head of Workforce Transformation was in post.<br />

The <strong>Board</strong> noted that the difference in the workforce numbers reported in this report <strong>and</strong> the Finance<br />

Report was due to the <strong>Trust</strong> having to report staff that had transferred to Sodexo under ROE, as these<br />

members of staff maintained their terms <strong>and</strong> conditions of employment with BHRUT.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the report.<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


7<br />

<strong>2012</strong>/053 TRANSFORMATION BOARD UPDATE<br />

Mrs Hosein informed the <strong>Board</strong> that against the CIP target of £23.1m, the <strong>Trust</strong> had identified £17.6m,<br />

following a review carried out by Ernst & Young. Further schemes were being worked on to address the<br />

gap <strong>and</strong> the Project Management Office/Service Transformation Team was working with the Workstream<br />

Leads to strengthen the existing schemes, in order to ensure delivery.<br />

The Programme had delivered the target for last month <strong>and</strong> would be working towards achieving a £2m run<br />

rate by the end of March. One Ward had been closed <strong>and</strong> the Team was currently working up a further<br />

proposal to close another Ward. Accountability meetings with the SRO’s were continuing to ensure the<br />

Programme was kept on track. The <strong>Board</strong> was asked to refer to a table within the Finance Report, which<br />

set out the workstreams <strong>and</strong> the deliverables for the CIP.<br />

Mr Langley raised the issue of improving <strong>and</strong> embedding controls in relation to bank <strong>and</strong> agency staff <strong>and</strong><br />

Mrs Hosein confirmed that a lot of work had been put into this with the Wards <strong>and</strong> they would now be<br />

concentrating <strong>and</strong> drilling down on the medical spend. Each Directorate had been asked to identify their<br />

medical staff expenditure <strong>and</strong> to come back with their short, medium <strong>and</strong> long term actions on how they<br />

would reduce their bank <strong>and</strong> agency spend in this area, albeit there were obviously still recruitment issues<br />

in some areas, e.g. Emergency Department.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the update report.<br />

<strong>2012</strong>/054 ANNUAL AUDIT LETTER 2011/12<br />

The <strong>Trust</strong> <strong>Board</strong> noted the Annual Audit Letter 2011/12 submitted to the <strong>Trust</strong> from the Audit Commission.<br />

<strong>2012</strong>/055 END OF LIFE CARE ADVISORY BOARD – BRIEFING PAPER<br />

Ms Heather Wright, Team Leader for Palliative Care <strong>and</strong> Dr Andrew Gage, Palliative Care Consultant<br />

presented their end of life video. Dr Gage informed the <strong>Board</strong> that along with Dr Claire Bates, they had<br />

developed the End of Life Care (EOLC) Advisory <strong>Board</strong> (ELCAB), which aimed to facilitate the<br />

implementation of the EOLC Strategy (2008) <strong>and</strong> NICE End of Life Quality St<strong>and</strong>ards (2011) within the<br />

<strong>Trust</strong>. The Strategy was comprehensive <strong>and</strong> would assist the <strong>Trust</strong> in improving practices in the short term<br />

<strong>and</strong> for the longer term change the culture of End of Life Care. Dr Gage highlighted that there were a high<br />

number of deaths in Outer North East London (ONEL), compared with the rest of the Country <strong>and</strong> the<br />

ONEL community palliative care services were poorly resourced, with inequity across the Boroughs. The<br />

<strong>Board</strong> noted that there was a CQUIN for EOLC, which commenced in April this year following negotiation<br />

with the Commissioners to ensure there was a realistic, but challenging goal agreed (c.£478k to the <strong>Trust</strong>).<br />

It was acknowledged that the education of Doctors was important <strong>and</strong> they had developed a bespoke DVD<br />

for the ‘Dying Matters Week’ in order to empower <strong>and</strong> support <strong>Trust</strong> clinicians to take on the responsibility<br />

themselves. Ms Wright informed the <strong>Board</strong> that the Dying Matters Coalition wanted to put the <strong>Trust</strong>’s DVD<br />

on their website, after addressing any copyright issues.<br />

The <strong>Board</strong> was advised that there were Borough Facilitators who trained staff in the nursing <strong>and</strong> residential<br />

homes, but access to specialist palliative care seven days a week, or ’out of hours’, was difficult, as the<br />

community <strong>and</strong> the acute sector were not joined up at the moment.<br />

The Directorate had been highlighting since 2004 the requirement for an additional nurse at the <strong>Trust</strong>. The<br />

organisation also needed to address the under resourcing of specialist beds. The number of in hospital<br />

deaths occurring on the Liverpool Care Pathway was raised by the Interim Chairman, as well as the<br />

available bed base. Dr Gage confirmed that the current figure for these beds in this locality was three per<br />

100k population, against seven in Tower Hamlets <strong>and</strong> 4.55 for the <strong>Trust</strong>, which was below the National<br />

average. Dr Gage also informed the <strong>Board</strong> that Redbridge <strong>and</strong> Waltham Forest were under resourced for<br />

24 hour cover. Mr Wood would take this up outside of the meeting, in order to assist in moving things<br />

forward in this area.<br />

It was noted that this paper had not been through the normal channels <strong>and</strong> discussions had not taken<br />

place at Executive Director level. The Quality & Safety Committee would therefore review the issues<br />

raised <strong>and</strong> recommend the appropriate actions to be taken.<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


8<br />

The Co-Chair of the Improving Patient Experience Group (IPEG) Mrs Elaine Clarke raised the point that<br />

there was no provision for End of Life Care for patients with long term conditions, as with these patients it<br />

was difficult to assess when they would die. The Quality & Safety Committee would also consider this<br />

cohort of patients <strong>and</strong> provide the <strong>Board</strong> with their recommendations.<br />

The <strong>Board</strong> noted the key achievements during 2011/12 <strong>and</strong> the work now in progress.<br />

The <strong>Trust</strong> <strong>Board</strong> agreed that the Quality & Safety Committee should discuss <strong>and</strong> agree the named<br />

Executive <strong>Trust</strong> Lead for End of Life Care <strong>and</strong> this individual would chair the End of Life Care Advisory<br />

<strong>Board</strong> (previously chaired by the Director of Nursing).<br />

Action: Caroline Wright/Anthony Warrens 7.11.12<br />

<strong>2012</strong>/056 DEMENTIA STRATEGY – PHASE 2<br />

Ms Douglas presented the Dementia Strategy – Phase 2, which included meeting the National CQUIN <strong>and</strong><br />

the roll out of the Butterfly Scheme. All the work in the Dementia Strategy would be undertaken in<br />

conjunction with the Elderly Care Strategy.<br />

The Dementia Strategy was launched in 2010 <strong>and</strong> following a gap analysis against the National Dementia<br />

Strategy, 17 key objectives were agreed. Ms Douglas informed the <strong>Board</strong> that a Dementia Steering Group<br />

had been established <strong>and</strong> an Action Plan agreed. She also confirmed that the <strong>Trust</strong>’s overall<br />

responsibilities would be monitored through the Action Plan, in order to ensure a smooth pathway from the<br />

community into hospital. BHRUT had worked with North East London Foundation <strong>Trust</strong> (NELFT), as they<br />

were the leading partner for this Strategy. This Strategy was part of the operational plan requirements<br />

from the Department of Health to improve Dementia Services for all. The <strong>Board</strong> agreed it would be useful<br />

to see the framework of the organisations involved, in order to underst<strong>and</strong> the structure.<br />

It was noted by the <strong>Board</strong> that the Borough of <strong>Havering</strong> had the highest population numbers in this<br />

category <strong>and</strong> this was going to increase by at least 15% over the next ten to fifteen years. The <strong>Trust</strong><br />

therefore needed to prepare for this <strong>and</strong> be assured that someone would be taking this on, as the <strong>Board</strong><br />

did not currently have confidence that the organisation was in a position to meet the challenges that would<br />

present themselves over the coming years. The Chief Executive advised the <strong>Board</strong> that she would be<br />

attending an Integrated Care Coalition meeting with members of the Cluster tomorrow <strong>and</strong> she would<br />

ensure that the <strong>Board</strong>’s concerns were raised there.<br />

Dr Dalziel referred to the earlier End of Life presentation <strong>and</strong> the requirement for both of these to be linked<br />

in a different cultural approach towards people dying, whether they had dementia or not. A lot of patients<br />

were at home, rather than in hospital, <strong>and</strong> it should be acknowledged that this was quite complicated <strong>and</strong><br />

needed to be brought together in some way.<br />

The Interim Chairman raised the point relating to Discharge Coordination rated ‘red’ in the Action Plan <strong>and</strong><br />

the requirement for a <strong>Trust</strong> Lead to be agreed as part of the restructure. Ms Douglas confirmed to the<br />

<strong>Board</strong> that there was a lot of work ongoing on the Wards regarding the discharge coordination of patients<br />

with dementia, in order to ensure patients were being discharged appropriately. The identification of a<br />

<strong>Trust</strong> Lead was obviously a priority, as the Action Plan stated the timescale as January <strong>2012</strong>. Questions<br />

were raised as to why this timescale had slipped <strong>and</strong> how this fitted into the whole Governance<br />

Framework. The <strong>Board</strong> agreed that Ms Douglas would go back <strong>and</strong> review with the relevant clinicians if<br />

there was a case to recruit someone for this post, or for Dr Mike Gill, the Medical Director, to be the Lead.<br />

Mr Langley referred to a further ‘red’ rated theme on the Expected Outcome Measures in relation to<br />

Improved patient <strong>and</strong> carer experience <strong>and</strong> the outcome noted as ‘data non specific for dementia’. He had<br />

concerns that there was insufficient measurement criteria to provide comfort to the <strong>Board</strong>. Ms Douglas<br />

agreed that there was some work to do on this linking to the patient pathway <strong>and</strong> the Butterfly Scheme <strong>and</strong><br />

she informed the <strong>Board</strong> that this would all be tied together.<br />

The <strong>Board</strong> noted the impact of dementia <strong>and</strong> the staggering numbers involved with 700k people living with<br />

dementia in Engl<strong>and</strong>, with this number likely to double over the next thirty years, costing the UK economy<br />

£17bn per year. With the expected increase in patients, the costs in the next thirty years would rise to<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


9<br />

£50bn a year. It was also noted by the <strong>Board</strong> that the number of people over the age of 65 would increase<br />

by 15% <strong>and</strong> over age 85 would increase by 27%. With the number of older people in the population<br />

continuing to rise, it was likely the future cost of dementia care would increase considerably.<br />

The <strong>Board</strong> agreed that all reports of this nature should be presented to the Quality & Safety Committee,<br />

prior to coming to the <strong>Trust</strong> <strong>Board</strong>.<br />

The <strong>Trust</strong> <strong>Board</strong> supported the ongoing development of the work <strong>and</strong> agreed that Ms Douglas would look<br />

into who would be the Executive Champion/Lead for Dementia/Elderly Care.<br />

<strong>2012</strong>/057 MATTERS FOR NOTING:<br />

INTERIM CHAIR AND CHIEF EXECUTIVE’S REPORT<br />

The <strong>Trust</strong> <strong>Board</strong> noted the Interim Chair <strong>and</strong> Chief Executive’s Report.<br />

<strong>2012</strong>/058 DECLARATION OF MEMBERS’ INTERESTS <strong>2012</strong>/13 UPDATE<br />

The <strong>Trust</strong> <strong>Board</strong> noted the Declaration of Members’ Interests <strong>2012</strong>/13 Update.<br />

Action: Averil Dongworth 6.9.12<br />

Judith Douglas 7.11.12<br />

<strong>2012</strong>/059 MINUTES OF THE QUALITY & SAFETY COMMITTEE MEETING HELD ON THE<br />

12 JUNE <strong>2012</strong><br />

The <strong>Trust</strong> <strong>Board</strong> noted the minutes of the Quality & Safety Committee meeting held on the 12 June <strong>2012</strong>.<br />

<strong>2012</strong>/060 MINUTES OF THE CHARITABLE FUNDS COMMITTEE MEETING HELD ON THE<br />

29 MAY <strong>2012</strong><br />

The <strong>Trust</strong> <strong>Board</strong> noted the minutes of the Charitable Funds Committee meeting held on the 29 May <strong>2012</strong>.<br />

<strong>2012</strong>/061 ANY OTHER BUSINESS<br />

No further business.<br />

Meeting closed at 3.30 p.m.<br />

The next meeting of the <strong>Barking</strong>, <strong>Havering</strong> <strong>and</strong> Redbridge University Hospitals NHS <strong>Trust</strong> <strong>Board</strong> will take<br />

place on Wednesday, 7 <strong>November</strong> <strong>2012</strong> in the <strong>Board</strong> Room, <strong>Trust</strong> Headquarters, Queen’s Hospital.<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


TRUST BOARD MEETING<br />

Actions from Minutes of Part I meeting held on 5 September <strong>2012</strong><br />

in the <strong>Board</strong> Room, <strong>Trust</strong> Headquarters, Queen’s Hospital<br />

Agenda Item Action Deadline<br />

Date<br />

Date<br />

Completed/Upd<br />

ate/<br />

Agenda Item<br />

<strong>2012</strong>/011<br />

(Issues for<br />

Escalation from<br />

Quality & Safety<br />

Committee)<br />

<strong>2012</strong>/031<br />

(Learning Disability<br />

Progress Report)<br />

<strong>2012</strong>/032<br />

(Milestone<br />

Tracker/Composite<br />

Plan)<br />

<strong>2012</strong>/045<br />

(<strong>Board</strong> Assurance<br />

Framework)<br />

Review Patient Stories paper at<br />

Quality & Safety Committee <strong>and</strong><br />

prepare proposal for <strong>Trust</strong> <strong>Board</strong><br />

members to review at<br />

September <strong>Trust</strong> <strong>Board</strong> meeting.<br />

Check mechanisms in place in<br />

each Borough regarding health<br />

checks for people with learning<br />

disabilities.<br />

Draft OBC to be presented at<br />

August <strong>Trust</strong> <strong>Board</strong> meeting.<br />

Review quality control of<br />

information being presented to<br />

the <strong>Board</strong> <strong>and</strong> ensure it<br />

complies with Information<br />

Governance.<br />

CW/AW 5.9.12 Deferred<br />

PW 5.9.12<br />

(advise SW when<br />

proposal ready to<br />

present)<br />

NH 1.8.12 Deferred to<br />

<strong>November</strong><br />

NM 7.11.12 7.11.12<br />

<strong>2012</strong>/046<br />

(Quality & Patient<br />

St<strong>and</strong>ards<br />

Performance<br />

Report – July <strong>2012</strong>)<br />

Ensure Clinical Directors<br />

objectives are set <strong>and</strong> they are<br />

cascading down through their<br />

Directorates.<br />

Review staff turnover figure, as<br />

trend indicated this was going<br />

up.<br />

AD<br />

DH/NM<br />

7.11.12<br />

7.11.12<br />

7.11.12<br />

7.11.12<br />

<strong>2012</strong>/047<br />

(Emergency<br />

Care/RESET<br />

Programme Update<br />

Arrange for the IT Department to<br />

review the double entry of data<br />

for Health Needs Assessment<br />

Forms <strong>and</strong> look at a short term<br />

solution that could minimise the<br />

time involved in completing<br />

these.<br />

Composite Plan around <strong>Trust</strong>’s<br />

forecast for community beds, in<br />

AD<br />

DH<br />

7.11.12<br />

7.11.12<br />

7.11.12<br />

<strong>Trust</strong> <strong>Board</strong> Meeting (Part I) 5 September <strong>2012</strong>


Agenda Item Action Deadline<br />

Date<br />

Date<br />

Completed/Upd<br />

ate/<br />

Agenda Item<br />

<strong>2012</strong>/048<br />

(Maternity Services<br />

Update)<br />

<strong>2012</strong>/049<br />

(<strong>Barking</strong> &<br />

Dagenham<br />

Safeguarding<br />

Children <strong>Board</strong><br />

(BDSCB) Annual<br />

Report 2011/12)<br />

<strong>2012</strong>/050<br />

(BHRUT TFA<br />

Composite Plan)<br />

<strong>2012</strong>/051<br />

(Finance Report –<br />

Month 4 (July)<br />

<strong>2012</strong>/13)<br />

<strong>2012</strong>/055<br />

(End of Life Care<br />

Advisory <strong>Board</strong> –<br />

Briefing Paper)<br />

<strong>2012</strong>/056<br />

(Dementia Strategy<br />

– Phase 2)<br />

relation to Winter Plan, including<br />

plans the Cluster is putting in<br />

place to bridge the gap in<br />

available community beds, to be<br />

presented at the <strong>November</strong><br />

<strong>Board</strong> meeting.<br />

Review reasons for delays for<br />

C/S deliveries, by Grade, <strong>and</strong><br />

report back to the <strong>Board</strong> at the<br />

next meeting in <strong>November</strong>.<br />

Ensure there is a timetable for<br />

appropriate Executive Director<br />

representation at Safeguarding<br />

<strong>Board</strong> meetings, across all<br />

Boroughs.<br />

Prepare a list of forthcoming<br />

reports, so the <strong>Board</strong> is aware of<br />

the publication dates for these,<br />

prior to them being issued.<br />

Arrange for the TFA to indicate<br />

the trends on the key<br />

milestones.<br />

Ensure the summary progress in<br />

the Financial Viability section is<br />

aligned to the Finance Report.<br />

Review Capital Programme to<br />

identify priority schemes.<br />

Quality & Safety Committee to<br />

consider the cohort of patients<br />

with long term conditions in<br />

relation to their End of Life Care<br />

<strong>and</strong> provide the <strong>Board</strong> with their<br />

recommendations for addressing<br />

this.<br />

Agree Executive <strong>Trust</strong> Lead for<br />

End of Life Care at the next<br />

Quality & Safety Committee<br />

meeting <strong>and</strong> advise <strong>Board</strong><br />

members.<br />

Attend Integrated Care Coalition<br />

meeting <strong>and</strong> raise <strong>Board</strong>’s<br />

concerns in relation to the<br />

challenge ahead for patients<br />

with Dementia, considering the<br />

AD 7.11.12 7.11.12<br />

JD<br />

JD<br />

NM<br />

DG<br />

7.11.12<br />

7.11.12<br />

30.9.12<br />

30.9.12<br />

7.11.12<br />

7.11.12<br />

Format of plan<br />

has now<br />

changed.<br />

30.9.12<br />

DG/NM 7.11.12 Review has<br />

taken place <strong>and</strong><br />

has been<br />

presented to<br />

the Finance<br />

Committee<br />

CW/AW<br />

CW/AW<br />

7.11.12<br />

7.11.12 7.11.12<br />

AD 6.9.12 6.9.12<br />

<strong>Trust</strong> <strong>Board</strong> Meeting (Part I) 5 September <strong>2012</strong>


Agenda Item Action Deadline<br />

Date<br />

Date<br />

Completed/Upd<br />

ate/<br />

Agenda Item<br />

increasing population numbers.<br />

Agree an Executive<br />

Champion/Lead for<br />

Dementia/Elderly Care <strong>and</strong><br />

advise <strong>Board</strong> members (as<br />

above).<br />

JD 7.11.12 7.11.12<br />

Chairman …………………<br />

Date …………………..<br />

<strong>Trust</strong> <strong>Board</strong> Meeting (Part I) 5 September <strong>2012</strong>


TRUST BOARD MEETING<br />

5 September <strong>2012</strong><br />

<strong>Board</strong> Room, <strong>Trust</strong> Headquarters, Queen’s Hospital<br />

Points <strong>and</strong> Questions raised by members of the Public<br />

at the above <strong>Trust</strong> <strong>Board</strong> meeting<br />

Question:<br />

In reference to the Maternity Services<br />

Update report <strong>and</strong> the transfer of<br />

women to other <strong>Trust</strong>s with the change<br />

in boundaries, Mr Skillman asked if<br />

patient choice was taken into account<br />

when transferring women, as this had<br />

been highlighted when the Survey was<br />

undertaken regarding the closure of<br />

Maternity Services at King George<br />

Hospital (the vast majority of women<br />

had confirmed in the Survey that they<br />

wanted to give birth at KGH). He was<br />

concerned that there would not be any<br />

patient choice whatsoever if the<br />

proposals came to fruition.<br />

Response/Action:<br />

The Chief Executive confirmed that<br />

there would be a choice for women <strong>and</strong><br />

this would be managed by the GPs.<br />

The <strong>Trust</strong> would want women to be<br />

delivering their babies as close to home<br />

as possible, but it needed to be open<br />

<strong>and</strong> honest about its capacity issues, to<br />

ensure it was running a safe service. It<br />

was acknowledged that the proposal did<br />

take away some choice for women.<br />

Mr Skillman raised the point that the<br />

number of deliveries at the <strong>Trust</strong> had<br />

been discussed at the recent Overview<br />

& Scrutiny Committee meeting with<br />

Heather Mullin, as they differed from<br />

the number the <strong>Trust</strong> was reporting<br />

between Queen’s <strong>and</strong> the Midwifery<br />

Led Unit (MLU). Mr Skillman noted that<br />

an escalation plan was in place, but he<br />

wanted confirmation that the <strong>Trust</strong> was<br />

not going backwards, that it had<br />

everything under control, it was not<br />

going to have problems again with the<br />

service <strong>and</strong> that the figures were not<br />

going to change.<br />

Mr Moloney confirmed that for this year<br />

the <strong>Trust</strong> was expecting to deliver just<br />

over 9k <strong>and</strong> the plan for the next<br />

financial year was approximately 8k,<br />

when taking into account activity from<br />

Outer North East London PCTs <strong>and</strong><br />

some women from Essex.<br />

Mr Moloney also confirmed that the<br />

figures were not changing, as Heather<br />

Mullin would have been referring to<br />

KGH not running a maternity service at<br />

all (the <strong>Trust</strong> could deliver 2,500 at<br />

KGH).<br />

<strong>Trust</strong> <strong>Board</strong> Meeting (Part I) 5 September <strong>2012</strong>


Question:<br />

Mr Skillman was pleased to read in the<br />

Telegraph that the Department of<br />

Health was looking to assist some<br />

financially challenged <strong>Trust</strong>s with their<br />

Private Finance Initiatives (PFI’s) <strong>and</strong><br />

wanted to know if anything had been<br />

agreed with BHRUT for this financial<br />

year, or would it be next year.<br />

Mr Skillman mentioned that when<br />

attending outpatients to see a<br />

Consultant, if a follow-up appointment<br />

was required, the patient had to go<br />

back to book this at the desk <strong>and</strong> was<br />

then informed that an appointment<br />

letter would be sent in the post. He<br />

questioned whether appointment cards<br />

could not be re-introduced, which<br />

would not only save posting costs, but<br />

would also be more efficient for the<br />

patient.<br />

Response/Action:<br />

Mr Wood confirmed that BHRUT was<br />

one of the <strong>Trust</strong>s involved <strong>and</strong> the<br />

Department of Health had used<br />

BHRUT’s practices with its PFI partners<br />

to share with other <strong>Trust</strong>s. Most of the<br />

Soft FM contracts were non negotiable,<br />

but some savings had been made on<br />

initiatives led by the <strong>Trust</strong>.<br />

The initial Bond for the PFI could not be<br />

renegotiated, but the <strong>Trust</strong> was working<br />

to achieve as many efficiencies as<br />

possible outside the terms of the<br />

contract.<br />

Mr Wood informed Mr Skillman that it<br />

was worth noting that the PFI had not<br />

just been signed by BHRUT, it had<br />

been agreed by the Strategic Health<br />

Authority, the Department of Health <strong>and</strong><br />

the Treasury.<br />

Mrs Hosein acknowledged that Mr<br />

Skillman was absolutely right <strong>and</strong> this<br />

was part of the outpatient improvement<br />

project that was currently being<br />

undertaken, but due to the <strong>Trust</strong>’s<br />

Patient Administration System (PAS)<br />

<strong>and</strong> how patients were booked, it was<br />

not possible to do this. The <strong>Trust</strong> was<br />

currently installing a new Savience<br />

system (kiosks) for patients to book<br />

themselves in for appointments. It was<br />

acknowledged that the <strong>Trust</strong> currently<br />

generated a lot of unnecessary letters<br />

<strong>and</strong> the new Savience system would<br />

improve this area in the future. Mrs<br />

Hosein asked the public to bear with the<br />

<strong>Trust</strong> in the meantime, as these<br />

improvements involved a great deal of<br />

process change, which would take time<br />

to implement.<br />

Mr Skillman noted that he was pleased<br />

to see in the Finance Report that there<br />

were now vacancy controls in place<br />

<strong>and</strong> recruitment/new posts could only<br />

be approved by the Chief Executive, or<br />

the Director of Transformation.<br />

<strong>Trust</strong> <strong>Board</strong> Meeting (Part I) 5 September <strong>2012</strong>


EXECUTIVE SUMMARY<br />

TITLE:<br />

Update on <strong>Trust</strong> wide CQC action plan<br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

This report outlines the progress to date with the<br />

completion of the <strong>Trust</strong> wide action plan following a<br />

series of unannounced CQC inspections in 2010 <strong>and</strong><br />

2011.<br />

Transformation <strong>Board</strong> ( 17/10/12)<br />

2. DECISION REQUIRED: CATEGORY:<br />

The <strong>Board</strong> is asked to:-<br />

• Agree the formal closure report of the <strong>Trust</strong><br />

wide CQC action plan.<br />

• Recognise the progress since June <strong>2012</strong><br />

• Formally agree the ongoing work required for<br />

the ‘part met’ recommendations with key<br />

performance indicators.<br />

• Agree the transition into business as usual<br />

<strong>and</strong> monitoring process.<br />

N.B.<br />

Please note that live access to the<br />

evidence files will be in place<br />

during the <strong>Board</strong> meeting<br />

CQC registration<br />

Health & safety<br />

Assurance framework<br />

Corporate objectives<br />

AUTHOR/PRESENTER:<br />

Dr M. Gill - Medical Director BHRUT<br />

Donna Kinnair- Director Governance<br />

DATE:<br />

25 October <strong>2012</strong><br />

The PMO/STT office will have 6 PC<br />

terminals available on the morning<br />

of the 7 <strong>November</strong> if <strong>Board</strong><br />

members would like to review any<br />

evidence with colleagues on h<strong>and</strong><br />

to provide navigation <strong>and</strong><br />

assistance.<br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

4. DELIVERABLES<br />

5. KEY PERFORMANCE INDICATORS<br />

AGREED AT : CQC <strong>Trust</strong> project board. DATE: 29 October <strong>2012</strong><br />

REVIEW DATE (if applicable) ___________________________


CQC <strong>Trust</strong>-wide Action Plan<br />

Review <strong>and</strong> Closure Report<br />

OCTOBER <strong>2012</strong><br />

Version: <strong>2012</strong>1028.2<br />

Page 1 |<br />

26-Oct-12


EXECUTIVE SUMMARY<br />

This paper has been developed to reassure the <strong>Trust</strong> <strong>Board</strong> of the progress made in respect<br />

of the <strong>Trust</strong> response to the CQC Investigation report <strong>and</strong> subsequent action plan originally<br />

produced in October <strong>and</strong> <strong>November</strong> 2011.<br />

The paper seeks to reassure the <strong>Board</strong> of the current status of the Action Plan, <strong>and</strong> the<br />

transition to routine business as usual, monitored via normal service reviews.<br />

The <strong>Trust</strong> <strong>Board</strong> is asked to :<br />

• To agree the formal closure of the <strong>Trust</strong>-wide CQC Action Plan,<br />

• To recognise the progress made since <strong>November</strong> 2011.<br />

• To recognise the progress made since June <strong>2012</strong>.<br />

• To formally recognise the need for monitoring <strong>and</strong> implementation of the plan <strong>and</strong> its<br />

recommendations, whilst in transition to ‘Business as Usual’<br />

Page 2 |<br />

26-Oct-12


1.0 PURPOSE<br />

1.1 Background<br />

This report has been produced predominantly for information regarding progress against<br />

agreed actions originally identified by the CQC following their formal investigation report in<br />

October <strong>and</strong> <strong>November</strong> 2011.<br />

The initial CQC assessment indicated that <strong>Barking</strong>, <strong>Havering</strong> <strong>and</strong> Redbridge University<br />

Hospitals NHS <strong>Trust</strong> had a history of poor performance under the previous regulatory<br />

framework. At the time of CQC registration, the <strong>Trust</strong> had a high number of ‘conditions’<br />

placed on it to require improvements in care. A series of unannounced inspections in 2010/11<br />

resulted in some of these being lifted, but also resulted in warning notices being issued to the<br />

trust (in March, June <strong>and</strong> July 2011) on staffing levels <strong>and</strong> maternity care.<br />

The CQC saw some evidence of improvements being made in response to these notices, but<br />

the <strong>Trust</strong>’s overall capacity to respond to the extent <strong>and</strong> level of CQC’s concerns was in<br />

question. Throughout this period, the CQC continued to receive information about poor quality<br />

care from patients <strong>and</strong> the public.<br />

This report will confirm the ‘journey’ the <strong>Trust</strong> has taken; the progress made; the current<br />

status of the report <strong>and</strong> its associated action plans <strong>and</strong> the recommendations requiring further<br />

work. It will also seek to outline the key ‘milestones’ which have been reached, which will<br />

demonstrate the continuous improvement of the organisation in addressing the CQC<br />

recommendations.<br />

1.2 Project Closure Status<br />

The CQC have advised the <strong>Trust</strong> that having reviewed the formal Action Plan, its evidence<br />

<strong>and</strong> supporting documentation, <strong>and</strong> given that the formal investigation has been completed,<br />

future monitoring of compliance would be undertaken as part of the normal routine service<br />

reviews. Hence the formal update report published by the CQC in June <strong>2012</strong>, the monitoring<br />

phase has developed into continued improvement being ‘Business as Usual’.<br />

This report is a project review <strong>and</strong> closure report. The original recommendations have either<br />

been met, or embedded into normal business, or have been superseded by other projects<br />

<strong>and</strong> initiatives which will deliver compliance against the CQC’s essential st<strong>and</strong>ards.<br />

1.3 Summary of Actions required by the <strong>Trust</strong> <strong>Board</strong><br />

The <strong>Board</strong> is asked:<br />

• To agree the formal closure of the <strong>Trust</strong>-wide CQC Action Plan,<br />

• To recognise the progress made since <strong>November</strong> 2011.<br />

• To recognise the progress made since June <strong>2012</strong>.<br />

• To formally recognise the need for monitoring <strong>and</strong> implementation of the plan <strong>and</strong> its<br />

recommendations, whilst in transition to ‘Business as Usual’<br />

2.0 CONTEXT AND BACKGROUND<br />

Following the imposition of registration conditions on the <strong>Trust</strong> in 2010, the CQC’s judgement<br />

was that continuing to tackle poor performance at the trust on a case-by-case basis was not<br />

going to address deep-seated issues around the quality of care at the <strong>Trust</strong>. As a result, the<br />

CQC took the decision to launch a full investigation into the quality of care provided by the<br />

trust at Queen’s Hospital <strong>and</strong> King George Hospital.<br />

Page 3 |<br />

26-Oct-12


On 29 June 2011, a team of CQC inspectors <strong>and</strong> external expert advisors, including experts<br />

in maternity, accident <strong>and</strong> emergency, <strong>and</strong> nursing care, began the investigation on 4 July<br />

2011.<br />

The investigation assessed the systems <strong>and</strong> procedures the <strong>Trust</strong> had in place to ensure that<br />

people are protected against the risk of inappropriate care <strong>and</strong> treatment. The team focused<br />

on three care pathways – maternity, elective vascular surgery, <strong>and</strong> emergency care, <strong>and</strong><br />

examined the trust’s governance <strong>and</strong> management systems.<br />

http://www.cqc.org.uk/sites/default/files/media/reports/RF4_<strong>Barking</strong>_<strong>Havering</strong>_<strong>and</strong>_Redbridge_Universit<br />

y_Hospitals_NHS_<strong>Trust</strong>_RF4QH_Queens_Hospital_20110729.pdf<br />

At the end of October 2011, the CQC published its Investigation Report, containing a total of<br />

75 recommendations, with which BHRUT were required to comply; a further 6<br />

recommendations were added in late <strong>November</strong> 2011. These 81 recommendations are<br />

spread across a number of general categories; strategy, capacity, leadership, <strong>and</strong> some more<br />

specific outcomes, including those in relation to maternity services.<br />

14 themes were identified against which the 81 actions were identified:<br />

1) Respecting <strong>and</strong> involving people<br />

2) Care <strong>and</strong> welfare of people<br />

3) Cooperating with other providers<br />

4) Safeguarding people from abuse<br />

5) Cleanliness <strong>and</strong> infection control<br />

6) Management of Medicines<br />

7) Safety <strong>and</strong> suitability of premises<br />

8) Safety, availability <strong>and</strong> suitability of equipment<br />

9) Staffing <strong>and</strong> supporting workers<br />

10) Assessing <strong>and</strong> monitoring the quality of service provision<br />

11) Complaints<br />

12) Records<br />

13) Leadership<br />

14) Capacity<br />

Upon receipt of the full Investigation Report, the <strong>Trust</strong> developed a <strong>Trust</strong>-wide Action Plan,<br />

detailing all 81 recommendations, <strong>and</strong> began implementing the necessary actions required to<br />

achieve compliance with the CQC essential st<strong>and</strong>ards; along with an identification of officers<br />

<strong>and</strong> clinicians responsible for delivery, <strong>and</strong> the target dates for delivery.<br />

http://aglovale/assets/pdfs/comms/cqcactionplan11.xls<br />

As previously reported to the <strong>Board</strong>, significant progress has been made to the point where in<br />

June <strong>2012</strong>, the CQC revisited the <strong>Trust</strong> <strong>and</strong> further assessed progress made against the<br />

original action plan. Report available at http://aglovale/assets/pdfs/comms/cqcupdatereportjun12.pdf<br />

The <strong>Trust</strong> was encouraged that the CQC had confirmed that of the original 81<br />

recommendations identified:<br />

27 were assessed as MET<br />

48 were assessed as PART MET<br />

6 were assessed as NOT MET<br />

In August <strong>2012</strong>, the newly appointed Medical Director commissioned the Service<br />

Transformation Team to review, re-engage <strong>and</strong> re-evaluate progress against implementation<br />

of the required actions allowing the <strong>Trust</strong> to update the current status of each of the ‘PART<br />

MET’ <strong>and</strong> ‘NOT MET’ recommendations from the CQC Update of July <strong>2012</strong>.<br />

http://aglovale/assets/pdfs/comms/cqcstakeholderupdate250612.pdf<br />

In addition to the review of completeness the Team was asked to:<br />

Page 4 |<br />

26-Oct-12


• Review the Senior Responsible Officers (SROs) to align with the new management<br />

<strong>and</strong> executive structures.<br />

• Ensure the Operational leads are appropriate <strong>and</strong> aligned with the organisational<br />

structures.<br />

• Where appropriate, to develop measurable objectives <strong>and</strong> incorporate into a revised<br />

Action Plan<br />

• Reformat the Action Plan to facilitate improved navigation for users <strong>and</strong> external<br />

stakeholders<br />

• Integrate the evidence inventory to the action plan, improving access to users <strong>and</strong><br />

stakeholders.<br />

• Drafting of a formal response to the internal draft Audit Report.<br />

• This assessment was presented to the Quality <strong>and</strong> Safety Committee on the 16 th October.<br />

• This revised Action Plan was presented to the Transformation <strong>Board</strong> on the 17 th October.<br />

This work has been undertaken in conjunction with the Internal Audit report conducted by<br />

Park Hill in August <strong>2012</strong>. A formal response to this report is due to be presented at the next<br />

Audit Committee.<br />

3.0 EXCEPTION REPORT<br />

The Exception report below highlights that 6 of the original 81 recommendations are<br />

assessed as PART MET. This recognises the timescales involved in completion, or the<br />

strategic context by which it is influenced.<br />

The current <strong>Trust</strong> assessment finds that none of the original 81 recommendations remains<br />

‘NOT MET’<br />

The action plan <strong>and</strong> evidence log for this are attached at Appendix 2. Where sufficient<br />

evidence of progress has been made, continued progress continues via ‘Business as Usual’<br />

with Clinical Directors being accountable for delivery <strong>and</strong> achievement on a routine basis.<br />

Where appropriate this is monitored via the <strong>Trust</strong> Audit Programme, <strong>and</strong> clinical governance<br />

structures.<br />

4.0 THE WAY FORWARD<br />

As a result of the work to meet the recommendations of the original action plan, there have<br />

been significant moves to establish good practice <strong>and</strong> embed this in the routine workings of<br />

the <strong>Trust</strong>.<br />

The evidence <strong>and</strong> supporting documentation will be migrated as appropriate to a web based<br />

page. Evidence is currently restricted to those individuals who can access shared secured<br />

drives on the <strong>Trust</strong> system.<br />

These include :<br />

• New Senior Management Team<br />

• New Clinical Leadership structures in place<br />

• Revised Clinical Governance Structure<br />

• Robust Audit Programme<br />

• Improved Communications (Internal <strong>and</strong> External)<br />

• Revised Performance Management arrangements.<br />

• Use of shared drives for the archiving <strong>and</strong> sharing of evidence.<br />

Other helpful documents can be found at :<br />

Page 5 |<br />

26-Oct-12


http://aglovale/assets/pdfs/comms/cqcrecommendationactionplansept12.pdf (Draft)<br />

http://aglovale/assets/pdfs/comms/cqccomp5.pdf (Radiology)<br />

http://aglovale/assets/pdfs/comms/cqccomp4.pdf (Maternity)<br />

http://aglovale/assets/pdfs/comms/cqccomp2.pdf (EU)<br />

http://aglovale/assets/pdfs/comms/cqccomp1.pdf (KGH)<br />

http://www.cqc.org.uk/directory/rf4qh<br />

Page 6 |<br />

26-Oct-12


APPENDIX 1 ‐ CQC ACTION PLAN – EXCEPTION REPORT<br />

(OCTOBER <strong>2012</strong>)<br />

Theme/Outcome CQC Recommendation CQC Observation (June <strong>2012</strong>) Progress Executive Lead Current Status<br />

LEADERSHIP 21. Put a cultural change Building blocks are in place – ‘Big Conversation’ The <strong>Trust</strong> has submitted a bid to NHS Director of Nursing PART MET<br />

programme in place across the underway with staff engagement group set up <strong>and</strong> London for some Organisational<br />

organisation. The programme<br />

of change needs to engage all<br />

staff so that the trust can<br />

clearly articulate what the<br />

expectations are of individual<br />

staff, what a high performing<br />

several staff engagement meetings held.<br />

Executive team now dedicate one day a month to<br />

take on a front line role in order to increase<br />

underst<strong>and</strong>ing of care challenges <strong>and</strong> improve<br />

management visibility <strong>and</strong> accessibility.<br />

Conflict resolution training is being delivered for<br />

Development funding.<br />

Funding has been allocated <strong>and</strong> the<br />

<strong>Trust</strong> is currently identifying suitable<br />

development support to take this<br />

work forward.<br />

The <strong>Trust</strong> is currently working with a<br />

organisation feels like to work managers; BHRUT Code being reviewed with range of external consultants<br />

in <strong>and</strong> be clear of the penalties significant staff input, including seeking clear including:<br />

for staff they should not examples of acceptable <strong>and</strong> unacceptable practice. QFI who run a leadership programme<br />

behave appropriately.<br />

Consultants are carrying out an analysis of team<br />

working <strong>and</strong> practice in women’s services<br />

for CD’s, Clinical Fellows <strong>and</strong> senior<br />

leads, supported <strong>and</strong> funded by NHS<br />

London.<br />

Management Information <strong>and</strong><br />

Development (MIAD) for Consultants<br />

Tavistock Consulting working with<br />

maternity<br />

McKinsey to embed sustainable<br />

patient flow through the <strong>Trust</strong><br />

Ernst <strong>and</strong> Young to support financial<br />

sustainability <strong>and</strong> governance<br />

Transformation Team has been<br />

established <strong>and</strong> is working across the<br />

<strong>Trust</strong> to develop <strong>and</strong> implement<br />

leadership skills locally in multiprofessional<br />

groups.<br />

ASSESSING &<br />

MONITORING<br />

75. Ensure that it has<br />

appropriate levels of staff in<br />

place to allow its governance<br />

systems to function effectively<br />

<strong>and</strong> that these staff are<br />

embedding appropriate<br />

systems in clinical services.<br />

Following the review of governance, suitable staff<br />

have been identified to ensure its recommendations<br />

are properly implemented. As above, proof of<br />

success will be seen through delivery.<br />

Associate Medical Director for Clinical<br />

Governance now in post (3 P.A.)<br />

Business case for Patient Safety<br />

Managers covering Clinical<br />

Directorates in progress following<br />

approval by the Q&S Committee.<br />

Medical Director<br />

PART MET<br />

CARE & WELFARE 29. Develop a culture where The appraisal process for emergency department An additional patient information Medical Director PART MET<br />

Page 7 |<br />

26-Oct-12


‐ EMERGENCY<br />

CARE<br />

SAFETY &<br />

SUITABILITY OF<br />

PREMISES<br />

everyone feels empowered to<br />

challenge episodes of variable<br />

or poor practice, including<br />

regular monitoring of practice<br />

<strong>and</strong> feedback <strong>and</strong> learning<br />

opportunities for staff.<br />

53. Ensure that appropriate<br />

waiting facilities are available<br />

for patients <strong>and</strong> relatives in<br />

the urgent care centre.<br />

staff has been reviewed; all staff in this area have<br />

personal development plans. Hourly vital signs<br />

checks are underway <strong>and</strong> monthly spot audits are<br />

being carried out to ensure staff feel empowered to<br />

challenge poor performance. Patient satisfaction<br />

surveys are in place <strong>and</strong> staff are reminded of the<br />

importance of challenging poor practice as a<br />

st<strong>and</strong>ing item on A&E team meetings. Audit results<br />

do not yet support the processes that have been put<br />

in place.<br />

As above, these waiting facilities are being reviewed<br />

as part of the Health for NEL programme.<br />

leaflet explaining the process of the<br />

ED is being drafted which will have a<br />

section to write who the patients<br />

named nurse <strong>and</strong> doctor are. There<br />

will be a feedback area on this leaflet<br />

to enable patients to anonymously<br />

write any feedback both positive <strong>and</strong><br />

negative. This will enable direct<br />

feedback to the staff that cared for<br />

the patient. It is hoped that this will<br />

provide more audit results as the<br />

feedback mechanism will be directly<br />

accessible for patients.<br />

Trend information on complaints is<br />

being collated to further support<br />

feedback to all staff.<br />

Customer service competency<br />

checklist is being developed to<br />

provide staff with additional training<br />

to support improvements in<br />

communication skills.<br />

Peer challenge on poor practice<br />

remains in place.<br />

The current waiting facilities are<br />

deemed sufficient for the needs of<br />

patients currently.<br />

Investment is currently underway to<br />

extend the Rapid Assessment &<br />

Treatment areas within the<br />

department. This initiative will deliver<br />

shorter waiting times <strong>and</strong> improve<br />

the patient experience. Work is due<br />

to be completed before Christmas.<br />

Patient experience will be measured<br />

via the annual patient surveys, <strong>and</strong> in<br />

house paper <strong>and</strong> electronic solutions.<br />

Director of Nursing<br />

Divisional Manager<br />

(Estates, Facilities &<br />

Capital)<br />

PART MET<br />

RECORDS 80. Improve its systems for The <strong>Trust</strong>’s Medical Records Committee has been re‐ The development of the eH<strong>and</strong>over Chief Operating PART MET<br />

Page 8 |<br />

26-Oct-12


RECORDS<br />

records management to<br />

ensure that notes can be<br />

retrieved effectively <strong>and</strong><br />

expediently, <strong>and</strong> reduce the<br />

risks associated with multiple<br />

sets of temporary notes <strong>and</strong><br />

poor data h<strong>and</strong>ling.<br />

81. Develop integrated patient<br />

administration<br />

<strong>and</strong><br />

information systems to ensure<br />

that, where ever a patient is<br />

being treated within the trust,<br />

their full healthcare history<br />

can be accessed by all staff.<br />

established with new Terms of Reference; training<br />

levels for healthcare professionals are discussed at<br />

this Committee on a regular basis. Weekend<br />

transport for transfer of notes has been<br />

reintroduced <strong>and</strong> a nursing documentation booklet<br />

has been piloted across several wards <strong>and</strong> will be<br />

fully implemented by the autumn.<br />

A procurement process is underway to introduce an<br />

effective system to enable access to patient<br />

histories. Funding challenges have slowed<br />

introducing of a full electronic patient record.<br />

system will provide a <strong>Trust</strong>wide<br />

joined up reference database for the<br />

use in patient care.<br />

A new PAS is being commissioned in<br />

2013 for implementation which will<br />

improve the availability of Patient<br />

records <strong>and</strong> reduce the incidence of<br />

Temporary folders.<br />

It is anticipated that patients will be<br />

migrated onto one hospital number<br />

covered by barcode scanning options<br />

as part of the roll‐out <strong>and</strong><br />

implementation.<br />

Decision on Strategic Capital Funding<br />

for PAS Replacement by NHS London<br />

immanent<br />

A new PAS is being commissioned in<br />

2013 for implementation which will<br />

improve the availability of Patient<br />

records <strong>and</strong> reduce the incidence of<br />

Temporary folders.<br />

It is anticipated that patients will be<br />

migrated onto one hospital number<br />

covered by barcode scanning options<br />

as part of the roll‐out <strong>and</strong><br />

implementation.<br />

Decision on Strategic Capital Funding<br />

by NHS London immanent.<br />

Officer<br />

<strong>and</strong><br />

Director of<br />

Performance &<br />

Planning<br />

Director of<br />

Performance &<br />

Planning<br />

PART MET<br />

Page 9 |<br />

26-Oct-12


APPENDIX 2 ‐ CQC ACTION PLAN – OCTOBER ACTION PLAN FOR<br />

PART MET AND NOT MET RECOMMENDATIONS.<br />

Page 10 |<br />

26-Oct-12


CQC Update Report<br />

<strong>2012</strong><br />

Theme CQC Recommendation CQC Observation (June <strong>2012</strong>) Further Organisational Progress Operational<br />

Lead<br />

LEADERSHIP 20. Ensure its board assures<br />

Averil<br />

itself that it has the right<br />

Dongworth<br />

leaders <strong>and</strong> managers in place<br />

to develop the trust <strong>and</strong><br />

improve the quality of services.<br />

LEADERSHIP 21. Put a cultural change<br />

programme in place across the<br />

organisation. The programme of<br />

change needs to engage all staff<br />

so that the trust can clearly<br />

articulate what the expectations<br />

are of individual staff, what a<br />

high performing organisation<br />

feels like to work in <strong>and</strong> be clear<br />

of the penalties for staff they<br />

should not behave<br />

appropriately.<br />

The <strong>Trust</strong> <strong>Board</strong> has completed its<br />

review of the Executive Team,<br />

leading to appointments of chief<br />

operating officer <strong>and</strong> director of<br />

transformation.<br />

A new management structure is in<br />

place based around clinical<br />

directorates, led by clinical<br />

directors <strong>and</strong> associate directors.<br />

Recent information indicates that<br />

there are several changes being<br />

made to senior management at<br />

the <strong>Trust</strong> <strong>and</strong> the impact of this<br />

will need to be assessed.<br />

Significant staff engagement<br />

process is underway to consult on<br />

wider implementation of the new<br />

structure.<br />

Building blocks are in place – ‘Big<br />

Conversation’ underway with staff<br />

engagement group set up <strong>and</strong><br />

several staff engagement meetings<br />

held.<br />

Executive team now dedicate one<br />

day a month to take on a front line<br />

role in order to increase<br />

underst<strong>and</strong>ing of care challenges<br />

<strong>and</strong> improve management visibility<br />

<strong>and</strong> accessibility.<br />

Conflict resolution training is being<br />

delivered for managers; BHRUT<br />

Code being reviewed with<br />

significant staff input, including<br />

seeking clear examples of<br />

The following appointments have been made to the <strong>Board</strong>:<br />

1. Director of Operations<br />

2. Director of Transformation<br />

3. Director of Governance<br />

4. New Medical Director appointed<br />

5. Director of Nursing appointed<br />

6. New Director of Finance<br />

Clinical Directors <strong>and</strong> Associate Directors now in post.<br />

Consultation on going relating to the final supporting<br />

management structure.<br />

Management structure corporately is now in place with Associate<br />

Medical Directors <strong>and</strong> Deputy Nurse Directors Appointed.<br />

Consultation now ended <strong>and</strong> appointments <strong>and</strong> structure will be<br />

put in place during June '12.<br />

Changes at senior level in June <strong>2012</strong> have now posed questions<br />

about the possibility of delivering as anticipated.<br />

The <strong>Trust</strong> has submitted a bid to NHS London for some<br />

Organisational Development funding.<br />

(JM to share copy of bid)<br />

Donna Kinnear<br />

Julie Meddings<br />

<strong>Trust</strong> RAG<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

PART MET<br />

BUSINESS<br />

AS USUAL<br />

Page 1 of 22


CQC Update Report<br />

<strong>2012</strong><br />

acceptable <strong>and</strong> unacceptable<br />

practice.<br />

Consultants are carrying out an<br />

analysis of team working <strong>and</strong><br />

practice in women’s services<br />

LEADERSHIP<br />

LEADERSHIP<br />

22. Develop a culture of whole<br />

systems working across all<br />

divisions to reduce ‘silo’<br />

working <strong>and</strong> the combative<br />

nature of bed management.<br />

24. Explore how to improve its<br />

communications both internally<br />

<strong>and</strong> externally so that<br />

perceptions of poor<br />

communication can be reduced.<br />

Weekly operations meeting, with<br />

directorate managers, is now in<br />

place; multidisciplinary working<br />

being pursued as part of RESET<br />

project. New bed management<br />

structures is in place, with all<br />

divisions <strong>and</strong> specialities<br />

attending; Matrons working<br />

together to ensure effective<br />

discharge process.<br />

Internally, significant staff<br />

engagement is underway;<br />

externally, meetings have taken<br />

place with LINks <strong>and</strong> Improving<br />

Patient Experience Group (IPEG);<br />

stakeholder briefings being<br />

disseminated; stakeholder event<br />

with commissioners, CQC, LINks,<br />

IPEG <strong>and</strong> local authorities took<br />

place in May.<br />

Some feedback to CQC suggests<br />

there are further improvements<br />

that could be made, particularly in<br />

terms of engagement with MPs.<br />

There has been significant progress in a <strong>Trust</strong>‐wide response to<br />

patient pathways. Initially focussing on Emergency admissions<br />

<strong>and</strong> pathways<br />

Daily Bed <strong>and</strong> Site team meetings held (0830;1200;1500) to<br />

ensure patient flow <strong>and</strong> effective discharge management, Issue<br />

Log kept daily <strong>and</strong> updated at each meeting. Performance tracker<br />

updated daily for the current week. Senior representatives<br />

available from all divisions, escalation protocols allow for this to<br />

be supplemented by executive input, community <strong>and</strong> LAS<br />

representatives<br />

Ward sponsor programme in place to support escalation <strong>and</strong><br />

discharge management. Intensive support is provided by the<br />

Service Transformation Team, <strong>and</strong> QFI.<br />

Performance Meetings weekly with CDs <strong>and</strong> CEO, Dir. of<br />

Transformation.<br />

Daily multidisciplinary JONAH meetings, complex discharge<br />

meetings, cross buffer meeting <strong>and</strong> Top 25 delays all support this.<br />

Dorothy Hosein<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

This is now monitored via normal <strong>Trust</strong> Operations. Imogen Shilito MET<br />

BUSINESS<br />

AS USUAL<br />

Page 2 of 22


CQC Update Report<br />

<strong>2012</strong><br />

ASSESSING &<br />

MONITORING<br />

70. Ensure that it has adequate<br />

systems of governance to<br />

promote high quality care for<br />

patients <strong>and</strong> to deal with<br />

concerns about performance in<br />

an effective <strong>and</strong> timely manner.<br />

Clinical <strong>and</strong> committee structures<br />

have been reviewed <strong>and</strong> a new<br />

Clinical Governance Structure has<br />

recently been considered by the<br />

<strong>Trust</strong>’s <strong>Board</strong>.<br />

Exp<strong>and</strong>ed central data collection<br />

for the Quality <strong>and</strong> Safety<br />

Committee has been proposed. A<br />

central monitoring <strong>and</strong> evidence<br />

database has been introduced for<br />

Serious Incidents, with <strong>Trust</strong>‐wide<br />

audits being introduced <strong>and</strong> KPIs<br />

introduced for reporting <strong>and</strong><br />

completion of investigations. A<br />

web‐based incident reporting<br />

system is being introduced across<br />

the <strong>Trust</strong> after a pilot in maternity.<br />

• All Clinical Directorates have clinical governance<br />

meetings which feed into the Quality <strong>and</strong> Safety<br />

Committee structure.<br />

• Dashboards developed for Quality KPI reports.<br />

• Rolling risk reviews in place for Q&S Committee<br />

• Action Plan monitoring in place.<br />

• Snapshot Audits underway<br />

• Web‐based tracking system in place with on going<br />

training at Induction.<br />

Pam Strange<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

ASSESSING &<br />

MONITORING<br />

72. Carry out a comprehensive<br />

review of all corporate <strong>and</strong><br />

clinical governance systems<br />

across the organisation to<br />

ensure that effective <strong>and</strong><br />

streamlined systems <strong>and</strong><br />

reporting structures are in place<br />

to provide robust assurance to<br />

the board.<br />

Clinical <strong>and</strong> committee structures<br />

have been reviewed <strong>and</strong> a new<br />

Clinical Governance Structure has<br />

recently been considered by the<br />

<strong>Trust</strong>’s <strong>Board</strong>.<br />

A complete review of <strong>Trust</strong><br />

corporate committees has been<br />

completed <strong>and</strong> was recently put to<br />

the <strong>Trust</strong> <strong>Board</strong>. A complete<br />

review of maternity clinical<br />

governance was completed by<br />

October 2011 to ensure full<br />

integration with the <strong>Trust</strong>’s main<br />

governance structures. The review<br />

also led to Divisional managers<br />

taking on responsibility for alerting<br />

clinical governance teams to all<br />

external quality <strong>and</strong> safety<br />

recommendations (reinforced<br />

through stringent audit <strong>and</strong><br />

• New Director of Governance <strong>and</strong> Special Projects in<br />

post (September <strong>2012</strong>)<br />

• CDs Governance meetings supported by Facilitators.<br />

• SI reviews embedded in performance structures<br />

• QIPP programme supported by QIAs (Quality Impact<br />

Assessments) within a formalised governance structure.<br />

Averil<br />

Dongworth<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 3 of 22


CQC Update Report<br />

<strong>2012</strong><br />

reporting), with regular reporting<br />

between HR <strong>and</strong> Clinical<br />

Governance to ensure joint<br />

management of patient safety<br />

issues.<br />

ASSESSING &<br />

MONITORING<br />

73. Ensure that it has systems in<br />

place that allow effective<br />

sharing <strong>and</strong> learning across the<br />

whole organisation.<br />

Existing guidance on learning from<br />

serious incidents has been<br />

reviewed <strong>and</strong> KPIs for<br />

implementation have been<br />

introduced. A bi‐monthly ‘Lessons<br />

Learned’ group meets to generate<br />

shared learning. This includes<br />

using the content of Ombudsman<br />

action plans to ensure learning<br />

points are appropriately extracted<br />

<strong>and</strong> shared. A rolling programme<br />

of articles in the Link is supporting<br />

learning. Directorate <strong>Board</strong>s now<br />

review Serious Incident reports<br />

<strong>and</strong> action plans to ensure timely<br />

implementation.<br />

Clinical Directors are sent details<br />

of each relevant Serious Incident<br />

<strong>and</strong> these are agenda items for<br />

directorate clinical governance<br />

meetings until they are responded<br />

to in a suitable way.<br />

This recommendation will only be<br />

fully met when success can be<br />

demonstrated over time. CQC <strong>and</strong><br />

other stakeholders not only expect<br />

to see evidence that Serious<br />

Incidents are being dealt with<br />

internally, but also to see<br />

commissioners <strong>and</strong> other external<br />

organisations being informed<br />

when relevant.<br />

• All closed SIs are available on the <strong>Trust</strong> intranet.<br />

• Clinical Directorate Governance leads review Sis <strong>and</strong><br />

other incidents for learning.<br />

• Clinical Governance is a core topic on all monthly<br />

meeting agendas.<br />

Pam Strange<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 4 of 22


CQC Update Report<br />

<strong>2012</strong><br />

ASSESSING &<br />

MONITORING<br />

74. Ensure that the incident<br />

reporting system for the whole<br />

trust is operating effectively <strong>and</strong><br />

all staff are learning from<br />

incidents rather than simply<br />

reporting incidents.<br />

As noted above, a web‐based<br />

incident reporting system is being<br />

introduced across the <strong>Trust</strong> after a<br />

pilot in maternity. If the proposed<br />

clinical governance structure is<br />

introduced as planned, directorate<br />

boards will take on responsibility<br />

for regular reviews of learning<br />

from incidents. Learning from<br />

incidents is now integrated into<br />

the ward staff meeting structure,<br />

<strong>and</strong> better structures have been<br />

introduced to ensure learning is<br />

shared between staff across<br />

divisions. Again, this will need to<br />

be demonstrated over time.<br />

• All closed SIs are available on the <strong>Trust</strong> intranet.<br />

• Clinical Directorate Governance leads review Sis <strong>and</strong><br />

other incidents for learning.<br />

• Clinical Governance is a core topic on all monthly<br />

meeting agendas.<br />

Pam Strange<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

ASSESSING &<br />

MONITORING<br />

75. Ensure that it has<br />

appropriate levels of staff in<br />

place to allow its governance<br />

systems to function effectively<br />

<strong>and</strong> that these staff are<br />

embedding appropriate systems<br />

in clinical services.<br />

Following the review of<br />

governance, suitable staff have<br />

been identified to ensure its<br />

recommendations are properly<br />

implemented. As above, proof of<br />

success will be seen through<br />

delivery.<br />

• Associate Medical Director for Clinical Governance now<br />

in post (3 P.A.)<br />

• Business case for Patient Safety Managers covering<br />

Clinical Directorates in progress following approval by<br />

the Q&S Committee.<br />

Pam Strange<br />

PART MET<br />

STRATEGY<br />

1. The <strong>Trust</strong>, in conjunction with<br />

NHS London, should seek<br />

appropriate external expertise<br />

to support a programme of<br />

organisational change <strong>and</strong><br />

service improvement.<br />

The <strong>Trust</strong> has introduced 10<br />

clinical fellows <strong>and</strong> four midwifery<br />

clinical fellows as part of a clinical<br />

leadership <strong>and</strong> engagement<br />

programme, supported by NHS<br />

London. Commissioners are<br />

offering support at executive level<br />

in the development of the <strong>Trust</strong>’s<br />

programme management board to<br />

coordinate the transformation<br />

programme. Health for NEL, Skills<br />

for Health, <strong>and</strong> the RESET<br />

McKinsey Consultancy (RESET);<br />

Ernst & Young (QIPP/CIP);<br />

Averil<br />

Dongworth<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 5 of 22


CQC Update Report<br />

<strong>2012</strong><br />

programme in A&E are evidence of<br />

the <strong>Trust</strong>’s willingness to engage<br />

external support.<br />

STRATEGY<br />

2. The <strong>Trust</strong>, in conjunction with<br />

its commissioners <strong>and</strong> other<br />

partners, should identify <strong>and</strong><br />

implement plans to secure a<br />

long term solution to reduce<br />

over capacity at Queen’s<br />

Hospital.<br />

The Health for NEL proposals <strong>and</strong><br />

estates reconfiguration plan for<br />

the <strong>Trust</strong> should see dem<strong>and</strong><br />

reduce significantly over the next<br />

two years to address capacity<br />

issues. This includes seeing<br />

dem<strong>and</strong> on maternity fall by 15‐<br />

20% (between 1,500 <strong>and</strong> 2,000<br />

births a year) by April 2013<br />

through effective use of<br />

alternative maternity resources in<br />

North East London. Success<br />

depends on partnership working<br />

<strong>and</strong> on going commissioner<br />

engagement, including the role of<br />

primary care in making sure that<br />

people are aware of the treatment<br />

choices open to them.<br />

Project Teams now in place to formulate project briefs <strong>and</strong><br />

manage process to formal Business Case submission.<br />

Some schemes more advanced <strong>and</strong> ready for start on site of<br />

works ie MLU.<br />

April '12 meetings with Estates to discuss extent of plan <strong>and</strong><br />

proposals, which will help inform business case.<br />

Outline Business Case (OBC) being prepared for submission to<br />

<strong>Trust</strong> <strong>Board</strong> beginning of August <strong>and</strong> SHA CIC Sept.<br />

As part of the Health4Nel programme, quarterly meetings have<br />

been held with local authority CX's for some time.<br />

During transition to CCG's these will be wound down, <strong>and</strong> initial<br />

forums have been held with CCG's; these may become timetabled<br />

more regularly in due course.<br />

Options Appraisal recommendations ‐ relating to configuration of<br />

ED ‐ due to be submitted as part of OBC to <strong>Trust</strong> <strong>Board</strong> in Jul '12;<br />

which will be referred to commissioners before month end.<br />

This will be accompanied by discussions with planning providers<br />

<strong>and</strong> PFI, due to potential impact of proposals.<br />

Averil<br />

Dongworth<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

STRATEGY<br />

3. Improve the flow of patients<br />

not only in the emergency<br />

department, but across the<br />

whole hospital to ensure that<br />

processes that do not add value<br />

are removed <strong>and</strong> patients are<br />

seen <strong>and</strong> treated in a timely<br />

fashion.<br />

A range of work is underway to<br />

address this – bed mapping,<br />

revised length of stay, reviews of<br />

decisions to admit, care pathways<br />

in place for emergency <strong>and</strong><br />

gynaecology care.<br />

The RESET programme in A&E is<br />

designed to ensure stronger<br />

visibility <strong>and</strong> accountability of care<br />

Build could take up to 18 months from decision made. This is only<br />

an indicative timescale, which will be confirmed once option<br />

agreed.<br />

Length of S Work stream formed. Terms of reference agreed. 2<br />

bed modelling <strong>papers</strong> presented <strong>and</strong> discussed at Transformation<br />

<strong>Board</strong>.<br />

• A&E Escalation process being developed. This will support<br />

the timeliness of review <strong>and</strong> decision making by specialist<br />

team, <strong>and</strong> improve patients flow.<br />

• Further work has commenced via the Theatres work stream<br />

to improve utilisation of Theatre capacity, which include<br />

Gynaecology.<br />

Dorothy Hosein<br />

Shelagh Smith<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 6 of 22


CQC Update Report<br />

<strong>2012</strong><br />

pathways throughout the hospital,<br />

from admission to discharge.<br />

Progress in this will be carefully<br />

monitored both within the <strong>Trust</strong><br />

(including at Executive <strong>and</strong> <strong>Board</strong><br />

level) <strong>and</strong> by external partners.<br />

• Patient Improvement Programme (PIP)<br />

• Discharge Jonah rolled out in all wards.<br />

• Top delays meetings every Tuesday <strong>and</strong> Thursday at 11h30<br />

reviewing reasons for patient delays.<br />

• Daily Operational Jonah meetings occurring with matrons<br />

<strong>and</strong> senior nursing staff to review bed position <strong>and</strong> delays.<br />

• Now linked with RESET project work stream 3: Improving<br />

continuity of care <strong>and</strong> discharge rate in MAU.<br />

• Now linked with RESET project work stream 5: Pre‐11am<br />

Discharges<br />

• Now linked with RESET project work stream 7: Effective Care<br />

for Elderly Patients.<br />

EQUIPMENT<br />

CLEANLINESS<br />

CLEANLINESS<br />

59. Develop as part of its<br />

cultural change programme<br />

people’s sense of responsibility<br />

to take positive action to ensure<br />

that clinical areas are suitably<br />

equipped to provide safe<br />

patient care.<br />

45. Ensure that all equipment<br />

<strong>and</strong> disposable products are<br />

stored appropriately.<br />

47. Ensure that staff are not<br />

posing an increased risk to<br />

patients from cross infection.<br />

The trust should take any<br />

necessary steps to ensure that<br />

staff can store personal<br />

This will be audited by monitoring<br />

complaints on availability of<br />

equipment <strong>and</strong> regular equipment<br />

audits; a business case may be<br />

considered for a dedicated medical<br />

devices coordinator / trainer if the<br />

need is firmly identified. CQC’s<br />

inspections suggest this remains a<br />

serious issue that needs to be<br />

addressed.<br />

Ward managers have completed<br />

risk assessments of equipment<br />

management <strong>and</strong> storage facilities.<br />

A new <strong>Trust</strong> environment /<br />

equipment disposal policy is in<br />

place. Weekly walkabouts with<br />

facilities <strong>and</strong> estates have been<br />

implemented <strong>and</strong> an action log is<br />

in place.<br />

The staff uniform <strong>and</strong> dress code<br />

policy is being reviewed to ensure<br />

st<strong>and</strong>ards are understood <strong>and</strong><br />

remedial actions are available. An<br />

infection control annual plan is in<br />

place <strong>and</strong> is reported against to<br />

• Equipment deficits are monitored via the Environmental<br />

audits utilised throughout the organisation. There has been<br />

a re‐launch of the Medical equipment policy (hyperlink).<br />

http://aglovale/assets/pdfs/governance/policymedicaldevices.pdf<br />

• Equipment issues are now reported thematically via the<br />

Complaints process. This is reported <strong>and</strong> monitored via the<br />

Patient Experience structures.<br />

• Environmental audits utilised throughout the organisation.<br />

Additional near ward storage is being utilised where<br />

appropriate. Ward stock levels are being reviewed as part of<br />

the CIP <strong>and</strong> procurement work streams, <strong>and</strong> consideration is<br />

being given to a ‘neutral warehouse’ solution<br />

• The Staff Uniform <strong>and</strong> dress policy has been revised <strong>and</strong><br />

ratified.<br />

Judith Douglas<br />

Gary Etheridge<br />

Judith Douglas<br />

Pam Strange<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 7 of 22


CQC Update Report<br />

<strong>2012</strong><br />

COMPLAINTS<br />

property as necessary.<br />

76. Continue to develop <strong>and</strong><br />

improve its complaints h<strong>and</strong>ling<br />

systems to ensure that<br />

complaints are responded to<br />

fully <strong>and</strong> in a timely manner.<br />

Infection Control Committee every<br />

other month.<br />

A review of outst<strong>and</strong>ing<br />

Ombudsman complaints has taken<br />

place; a dedicated manager has<br />

been appointed to follow up<br />

compliance with action plans or to<br />

report non‐compliance to the<br />

Director of Nursing. Complaint<br />

numbers <strong>and</strong> trends are reported<br />

to the Quality <strong>and</strong> Safety<br />

Committee. PALS processes have<br />

been reviewed to try to address<br />

patient concerns at an earlier<br />

stage. CQC is aware that the <strong>Trust</strong><br />

has seen a significant increase in<br />

complaint numbers since the<br />

investigation was published last<br />

year; as a result, while the<br />

underpinning systems have been<br />

improved, they are struggling to<br />

cope with an unprecedented surge<br />

in numbers.<br />

Sept <strong>2012</strong> – Interim Complaints <strong>and</strong> PALS manager appointed.<br />

Key priorities identified:<br />

• Weekly review of open complaints <strong>and</strong> associated<br />

timescales<br />

• Weekly look ahead trends <strong>and</strong> priorities<br />

• Working on resolving <strong>and</strong> clearing reactivated<br />

complaints<br />

• Written investigations of all complaints produced <strong>and</strong><br />

ratified in new complaints policy (can we attached the<br />

policy please)<br />

• Produced <strong>and</strong> ratified new complaints policy<br />

• Clarified <strong>and</strong> ratified the complaint h<strong>and</strong>ling procedures<br />

• Core complaint team <strong>and</strong> divisions working jointly<br />

• Monthly briefing paper sent to commissioners<br />

Gary Etheridge<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

COMPLAINTS<br />

77. Develop <strong>and</strong> support staff to<br />

ensure that open<br />

Transparent investigations take<br />

place, that complainants are<br />

involved as necessary <strong>and</strong> that<br />

culturally complaints are seen<br />

as opportunities to learn <strong>and</strong><br />

improve the quality<br />

of care.<br />

NHS London has supported the<br />

<strong>Trust</strong> to undertake a root cause<br />

analysis training campaign for<br />

senior management to ensure the<br />

importance of timely investigation<br />

of complaints is fully understood.<br />

A report of trends <strong>and</strong> themes<br />

aggregated across the <strong>Trust</strong> is<br />

reported every other month,<br />

including identification of trends<br />

<strong>and</strong> hotspots.<br />

• Quarterly patient experience report, which triangulates<br />

all patient experience issues reviewed by <strong>Trust</strong> <strong>Board</strong><br />

• More robust action planning process is under<br />

development. This will enable review <strong>and</strong> trend<br />

identification to implement changes in systems <strong>and</strong><br />

practice<br />

• ‘Learning lessons’ group chaired by Asst Dir. Of Nursing<br />

• Work in progress to review the support material that<br />

Divisions use to investigate complains this will ensure<br />

that we are following best practice.<br />

• Occupational Health support available to staff in the<br />

investigation process<br />

Gary Etheridge<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

COMPLAINTS 78. Ensure that any staff A revised policy has been drafted • The revised policy has been ratified <strong>and</strong> is now in place, Any Gary Etheridge MET<br />

Page 8 of 22


CQC Update Report<br />

<strong>2012</strong><br />

identified in a complaint are<br />

involved in resolving the<br />

complaint <strong>and</strong> the resulting<br />

learning, but where there is a<br />

complaint about an individual<br />

there is appropriate separation<br />

of the investigation from the<br />

individual.<br />

<strong>and</strong> is awaiting senior<br />

management approval; it is<br />

currently available to staff but will<br />

only be considered on its way to<br />

being met when it is implemented<br />

<strong>and</strong> progress audited.<br />

member of staff who is named in a complaint will be given<br />

access to the complaint. The <strong>Trust</strong> is also developing support<br />

mechanisms to support members of staff who have been<br />

sighted in a complaint. This work is being implemented by<br />

the core complaints team in collaboration with the Divisional<br />

teams.<br />

BUSINESS<br />

AS USUAL<br />

COMPLAINTS 79. Develop its reporting<br />

mechanisms to ensure that the<br />

board are fully informed of all<br />

complaints, that detailed<br />

trend analysis takes place <strong>and</strong><br />

that the board can assure itself<br />

that learning is taking place, <strong>and</strong><br />

repetition of themes is reduced.<br />

The <strong>Trust</strong> Executive Committee<br />

<strong>and</strong> <strong>Board</strong> now receive a monthly<br />

complaints<br />

analysis; reporting is discussed at<br />

the bimonthly Quality <strong>and</strong> Safety<br />

Committee. The Patient<br />

Experience report to the Quality<br />

<strong>and</strong> Safety Committee includes a<br />

full analysis by directorate <strong>and</strong><br />

highlights key issues.<br />

Reporting began in April <strong>2012</strong><br />

• Briefing report sent to commissioners <strong>and</strong> Quality Safety<br />

committee.<br />

• Key Non executives board members identified as Patient<br />

champions who sit on the Quality <strong>and</strong> safety committee <strong>and</strong><br />

IPEG<br />

• Monthly Complaints <strong>and</strong> patient experience to <strong>Trust</strong> <strong>Board</strong><br />

monthly<br />

Gary Etheridge<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

CO‐OPERATION<br />

39. Continue to engage, <strong>and</strong><br />

develop effective working<br />

relations, with external<br />

providers <strong>and</strong> partners.<br />

Regular stakeholder briefings have<br />

been introduced <strong>and</strong> the <strong>Trust</strong> has<br />

set up a regular programme of<br />

meetings at patient representative<br />

groups, OSCs, <strong>and</strong> briefing to<br />

media. CQC recently attended a<br />

stakeholder meeting at the <strong>Trust</strong><br />

<strong>and</strong> feedback from local authority<br />

partners <strong>and</strong> the Improving Patient<br />

Experience Group was that<br />

communications with stakeholders<br />

had significantly improved.<br />

• Active dialogue with Local Authority; Borough Councils, MPs,<br />

London Ambulance Service; PCTs, NHS London etc<br />

Neill Moloney<br />

Clare Burns<br />

Imogen Shilito<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

CO‐OPERATION 41. Work with social care<br />

partners to develop robust<br />

working practices to ensure<br />

appropriate admission <strong>and</strong><br />

A programme director is working<br />

at the <strong>Trust</strong> with funding from the<br />

Cluster to liaise between the acute<br />

<strong>Trust</strong> <strong>and</strong> borough <strong>and</strong> community<br />

Cross Buffer meeting held weekly with Social Service partners to<br />

facilitate timely discharge.<br />

Discharge Partnership <strong>Board</strong>s, Cross Buffer meetings, local<br />

escalations.<br />

Shelagh Smith<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 9 of 22


CQC Update Report<br />

<strong>2012</strong><br />

discharge practices<br />

services. This post will currently<br />

run until October <strong>2012</strong>. There is<br />

now a central point for escalation<br />

<strong>and</strong> consideration is being given to<br />

allocating a budge to the<br />

programme director to allow them<br />

to make spot purchases to resolve<br />

complex discharge problems.<br />

Work is underway to streamline<br />

processes across all boroughs to<br />

access community services. Gaps<br />

in acute <strong>Trust</strong> resources are being<br />

identified to improve discharge to<br />

community services; early data<br />

indicates reduced length of stay.<br />

Development of a patient‐centred management approach,<br />

replacing ward management approach<br />

DISCHARGE<br />

34. Develop its discharge <strong>and</strong><br />

bed management teams <strong>and</strong><br />

processes to ensure that they<br />

are interlinked <strong>and</strong> that patient<br />

flow is managed effectively<br />

from the point of entry to the<br />

point of discharge.<br />

A single discharge policy is now in<br />

place with clear roles <strong>and</strong><br />

responsibilities established <strong>and</strong> six<br />

discharge specialists employed to<br />

help with complex discharges. The<br />

RESET project is playing a crucial<br />

role in ensuring that discharge is<br />

managed across all relevant<br />

pathways <strong>and</strong> wards. The<br />

Discharge JONAH project <strong>and</strong><br />

accompanying audits are in place.<br />

Daily meetings with matrons <strong>and</strong><br />

senior nursing staff review the bed<br />

position <strong>and</strong> delays. The<br />

underpinning processes <strong>and</strong><br />

policies are in place here, but<br />

CQC’s inspections <strong>and</strong> other<br />

performance measures make clear<br />

that delivery needs to improve to<br />

match the <strong>Trust</strong>’s aspirations.<br />

There is a rotational programme of ward staff onto the complex<br />

discharge planning team. This will produce ‘skilled’ nurses back<br />

onto the wards to enable cascade of experience <strong>and</strong> training.<br />

Allocation of deputy nurse director for ops to oversee patient<br />

flow within the organisation including management of both bed<br />

<strong>and</strong> site teams <strong>and</strong> the discharge planning team.<br />

Daily operation JONAH meetings which include ward sisters,<br />

discharge planning team, therapies, <strong>and</strong> radiology These<br />

meetings discuss constraints <strong>and</strong> their resolution in order to aim<br />

for seamless patient pathways.<br />

Twice weekly JONAH meetings to discuss <strong>and</strong> resolve delayed<br />

transfers of care with key stakeholders i.e. <strong>Trust</strong> staff, Social<br />

Services, Discharge planning team, ward staff, management.<br />

Ward Sponsors programme in place throughout hospital<br />

supported by Ward Sponsor Guidelines <strong>and</strong> Service<br />

Transformation<br />

Caroline Moore<br />

Elaine Wynter<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

DISCHARGE 35. Ensure that clear guidance The <strong>Trust</strong> has suitably robust Ward based documentation has been revised <strong>and</strong> relaunched. Porti Omo‐Bare MET<br />

Page 10 of 22


CQC Update Report<br />

<strong>2012</strong><br />

outlining the expectations of all<br />

staff is produced <strong>and</strong> enforced<br />

so that the prescribing <strong>and</strong><br />

dispensing of ‘to take away’<br />

medication is managed<br />

effectively <strong>and</strong> patient<br />

discharges are not delayed. The<br />

trust needs to ensure that it<br />

monitors adherence with policy,<br />

guidance <strong>and</strong> audit <strong>and</strong> takes<br />

any appropriate action to<br />

support staff to deliver a high<br />

quality service.<br />

guidance <strong>and</strong> policies, which is<br />

reaffirmed at induction. Pharmacy<br />

is meeting dispensing targets, but<br />

better monitoring <strong>and</strong> audit needs<br />

to be introduced to ensure that<br />

treatment is appropriate <strong>and</strong><br />

supported by suitable information.<br />

This has also been linked into the<br />

RESET project. The <strong>Trust</strong>’s Visible<br />

Leadership programme has<br />

included a focus on this area of<br />

care, with reports to the Nursing<br />

<strong>and</strong> Midwifery <strong>Board</strong> <strong>and</strong> Quality<br />

<strong>and</strong> Safety Committee.<br />

Ward based Pharmacists in place to facilitate speedy discharge. Magda Smith BUSINESS<br />

AS USUAL<br />

DISCHARGE<br />

EMERGENCY<br />

UNIT<br />

36. Review <strong>and</strong> rationalise the<br />

discharge <strong>and</strong> bed management<br />

information systems to ensure<br />

that the most effective <strong>and</strong><br />

accurate system is fully utilised.<br />

28. Develop its strategy <strong>and</strong><br />

work for improving flow of<br />

emergency/urgent patients.<br />

This strategy needs to have the<br />

engagement of all clinicians <strong>and</strong><br />

managers as a key component.<br />

The Discharge JONAH tool has<br />

been rolled out as per above; this<br />

is linked in with the RESET project.<br />

As mentioned, the underpinning<br />

measures are in place but<br />

performance is yet to meet<br />

expectations.<br />

The ‘Discharge JONAH’ tool is<br />

being implemented to focus on<br />

discharge <strong>and</strong> length of stay. Daily<br />

meetings, weekly performance<br />

reviews, <strong>and</strong> the RESET project<br />

mean there is frequent <strong>and</strong> indepth<br />

scrutiny; this will be met<br />

when outputs match the<br />

aspirations in a sustainable way.<br />

• Discharge Jonah continues to be operational across both<br />

hospital sites. Daily operation meetings in place in addition<br />

to twice weekly top delays <strong>and</strong> monthly cross buffer<br />

meetings.<br />

• Ward sponsors in place <strong>and</strong> supporting Jonah application<br />

<strong>and</strong> timely escalation.<br />

• Intensive support in place <strong>and</strong> key performance indicators<br />

developed for on going monitoring.<br />

• Continue to work on predicted discharges <strong>and</strong> information<br />

flows into operational meetings <strong>and</strong> bed management.<br />

• BedWeb in use at Ward level also<br />

• Discharge Jonah rounds for all wards is completed daily<br />

• RESET project continues focusing on expediting discharges<br />

safely using various methods to ensure the whole MDT is<br />

supported in progressing the patients care plan, e.g. orange<br />

discharge forms at the weekend.<br />

• Daily analysis of 4hour <strong>and</strong> black breaches when they occur<br />

Julie Meddings<br />

Caroline Moore<br />

Claire Dixon<br />

Sam Elden‐Lee<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

EMERGENCY<br />

UNIT<br />

29. Develop a culture where<br />

everyone feels empowered to<br />

The appraisal process for<br />

emergency department staff has<br />

• An additional patient information leaflet explaining the<br />

process of the ED is being drafted which will have a section<br />

Derek Hicks<br />

Claire Dixon<br />

PART MET<br />

Page 11 of 22


CQC Update Report<br />

<strong>2012</strong><br />

challenge episodes of variable<br />

or poor practice, including<br />

regular monitoring of practice<br />

<strong>and</strong> feedback <strong>and</strong> learning<br />

opportunities for staff.<br />

been reviewed; all staff in this area<br />

have personal development plans.<br />

Hourly vital signs checks are<br />

underway <strong>and</strong> monthly spot audits<br />

are being carried out to ensure<br />

staff feel empowered to challenge<br />

poor performance. Patient<br />

satisfaction surveys are in place<br />

<strong>and</strong> staff are reminded of the<br />

importance of challenging poor<br />

practice as a st<strong>and</strong>ing item on A&E<br />

team meetings. Audit results do<br />

not yet support the processes that<br />

have been put in place.<br />

to write who the patients named nurse <strong>and</strong> doctor are.<br />

There will be a feedback area on this leaflet to enable<br />

patients to anonymously write any feedback both positive<br />

<strong>and</strong> negative. This will enable direct feedback to the staff<br />

that cared for the patient. It is hoped that this will provide<br />

more audit results as the feedback mechanism will be<br />

directly accessible for patients.<br />

• Trend information on complaints is being collated to further<br />

support feedback to all staff<br />

• Customer service competency checklist is being developed<br />

to provide staff with additional training to support<br />

improvements in communication skills<br />

• Peer challenge on poor practice remains in place.<br />

EMERGENCY<br />

UNIT<br />

30. Ensure that all staff, both<br />

permanent <strong>and</strong> temporary,<br />

follow hospital policy <strong>and</strong><br />

procedures.<br />

MATERNITY 4. In conjunction with its<br />

commissioners <strong>and</strong> other<br />

partners, identify <strong>and</strong><br />

implement immediate solutions<br />

to deliver safe maternity<br />

services at the <strong>Trust</strong>, especially<br />

at Queen’s Hospital, while<br />

developing plans to secure a<br />

long‐term solution.<br />

As noted, the appraisal process for<br />

emergency department staff has<br />

been reviewed; spot audits of<br />

elective surgical consent have<br />

indicated some issues with<br />

consistency; not all emergency<br />

patients receive all the information<br />

they need about procedures; <strong>and</strong> a<br />

new information leaflet on<br />

anaesthesia risks is being<br />

developed. Performance indicators<br />

are still negative.<br />

Work with NHS London in the<br />

short‐term <strong>and</strong> in the longer term<br />

via Health for NEL, has so far <strong>and</strong><br />

should address the highest risks to<br />

safety for mothers. Improved audit<br />

<strong>and</strong> reporting on c‐sections is in<br />

place. An audit of 1:1 care in<br />

established labour saw the <strong>Trust</strong><br />

achieve 100%. CQC’s inspections<br />

have confirmed that<br />

Some specialities consent elective patients within the outpatients<br />

some on the day of surgery on the ward.<br />

Emergency procedures are generally consented on the ward but<br />

dependant on type of case <strong>and</strong> urgency can be consented in the<br />

ED <strong>and</strong> very rarely in theatre holding bay.<br />

All patients receive an anaesthetic review but again this can vary<br />

due to urgency <strong>and</strong> unconscious patients receive a review but<br />

cannot have a conversation with the anaesthetists <strong>and</strong> are<br />

subject to a ‘Consent Form 4’ being unable to consent.<br />

A consultant Anaesthetist will be preparing a leaflet concerning<br />

Anaesthetic risks.<br />

Pre Admission services are currently under review <strong>and</strong><br />

development.<br />

Work continues in respect of the Health 4 NEL project.<br />

There are regular audits to ensure 1:1 care is maintained <strong>and</strong><br />

these are reported monthly via the performance dashboards.<br />

Geoff<br />

Middleditch<br />

Gill Perry<br />

Wendy<br />

Matthews<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 12 of 22


CQC Update Report<br />

<strong>2012</strong><br />

improvements have been made<br />

<strong>and</strong> are so far being sustained<br />

MATERNITY 9. Further improve the<br />

maternity triage process with<br />

the introduction of regular<br />

monitoring <strong>and</strong> learning to<br />

ensure that services improve for<br />

all mothers.<br />

MATERNITY<br />

10. Take appropriate action to<br />

ensure that babies are not<br />

transferred to the neonatal care<br />

unit unnecessarily.<br />

New pathway implemented with<br />

monitoring in place; performance<br />

reported weekly to NHS London;<br />

triage working group in place.<br />

Performance levels need to<br />

improve.<br />

Policy <strong>and</strong> guidelines in place but<br />

being reviewed; <strong>Trust</strong> audit has<br />

recently taken place. Performance<br />

outputs not meeting required<br />

levels.<br />

New pathway implemented 30th July <strong>2012</strong>. However still issues<br />

with middle grade doctor cover, this will be resolved when KGH<br />

closes. Performance continues to be monitored on a monthly<br />

basis<br />

OAU now has appointment system <strong>and</strong> achieves the st<strong>and</strong>ard.<br />

See performance report above<br />

Target moving towards women seen by a doctor within 30<br />

minutes.<br />

Work has been undertaken in HDU to minimalize hypothermic<br />

babies, e.g. skin to skin, bear‐hugger equipment, thermometers<br />

in each bay in HDU however there are some safeguard reports of<br />

environmental issues (cold rooms / non‐functioning thermostats)<br />

which are impacting the temperatures of babies on postnatal<br />

wards. Discussions underway with estates department The latest<br />

audit of all neonatal admissions was undertaken on the 8 th<br />

September <strong>and</strong> revealed no admission due to environmental<br />

conditions or hypothermic neonates.<br />

Averil Archibald<br />

Wendy<br />

Matthews<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MATERNITY 13. Continue with its<br />

recruitment plans in maternity<br />

services to ensure that it has<br />

suitable numbers of qualified<br />

staff across all service delivery<br />

departments.<br />

Recruitment is on target to deliver<br />

a 1:29 ratio, with higher numbers<br />

of substantive staff in post. CQC<br />

inspections have identified some<br />

concerns around midwifery care<br />

assistant staffing levels. <strong>Trust</strong> has<br />

faced challenges in recruitment<br />

<strong>and</strong> retention, although these are<br />

not particular to this <strong>Trust</strong> alone.<br />

Midwife to birth ratio 1:29 achieve with bank usage, however 26<br />

student midwives qualifying in September to <strong>November</strong> at which<br />

time bank will only be used for maternity leave <strong>and</strong> sickness<br />

HDU nurses available at all times in HDU. Midwives now<br />

undergoing training for management of critical obstetrically ill<br />

women<br />

all vacant MCA posts recruited. Study days for MCA's<br />

implemented as annual m<strong>and</strong>atory training. Competency training<br />

being rolled out.<br />

Proposed boundary changes will ensure that this ratio is<br />

maintained, <strong>and</strong> there are clear plans for the recruitment of<br />

midwives on an on going basis to ensure st<strong>and</strong>ards are<br />

maintained.<br />

Richard Howard<br />

Dele<br />

Olorunshola<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MATERNITY<br />

Increase the level of training on<br />

the interpretation of CTGs, so<br />

that all staff have undertaken<br />

All midwives were due to have<br />

completed training by end of<br />

March <strong>2012</strong>, although the<br />

JP comments ‐ M12.1 number of SIs coming through with CTG<br />

interpretation issues still. Discussion re management framework<br />

for response discussed with SOM <strong>and</strong> DOM with Risk Manager ‐<br />

Jude Piper<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 13 of 22


CQC Update Report<br />

<strong>2012</strong><br />

MATERNITY<br />

MATERNITY<br />

this. maternity dashboard showed 84%<br />

complete. Regular audits of<br />

attendance are in place.<br />

17. Improve the quality of<br />

record keeping <strong>and</strong> records<br />

management in maternity<br />

services.<br />

19. Ensure that maternity audit<br />

processes are integrated with<br />

the rest of the <strong>Trust</strong>.<br />

Training for staff <strong>and</strong> a maternity<br />

records tracker <strong>and</strong> audit process<br />

are in place, but some problems<br />

with implementation <strong>and</strong> targets<br />

not being met to date. More that<br />

50% of staff have now been<br />

trained in appropriate governance.<br />

While a clinical audit plan is in<br />

place <strong>and</strong> infection control is being<br />

audited, an audit midwife has only<br />

recently been recruited. The full<br />

set of policy <strong>and</strong> process measures<br />

are in place but performance is not<br />

meeting expected levels as of the<br />

time of writing.<br />

st<strong>and</strong>ard approach to be taken 1. SOM review <strong>and</strong> education is<br />

required / template to be developed <strong>and</strong> used to show audit trail<br />

2. second offence ‐ disciplinary process + SOM input.<br />

For obstetric team need to liaise with tutors to determine correct<br />

process in line with deanery programme<br />

90% for June <strong>2012</strong>, however due to a number of SI's with CTG<br />

misinterpretation please see new process <strong>and</strong> comments above.<br />

Training in place highlights ‘barn door’ competence. The revised<br />

training package which has just been implemented will ensure<br />

that there is a test <strong>and</strong> assess element to the training. Specific<br />

support is available to those midwives who require additional<br />

support.<br />

There have been no SUI reports which have involved CTG<br />

interpretation in September.<br />

Tracker implemented. Audit of compliance commencing Sept<br />

<strong>2012</strong>.<br />

Retrospective tracking has been completed <strong>and</strong> all women are<br />

now covered.<br />

Old Maternity notes are subject to tracking as women attend the<br />

unit.<br />

Training in this is now included in M<strong>and</strong>atory Training for all staff<br />

<strong>and</strong> as part of Induction for all new staff.<br />

Maternity Department has in place an annual audit plan for<br />

<strong>2012</strong>/13 compiled by the Audit Lead Consultant <strong>and</strong> the Audit<br />

Midwife. Audit findings are presented at monthly Audit meetings<br />

attended by multidisciplinary representation. The action plans are<br />

discussed at the meeting <strong>and</strong> uploaded onto the intranet by the<br />

Clinical Audit Team .<br />

FU comment: The crib sheet has not been shared with the Audit<br />

midwife therefore cannot provide an update.<br />

Wendy<br />

Matthews<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MEDICINES<br />

MANAGEMENT<br />

48. Reinforce its policy on<br />

medication prescribing,<br />

dispensing <strong>and</strong> administration,<br />

ensuring that all staff are<br />

A briefing for clinical staff<br />

explaining the importance of this<br />

policy <strong>and</strong> setting out<br />

accountabilities for prescribing <strong>and</strong><br />

FU comment: The audit team adheres to the <strong>Trust</strong> procedures,<br />

uses approved tools <strong>and</strong> ensures that the audits are centrally<br />

recorded by the <strong>Trust</strong> Clinical Audit Team.<br />

The BHRuT Medicines Care, Custody, prescribing <strong>and</strong><br />

Administration Policy has been finalised <strong>and</strong> ratified by the Drugs<br />

<strong>and</strong> Therapeutics Committee, Nursing <strong>and</strong> Midwifery <strong>Board</strong> <strong>and</strong><br />

the Policy ratification Committee. It is available on the intranet<br />

Ian Grant<br />

Jane Stevens<br />

Pam Strange<br />

Portia Omo‐Bare<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 14 of 22


CQC Update Report<br />

<strong>2012</strong><br />

aware of their roles <strong>and</strong><br />

responsibilities.<br />

administration has been prepared;<br />

this is due to be rolled out shortly.<br />

A Policy Ratification Group has<br />

been set up to ensure policies are<br />

corporately signed off, published<br />

on the<br />

intranet, with summaries added to<br />

the Link to raise awareness of<br />

changes <strong>and</strong> expectations around<br />

compliance. Trends <strong>and</strong> issues<br />

relating to prescribing <strong>and</strong><br />

medicines are reported in the Link,<br />

with a bimonthly prescribing<br />

newsletter in place to ensure a<br />

strong focus on medicines safety.<br />

An ongoing audit programme has<br />

looked at omitted drugs in the<br />

MAU, pharmacist errors, <strong>and</strong> is<br />

looking at a range of other<br />

relevant issues.<br />

<strong>and</strong> has been publicised for all staff in the Link <strong>and</strong> via the<br />

Medicine Matters Bulletin. Copies have been distributed to all<br />

wards <strong>and</strong> clinical areas in the <strong>Trust</strong> <strong>and</strong> ward matrons have been<br />

tasked with providing a list to pharmacy of all staff who have read<br />

the policy. A summary quick reference guide has also been<br />

prepared <strong>and</strong> distributed for nursing <strong>and</strong> medical staff which<br />

contains key responsibilities in the policy as applicable to these<br />

staff groups. This is reinforced in nurse induction <strong>and</strong> m<strong>and</strong>atory<br />

training.<br />

MEDICINES<br />

MANAGEMENT<br />

49. Ensure that the results of<br />

learning from medication errors<br />

are widely publicised across all<br />

services in the organisation.<br />

PREMISES 50. Review the directional<br />

signage at Queen’s Hospital.<br />

The trust should ensure that it<br />

seeks the input of patients,<br />

relatives, visitors <strong>and</strong> staff, to<br />

ensure that any new signage<br />

Safe Medicines Practice Group in<br />

place <strong>and</strong> produces a summary of<br />

incident themes <strong>and</strong> serious<br />

incidents to be used in directorate<br />

meetings. Pharmacists <strong>and</strong> wards<br />

receive monthly reports on<br />

medicines <strong>and</strong> prescribing. Error<br />

trends are fed back to relevant<br />

directorates <strong>and</strong> are published on<br />

the intranet.<br />

Working group involving patients,<br />

non‐execs <strong>and</strong> staff set up in<br />

December<br />

2011 to set signage st<strong>and</strong>ards;<br />

main signage reviewed with<br />

specialist input <strong>and</strong> new signs<br />

Monthly meetings are taking place to review all medicines related<br />

clinical incidents in which action plans are made to address<br />

serious incidents <strong>and</strong> also key trends are identified <strong>and</strong> reported<br />

back monthly to wards/directorates. Learning from these is also<br />

shared more widely across the <strong>Trust</strong> via a range of media<br />

including the intranet, The LINK <strong>and</strong> the pharmacy bulletin. All<br />

medicine incidents are reported to the <strong>Trust</strong> Quality <strong>and</strong> Safety<br />

Committee on the dashboard. The trust has recently introduced<br />

electronic incident reporting which will improve incident<br />

investigation timeframes <strong>and</strong> provide better data on key trends<br />

than the previous paper reporting system.<br />

This work has been completed. The new maps <strong>and</strong> directions are<br />

available to visitors via the <strong>Trust</strong> website. Sodexho are currently<br />

reviewing the signage throughout the hospital as part of the<br />

routine maintenance arrangements of the site.<br />

Portia Omo‐Bare<br />

Jackie Doyle<br />

Imogen Shilito<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 15 of 22


CQC Update Report<br />

<strong>2012</strong><br />

meets the needs of its<br />

populations.<br />

commissioned to arrive in June<br />

<strong>2012</strong>. Leaflet <strong>and</strong> map under<br />

review to ensure signage is in<br />

context of better overall patient<br />

information.<br />

Hyperlinks to the maps are given below:<br />

http://www.bhrhospitals.nhs.uk/for‐patients‐<strong>and</strong>‐visitors/mapof‐queens.htm<br />

http://www.bhrhospitals.nhs.uk/for‐patients‐<strong>and</strong>‐visitors/mapof‐king‐george.htm<br />

PREMISES 51. Review the emergency<br />

department paediatric facilities<br />

at Queen’s Hospital in line with<br />

the st<strong>and</strong>ards outlined in<br />

Services for children in<br />

Emergency<br />

Department’s document <strong>and</strong><br />

then develop an appropriate<br />

strategy involving both the<br />

emergency <strong>and</strong> paediatric<br />

departments.<br />

PREMISES 52. Finalise <strong>and</strong> implement<br />

plans to improve x‐ray facilities<br />

<strong>and</strong> ensure that patients<br />

waiting for x‐rays in the<br />

emergency department are<br />

appropriately cared for.<br />

Paediatric waiting areas reviewed<br />

<strong>and</strong> funding agreed to improve<br />

observation of sick children;<br />

project group set up to implement<br />

Health for NEL redesign of<br />

paediatric services.<br />

Review of x‐ray services including<br />

department layout linked to<br />

Health for NEL programme; project<br />

group set up with dedicated<br />

project management support.<br />

Current process of caring for<br />

patients in waiting area addressed<br />

via a short‐term solution using a<br />

mobile x‐ray device to limit patient<br />

waiting times.<br />

The Paediatrics A&E is a 24 hour unit.<br />

The Paediatric A&E is a st<strong>and</strong> alone area of the main department,<br />

with a dedicated entrance <strong>and</strong> waiting area.<br />

The Paediatric assessment Unit is currently part of the Paediatric<br />

ward Tropical Lagoon.<br />

There are currently plans being developed to extend A&E which<br />

will include Paediatrics, PAU <strong>and</strong> the HDU being housed alongside<br />

A&E.<br />

No child under the age of 16 is admitted onto an adult ward. Sick<br />

children are resuscitated in a Paediatric cubicle within the main<br />

adult resuscitation area.<br />

Seriously ill children are transferred via CATS to appropriate High<br />

Level units across London.<br />

The Paediatrics Early warning skills are currently being developed<br />

for A&E in collaboration with the Paediatric department.<br />

Work is planned to align facilities with health 4 NEL agenda.<br />

The current waiting facilities are deemed sufficient for the needs<br />

of patients currently. A programme of continuous review is on<br />

going <strong>and</strong> will form part of a focus visit for the new Director of<br />

Nursing.<br />

The redevelopment of the A&E <strong>and</strong> local waiting areas is under<br />

review. Schemes are under development <strong>and</strong> will be deployed<br />

when capital funding <strong>and</strong> complimentary schemes are realised.<br />

In the short term, two HCAs have been appointed to chaperone<br />

patients between A&E <strong>and</strong> A&E Radiology. This means that<br />

although the patients are still waiting on the hospital street, they<br />

Jackie Doyle<br />

Carol<br />

Drummond<br />

Stephen<br />

Griffiths<br />

Judith Douglas<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 16 of 22


CQC Update Report<br />

<strong>2012</strong><br />

are now supervised during part of the working day. This is an<br />

improvement because prior to this, patients were left unescorted<br />

outside of the A&E Radiology department. We also now have<br />

dedicated changing room facilities so that patients are afforded<br />

greater dignity <strong>and</strong> privacy. The <strong>Trust</strong> has also purchased a Digital<br />

Radiography Mobile X ray unit. This unit is based in Resus but has<br />

the potential to be used to support the service if the A&E<br />

Radiology room breaks down <strong>and</strong> services have to be diverted to<br />

the main X Ray Department.<br />

PREMISES<br />

53. Ensure that appropriate<br />

waiting facilities are available<br />

for patients <strong>and</strong> relatives in the<br />

urgent care centre.<br />

As above, these waiting facilities<br />

are being reviewed as part of the<br />

Health for NEL programme.<br />

The current waiting facilities are deemed sufficient for the needs<br />

of patients currently. A programme of continuous review is on<br />

going <strong>and</strong> will form part of a focus visit for the new Director of<br />

Nursing.<br />

Jackie Doyle<br />

PART MET<br />

BUSINESS<br />

AS USUAL<br />

PREMISES 55. Review <strong>and</strong> take any<br />

necessary action in all inpatient<br />

areas to ensure that there are<br />

clear lines of sight so that<br />

patients can be observed at all<br />

times.<br />

The ‘hourly staffing of wards’<br />

element of the Safer Nursing Care<br />

Tool <strong>and</strong> other tools are being<br />

used to try to ensure there is<br />

suitable observation of patients,<br />

although concerns about staffing<br />

levels suggest there is room for<br />

improvement.<br />

The <strong>Trust</strong> has decided against a ‘line of sight’ audit <strong>and</strong> opted to<br />

focus efforts on Ward Establishments, Patient Acuity scoring,<br />

Professional Judgement module; Dependency scoring; Patient<br />

safety tool<br />

These elements are also considerate of Hourly rounding <strong>and</strong><br />

single sex accommodation in assessing patient safety issues<br />

• Reflect <strong>and</strong> mitigate results from the National Patient<br />

Survey.<br />

Julie Meddings<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

PREMISES 56. Develop appropriate<br />

facilities to ensure the day case<br />

surgical patients are cared for in<br />

appropriate environments at<br />

Queen’s Hospital.<br />

The use of overnight recovery has<br />

been reviewed <strong>and</strong> works are<br />

underway to Improve facilities<br />

subject to funding. There is a plan<br />

in place to develop a 23‐hour<br />

facility in the day surgery unit <strong>and</strong><br />

allow space in Recovery to be used<br />

as a ‘day of surgery’ admissions<br />

area, but these are pending the<br />

outcomes of the bed‐modelling<br />

work stream.<br />

Appropriate use of Day Case <strong>and</strong> O/N recover is a st<strong>and</strong>ing<br />

agenda item on the Daily Bed Meetings.<br />

Any single‐sex or ‘step down’ breach is treated seriously <strong>and</strong><br />

investigated via RCA methodology<br />

Eileen Moore<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 17 of 22


CQC Update Report<br />

<strong>2012</strong><br />

RADIOLOGY<br />

31. Develop its planning <strong>and</strong><br />

bed management processes to<br />

ensure all patients are cared for<br />

in appropriate facilities.<br />

Matrons <strong>and</strong> ward sisters are<br />

monitoring this but the <strong>Trust</strong> has<br />

not yet established how best to<br />

measure success in this area. The<br />

X‐Ray department has introduced<br />

appropriate checklists for ensuring<br />

patients are properly prepared.<br />

The Department has developed St<strong>and</strong>ard Operating Procedures<br />

attached below which are evidence based <strong>and</strong> serve as the<br />

baseline expectation for all staff. These have been ratified<br />

internally, <strong>and</strong> are based on good practice examples.<br />

These are well publicised throughout the department, <strong>and</strong><br />

subject to internal review.<br />

• A Plan is in place to ensure publicity <strong>and</strong> accessibility at<br />

ward level<br />

• The impact of these documents is subject to audit in 6<br />

months time.<br />

Stephen<br />

Griffiths<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

RADIOLOGY<br />

32. Put in place clear protocols<br />

for the management of<br />

interventional rradiology<br />

patients with audit <strong>and</strong><br />

improvement cycles to ensure<br />

st<strong>and</strong>ards are attained <strong>and</strong><br />

maintained.<br />

Audit processes are in place <strong>and</strong><br />

are monitored at interventional<br />

radiology meetings <strong>and</strong> at the<br />

Divisional <strong>Board</strong>. SOPs are in place<br />

<strong>and</strong> are being implemented for<br />

each procedure in interventional<br />

radiology.<br />

CQC’s compliance activity supports<br />

the <strong>Trust</strong>’s assessment of<br />

significant progress in this area,<br />

although more audit activity needs<br />

to be delivered for this to be<br />

considered fully met.<br />

The Department has developed St<strong>and</strong>ard Operating Procedures<br />

attached below which are evidence based <strong>and</strong> serve as the<br />

baseline expectation for all staff. These have been ratified<br />

internally, <strong>and</strong> are based on good practice examples.<br />

These are well publicised throughout the department, <strong>and</strong><br />

subject to internal review.<br />

Stephen<br />

Griffiths<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

RECORDS<br />

80. Improve its systems for<br />

records management to ensure<br />

that notes can be retrieved<br />

effectively <strong>and</strong> expediently, <strong>and</strong><br />

reduce the risks associated with<br />

multiple sets of temporary<br />

notes <strong>and</strong> poor data h<strong>and</strong>ling.<br />

The <strong>Trust</strong>’s Medical Records<br />

Committee has been reestablished<br />

with new Terms of<br />

Reference; training levels for<br />

healthcare professionals are<br />

discussed at this Committee on a<br />

regular basis. Weekend transport<br />

for transfer of notes has been<br />

reintroduced <strong>and</strong> a nursing<br />

documentation booklet has been<br />

piloted across several wards <strong>and</strong><br />

will be fully implemented by the<br />

The development of the eH<strong>and</strong>over system will provide a<br />

<strong>Trust</strong>wide joined up reference database for the use in patient<br />

care.<br />

A new PAS is being commissioned in 2013 for implementation<br />

which will improve the availability of Patient records <strong>and</strong> reduce<br />

the incidence of Temporary folders.<br />

It is anticipated that patients will be migrated onto one hospital<br />

number covered by barcode scanning options as part of the rollout<br />

<strong>and</strong> implementation.<br />

Ian Grant<br />

Alex<br />

Hammerton<br />

PART MET<br />

BUSINESS<br />

AS USUAL<br />

Page 18 of 22


CQC Update Report<br />

<strong>2012</strong><br />

autumn.<br />

RECORDS<br />

81. Develop integrated patient<br />

administration <strong>and</strong> information<br />

systems to ensure that, where<br />

ever a patient is being treated<br />

within the trust, their full<br />

healthcare history can be<br />

accessed by all staff.<br />

A procurement process is<br />

underway to introduce an<br />

effective system to enable access<br />

to patient histories. Funding<br />

challenges have slowed<br />

introducing of a full electronic<br />

patient record.<br />

A new PAS is being commissioned in 2013 for implementation<br />

which will improve the availability of Patient records <strong>and</strong> reduce<br />

the incidence of Temporary folders.<br />

It is anticipated that patients will be migrated onto one hospital<br />

number covered by barcode scanning options as part of the rollout<br />

<strong>and</strong> implementation.<br />

Paul Richards<br />

RESPECT &<br />

INVOLVEMENT<br />

27. Make sure that proactive<br />

<strong>and</strong> m<strong>and</strong>atory training <strong>and</strong><br />

education regarding dignity,<br />

respect <strong>and</strong> tolerance is<br />

delivered to all staff.<br />

Dignity <strong>and</strong> respect benchmarking<br />

has been done; compliance<br />

reports on non‐attendance are<br />

being reviewed <strong>and</strong> a m<strong>and</strong>atory<br />

training programme is being<br />

developed. A leaflet for new staff<br />

about the <strong>Trust</strong>’s expectations of<br />

behaviour has been drafted <strong>and</strong> is<br />

due to be reviewed with the staff<br />

engagement group before roll out.<br />

The BHRUT Code is being reviewed<br />

<strong>and</strong> will be issued to all new<br />

starters with contract. Quality of<br />

Care audits of dignity <strong>and</strong> respect<br />

have been carried out in<br />

December <strong>and</strong> March so far <strong>and</strong><br />

will continue in order to audit<br />

feedback from the real time<br />

patient survey.<br />

Bank managers to ensure that<br />

competence of all temporary<br />

clinical staff in this respect is<br />

monitored; if concerns are raised<br />

about temporary staff they should<br />

either not be booked again or only<br />

done so with documented<br />

supervision.<br />

M<strong>and</strong>atory training development, reports on non‐attendance,<br />

leaflet re Behaviour <strong>and</strong> expectations; reviewed BHRUT Code;<br />

Survey Feedback, Update from Gill Perry re Bank competency<br />

framework monitoring.<br />

Gill Perry<br />

Claire O’Toole<br />

Alison Crombie<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 19 of 22


CQC Update Report<br />

<strong>2012</strong><br />

STAFFING 60. Continue to review its<br />

human resource information<br />

systems <strong>and</strong> ensure that<br />

accurate data is available for<br />

the entire organisation, so that<br />

a clear <strong>and</strong> comprehensive<br />

underst<strong>and</strong>ing of vacancies can<br />

be established.<br />

The <strong>Trust</strong> has introduced a phased<br />

programme to consolidate<br />

establishment data against the<br />

electronic staff record, including<br />

cleansing the record of posts that<br />

are no longer in use, <strong>and</strong> with<br />

finance support. There have been<br />

challenges in aligning the HR<br />

ledger data with the electronic<br />

record. Further work is needed<br />

<strong>and</strong> there is, as yet, no formal<br />

process in place or agreed for<br />

managing establishment control.<br />

The move to electronic staff<br />

change / termination forms has<br />

been difficult to implement, <strong>and</strong><br />

there has been a delay in getting<br />

fully accurate reporting on<br />

vacancies <strong>and</strong> establishment.<br />

The <strong>Trust</strong> systems to reconcile ledger <strong>and</strong> ESR will ‘go live’ on<br />

07/11/12 <strong>and</strong> will be evaluated for compliance on 30/11/12.<br />

The work is led by Gill Perry; Leigh Malyon supported by Mark<br />

Greene (Finance)<br />

Sept 12 update: A great deal of work has taken place to align the<br />

financial ledger with ESR. This work is now complete except for<br />

the updating of the old subjective codes for medical staff within<br />

the finance ledger. Updating these codes by finance will<br />

completely align the ledger to ESR. Finance are in the process of<br />

cleansing the old subjective codes ,<br />

it is envisaged that this work will be complete in the next few<br />

weeks. A process & procedure for establishment control has been<br />

developed <strong>and</strong> agreed. Next step is the development of the<br />

electronic change form <strong>and</strong> testing of the system – it is<br />

anticipated this will be complete by beginning <strong>November</strong>.<br />

Mark Smith<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

STAFFING 61. Continue to review its<br />

workforce strategy to ensure<br />

that it meets the needs of the<br />

organisation <strong>and</strong> reflects the<br />

reality of service delivery.<br />

A review of the Workforce<br />

Strategy has been completed <strong>and</strong><br />

is now being tested via the staff<br />

engagement group.<br />

A Number of work streams are currently active which affect the<br />

current workforce strategy. These schemes are led by senior<br />

managers <strong>and</strong> report to the Director of Transformation <strong>and</strong> the<br />

Transformation <strong>Board</strong> initially.<br />

• Length of Stay Work stream (Julie Meddings & Ernst<br />

<strong>and</strong> Young)<br />

• AHP Review (Nick Hume, Director of Strategy)<br />

• Workforce Transformation (Mark Smith, Head of<br />

Workforce Transformation)<br />

Mark Smith<br />

BUSINESS<br />

AS USUAL<br />

STAFFING<br />

62. Undertake systematic skill<br />

mix <strong>and</strong> staffing needs analysis<br />

to ensure that they have the<br />

right staff with the right skills at<br />

the right locations <strong>and</strong> that<br />

trust is receiving value for<br />

money.<br />

Skills for Health are supporting the<br />

<strong>Trust</strong> in this, funded via NHS<br />

London Financial Support. Pilot<br />

work in the Emergency <strong>and</strong><br />

Maternity Departments is<br />

underway. Future phases are<br />

heavily dependent on the success<br />

Sept 12 update: Paediatric skill mix project has now commenced<br />

Plan now in place to link overall SfH project with Clinical<br />

transformation lead’s work in relating to review of the ward<br />

nursing establishments. Meeting scheduled for Wed 3rd October<br />

to include discussions on implementing A&E recommendations<br />

provided by SfH in their review.<br />

Linda Baker<br />

PART MET<br />

Page 20 of 22


CQC Update Report<br />

<strong>2012</strong><br />

of the pilot analysis <strong>and</strong> capacity to<br />

roll its findings out across the <strong>Trust</strong><br />

<strong>and</strong> this will only be able to be<br />

assessed in the longer term. CQC<br />

compliance activity continues to<br />

suggest that the <strong>Trust</strong> faces<br />

challenges in terms of building a<br />

sustainable workforce with the<br />

right skills mix.<br />

STAFFING 63. Continue to recruit<br />

appropriate permanent staff to<br />

ensure that it reduces its<br />

reliance on agency <strong>and</strong> locum<br />

staff improving the quality of<br />

care, <strong>and</strong> have in place effective<br />

retention strategies.<br />

An accelerated recruitment project<br />

<strong>and</strong> reduced use of agency staff<br />

have been put in place, with<br />

recruitment needs assessed on a<br />

monthly basis. Exit interviews are<br />

now in place as part of KPIs <strong>and</strong><br />

are reviewed by Directors.<br />

The <strong>Trust</strong> has introduced suitable<br />

procedures here, but CQC<br />

compliance activity has identified<br />

on‐going challenges around locum<br />

use, particularly in A&E.<br />

Sept 12 update: Improved bank & agency controls have been<br />

introduced which are linked to more proactive booking of bank<br />

staff. E‐rostering KPI’s are measured at the same time as bank<br />

usage is requested in order to ensure every possible use of<br />

permanent staff has been explored first.<br />

Gill Perry<br />

Mark Smith<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

STAFFING<br />

66. Support a skills escalation<br />

programme in the emergency<br />

department that seeks to<br />

develop nurses who have<br />

already successfully completed<br />

an emergency nurse<br />

practitioner or advanced clinical<br />

practitioner course <strong>and</strong> reduce<br />

reliance on them undertaking<br />

traditional nursing duties due to<br />

shortages of staff.<br />

A review of the A&E workforce has<br />

been completed <strong>and</strong> the unit has<br />

been benchmarked against other<br />

comparable trusts. A review of the<br />

skills mix, current roles, <strong>and</strong><br />

supporting roles has been<br />

undertaken <strong>and</strong> budgets reviewed<br />

in light of this. Current staff are<br />

taking part in an on‐going training<br />

programme to ensure staff update<br />

<strong>and</strong> refresh their skills. CQC’s<br />

compliance activity has identified<br />

on‐going staffing challenges in A&E<br />

<strong>and</strong> the longer term impact of this<br />

review work will need to be<br />

Head of Nursing for A&E appointed <strong>and</strong> in Post September <strong>2012</strong>.<br />

Lead for ANP<br />

•Review of KGH ED nursing workforce has commenced <strong>and</strong> is<br />

being led by the Clinical Nurse Director for Emergency Care. A<br />

review of the paediatric nursing workforce on both sites <strong>and</strong> the<br />

RAT (rapid, assessment <strong>and</strong> treatment) area nursing workforce at<br />

QH will also be undertaken in October.<br />

•Training competencies are being reviewed for all roles in the<br />

department to ensure that all staff have clear responsibilities <strong>and</strong><br />

competencies to undertake that role. This work is being led by<br />

the Clinical Nurse Director with support from the Matrons.<br />

•Advanced nurse practitioners have started in the ED.<br />

•Established weekly middle grade <strong>and</strong> SHO teaching is in place<br />

with a clear <strong>and</strong> structured training curriculum<br />

Derek Hicks<br />

Clare Dixon<br />

Samantha<br />

Elden‐Lee<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 21 of 22


CQC Update Report<br />

<strong>2012</strong><br />

assessed at some point in<br />

the future<br />

STAFFING 67. Ensure that its<br />

whistleblowing systems <strong>and</strong><br />

processes allow staff a route to<br />

raise concerns early so that<br />

quick action can be taken <strong>and</strong><br />

staff feel empowered to raise<br />

concerns.<br />

The <strong>Trust</strong>’s whistleblowing policy<br />

has been revised <strong>and</strong><br />

communicated to staff through<br />

Team Brief, the Link <strong>and</strong> the<br />

intranet. Staff feedback on the<br />

effectiveness of the policy is now<br />

part of the staff engagement<br />

strategy <strong>and</strong> new starters will be<br />

audited after six months to see if<br />

they are aware of it. Delivery of<br />

this recommendation is contingent<br />

on cultural change embedding<br />

itself across the <strong>Trust</strong> (although it<br />

should be noted that CQC has<br />

usually found staff open <strong>and</strong><br />

willing to talk frankly about<br />

challenges during inspections,<br />

whether in confidence or openly).<br />

We are now launching a further communications exercise to raise<br />

the profile of the new policy <strong>and</strong> offer training to staff. In<br />

October <strong>2012</strong> this will include a payslip message <strong>and</strong> wide<br />

circulation of the attached letter signed by the Chief Executive<br />

<strong>and</strong> Staff side lead.<br />

Training sessions have now also been arranged on both sites <strong>and</strong><br />

will initially run from the end of October to beginning of<br />

December <strong>2012</strong> when they will be reviewed<br />

Claire O’Toole<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 22 of 22


EXECUTIVE SUMMARY<br />

TITLE:<br />

Information Governance (IG) Strategy <strong>2012</strong>/13<br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

7 th <strong>November</strong> <strong>2012</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

Information Governance (IG) is a framework □ PEQ ……………..….. □ STRATEGY……….….…….<br />

that brings together best practice, st<strong>and</strong>ards<br />

□ FINANCE ……..……… □ AUDIT ………….……..….<br />

<strong>and</strong> requirements that apply to the h<strong>and</strong>ling of<br />

information. This includes sensitive <strong>and</strong> □ CLINICAL GOVERNANCE …………..………….....……<br />

personal information, of patients <strong>and</strong> employees □ CHARITABLE FUNDS ………………………………...…<br />

as well as commercially sensitive information.<br />

√ TRUST BOARD …05/09/12…..………<br />

This strategy sets out <strong>Barking</strong> <strong>Havering</strong> <strong>and</strong> □ REMUNERATION ………………………………….…...<br />

Redbridge University Hospitals NHS <strong>Trust</strong>’s □ OTHER … ……………………..……. (please specify)<br />

(BHRUT’s) approach to providing a robust<br />

Information Governance framework. It is<br />

essential that appropriate management<br />

structures, leadership <strong>and</strong> organisational<br />

processes are in place to deliver successful<br />

information governance, <strong>and</strong> important the<br />

Information Governance agenda is adequately<br />

resourced.<br />

Purpose:<br />

• To ensure that patient <strong>and</strong> corporate data<br />

collected or created is of the best possible<br />

quality.<br />

• To ensure that data is held in such a<br />

manner as to prevent unauthorised access<br />

to loss, but to available to those authorised<br />

when required for the provision of patient<br />

care or for commissioning purposes.<br />

• To ensure that its policies <strong>and</strong> procedures<br />

reflect the requirements of the Information<br />

Governance agenda, in clearly outlining to<br />

staff their responsibilities.<br />

• To ensure there is a management structure<br />

to reflect IG requirements<br />

2. DECISION REQUIRED: CATEGORY:<br />

To approve the Information Governance<br />

Strategy.<br />

√ NATIONAL TARGET □ CNST<br />

√ CQC REGISTRATION □ HEALTH & SAFETY<br />

√ ASSURANCE FRAMEWORK<br />

□ CQUIN/TARGET FROM COMMISSIONERS<br />

□ CORPORATE OBJECTIVE ……………………………....<br />

□ OTHER … …………………….. (please specify)<br />

AUTHOR/PRESENTER: Neill Moloney<br />

Director of Planning <strong>and</strong> Performance<br />

DATE: 29 October <strong>2012</strong>


3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

4. DELIVERABLES<br />

Level 2 or above in all 45 IG Toolkit st<strong>and</strong>ards to achieve satisfactory IG compliance<br />

5. KEY PERFORMANCE INDICATORS<br />

Compliance with the IG toolkit<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________<br />

2


INFORMATION GOVERNANCE<br />

STRATEGY<br />

<strong>2012</strong>/2013<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 1 of 9<br />

Information Governance Strategy Version 1.4 Issued October <strong>2012</strong>


BACKGROUND<br />

Information Governance (IG) is a framework that brings together best practice, st<strong>and</strong>ards<br />

<strong>and</strong> requirements that apply to the h<strong>and</strong>ling of information. This includes sensitive <strong>and</strong><br />

personal information, of patients <strong>and</strong> employees as well as commercially sensitive<br />

information.<br />

Information Governance provides a way for employees to deal consistently with the many<br />

different rules about how information is h<strong>and</strong>led, including those set out in:<br />

• The Data Protection Act 1998<br />

• The common law duty of confidentiality<br />

• The Confidentiality NHS Code of Practice<br />

• The NHS Care Record Guarantee for Engl<strong>and</strong><br />

• The Social Care Record Guarantee for Engl<strong>and</strong><br />

• The international information security st<strong>and</strong>ard: ISO/IEC 27002: 2005<br />

• The Information Security NHS Code of Practice<br />

• The Records Management NHS Code of Practice<br />

• The Freedom of Information Act 2000<br />

• The Caldicott Report<br />

This strategy sets out <strong>Barking</strong> <strong>Havering</strong> <strong>and</strong> Redbridge University Hospitals NHS <strong>Trust</strong>’s<br />

(BHRUT’s) approach to providing a robust Information Governance framework. It is essential<br />

that appropriate management structures, leadership <strong>and</strong> organisational processes are in<br />

place to deliver successful information governance, <strong>and</strong> important the Information<br />

Governance agenda is adequately resourced.<br />

Information Governance sits alongside clinical <strong>and</strong> corporate governance in providing the<br />

service users <strong>and</strong> other organisations with the assurance that personal <strong>and</strong> commercially<br />

sensitive information is h<strong>and</strong>led in a confidential <strong>and</strong> secure manner to appropriate legal,<br />

ethical <strong>and</strong> quality st<strong>and</strong>ards.<br />

The Information Governance strategy is monitored by the Connecting for Health (CfH)<br />

Information Governance Toolkit. This is a performance tool produced by the Department of<br />

Health (DH) which draws together the legal rules <strong>and</strong> central guidance set out above <strong>and</strong><br />

presents them in one place as a set of Information Governance requirements.<br />

This document should be read in conjunction with the Information Governance Policy. The<br />

Action Plan sets out a delivery of actions to satisfy the requirements.<br />

PURPOSE<br />

1. To ensure that patient <strong>and</strong> corporate data collected or created is of the best possible<br />

quality.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 2 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


Information is a vital asset in terms of the clinical management of individual patients <strong>and</strong><br />

the efficient management of services <strong>and</strong> resources. It plays a key part in clinical<br />

governance, service planning <strong>and</strong> performance management. It is therefore important<br />

that information is efficiently managed within the <strong>Trust</strong> through a robust Information<br />

Governance Framework to assure <strong>and</strong> demonstrate that all information is dealt with<br />

legally, securely, effectively <strong>and</strong> efficiently in order to deliver the best possible care to<br />

patients, staff <strong>and</strong> other service users.<br />

As accurate, timely <strong>and</strong> relevant information is essential to deliver the highest quality<br />

health care, it is the responsibility of all clinicians <strong>and</strong> managers to ensure <strong>and</strong> promote<br />

the quality of information <strong>and</strong> to actively use information in decision making processes.<br />

2. To ensure that data is held in such a manner as to prevent unauthorised access to loss,<br />

but to available to those authorised when required for the provision of patient care or for<br />

commissioning purposes.<br />

As there is a need for an appropriate balance between openness <strong>and</strong> confidentiality in<br />

the management <strong>and</strong> use of information, the <strong>Trust</strong> fully supports the principles of<br />

corporate governance <strong>and</strong> recognises its public accountability. However it equally<br />

places importance on the confidentiality of <strong>and</strong> the security arrangements to safeguard<br />

personal information about patients <strong>and</strong> staff <strong>and</strong> commercially sensitive information.<br />

The <strong>Trust</strong> also recognises the need to share patient information with other health<br />

organisations <strong>and</strong> other agencies in a controlled manner.<br />

To achieve this aim BHRUT will:<br />

• Require the ongoing support of the <strong>Trust</strong> <strong>Board</strong> in placing IG as a high<br />

organisational priority, which promotes the importance to all staff of maintaining<br />

confidentiality <strong>and</strong> following policies/procedures outlined<br />

• Establish <strong>and</strong> maintain policies to ensure the secure management of its<br />

information assets <strong>and</strong> systems<br />

• Comply with legal <strong>and</strong> regulatory requirements, introducing best practice guidance<br />

relating to Information where appropriate<br />

• Ensure patient, staff <strong>and</strong> commercial information is treated as confidential<br />

• Ensure records are stored <strong>and</strong> transported securely<br />

• Ensure that Directorate <strong>and</strong> Service procedures <strong>and</strong> processes relating to<br />

information <strong>and</strong> data flows are fully mapped<br />

• Provide Information Governance training to staff at induction, <strong>and</strong> through<br />

m<strong>and</strong>atory training sessions/via e-training<br />

• Monitor information security alerts through the <strong>Trust</strong> incident reporting process<br />

• Ensure contracts with companies processing data on behalf of the <strong>Trust</strong> include<br />

clauses with reference to Information Governance, the expectations to follow this<br />

requirement <strong>and</strong> the consequences of non-compliance<br />

3. To ensure that its policies <strong>and</strong> procedures reflect the requirements of the Information<br />

Governance agenda, in clearly outlining to staff their responsibilities.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 3 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


There are three key components underpinning this strategy:<br />

• The <strong>Trust</strong> Information Governance Framework, which provides a<br />

summary/overview of how the <strong>Trust</strong> is addressing the IG agenda<br />

• The <strong>Trust</strong> Information Governance Policy, which outlines the objectives for<br />

Information Governance; <strong>and</strong><br />

• The annual action plan arising from a baseline assessment against the st<strong>and</strong>ards<br />

set out in the NHS Connecting for Health Information Governance Toolkit<br />

4. To ensure there is a management structure to reflect IG requirements<br />

Within the <strong>Trust</strong>, the Chief Executive Officer (CEO) has overall responsibility for<br />

Information Governance (IG), this responsibility is discharged through the Executive<br />

Chief Information Officer (from 3 rd December <strong>2012</strong>). This individual is responsible for all<br />

aspects of IG including the submission of the Connecting for Health’s Information<br />

Governance Toolkit, is the chair of the Information Governance Steering Group (IGSG),<br />

as well as being the <strong>Trust</strong>’s Senior Information Risk Officer (SIRO).<br />

The SIRO is responsible for underst<strong>and</strong>ing how the strategic business goals of the<br />

<strong>Trust</strong> may be impacted by information risks <strong>and</strong> for the ongoing development <strong>and</strong> dayto-day<br />

management of the <strong>Trust</strong>’s Risk Management Programme for information privacy<br />

<strong>and</strong> security. The SIRO will review <strong>and</strong> agree action in respect of identified information<br />

risks, ensure that the <strong>Trust</strong>’s approach to information risk is effective in terms of<br />

resource, commitment <strong>and</strong> execution <strong>and</strong> that this is communicated to all staff. In<br />

addition they will provide a focal point of resolution <strong>and</strong>/or discussion of information risk<br />

issues, <strong>and</strong> ensure the <strong>Board</strong> is adequately briefed on information risks.<br />

The IGSG comprises of senior representatives from across the <strong>Trust</strong> <strong>and</strong> its<br />

professional disciplines, to promote a holistic approach to IG. It has overall<br />

responsibility for overseeing the implementation of the Information Governance<br />

Strategy, Framework, IG Policy <strong>and</strong> any IG actions plans, by embedding IG within the<br />

organisational structure, <strong>and</strong> sharing the responsibility for completion of the annual IG<br />

Toolkit assessments. It is therefore vital to the development of best practices which are<br />

acceptable, practicable, ‘owned’ <strong>and</strong> therefore better supported across the whole <strong>Trust</strong>,<br />

<strong>and</strong> influences the integration <strong>and</strong> inclusion of IG st<strong>and</strong>ards with other governance,<br />

strategies, work programmes <strong>and</strong> projects, e.g. IT programmes.<br />

The IGSG is accountable to the <strong>Trust</strong> <strong>Board</strong> through the Executive Chief Information<br />

Officer, the named Director on the <strong>Board</strong> with responsibility for Information Governance<br />

(IG). This post is supported by the Director of Clinical Strategy who is the <strong>Trust</strong>’s<br />

Caldicott Guardian, the Head of Commissioning, Information <strong>and</strong> Planning, the IG Lead<br />

<strong>and</strong> members of the IGSG. The IGSG is a sub-group of the Quality <strong>and</strong> Safety<br />

Committee. Terms of Reference <strong>and</strong> membership of the IGSG are defined in the <strong>Trust</strong><br />

document, ‘Information Governance Steering Group Terms of Reference’.<br />

Developing an IG culture within the <strong>Trust</strong> will be achieved through IG training being<br />

provided as part of the <strong>Trust</strong>’s m<strong>and</strong>atory corporate induction programme for new<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 4 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


starters as well as being m<strong>and</strong>atory for all <strong>Trust</strong> staff as part of the <strong>Trust</strong>’s IG training<br />

program, requiring all staff to undertake IG training annually, either at face to face<br />

presentations or by e-learning.<br />

The Director of Clinical Governance <strong>and</strong> the Executive Chief Information Officer will<br />

ensure that IG requirements are reflected in the annual Clinical Governance<br />

Development plan <strong>and</strong> ICT strategy.<br />

IG PROCESS<br />

The wide range of processes covered by the IG Toolkit <strong>and</strong> the diversity of specialisation<br />

resulted in the IGSG taking the decision that responsibility for IG within the <strong>Trust</strong> should not<br />

be allocated to one individual or department. The <strong>Trust</strong> approach is to identify senior<br />

managers who will have responsibility for the management <strong>and</strong> co-ordination of IG<br />

Requirements. These senior staff will be Executive Directors, Directorate Managers or, in<br />

some cases, General Managers. They will be referred to in IG documentation as<br />

Requirement Owners. All Requirement Owners will be full members of the Information<br />

Governance Steering Group. Other staff with specific areas of expertise will be co-opted onto<br />

the Group when required.<br />

As there is often an overlap between IG Requirements, by agreement; one Requirement<br />

Owner may provide evidence for another IG Requirement. However, the identified<br />

Requirement Owner has ultimate responsibility for ensuring that the Requirement is complete<br />

<strong>and</strong> with evidence uploaded to support the compliance level.<br />

The IG Lead will be supporting the st<strong>and</strong>ard owners in developing their action plans, <strong>and</strong> is<br />

responsible for submitting the baseline, performance <strong>and</strong> final assessment to CfH. The<br />

Director of Planning <strong>and</strong> Performance will sign off a report from the IG Toolkit, to confirm he<br />

has authorised the final submission for 31st March 2013.<br />

The <strong>Trust</strong>’s IG performance will be monitored by the IGSG throughout the year with reports<br />

that monitor achievements against requirements. These regularly presented reports <strong>and</strong><br />

minutes of the IGSG meetings where they were approved, will provide the evidence to be<br />

uploaded into the IG Toolkit.<br />

In February 2013 an independent audit will be undertaken of a selection of IG st<strong>and</strong>ards, to<br />

highlight to st<strong>and</strong>ard owners changes <strong>and</strong> improvements required before the final<br />

submission.<br />

PAST PERFORMANCE<br />

Although in 2010/11 64% IG compliance was reported to CfH, following further review the<br />

IGSG considered that evidence submitted needed strengthening, policies <strong>and</strong> procedures<br />

needed to be improved <strong>and</strong> updated, <strong>and</strong> the IGSG governance strengthened to reflect a<br />

more structured approach to completing the requirements. With a baseline return of only 9%<br />

in July 2011, reliance was being placed on old evidence submitted, which was now either not<br />

fit for purpose or required updating.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 5 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


The IGSG was changed to ensure that attendance at meetings was improved with deputies<br />

attending in place of absentees. In addition minutes were more structured to accurately<br />

reflect the subjects discussed, outst<strong>and</strong>ing <strong>and</strong> completed action logs were developed to<br />

ensure action points were resolved, <strong>and</strong> an overall IG action plan was added as a regular<br />

agenda item. To support the evidence required for the st<strong>and</strong>ards <strong>and</strong> ensure IG key subjects<br />

are regularly discussed, monthly, quarterly <strong>and</strong> yearly reports were introduced with a<br />

st<strong>and</strong>ard format for presentation.<br />

It was also identified that IG awareness needed improving across the organisation. To<br />

support this the intranet pages were rebr<strong>and</strong>ed <strong>and</strong> improved to provide a good source of<br />

information for staff, including grouping all IG policies in one place for ease of reference. An<br />

IG local brochure was also developed to be given to staff at training sessions.<br />

In light of the Department of Health (DH) requirement to train staff annually in Information<br />

Governance, the current training presentation was rebr<strong>and</strong>ed to incorporate all aspects of<br />

Information Governance, <strong>and</strong> added to the Central Induction to capture all new starters. An<br />

e-learning system was also procured which reflected the IG content of face to face training<br />

sessions, to improve the choice to staff for completing their training <strong>and</strong> the potential to<br />

achieve the requirements of CfH for 95% of staff to be trained annually.<br />

Improvements were also made to the information given to patients <strong>and</strong> service users, by<br />

rebr<strong>and</strong>ing the <strong>Trust</strong> website pages <strong>and</strong> updating the patient information leaflet.<br />

An audit was undertaken of the IG policies <strong>and</strong> procedures, <strong>and</strong> any gaps where these were<br />

missing or out of date, allocated to areas to resolve.<br />

These improvements enabled us to submit a final assessment of 62%.<br />

<strong>2012</strong>/13 PERFORMANCE<br />

With a strengthened IGSG the overall managerial commitment has improved, including joint<br />

working between st<strong>and</strong>ards owners where the st<strong>and</strong>ard covers several areas.<br />

Several st<strong>and</strong>ard owners have also developed action plans for their st<strong>and</strong>ards <strong>and</strong> uploaded<br />

evidence currently available, rather than waiting until the final submission date. As such the<br />

baseline return submitted 31 st July <strong>2012</strong> was 28%. However, it was noted that further<br />

improvements are required in:<br />

• All members of the IGSG regularly attending the IGSG<br />

• The presentation of all reports required to the IGSG<br />

• All polices <strong>and</strong> procedures identified as requiring updating/creation completed in<br />

<strong>2012</strong>/2013<br />

• All st<strong>and</strong>ard owners reviewing the IG Toolkit st<strong>and</strong>ards <strong>and</strong> removing out of date<br />

information<br />

• All st<strong>and</strong>ard owners developing action plans for each of their st<strong>and</strong>ards to chart their<br />

progress<br />

There is a commitment by the IGSG to achieve at least a level 2 in all 45 st<strong>and</strong>ards, which as<br />

required by the CfH will provide satisfactory assurance of the <strong>Trust</strong>’s IG compliance.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 6 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


The st<strong>and</strong>ards are split into the areas of information governance management, confidentiality<br />

& data protection assurance, information security assurance, clinical information assurance,<br />

secondary use assurance <strong>and</strong> corporate information assurance. As such the st<strong>and</strong>ard<br />

owners have been allocated reflecting their knowledge <strong>and</strong> skill set in the subjects, to ensure<br />

both an underst<strong>and</strong>ing of the requirements <strong>and</strong> an ability to achieve these.<br />

To make sure adequate progress is being made with all st<strong>and</strong>ards, all st<strong>and</strong>ard owners will<br />

be presenting their individual action plans at the September <strong>2012</strong> IGSG. This will highlight<br />

any potential barriers to achieving the level 2 required, which as appropriate will be fed<br />

through to the <strong>Trust</strong> <strong>Board</strong>.<br />

In addition, recommendations from the 2011/12 internal audit of 20 IG Toolkit st<strong>and</strong>ards<br />

received in August <strong>2012</strong> will be developed into an action plan agreed with the Executive<br />

Director of Planning <strong>and</strong> Performance. Where appropriate, these will then be incorporated<br />

into the individual st<strong>and</strong>ard action plans to ensure compliance.<br />

The over-arching IG action plan (see below) continues to be reviewed at the IGSG, <strong>and</strong> in<br />

co-ordination with the individual st<strong>and</strong>ard action plans there is the potential to achieve at<br />

least 73% compliance rate by the final return on 31 st July 2013.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 7 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


Over-arching IG action plan<br />

Action Plan for improvements to IG compliance<br />

Task Programme of work Task owner Current<br />

status<br />

Status<br />

date<br />

1 Consistent attendance from all<br />

st<strong>and</strong>ard owners in IGSG <strong>and</strong><br />

support for IG Toolkit compliance<br />

2 Submission of monthly, quarterly<br />

<strong>and</strong> yearly reports to IGSG<br />

3 Review latest version of IG toolkit<br />

to identify any changes to<br />

requirements<br />

3a Advise all st<strong>and</strong>ard owners of<br />

requirements/function changes<br />

<strong>and</strong> need to start work on version<br />

10<br />

3b<br />

Remove out of date information<br />

on Version 10 of IG toolkit <strong>and</strong><br />

upload current information where<br />

available<br />

4 Development of st<strong>and</strong>ard owner<br />

action plans<br />

4a Presentation of st<strong>and</strong>ard owner<br />

action plans at September IGSG<br />

4b Further discussion concerning<br />

st<strong>and</strong>ard owner action plans<br />

5 Submission of baseline return by<br />

31/07/12<br />

6 Updating of IG policies required<br />

out of date to IGSG for approval<br />

7 Review of IG toolkit report from<br />

auditors<br />

7a Formulate <strong>Trust</strong> response to<br />

audit report<br />

7b Incorporation of auditor<br />

comments into st<strong>and</strong>ard owner<br />

action plans<br />

8 Conclude distribution of IG local<br />

Guide<br />

9 Update e-learning instructions for<br />

IG module <strong>and</strong> include on the<br />

Intranet<br />

10 Promote annual training<br />

requirement via the Link,<br />

updating Learning &<br />

Development prospectus<br />

St<strong>and</strong>ard<br />

owners<br />

St<strong>and</strong>ard<br />

owners<br />

Completion<br />

due date<br />

In progress 02/10/<strong>2012</strong> On going<br />

through the<br />

year<br />

In progress 02/10/<strong>2012</strong> On going<br />

through the<br />

year<br />

SB Completed 01/06/<strong>2012</strong> 01/06/<strong>2012</strong><br />

SB Completed 01/06/<strong>2012</strong> 01/06/<strong>2012</strong><br />

St<strong>and</strong>ard<br />

owners<br />

St<strong>and</strong>ard<br />

owners<br />

St<strong>and</strong>ard<br />

owners<br />

St<strong>and</strong>ard<br />

owners<br />

In progress 02/10/<strong>2012</strong> Imminent<br />

for<br />

remaining<br />

st<strong>and</strong>ard<br />

owners<br />

In progress 02/10/<strong>2012</strong> Imminent<br />

for<br />

remaining<br />

st<strong>and</strong>ard<br />

owners<br />

Completed 02/10/<strong>2012</strong> 26/09/<strong>2012</strong><br />

To start 02/10/<strong>2012</strong> 22/10/<strong>2012</strong><br />

SB Completed 31/07/<strong>2012</strong> 31/07/<strong>2012</strong><br />

St<strong>and</strong>ard On going 02/10/<strong>2012</strong> 31/12/<strong>2012</strong><br />

owners<br />

NM/SB/NMk Completed 22/08/<strong>2012</strong> 24/08/<strong>2012</strong><br />

NM/SB/NMk To start 22/08/<strong>2012</strong> 30/09/<strong>2012</strong><br />

St<strong>and</strong>ard<br />

owners<br />

To start 02/10/<strong>2012</strong> 31/10/<strong>2012</strong><br />

SB Started 02/10/<strong>2012</strong> on-going via<br />

training<br />

courses<br />

SB Completed 17/05/<strong>2012</strong> 17/05/<strong>2012</strong><br />

SB Completed 17/05/<strong>2012</strong> 17/05/<strong>2012</strong><br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 8 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


10a Reapproval of IG training<br />

programme with DOH<br />

11 Sub group to review risk<br />

assessments/information flows<br />

from Parkhill project<br />

11a Ensure current risk register<br />

captures all systems <strong>and</strong><br />

appropriate risk owners<br />

11b<br />

11c<br />

Proposal from Auditors of IG<br />

work programme for <strong>2012</strong>/13 for<br />

improving risk assessment <strong>and</strong><br />

information flow st<strong>and</strong>ards<br />

Auditor IG work programme roll<br />

out<br />

12 Submit IG Toolkit performance<br />

return by 31/10/12 deadline<br />

13 Fax directory - work to identify all<br />

fax numbers, ensure<br />

confidentiality posters displayed,<br />

update fax directory on the<br />

intranet<br />

14 Distribute Patient Information<br />

Leaflets<br />

15 Review Data Quality processes -<br />

linked with Data Quality Group<br />

16 Review Business Continuity<br />

Management plans<br />

SB To start 02/10/<strong>2012</strong> Imminent<br />

Sub-group Completed 30/05/<strong>2012</strong> 30/05/<strong>2012</strong><br />

SB/Subgroup<br />

NMk/agreed<br />

with NM<br />

NMk in coordination<br />

with SB<br />

To start 02/10/<strong>2012</strong> 31/12/<strong>2012</strong><br />

Completed 31/07/<strong>2012</strong> 31/07/<strong>2012</strong><br />

Started 02/10/<strong>2012</strong> 30/10/<strong>2012</strong><br />

SB To start 02/10/<strong>2012</strong> 31/10/<strong>2012</strong><br />

SB/Telecoms To start 02/10/<strong>2012</strong> 31/12/<strong>2012</strong><br />

GE In progress 02/10/<strong>2012</strong> on-going<br />

CB To start 02/10/<strong>2012</strong> on-going<br />

DB/JH In progress 02/10/<strong>2012</strong> 31/12/<strong>2012</strong><br />

17<br />

Development of survey monkey<br />

training evaluation forms SB In progress 02/10/<strong>2012</strong> 31/12/<strong>2012</strong><br />

17a Sending of evaluation forms SB To start 02/10/<strong>2012</strong> 31/01/2013<br />

17b<br />

Evaluation of training evaluation<br />

forms SB To start 02/10/<strong>2012</strong> 28/02/2013<br />

18<br />

Review <strong>and</strong> update Information<br />

Governance Information on the<br />

<strong>Trust</strong> website SB Completed 22/08/<strong>2012</strong> 22/08/<strong>2012</strong><br />

18a<br />

Update FOI Publication Scheme,<br />

update on website SB To start 02/10/<strong>2012</strong> 28/02/2013<br />

19<br />

Arrange audit date for <strong>2012</strong>/13<br />

Toolkit return NM/SB To start 02/10/<strong>2012</strong> 31/12/<strong>2012</strong><br />

20<br />

All evidence uploaded to IG<br />

toolkit<br />

St<strong>and</strong>ard<br />

owners To start 02/10/<strong>2012</strong> 15/03/2013<br />

20a<br />

Final review of evidence,<br />

marking all st<strong>and</strong>ards as<br />

complete SB To start 02/10/<strong>2012</strong> 25/03/2013<br />

20b Sign off of final IG toolkit return NM To start 02/10/<strong>2012</strong> 28/03/2013<br />

20c<br />

Submission of final IG toolkit<br />

return by 31/03/13 deadline SB To start 02/10/<strong>2012</strong> 29/03/2013<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 9 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


EXECUTIVE SUMMARY<br />

TITLE:<br />

<strong>Board</strong> Assurance Framework – <strong>2012</strong> Quarter 2<br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong><br />

DATE:<br />

Attached is the <strong>Board</strong> Assurance Framework for the second quarter of<br />

<strong>2012</strong>.<br />

The purpose of the BAF is for the risks which impact on the <strong>Trust</strong>’s strategic<br />

& principal objectives to be assessed <strong>and</strong> current controls reviewed to<br />

provide assurance to the <strong>Board</strong> that mitigating actions are undertaken to<br />

reduce the impact <strong>and</strong> risk level.<br />

Progress<br />

Following detailed review at the October <strong>Trust</strong> Executive Committee,<br />

elements of the BAF have been amended to reflect a more detailed risk<br />

profile. This continues to be work in progress.<br />

The following improvements have been made:<br />

1. The recommendations from the recent TEC meeting have been<br />

implemented.<br />

2. Risk Review forms were introduced to ensure efficiency of risk<br />

reporting.<br />

3. Closure Forms were introduced to ensure that Clinical Directors<br />

<strong>and</strong> General Managers gave approval for risk closure<br />

4. Corporate Risk Register training including the use of controlling<br />

documents is ongoing<br />

5. Evidence of updated Action plans for each Extreme <strong>and</strong> High Risk will<br />

streamline management of the BAF <strong>and</strong> is ongoing.<br />

□ TEC ……….. □ STRATEGY……….…..…<br />

□ FINANCE ……..……… □ AUDIT ………….<br />

□ QUALITY & SAFETY<br />

…………..………….....……….…<br />

□ WORKFORCE<br />

………………………………………….…<br />

□ CHARITABLE FUNDS<br />

………………………………...…<br />

□ TRUST BOARD<br />

……………………………….……….….<br />

□ REMUNERATION<br />

………………………………….….....<br />

□ OTHER …………………………..……. (please<br />

specify)<br />

6. Continued review has resulted in the following changes to the BAF this<br />

month: Risks Removed or Added to the BAF:<br />

<strong>Trust</strong> Information<br />

Status<br />

Ref:<br />

339 Complaints has been removed from the BAF Removed<br />

the controls have reduced the residual risk<br />

impact on the <strong>Trust</strong>s but it would remain on<br />

the corporate risk register <strong>and</strong> monitored via<br />

action plans<br />

311 Potential severe disruption to services arising Removed<br />

from the removal of London Deanery posts pose<br />

major difficulties in the delivery of quality care at<br />

KGH obstetric services. This risk was removed<br />

following TEC review, this was approved by<br />

the Clinical Director<br />

323 Risk of adverse impact on profitability due to Removed<br />

introduction of new London wide GU <strong>and</strong> FP<br />

Tariff in April <strong>2012</strong>, this risk would be<br />

managed within the Women Directorate<br />

342 Risks: Executive leadership changes would Removed<br />

compromise the strategic agenda This risk<br />

was closed by the CEO because of<br />

successful recruitment of suitable strategic<br />

directors to progress BHRUT's plans / goals.<br />

341 End of life Strategy because the internal<br />

control <strong>and</strong> action plan was instrumental in<br />

reducing the risk scoring <strong>and</strong> there is<br />

reasonable assurance that it is managed<br />

adequately with the aid of the Life <strong>Board</strong>s<br />

Removed<br />

1


343 Directorate Anaesthetic:<br />

Risk: Failure to comply with NSPA directive<br />

(see BAF P.7 for more details)<br />

Added /<br />

New<br />

7. Action Plans<br />

Monthly review <strong>and</strong> management of the action plans in place to mitigate all<br />

of the extreme <strong>and</strong> high risks is in place.<br />

2. DECISION REQUIRED: CATEGORY:<br />

The <strong>Trust</strong> <strong>Board</strong> is asked to note the changes to the BAF.<br />

□ NATIONAL TARGET<br />

□ CQC REGISTRATION<br />

□ RMS<br />

□ HEALTH & SAFETY<br />

X ASSURANCE FRAMEWORK<br />

□ CQUIN/TARGET FROM COMMISSIONERS<br />

□ CORPORATE OBJECTIVE<br />

……………………………....<br />

□ OTHER …………………….. (please specify)<br />

AUTHOR/PRESENTER Pam Strange Clinical<br />

Governance Director/ Donna Kinnair, Director of<br />

Governance<br />

DATE: 26th October <strong>2012</strong><br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

4. DELIVERABLES<br />

<strong>Trust</strong> key objectives.<br />

5. KEY PERFORMANCE INDICATORS<br />

As detailed in the BAF.<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________<br />

2<br />

EXECUTIVE SUMMARY/ Clinical Governance Pam Strange


BOARD ASSURANCE FRAMEWORK <strong>2012</strong><br />

2nd Quarter: July to September <strong>2012</strong><br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

1


Table of Contents<br />

TRUST PRINCIPAL OBJECTIVES ........................................................................................................................................................... 3<br />

BHRUT STRATEGIC OBJECTIVES WITH EACH PRINCIPAL OBJECTIVE ............................................................................................ 4<br />

BHRUT RISK TREND ANALYSIS FOR 2007- <strong>2012</strong> .................................................................................................................................. 5<br />

RISKS DETAILS ........................................................................................................................................................................................ 8<br />

Strategic Objective 1 – Deliver Safe, Quality Effective Care ............................................................................................................................... 8<br />

Strategic Objective 4: Services Are Rated Positively By Patients. Families & All Stakeholders ................................................................... 13<br />

Strategic Objective 5 – To Ensure BHRUT is Financially Secure...................................................................................................................... 14<br />

RISK DESCRIPTORS.............................................................................................................................................................................. 16<br />

TABLE: RISK SCORING = SEVERITY X LIKELIHOOD (S X L) .......................................................................................................................... 17<br />

BOARD ASSURANCE FRAMEWORK ELEMENTS .............................................................................................................................................. 18<br />

CARE QUALITY COMMISSION: Regulations <strong>and</strong> Outcome Guide ................................................................................................................... 19<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

2


TRUST PRINCIPAL OBJECTIVES<br />

BHRUT Strategic Objectives are: To Deliver Safe, Quality <strong>and</strong> Effective Care, To Deliver Operational Excellence ensuring that all st<strong>and</strong>ards are met, To<br />

Provide a First -Class Educational Experience, Services are Rated Positively by Patients, Families <strong>and</strong> all Stakeholders, Ensure that BHRUT’s <strong>Trust</strong> is<br />

Financially Secure <strong>and</strong> Staff Actively engaged in the Success of the <strong>Trust</strong>.<br />

Introduction: The <strong>Board</strong> Assurance Framework (BAF) evidences the <strong>Board</strong> control over delivery of its principle objectives. The BAF directly underpins the<br />

annual statement on Internal Control (SIC) <strong>and</strong> is the subject of annual enquiry by its host commissioning body <strong>and</strong> Internal <strong>and</strong> External Audit.<br />

Function of the BAF<br />

The BAF is a tool for the <strong>Board</strong> corporately to assure itself (be assured based on evidence) about successful delivery of the organisation’s principle objectives.<br />

The framework is designed to focus the <strong>Board</strong> on controlling principle risks threatening the delivery of those objectives. The BAF aligns principle risks, key<br />

controls <strong>and</strong> assurances on controls alongside each objective. Gaps are identified where key controls <strong>and</strong> assurances are insufficient to reduce the risk of<br />

non-delivery of objectives. This enables the <strong>Board</strong> to develop <strong>and</strong> subsequently monitor a <strong>Board</strong> Assurance Action Plan for closing gaps. The Direction of the<br />

<strong>Board</strong> in these matters ensures appropriate allocation of resources to improve the effectiveness of management.<br />

The process <strong>and</strong> purpose of the BAF may be summarised as:<br />

• Description of the risks which present a major threat to achievement of any of the objectives <strong>and</strong> are not well controlled.<br />

• Identify <strong>and</strong> evaluate the design of key controls intended to manage these principle risks, underpinned by self assessment against the Care Quality<br />

Commission regulated st<strong>and</strong>ards.<br />

• BHRUT CQC development action plan is referenced to each risk on the BAF<br />

• All significant risks whether to the objectives or otherwise are also described on the <strong>Trust</strong> Risk Register. Those risks are identified initially through<br />

review of the objectives themselves. Alternatively they may initially be identified by Directorates as operational risks.<br />

• The BAF <strong>and</strong> the Risk Register will provide confirmation that there are action plans to put in place controls for the risks they contain <strong>and</strong> that there is<br />

assurance that plans <strong>and</strong> controls are robust.<br />

• Those risks which present a major threat to any of the objectives <strong>and</strong> are not well controlled are defined <strong>and</strong> graded as Extreme (red). By definition all<br />

the <strong>Trust</strong>’s residual Extreme risks appear on the BAF. Q1 BAF: An action plan would be attached Extreme risks.<br />

• Significant risks which require high level attention but do not present a major threat to any of the objectives are defined <strong>and</strong> graded as residual High<br />

(orange) <strong>and</strong> are described on the Risk Register but not on the BAF unless a potential for major threat.. Oversight of their control <strong>and</strong> assurance is<br />

allocated to the responsible Directorate. This is monitored <strong>and</strong> tracked by the Compliance Team at the Directorate level.<br />

• Extreme risks that threaten any of the objectives but which then become better controlled will be downgraded to a less threatening High or Moderate<br />

risks will be relegated from the BAF to the Risk Register alone <strong>and</strong> oversight of their control will be allocated to the responsible Directorate.<br />

• The Framework will be reviewed by the Audit Committee at each meeting <strong>and</strong> by the <strong>Board</strong> quarterly.<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

3


BHRUT STRATEGIC OBJECTIVES WITH EACH PRINCIPAL OBJECTIVE<br />

VISION: BHRUT is a flourishing Foundation <strong>Trust</strong> providing first class services to patients <strong>and</strong> families,<br />

in which the public <strong>and</strong> commissioner’s have full confidence<br />

MISSION: To become a Foundation <strong>Trust</strong><br />

THERE ARE 6 STRATEGIC OBJECTIVES<br />

1. DELIVER SAFE,<br />

QUALITY, EFFECTIVE<br />

CARE<br />

2. DELIVER OPERATIONAL<br />

EXCELLENCE ENSURING<br />

THAT ALL STANDARDS ARE<br />

MET<br />

3. TO PROVIDE A FIRST<br />

CLASS EDUCATIONAL<br />

EXPERIENCE<br />

4. SERVICES ARE RATED<br />

POSITIVELY BY PATIENTS,<br />

FAMILIES & ALL<br />

STAKEHOLDERS<br />

5. TO ENSURE BHRUT<br />

TRUST IS FINANCIALLY<br />

SECURE<br />

6. STAFF ACTIVELY<br />

ENGAGED IN SUCCESS OF<br />

TRUST<br />

THERE ARE 4 PRINCIPAL OBJECTIVES FOR EACH STRATEGIC OBJECTIVE<br />

Ensure that robust plans<br />

are in place to produce <strong>and</strong><br />

deliver the Schedule of<br />

Information (Quality<br />

Accounts)<br />

Achieving excellence in<br />

patient safety <strong>and</strong> clinical<br />

effectiveness including:<br />

Developing <strong>and</strong> using<br />

technology <strong>and</strong> information<br />

systems to improve quality<br />

Deliver all local / national<br />

st<strong>and</strong>ards <strong>and</strong> targets<br />

including comply with CQC,<br />

RMS & HSE regulations.<br />

To ensure service line<br />

reporting is fully established<br />

<strong>and</strong> working effectively<br />

To increase service quality,<br />

delivery <strong>and</strong> choice<br />

Ensuring learners <strong>and</strong> new staff<br />

have an excellent experience<br />

<strong>and</strong> that all elements of<br />

education <strong>and</strong> training are<br />

delivered in a safe environment<br />

for patients, staff <strong>and</strong> learners.<br />

All staff to undergo a high<br />

quality Personal Development<br />

Plan, identifying opportunities<br />

for staff development<br />

To embed a reputation of being<br />

a high performing <strong>Trust</strong> with the<br />

best outcomes for patients<br />

,families, visitors, all<br />

stakeholders & the media<br />

Continuous improvements to<br />

be demonstrated in staff &<br />

patient surveys (locally &<br />

nationally)<br />

Maintain efficient economic<br />

use of resources : costs<br />

reduced productivity improved<br />

income collected<br />

Ensure capital programme is<br />

effectively prioritised.<br />

Staff have the necessary<br />

values <strong>and</strong> behaviors to<br />

enhance the quality of the<br />

patient experience through<br />

education, training <strong>and</strong><br />

Personal <strong>and</strong> Professional<br />

development<br />

To establish the correct<br />

governance arrangements<br />

<strong>and</strong> ensuring we recruit <strong>and</strong><br />

retain staff to deliver our<br />

objectives<br />

Maintain patient flow at all<br />

times through the<br />

organisation<br />

- 4 Hour<br />

- Cancer<br />

- 18 Weeks<br />

-<br />

To ensure the patient<br />

safety agenda is fully<br />

established in all areas of<br />

the <strong>Trust</strong>.<br />

A system to ensure that<br />

infection, prevention <strong>and</strong><br />

control is in place<br />

Full achievement of all<br />

contract KPIs & CQUIN<br />

indicators resulting in<br />

maximum contract<br />

income<br />

Achievement of all m<strong>and</strong>atory<br />

training targets<br />

Robust & successful systems<br />

in place for succession<br />

planning & talent<br />

management<br />

To fully embed the patient<br />

experience framework &<br />

demonstrate improvements<br />

made to patient experience<br />

Improve stakeholders<br />

relationship to deliver a<br />

seamless service that improves<br />

health outcomes for patients /<br />

service users<br />

The CIP be delivered fully to<br />

the agreed timescales without<br />

affecting the quality of care<br />

adversely<br />

Meet our in-year<br />

financial targets<br />

(including net<br />

I&E surplus, liquidity,<br />

Productivity)<br />

Ensure that capacity <strong>and</strong><br />

dem<strong>and</strong> planning is based on<br />

robust health <strong>and</strong> workforce<br />

demographic information<br />

To manage a positive,<br />

inclusive <strong>and</strong> engaging<br />

culture within the <strong>Trust</strong><br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

4


BHRUT RISK TREND ANALYSIS FOR 2007- <strong>2012</strong><br />

CORPORATE RISKS ON BAF<br />

6<br />

High<br />

Extreme<br />

45<br />

40<br />

CURRENT RISKS ON CORPORATE RISK REGISTER<br />

43<br />

34<br />

Low<br />

Moderate<br />

High<br />

Extreme<br />

6<br />

4<br />

2<br />

1<br />

35<br />

30<br />

25<br />

20<br />

15<br />

10<br />

7<br />

12<br />

0<br />

High<br />

Extreme<br />

5<br />

0<br />

Low Moderate High Extreme<br />

CORPORATE RISKS BY TYPE<br />

4 2 6<br />

Risks on the BAF: The BAF only reflects residual risks after controls / assurance have been<br />

agreed. Currently there are 2 High <strong>and</strong> 7 Extreme risks.<br />

Risks Removed:<br />

17<br />

Risk 339: Complaints has been removed from the BAF, the controls have reduced the<br />

residual risk but it would remain on the corporate risk register <strong>and</strong> monitored via action plans.<br />

30<br />

Risk 323: Risk of adverse impact on profitability due to introduction of new London wide GU<br />

<strong>and</strong> FP Tariff in April <strong>2012</strong>, this risk would be managed within the directorate<br />

18<br />

19<br />

Accreditation<br />

Clinical<br />

Health & Safety<br />

Finance<br />

Service Delivery<br />

Security<br />

Reputation<br />

Risk 341: End of life Strategy. The internal control <strong>and</strong> action plan was instrumental in<br />

reducing the risk scoring <strong>and</strong> there is reasonable assurance that it is managed adequately<br />

with the aid of the Life <strong>Board</strong>s<br />

Risk 311: Potential severe disruption to services arising from the removal of London Deanery<br />

posts pose major difficulties in the delivery of quality care at KGH obstetric services. The<br />

London Deanery agreed plans have removed the risks.<br />

It is evident that the Internal risk management processes have successfully reduced the<br />

number of corporate of risk by mitigating the risk either with local resources or closure<br />

because the risk no longer impacts the Department or the <strong>Trust</strong> objectives. This is widely<br />

contributed by the willingness of management <strong>and</strong> employees to embrace the BHRUT risk<br />

management framework of action plan, risk validation forms, closure forms <strong>and</strong> exception<br />

reporting.<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

5


DIRECTORATES RISKS REVIEW<br />

12<br />

10<br />

8<br />

6<br />

4<br />

2<br />

0<br />

3<br />

2<br />

Acute Med<br />

Anaest.<br />

Child ren<br />

3<br />

NO. OF RISKS BY DIRECTORATES<br />

11<br />

0<br />

6<br />

4<br />

0<br />

Emerg.Care<br />

Neuro Scie<br />

Pathology<br />

Radiology<br />

Surgery<br />

9<br />

6 6<br />

10<br />

Spec. Surg<br />

Spec.M ed<br />

Supp. Serv<br />

Women<br />

Estates<br />

1<br />

1<br />

0.9<br />

0.8<br />

0.7<br />

0.6<br />

0.5<br />

0.4<br />

0.3<br />

0.2<br />

0.1<br />

0<br />

ANAESTHETIC RISKS<br />

1<br />

1<br />

0<br />

0<br />

Low Moderate High Extreme<br />

EM ERGENCY CARE RISKS<br />

WOMEN RISKS<br />

7<br />

6<br />

7<br />

6<br />

6<br />

5<br />

4<br />

3<br />

2<br />

1<br />

1<br />

2<br />

1<br />

5<br />

4<br />

3<br />

2<br />

1<br />

1<br />

3<br />

0<br />

0<br />

Low Moderate High Extreme<br />

0<br />

Low Moderate High Extreme<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

6


SPECIALISTS MEDICINE RISKS<br />

SUPPORT SERVICES RISKS<br />

4<br />

6<br />

4<br />

3.5<br />

6<br />

5<br />

3<br />

2.5<br />

2<br />

1.5<br />

1<br />

0.5<br />

0<br />

0<br />

1 1<br />

Low Moderate High Extreme<br />

4<br />

3<br />

2<br />

1<br />

0<br />

0 0<br />

Low Moderate High Extreme<br />

0<br />

New Risk on the Corporate Risk Register<br />

<strong>Trust</strong> Reference: 343<br />

Area: Directorate Anaesthetic:<br />

Risk: Failure to comply with NSPA Alert to change over to a non-Luer connection on needles used for Neuroaxial procedures can potentially cause serious harm to patients<br />

Controls: All current safety measures are in keeping with recommendations made by the Royal Colleges of Anaesthesia <strong>and</strong> Pharmacology. NPSA has recommended the use<br />

of one system but this is at present untested <strong>and</strong> potentially unsafe. All Anaesthetic <strong>and</strong> Pharmacology Professional Agencies <strong>and</strong> the Medical Director for NHSL have voiced<br />

concern in proceeding to the change without assurance of safety. Paper presented to Quality <strong>and</strong> Safety for decision on way forward where it was agreed that it would be unwise<br />

to invest in an untested <strong>and</strong> potentially unsafe system <strong>and</strong> this would be raised with the Commissioners.<br />

Directorates<br />

The Directorates that are not reflected currently on the BAF have risks that are controlled within their own Directorate <strong>and</strong> mirrored on their locals risk registers. All risks are<br />

renewed regularly.<br />

The Directorates are increasingly building their local risk management systems by a continuous process which is dem<strong>and</strong>ing awareness <strong>and</strong> proactive action. The drivers are to<br />

base each risk on reducing the likelihood <strong>and</strong> consequences of adverse impacts on agreed objectives <strong>and</strong> on increasing the opportunities for improvement.<br />

This requires infusing risk management into organisational culture <strong>and</strong> everyday business operations including planning, reporting <strong>and</strong> governance. This is monitored by the<br />

Clinical Governance team.<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

7


RISKS DETAILS<br />

PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Strategic Objective 1 – Deliver Safe, Quality Effective Care<br />

Principal Objective: Achieving excellence in patient safety <strong>and</strong> clinical effectiveness – Corporate Clinical<br />

Risk No 87: The inability<br />

to manage patient flow<br />

through the <strong>Trust</strong> could<br />

result in patients<br />

attending the ED<br />

experiencing delays in<br />

care <strong>and</strong> treatment which<br />

would be detrimental to<br />

patient safety <strong>and</strong><br />

experience.<br />

Date on Register: 01.04.2009<br />

Rating Scoring: Impact:4 x<br />

Likelihood:4 = 16<br />

Area: Emergency Care<br />

<strong>Trust</strong> Objective: To deliver 95%<br />

of patients seen in 4 hours<br />

Impact on:<br />

Patient: Patient safety<br />

Staff: increase stress levels,<br />

workforce development <strong>and</strong><br />

recruitment<br />

Stakeholder: Confidence is<br />

compromised<br />

<strong>Trust</strong>: Viability of the <strong>Trust</strong><br />

Constantly monitored by TEC<br />

Paper presented to <strong>Trust</strong><br />

<strong>Board</strong> which addresses<br />

processes in place to reduce<br />

length of stay – Jonah<br />

programme will assist in this<br />

issue.<br />

Emergency Care Programme<br />

superseded by RESET<br />

programme approved by <strong>Trust</strong><br />

<strong>Board</strong><br />

4 9 6 16<br />

Extreme Risk<br />

(RESET) Rapid End to<br />

End Sustainable<br />

Emergency<br />

Transformation Steering<br />

Group <strong>and</strong> Programme<br />

<strong>Board</strong> in place.<br />

Transformation<br />

Reports to TEC <strong>and</strong> <strong>Trust</strong><br />

<strong>Board</strong><br />

This risk is cross<br />

referenced to the BHRUT<br />

CQC related<br />

development plan <strong>and</strong><br />

the references are G4 5<br />

6. 7 10 11 12 18 53 54<br />

Maintain improved resilience<br />

within the A&E systems <strong>and</strong><br />

throughput to the MAU<br />

There are 4 work -streams:<br />

• Emergency care<br />

• EMAU<br />

• Medicine<br />

• Care of the Elderly<br />

Work-streams plans are led by<br />

Consultants<br />

Emergency Care action plan<br />

is currently being audited for<br />

effectiveness.<br />

The focus is on<br />

Emergency Care <strong>and</strong><br />

Medicine <strong>and</strong> doesn’t<br />

include other speciality -<br />

these can impact on<br />

Emergency Departments<br />

waiting times <strong>and</strong> bed<br />

occupancy<br />

Failure to improve<br />

against the 95%<br />

compliance within<br />

the four hour<br />

st<strong>and</strong>ard<br />

Manpower<br />

resources to<br />

maintain systems<br />

Whilst<br />

improvement in<br />

trajectory is<br />

moving upward<br />

the day to day<br />

stability is<br />

variable resulting<br />

in increased<br />

number of<br />

breaches often<br />

during or<br />

immediately after<br />

the weekend<br />

Financial<br />

implication for the<br />

Directorate in<br />

delivering the<br />

programme.<br />

Claire Dixon (GM) / Dr Derek Hicks Clinical Director<br />

Details updated: 15.10.12<br />

There has been no major change<br />

Educating<br />

Directorates<br />

ensuring support<br />

for: Consultant<br />

leadership <strong>and</strong><br />

prompt discharge<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

8


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

Principal Objective: To ensure the patient safety agenda is fully established in all areas of the <strong>Trust</strong> – Nursing<br />

Risks No 251: Failure to Admission screening for all<br />

protect our patients<br />

elective <strong>and</strong> emergency<br />

against Health Care<br />

admissions.<br />

Associated Infections Decolonisation therapy for<br />

(HCAI’s)<br />

known positive patients.<br />

Limit set at 7 for MRSA Patients known to be<br />

Bacteraemia <strong>and</strong> 59 for previously positive are flagged<br />

on PAS.<br />

C.difficile<br />

Date on Register: 25.01.2010<br />

Rating Scoring: Impact:4 x<br />

Likelihood:4 = 16<br />

Area: <strong>Trust</strong><br />

Impact on:<br />

Patient: Poor patient outcomes<br />

Staff: Risk to <strong>Trust</strong> reputation<br />

affecting staff morale<br />

<strong>Trust</strong>: In year financial risk of<br />

every C.difficile cases over the<br />

limit <strong>and</strong> on ability for <strong>Trust</strong> to<br />

reach FT status<br />

Details updated: 24.10.<strong>2012</strong><br />

Detailed RCA of all<br />

bacteraemia led by DIPC.<br />

Daily reporting on MRSA<br />

bacteraemia numbers <strong>and</strong><br />

C.difficile<br />

CQC supporting actions have<br />

been completed<br />

Re-launching h<strong>and</strong> hygiene<br />

awareness training in<br />

September<br />

All clinical staff are being<br />

taught <strong>and</strong> assessed on<br />

aseptic non-touch technique<br />

started in July 3 sessions<br />

occurred – ( FY1 51junior<br />

doctors trained)<br />

8 16<br />

Extreme Risk<br />

RCA summary action<br />

sheets highlights key non<br />

compliances, screening<br />

of patients, appropriate<br />

decontamination of<br />

positive patients,<br />

documentation of such<br />

<strong>and</strong> the practice of blood<br />

culture taking. Training<br />

implementation of<br />

policies is actively<br />

reviewed.<br />

Internal –Internal Audit,<br />

Infection Prevention<br />

Control Committee<br />

External – CQC<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

A <strong>Trust</strong> wide RCA action plan<br />

has been developed.<br />

Learning from previous RCA’s<br />

– this is included in the annual<br />

infection prevention control<br />

plan for <strong>2012</strong>/ 2013<br />

Monthly action plan is being<br />

developed<br />

Plans to be developed for<br />

rapid reduction in rate of<br />

progress in C.difficile curve<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

MRSA trajectory target<br />

breached for <strong>2012</strong>, ( 8<br />

incidents)<br />

C.difficile 59 or<br />

exceeding this target<br />

with 38 cases mid year<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

Targets set but<br />

not achieved<br />

consistently<br />

because of lack<br />

of underst<strong>and</strong>ing<br />

<strong>and</strong> also<br />

insufficient<br />

implementation of<br />

the controls.<br />

Requires<br />

constant<br />

monitoring <strong>and</strong><br />

evaluation.<br />

LEAD<br />

Ian Hosein, Director of Infection Control<br />

Full review of all C difficile<br />

case to date to be undertaken<br />

to determine key themes on<br />

causation. Action to be<br />

completed by mid Nov. for<br />

review by DIPC<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

9


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Principal Objective: Deliver all local / national st<strong>and</strong>ards <strong>and</strong> targets including comply with CQC, RMS & HSE regulations - NHSLA<br />

Risks 298: Failure to achieve<br />

Level 2 Accreditation of Risk<br />

Management St<strong>and</strong>ards<br />

(RMS) which will achieve<br />

increased patient safety<br />

systems recognised by NHS<br />

Litigation Authority <strong>and</strong><br />

reduction in annual premium,<br />

causing increased scrutiny<br />

from external regulators.<br />

Date on Register: 17.08.2011<br />

Rating Scoring: Impact :4 x<br />

Likelihood:4 = 20<br />

Area: <strong>Trust</strong><br />

Impact on:<br />

Patient: Increased patient safety<br />

Staff: Morale <strong>and</strong> pride in care<br />

provided.<br />

<strong>Trust</strong>: The <strong>Trust</strong> sustaining<br />

progressive quality improvement<br />

measures<br />

Up-to-date gap analysis,<br />

Medical Devices Committee,<br />

Medical Records keeping<br />

committee, RMS co-ordinating<br />

committee.<br />

16<br />

High Risk<br />

Frequent meeting with<br />

Risk Management<br />

Criterion Leads the<br />

feedback is filtered in the<br />

gap analysis report<br />

Risk Management<br />

Steering Group monitors<br />

the status<br />

This risk is cross<br />

referenced to the BHRUT<br />

CQC related<br />

development plan <strong>and</strong><br />

the references are G 40 -<br />

45<br />

Proposal to provide a<br />

businesses case for staff to<br />

support the RMS process, job<br />

descriptions are currently<br />

reviewed in light of potential<br />

posts<br />

Review in resourcing as part<br />

of the clinical governance<br />

overview was presented to<br />

TEC <strong>and</strong> <strong>Trust</strong> <strong>Board</strong>.<br />

Quality <strong>and</strong> Safety Committee<br />

approved resource plan in<br />

principle. An “ invest to save”<br />

business case being<br />

developed against the<br />

achievement of level 2 <strong>and</strong> 3<br />

RMS st<strong>and</strong>ards.<br />

Financial resourcing<br />

required<br />

Areas of high risk:<br />

Medical Devices<br />

Lead Trainer,<br />

Centralised<br />

training records,<br />

Release of staff<br />

for training,<br />

Medical record<br />

keeping<br />

(documentation)<br />

Collecting<br />

evidence of Risk<br />

Management<br />

St<strong>and</strong>ards<br />

Storage of data<br />

(electronic)<br />

Lyn Wilson/ Pam Strange Clinical Governance Director<br />

Details updated: 15.10.12<br />

No change<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

10


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Principal Objective: To ensure a robust IM&T infrastructure to an improve our care <strong>and</strong> service delivery<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

11


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Risk No 340: The contract<br />

for the current PAS<br />

system provided by<br />

McKesson terminates on<br />

1 st April 2014. This is a<br />

national contract awarded<br />

via CFH. Following this<br />

date PAS will become<br />

“read only” <strong>and</strong> not<br />

available as a “live”<br />

system. Failure to<br />

procure another system in<br />

time will seriously<br />

compromise service<br />

delivery.<br />

Business case is going to the<br />

<strong>Trust</strong> <strong>Board</strong> for sign off <strong>and</strong><br />

NHS London for approval <strong>and</strong><br />

funding<br />

Received <strong>Trust</strong> board<br />

approval for replacement of<br />

PAS with the additional<br />

functionality of order<br />

communications.<br />

The recently appointed<br />

Chief Information Officer<br />

will review this risk as a<br />

priority on joining the<br />

<strong>Trust</strong>.<br />

The <strong>Trust</strong> must plan to<br />

procure <strong>and</strong> deploy a new<br />

PAS. This procurement<br />

process is at an advanced<br />

stage<br />

Awaiting on NHS London for<br />

ratification <strong>and</strong> financial<br />

approval<br />

None identified during<br />

review<br />

Reliant upon the<br />

timeliness of the<br />

approval process.<br />

The timeline is<br />

very tight, a<br />

typical PAS<br />

implementation is<br />

12 - 18 months<br />

19.6.<strong>2012</strong>: none<br />

identified to date<br />

Simon Adams IMT Manager<br />

Date on Register:13.04.<strong>2012</strong><br />

Rating Scoring:Impact:4 x<br />

Likelihood: 4 = 16<br />

11 21<br />

Extreme Risk<br />

Area: <strong>Trust</strong><br />

Impact on:<br />

Patient: Poor patient outcome<br />

Staff: Inability to access key<br />

information.<br />

<strong>Trust</strong>: major impact on service<br />

delivery including disruption to<br />

service<br />

Details updated: 25.09.<strong>2012</strong><br />

No change<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

12


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Strategic Objective 4: Services Are Rated Positively By Patients. Families & All Stakeholders<br />

Principal Objective: To embed a reputation of being a high performing <strong>Trust</strong> with the best outcomes for patients with all external stakeholder & the media<br />

Risk No: 258 Failure to<br />

provide timely quality of<br />

care will compromise the<br />

<strong>Trust</strong>s reputation which<br />

will impact on future<br />

service business,<br />

development & recruitment<br />

opportunities.<br />

Date on Register: 23.02.2011<br />

Rating Scoring: Impact: 3 x<br />

Likelihood:5 = 15<br />

Area: <strong>Trust</strong>-wide<br />

Impact on:<br />

Patient: Outcomes/ service/<br />

developments/achievements<br />

Staff: ~ Staff morale <strong>and</strong> staff<br />

engagement<br />

<strong>Trust</strong>: Media interest which<br />

compromised the <strong>Trust</strong> Reputation<br />

Quality <strong>and</strong> Safety Committee<br />

to identify root causes <strong>and</strong> to<br />

disseminate learning <strong>and</strong><br />

monitor improvements in care.<br />

Quality <strong>and</strong> Improvement plan<br />

focus <strong>and</strong> resource for<br />

improvement.<br />

Clinical Governance Team<br />

monitor Directorate<br />

implementation.<br />

16<br />

Extreme Red<br />

Quality & Safety<br />

Committee bi-monthly<br />

reviewed the risks<br />

Learning Lessons Group<br />

meeting identify trends<br />

from PALS, Complaints,<br />

Incidents <strong>and</strong> other<br />

feedback.<br />

Audit quarterly patient<br />

experience reports<br />

Reputational risks are<br />

escalated to the<br />

Executive <strong>and</strong> impending<br />

media coverage alerted<br />

to the <strong>Trust</strong> <strong>Board</strong>. <strong>Trust</strong><br />

<strong>Board</strong> is also made<br />

aware by satisfaction<br />

surveys<br />

CQC Action plan provides the<br />

knowledge of key issues <strong>and</strong><br />

concerns liable to affect<br />

reputation.<br />

Whistle blowing policy is being<br />

widely promoted<br />

There is a drive to strengthen<br />

the relationship between all<br />

stakeholders <strong>and</strong> the <strong>Trust</strong>.<br />

CQC Report on Maternity<br />

Directorate reflected that out<br />

of the 16 recommendations 9<br />

were fully met <strong>and</strong> 6 were<br />

partly met <strong>and</strong> only 1 was not<br />

met, this was added to the<br />

BHRUT development plan for<br />

review on the 1/11/12.<br />

Evidence for reputation<br />

rebuilding, particularly<br />

focusing on Emergency<br />

department performance,<br />

improved patient<br />

experience, complaints<br />

h<strong>and</strong>ling, finance.<br />

Resourcing of exp<strong>and</strong>ed<br />

programmes of staff <strong>and</strong><br />

community engagement.<br />

None identified<br />

following review<br />

Imogen Shillito, Director of Comms<br />

Details updated: 19.10.<strong>2012</strong><br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

13


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Strategic Objective 5 – To Ensure BHRUT is Financially Secure<br />

Principal Objective: The CIP be delivered fully to the agreed timescales without affecting the quality of care adversely<br />

Risk No: 292 Clinical<br />

Directorates will not<br />

achieve financial target<br />

<strong>and</strong> CIP deliveries<br />

Previous descriptor: <strong>Trust</strong><br />

would not achieve financial<br />

balance<br />

Date on Register: 15.06.2011<br />

Rating Scoring:<br />

Severity:5 x Likelihood:5 = 25<br />

Area: All Clinical<br />

Impact on:<br />

Patient: Poor patient outcome<br />

Staff: none<br />

<strong>Trust</strong>: The <strong>Trust</strong> sustaining<br />

progressive measures<br />

Details updated 24.10.12<br />

**All financial risks will be<br />

reviewed by the newly<br />

appointed Finance Director<br />

8.10.12<br />

- <strong>Trust</strong> has prepared Clinical<br />

Strategy <strong>and</strong> Long-Term<br />

Financial Model (with support<br />

from EY) - reviewed at<br />

October <strong>Trust</strong> <strong>Board</strong>. Model<br />

shows <strong>Trust</strong> reducing but not<br />

eliminating deficit by 2017/18,<br />

although further options are<br />

now being reviewed.<br />

- PMO with support from EY is<br />

developing CIP plans for<br />

2013/14 <strong>and</strong> ensuring full year<br />

benefit from existing schemes<br />

meets <strong>2012</strong>/13 target<br />

4 16<br />

Extreme Red<br />

8.10.12<br />

- Review of Clinical<br />

Strategy, LTFM,<br />

CIP/Transformation<br />

programme by<br />

Transformation <strong>Board</strong>,<br />

Finance Committee,<br />

<strong>Trust</strong> <strong>Board</strong>, NHS<br />

London <strong>and</strong><br />

Commissioners.<br />

Executive sponsorship of<br />

all programmes.<br />

8.10.12<br />

Ongoing work to finalise<br />

clinical strategy <strong>and</strong> LTFM<br />

<strong>and</strong> CIP plan for 2013 /14<br />

8.10.12<br />

- Further options to be<br />

fully developed to<br />

demonstrate financial<br />

viability in the longer<br />

term<br />

- Full year CIP<br />

programme yet to be fully<br />

developed<br />

None identified<br />

following review<br />

David Gilburt Finance Director / Alan Davies Deputy Director of Finance<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

14


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Principal Objective: Meet our in-year financial targets (including net I&E surplus, liquidity, productivity)<br />

Risk no: 104 Failure in<br />

financial management <strong>and</strong><br />

budgetary control including<br />

expenditure restrictions,<br />

leading to reputational<br />

damage.<br />

Date on Register: 18.01.2008<br />

Rating Scoring: Impact 4 x<br />

Likelihood:5 = 20<br />

Area: <strong>Trust</strong><br />

Impact on:<br />

Patient: Cash shortfalls may lead<br />

to suppliers suspending deliveries<br />

Staff: Cash shortfalls may lead to<br />

delays in payroll<br />

<strong>Trust</strong>: Financial Risks<br />

Details updated 24.10.12<br />

8.10.12<br />

- Monthly budget statements,<br />

Business Unit financial reports,<br />

<strong>Trust</strong> financial reports<br />

- Monthly Business Unit<br />

performance review meetings<br />

(including CIP) to review key<br />

financial risks & agree<br />

mitigating actions.<br />

- Budget training provided to<br />

budget holders (April-June)<br />

- CIP governance<br />

arrangements – Work-stream<br />

Accountability review<br />

meetings; weekly pay controls;<br />

weekly vacancy controls;<br />

Transformation <strong>Board</strong>.<br />

- Non-pay expenditure <strong>and</strong><br />

capital expenditure restrictions<br />

in place<br />

4 6 16<br />

Extreme Red<br />

8.10.12<br />

- Internal Audit of<br />

Financial Management<br />

arrangements - limited<br />

assurance given<br />

8.10.12<br />

- Actions have been agreed<br />

through monthly Business Unit<br />

performance review meetings<br />

to address adverse variances,<br />

including CIP<br />

- Actions being progressed<br />

via CIP Accountability<br />

meetings with work-stream<br />

leads to implement further<br />

savings<br />

- Further discussions with<br />

budget holders to resolve<br />

outst<strong>and</strong>ing budget ownership<br />

issues<br />

- Ongoing discussions with<br />

commissioners regarding<br />

transitional funding<br />

24.10.12: This risk is<br />

currently being reviewed<br />

<strong>and</strong> will be updated as soon<br />

as we have concluded our<br />

conversations with<br />

commissioners.<br />

8.10.12<br />

- Ownership of budgets<br />

by budget holders<br />

remains a key issue, as<br />

identified by the Internal<br />

Audit report.<br />

- Significant risk of c.<br />

£13m in achieving I&E<br />

control total of £40m,<br />

primarily related to high<br />

risk CIPs £6.3m,<br />

unidentified CIP £5.4m<br />

<strong>and</strong> transitional funding<br />

risk of £4.3m<br />

Mitigation plan<br />

being drawn up<br />

but at significant<br />

risk<br />

CIP non-delivery<br />

by issue<br />

David Gilburt Finance Director / Alan Davies Deputy Director of Finance<br />

No significant change except risk<br />

descriptor has been changed.<br />

*All financial risks will be reviewed<br />

by the newly appointed Finance<br />

Director<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

15


RISK DESCRIPTORS<br />

OBJECTIVE<br />

SAFE, HIGH<br />

QUALITY<br />

EFFECTIVE<br />

CARE:<br />

EFFICIENT<br />

ECONOMIC USE<br />

OF<br />

RESOURCES:<br />

PROVIDE A<br />

FIRST CLASS<br />

EDUCATIONAL<br />

EXPERIENCE<br />

AND A<br />

EFFECTIVE AND<br />

VALUED<br />

WORKFORCE<br />

MAJOR<br />

High Orange = 9-12 score<br />

Major injury leading to long-term<br />

incapacity/disability<br />

Requiring time off work for >14<br />

days<br />

Increase in length of hospital stay<br />

by >15 days<br />

Mismanagement of patient care<br />

with long-term effects<br />

Uncertain delivery of key objective<br />

/Loss of 0.5–1.0 per cent of budget<br />

Claim(s) between £100,000 <strong>and</strong> £1<br />

million<br />

Purchasers failing to pay on time<br />

Non-compliance with national 10–<br />

25 per cent over project budget<br />

Schedule slippage / Key objectives<br />

not met<br />

Uncertain delivery of key<br />

objective/service due to lack of staff<br />

Unsafe staffing level or competence<br />

(>5 days)<br />

Loss of key staff or Very low staff<br />

morale<br />

No staff attending m<strong>and</strong>atory/ key<br />

training<br />

CATASTROPHIC<br />

Extreme Reds = 15-25 score<br />

Incident leading to death<br />

Multiple permanent injuries or<br />

irreversible health effects<br />

An event which impacts on a large<br />

number of patients<br />

Non-delivery of key objective/ Loss of<br />

>1 per cent of budget<br />

Claim(s) >£1 million<br />

Failure to meet specification/ slippage<br />

Loss of contract / payment by results<br />

Incident leading >25 per cent over<br />

project budget<br />

Schedule slippage /Key objectives not<br />

met<br />

Non-delivery of key objective/service<br />

due to lack of staff<br />

Ongoing unsafe staffing levels or<br />

competence<br />

Loss of several key staff<br />

No staff attending m<strong>and</strong>atory training<br />

/key training on an ongoing basis<br />

OBJECTIVE<br />

CREATING AND<br />

SUSTAINING<br />

PURPOSEFUL<br />

PARTNERSHIPS<br />

DELIVERY<br />

AGAINST BHRUT<br />

PRIORITIES AND<br />

OBJECTIVES:<br />

STRONG<br />

RESPECTED AND<br />

CREDIBLE<br />

LEADERSHIP<br />

MAJOR<br />

High Orange = 9-12 score<br />

Loss/interruption of >1 week<br />

Major impact on environment<br />

Enforcement action<br />

Multiple breeches in statutory duty<br />

Improvement notices<br />

Low performance rating<br />

Critical report<br />

National media coverage with 3 days service well below<br />

reasonable public<br />

expectation. MP concerned<br />

(questions in the House)<br />

Total loss of public<br />

confidence<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

16


TABLE: RISK SCORING = SEVERITY X LIKELIHOOD (S X L)<br />

SEVERITY SCORE<br />

5 CATASTROPHIC - Death or major disaster / loss; loss of<br />

>£1million including litigation settlement. Loss of ability to<br />

achieve/maintain financial stability of BHRUT<br />

4 MAJOR - Significant / permanent harm Major financial loss<br />

(£100K - £1 million) Including litigation settlement.<br />

3 MODERATE - Hospitalised or medium term injury Major<br />

financial loss (£20K to £100K) including litigation settlement.<br />

2 MINOR - More than 3 days off sick due to injury moderate<br />

financial loss (£1K to 20K);<br />

1 NEGLIGIBLE - No obvious injury or harm Minimal financial<br />

loss (


BOARD ASSURANCE FRAMEWORK ELEMENTS<br />

STEP1<br />

KEY PILLARS OF THE BAF<br />

Principal Objectives<br />

Principal Risks<br />

Key Controls<br />

Assurances on Controls<br />

STEP2<br />

APPLICATION TO THE BAF<br />

Those strategic <strong>and</strong> directorate level principal objectives crucial to the <strong>Board</strong>'s overall goals<br />

Risks threatening the achievement of principal objectives<br />

Control (s) to manage one or more principal risks<br />

Confidence, based on sufficient evidence, that internal controls are in place, operating<br />

effectively <strong>and</strong> objectives are being achieved<br />

.<br />

Regular <strong>Board</strong> reports, Directorates escalation <strong>and</strong> recognition of Principal<br />

Risks as well as summary reports from the Audit Committee identify:<br />

Gaps in Assurance<br />

Failure to gain sufficient evidence that policies/ procedures, practices or organisational<br />

resources / structures on which reliance is placed are operating effectively <strong>Trust</strong>-wide.<br />

Failure to put controls / systems in place to mitigate the risks adequately <strong>and</strong> effectively.<br />

STEP 3<br />

Gaps in Control<br />

Action plan generated from the Gaps<br />

<strong>Board</strong> Assurance Action Plan<br />

An action plan approved by the board to improve its key controls to manage its principal<br />

risks, <strong>and</strong> gain assurances where required <strong>and</strong> mitigate the gaps in assurance.<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

18


CARE QUALITY COMMISSION: Regulations <strong>and</strong> Outcome Guide<br />

Regulation 17 Outcome 1: Respecting <strong>and</strong> involving people who use services<br />

Regulation 18 Outcome 2: Consent to care <strong>and</strong> treatment<br />

Regulation 9 Outcome 4: Care <strong>and</strong> welfare of people who use services<br />

Regulation 14 Outcome 5: Meeting nutritional needs<br />

Regulation 24 Outcome 6: Co-operating with other providers<br />

Regulation 11 Outcome 7: Safeguarding people who use services from abuse<br />

Regulation 12 Outcome 8: Cleanliness <strong>and</strong> infection control<br />

Regulation 13 Outcome 9: Management of medicines<br />

Regulation 15 Outcome 10: Safety <strong>and</strong> suitability of premises<br />

Regulation 16 Outcome 11: Safety, availability <strong>and</strong> suitability of equipment<br />

Regulation 21 Outcome 12: Requirements relating to workers<br />

Regulation 22 Outcome 13: Staffing<br />

Regulation 23 Outcome 14: Supporting workers<br />

Regulation 10 Outcome 16: Assessing <strong>and</strong> monitoring the quality of services<br />

Regulation 19 Outcome 17: Complaints<br />

Regulation 20 Outcome 21: Records<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

19


EXECUTIVE SUMMARY<br />

TITLE:<br />

Risk Management Strategy <strong>and</strong> Policy<br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

The attached Risk Management Strategy <strong>and</strong> Policy<br />

describes the <strong>Trust</strong>s expectations of how the management<br />

of risk at different levels within the organisation must be<br />

managed. This has been updated in line with national<br />

guidance <strong>and</strong> local developments <strong>and</strong> changes to systems<br />

<strong>and</strong> processes.<br />

The key changes to this document over the previous one<br />

include:<br />

Update to comply with the revised NHS Litigation Authority<br />

Risk Management St<strong>and</strong>ards issued this year.<br />

The Roles <strong>and</strong> Responsibilities have been revised in line<br />

with leadership <strong>and</strong> responsibility changes. (P.6)<br />

Introduction of the NPSA recently revised risk grading<br />

matrix. (Appendix 1 P.33)<br />

Framework for Risk Management self assessment tool to<br />

support staff in the development <strong>and</strong> monitoring of risk<br />

management systems. (Appendix 3 P. 38)<br />

The routine systems for all staff remain essentially the<br />

same.<br />

□ TEC ……………... □ STRATEGY……….….…….<br />

□ FINANCE ……..……… □ AUDIT ………….……..….<br />

x QUALITY & SAFETY …………..………….....……<br />

□ WORKFORCE<br />

□ CHARITABLE FUNDS ………………………………...…<br />

□ TRUST BOARD ……………………………….………….<br />

□ REMUNERATION ………………………………….…...<br />

□ OTHER …………………………..……. (please specify)<br />

Training on the document is provided at every Induction,<br />

M<strong>and</strong>atory Training <strong>and</strong> Junior Doctor training.<br />

.<br />

2. DECISION REQUIRED: CATEGORY:<br />

It is a requirement of the NHSLA Risk Management<br />

St<strong>and</strong>ards that the <strong>Trust</strong> <strong>Board</strong> approve the attached<br />

Strategy <strong>and</strong> Policy<br />

NATIONAL TARGET x RMS<br />

x CQC REGISTRATION x HEALTH & SAFETY<br />

x ASSURANCE FRAMEWORK<br />

□ CQUIN/TARGET FROM COMMISSIONERS<br />

CORPORATE OBJECTIVE ……………………………....<br />

□ OTHER …………………….. (please specify)<br />

AUTHOR/PRESENTER: Dr Mike Gill<br />

DATE: 26.10.12<br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

4. DELIVERABLES<br />

5. KEY PERFORMANCE INDICATORS<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________


RISK MANAGEMENT STRATEGY AND POLICY<br />

This policy can be made available in other formats <strong>and</strong> languages<br />

upon request to the PALS office on 01708 435454<br />

Contents Include: Purpose, Definitions, Risk Management Approach, Tools, Risk Register<br />

Policy Number:<br />

Ratified by:<br />

Approved by:<br />

Name & Title of originator/author:<br />

Responsible committee/individual:<br />

Responsible Division:<br />

Date issued:<br />

Target audience:<br />

Policy Template Issued 2nd <strong>November</strong> 2011<br />

Version:<br />

Date:<br />

Date:<br />

Review Date<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 1 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Contents<br />

Section<br />

Page<br />

1 Introduction 3<br />

2 Purpose 3<br />

3 Definitions 4<br />

4 Roles <strong>and</strong> Responsibilities 6<br />

4.1 <strong>Trust</strong> Committees with responsibility for Risk Management 9<br />

4.2 Strategic Objectives 11<br />

4.3 <strong>Trust</strong> Risk Management Approach 11<br />

4.4 The Risk Management Process 12<br />

4.5 Risk Identification tools 13<br />

4.6 Risk Grading <strong>and</strong> acceptable/unacceptable risk 16<br />

4.7 Assessments, control <strong>and</strong> acceptance of risk 16<br />

4.8 Risk Register 19<br />

4.9 <strong>Board</strong> Assurance Framework 19<br />

5 Development of the Policy 20<br />

5.2 Equality Impact Assessment 21<br />

5.3 Approval <strong>and</strong> Ratification 21<br />

6 Review <strong>and</strong> Revision Processes 21<br />

7 Dissemination <strong>and</strong> Implementation 22<br />

7.1 Implementation 22<br />

8 Monitoring 22<br />

9 References 25<br />

10 Associated Documents 26<br />

11. Amendments 26<br />

Appendices<br />

1 Risk Grading Matrix 32<br />

2 Reporting Structure for Risk 36<br />

3 Framework for Risk Management 37<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 2 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


1. INTRODUCTION<br />

"<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals <strong>Trust</strong> is committed to the<br />

control of risks in a strategic <strong>and</strong> organised fashion, to ensure that risks can be<br />

eliminated or reduced to an acceptable level thereby improving the experience <strong>and</strong><br />

safety of patients, staff, visitors <strong>and</strong> the public. This commitment is commensurate<br />

with the <strong>Trust</strong>'s aim to provide Excellence in Healthcare. Managing business risk<br />

is fundamental to achieving this aim.”<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> (the <strong>Trust</strong>) is aware that, as a<br />

large organisation, it is exposed to a very wide range of risks <strong>and</strong> threats to the delivery of key<br />

services <strong>and</strong> it has a responsibility to identify, evaluate <strong>and</strong> manage those risks. There is a<br />

structured approach to risk management through its systematic identification, assessment,<br />

evaluation <strong>and</strong> treatment of risk. It is a continuous process aimed at reducing <strong>and</strong> monitoring<br />

risks to the organisation <strong>and</strong> individuals alike. The <strong>Trust</strong> <strong>Board</strong> expects staff to adhere to the risk<br />

management processes outlined in this document.<br />

The increasing numbers of recommendations from the National Patient Safety Agency (NPSA)<br />

<strong>and</strong> National Institute of Health <strong>and</strong> Clinical Excellence (NICE), developments in Information<br />

Governance, Care Quality Commission (CQC) Quality St<strong>and</strong>ards <strong>and</strong> the NHSLA Risk<br />

Management St<strong>and</strong>ards for CNST are all factors which require the <strong>Trust</strong> <strong>Board</strong> to consider <strong>and</strong><br />

regularly review the organisational arrangements for integrated governance <strong>and</strong> risk<br />

management.<br />

To support this it is essential that the appropriate policy is in place to minimise risk.<br />

The <strong>Trust</strong> adopts an inclusive approach to risk management:<br />

• The <strong>Trust</strong> board sets the strategy for the organisation <strong>and</strong> identifying the risk to that<br />

strategy, determining appropriate mitigating actions <strong>and</strong>/or deciding to ‘carry the risk’<br />

• Each Directorate will identify the operational risk/s that arise within their area which<br />

compromises their delivery of the <strong>Trust</strong> key objectives <strong>and</strong> mitigating it where possible, or<br />

escalating the risk for higher level review <strong>and</strong> decision making.<br />

This Policy sets out the strategy for the continued development of risk management throughout<br />

the <strong>Trust</strong> <strong>and</strong> the processes to implement it. This document applies to all staff working within the<br />

<strong>Trust</strong>, or on behalf of the <strong>Trust</strong> in other environments.<br />

It is imperative that all Directorates ensure that the message “risk management is everybody’s<br />

responsibility” is well understood <strong>and</strong> acted upon throughout the <strong>Trust</strong><br />

2. PURPOSE<br />

This Risk Management Strategy, Policy <strong>and</strong> Guidance sets out the <strong>Barking</strong>, <strong>Havering</strong> <strong>and</strong><br />

Redbridge University Hospitals NHS <strong>Trust</strong> (BHRUT) key aims <strong>and</strong> objectives to ensure there are<br />

strong systems to manage risks <strong>Trust</strong>-wide, with which the staff are familiar.<br />

This document provides advice on implementing effective risk management. It also outlines the<br />

objectives, duties, benefits of managing risk, describes the responsibilities for risk management<br />

<strong>and</strong> provides an overview of the process that we will implement together to manage risk<br />

successfully.<br />

The Policy describes how the <strong>Trust</strong> will record all risks <strong>and</strong> the high <strong>and</strong> extreme risks which are<br />

identified as potential threats to the delivery of its key objectives within Risk Registers <strong>and</strong><br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 3 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


incorporate mitigation controls within action plans, allocating appropriate resources according to<br />

the level of risk exposure <strong>and</strong> will report findings within the reporting <strong>Board</strong> Assurance<br />

Framework.<br />

This Policy requires Clinical Directorates, Executive Leads <strong>and</strong> Employees alike to assist in, <strong>and</strong><br />

take responsibility for, the identification, control <strong>and</strong> reduction of risk <strong>and</strong> containment of cost in all<br />

aspects of their activities <strong>and</strong> areas of responsibility.<br />

It explains how the benefits gained with through Risk Management Framework are improved<br />

strategic, operational <strong>and</strong> financial management, improved decision making, compliance,<br />

improved customer service which result in better outcomes for patients <strong>and</strong> a safe <strong>and</strong> secure<br />

environment for patients, staff <strong>and</strong> visitors.<br />

The document should be read in conjunction with the <strong>Trust</strong>’s:<br />

• Complaints Policy<br />

• Claims Policy<br />

• Incident & Serious Incident Policy<br />

• Investigating <strong>and</strong> Learning from Incidents, Claims <strong>and</strong> Complaints Policy<br />

• Risk Assessment Toolkit<br />

BHRUT requires that the management of risk supports the delivery of the <strong>Trust</strong> objectives to<br />

enable the provision of high quality services for service users, visitors, stakeholders <strong>and</strong> staff;<br />

also minimise loss of resources <strong>and</strong> protect the reputation of the <strong>Trust</strong>.<br />

3. DEFINITIONS<br />

BHRUT<br />

CAS<br />

CNST<br />

COSHH<br />

CPA<br />

Directorates<br />

ESR<br />

HSE<br />

H&S<br />

MHRA<br />

NCEPOD<br />

NHSLA<br />

NICE<br />

NSF<br />

PALS<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong><br />

Central Alerting System<br />

Clinical Negligence Scheme for <strong>Trust</strong>s<br />

Control of Substances Hazardous to Health<br />

Clinical Pathology Accreditation<br />

Electronic Staff Record<br />

Health & Safety Executive<br />

Health <strong>and</strong> Safety<br />

Medicines Practice & Healthcare products Regulatory Agency<br />

National Confidential Enquiry into Patient Outcome <strong>and</strong> Death<br />

National Health Services Litigation Authority - responsible for the Clinical<br />

Negligence Scheme for <strong>Trust</strong>s<br />

National Institute of Health & Clinical Excellence<br />

National Service Framework<br />

Patient Advice & Liaison Service<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 4 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


PARTENRSHIP<br />

PFI<br />

SIC<br />

SI<br />

TNA<br />

Partners who provide to the <strong>Trust</strong> e.g. Sodexo, Siemens<br />

Partners for whom the <strong>Trust</strong> provide services, e.g. Barts Renal Services, HCA<br />

Harley Street at Queen’s<br />

Commissioning partnerships, e.g. Commissioning Cluster, SLAs with other<br />

commissioners<br />

Private Finance Initiative<br />

Statement of Internal Control<br />

Serious Incident<br />

Training Needs Analysis<br />

Any expression, to which a meaning is given in the Health Service Act, or in the Financial<br />

Directions made under the Act, shall have the same meaning in this Policy:<br />

“Action Owner”<br />

“Serious Incident”<br />

“Clinical Risk”<br />

“<strong>Board</strong> Assurance<br />

Framework”<br />

“Corporate Risk”<br />

“Information Risk”<br />

“Initial Risk Score”<br />

“Risk List”<br />

“Risk Management<br />

System”<br />

“Risk Mitigation”<br />

Assurance on<br />

effectiveness of<br />

identified controls<br />

“Risk Owner”<br />

The individual responsible for completing the actions to mitigate the<br />

risk.<br />

Any event or circumstance that could or did lead to unintended or<br />

unexpected harm, loss or damage to persons, property or the<br />

organisation.<br />

An uncertain event or set of events which, should it occur, will have<br />

an effect upon patient care<br />

Comprehensive method for the effective <strong>and</strong> focused management<br />

of the principal risks to meeting the BHRUT objectives.<br />

An uncertain event or set of events which, should it occur, will have<br />

an effect upon the achievement of objectives.<br />

An uncertain event or set of events which, should it occur, will have<br />

an effect on persons, property or the organisation.<br />

The calculation of risk consequence <strong>and</strong> probability excluding<br />

control mechanisms.<br />

The simple list of areas of risk, derived from relevant objectives<br />

The detailed explanation of how things work in practice. It includes<br />

this procedural guidance, the reporting processes that secure<br />

implementation of the procedural guidance, the st<strong>and</strong>ard forms, IT<br />

system <strong>and</strong> processes to support implementation, together with local<br />

application of the procedural guidance<br />

Is the process of selecting <strong>and</strong> implementing appropriate controls to<br />

modify the risk. Control – a process (not a committee or group) in<br />

place that contributes to mitigating / managing risk - The real<br />

challenge is not just to design appropriate processes, but to ensure<br />

they are properly embedded into the operations <strong>and</strong> culture of the<br />

organisation. Integral to this is the quality of the reporting of risk <strong>and</strong><br />

operational performance.<br />

Assurance – evidence that control is real <strong>and</strong> operates effectively in<br />

mitigating / managing risk. (Internal <strong>and</strong> External) These assurances<br />

must be relevant in time <strong>and</strong> support the control in its effectiveness.<br />

The individual responsible for:<br />

Completing the entry on the risk register,<br />

Assigning actions to mitigate the risk <strong>and</strong> completion targets for<br />

these actions (in consultation with action owners)<br />

Reviewing the risk at least every fortnight to ensure that the action<br />

plan is being implemented, the current risk score is calculated <strong>and</strong><br />

that all stakeholders are being updated regarding the management<br />

of this risk.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 5 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


“Risk Register”<br />

“Risk Register<br />

Manager”<br />

“Risk Register<br />

Owner”<br />

“Risk Tolerance”<br />

“Target Risk<br />

Score”<br />

The register is a refined <strong>and</strong> developed version of the Risk List. It is<br />

a table which shows – the risk assessment, risk mitigation actions,<br />

re-assessment <strong>and</strong> action plans. The table thereby shows the risk<br />

portfolio of the whole organisation or a selected part of it.<br />

Is the individual who is responsible for ensuring that the risk register<br />

is kept up to date <strong>and</strong> reviewed at least once a month.<br />

The risk register owners are as follows:<br />

Directorate Risk Register – Clinical Director<br />

Matrix/Commissioning Risk Register – Senior Commissioners<br />

<strong>Board</strong> Assurance Framework – Chief Executive/Medical Director<br />

Information Risk Register – Executive Director / Manager of<br />

Information Management <strong>and</strong> Technology/Information Governance<br />

Lead<br />

Is the level of risk the BHRUT is prepared to tolerate<br />

The calculation of risk consequence <strong>and</strong> probability including control<br />

mechanisms. This score provides a measure of how controllable the<br />

risk is <strong>and</strong> will help management decide which risks they should be<br />

4. ROLES AND RESPONSIBILITIES<br />

The <strong>Trust</strong> <strong>Board</strong> is a statutory body, governed by the Act of Parliament with the function of the<br />

<strong>Trust</strong> conferred by legislation. The Code of Accountability requires clear arrangements to be in<br />

place to demonstrate that responsibilities have been delegated to Executive Directors <strong>and</strong> for<br />

BHRUT this requirement is fulfilled by the <strong>Trust</strong>’s St<strong>and</strong>ing Orders, St<strong>and</strong>ing Financial Instructions<br />

<strong>and</strong> Scheme of Delegation, all of which are available on the Intranet.<br />

The arrangements set out in this document regarding identification, assessment <strong>and</strong> control of<br />

risk, apply to the <strong>Trust</strong>’s corporate risks as they apply to all other risks. At an Executive level<br />

responsibility for their implementation is allocated as follows:<br />

• <strong>Trust</strong> Objectives Chief Executive Officer<br />

• Service objectives Chief Operating Officer<br />

• Staffing objectives Chief Operating Officer<br />

• Financial objectives Director of Finance<br />

• Clinical Governance objectives Medical Director / Director of Nursing<br />

• Corporate <strong>and</strong> Clinical Governance Director of Governance/Clinical Governance Director<br />

• Maternity Services Director of Nursing<br />

Responsibility for the maintenance <strong>and</strong> assessment of effective internal <strong>and</strong> external assurances<br />

for organisational risk <strong>and</strong> patient safety is allocated on the same basis.<br />

The <strong>Trust</strong> <strong>Board</strong><br />

The <strong>Trust</strong> <strong>Board</strong>’s monitoring responsibilities, as defined in the Scheme of Delegation are to<br />

‘receive such reports as the <strong>Board</strong> sees fit from committees in respect of their exercise of<br />

delegated powers’.<br />

The <strong>Trust</strong> <strong>Board</strong> is made up of Executive <strong>and</strong> Non Executive Directors that are required to<br />

implement sound <strong>and</strong> effective systems of internal control; challenging poor performance <strong>and</strong><br />

deciding the priority of risks carried. The <strong>Trust</strong> <strong>Board</strong> reviews all risks rated as 'red'/extreme via<br />

the <strong>Board</strong> Assurance Framework. The <strong>Trust</strong> <strong>Board</strong> will review other risks drawn to their attention<br />

through the Quality <strong>and</strong> Safety Committee <strong>and</strong> Audit Committee.<br />

The <strong>Trust</strong> <strong>Board</strong> will receive regular reports from various <strong>Trust</strong> Committees which ensures<br />

significant risks are escalated, considered <strong>and</strong> actioned accordingly. The <strong>Trust</strong> <strong>Board</strong> members<br />

will receive annual risk assessment training to support them in their assessment of risk<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 6 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Chief Executive<br />

The Chief Executive has overall responsibility for having an effective governance system,<br />

including risk management, in place in the <strong>Trust</strong> <strong>and</strong> for meeting all statutory requirements <strong>and</strong><br />

adhering to guidance issued by the Department of Health in respect of governance <strong>and</strong> risk<br />

management. To fulfil this responsibility the Chief Executive will:<br />

• Ensure that full support <strong>and</strong> commitment is provided <strong>and</strong> maintained in the risk<br />

management activities;<br />

• Ensure an appropriate <strong>Board</strong> Assurance Framework is in place;<br />

• Ensure that the Annual Governance Statement adequately reflects the risk<br />

management issues within the organisation<br />

Executive Directors<br />

All Executive Directors have corporate responsibility for risk management within the activities of<br />

the <strong>Trust</strong>. This is exercised through attendance at <strong>Trust</strong> <strong>Board</strong> meetings <strong>and</strong> through the<br />

reviewing of the <strong>Board</strong> Assurance Framework.<br />

Non-Executive Directors<br />

The Non-Executive Directors are responsible for providing independent assurance to the <strong>Trust</strong><br />

<strong>Board</strong> on the risk management structure <strong>and</strong> processes as described in this policy.<br />

Director of Finance<br />

The Director of Finance, on behalf of the Chief Executive has responsibility for systems of<br />

financial control, implementing the <strong>Trust</strong>’s financial procedures, providing financial advice<br />

to the <strong>Trust</strong> <strong>Board</strong>, preparing <strong>and</strong> maintaining <strong>Trust</strong> accounts <strong>and</strong> all areas of financial<br />

<strong>and</strong> business risk. The Director of Finance is the Accountable Officer who signs the<br />

Annual Governance Statement.<br />

Medical Director<br />

The Medical Director, on behalf of the Chief Executive, is charged with the responsibility for<br />

providing assurance on the outcomes Medical Leadership, Clinical Governance <strong>and</strong> Risk<br />

Management systems throughout the <strong>Trust</strong>, with a special responsibility for clinical risk<br />

management.<br />

Director of Nursing<br />

The Director of Nursing, on behalf of the Chief Executive, is charged with the responsibility for<br />

Professional Leadership of Nurses, Midwives <strong>and</strong> Allied Health Professionals, quality st<strong>and</strong>ards<br />

<strong>and</strong> practice.<br />

Director of Governance <strong>and</strong> Special Projects.<br />

On behalf of the Chief Executive, the Director of Governance is the nominated lead for<br />

compliance to Care Quality Commission St<strong>and</strong>ards, NHSLA Risk Management St<strong>and</strong>ards,<br />

NHSLA Maternity Clinical Negligence Scheme St<strong>and</strong>ards, <strong>and</strong> Clinical Governance systems <strong>and</strong><br />

is managerially responsible for the Clinical Governance Department.<br />

Clinical Governance Director<br />

On behalf of the Executive Directors, the Clinical Governance Director has the day to day<br />

responsibility for all areas of development of clinical governance <strong>and</strong> clinical risk management<br />

Chief Information Officer<br />

The Chief Information Officer, on behalf of the Chief Executive is responsible for Information<br />

Governance <strong>and</strong> is the designated Senior Information Risk Owner (SIRO)<br />

Partnerships<br />

In order to deliver a successful partnership, risk management must form an integral part of the<br />

incident management system <strong>and</strong> evaluation process. Partners need to underst<strong>and</strong> what<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 7 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


potential risks they may face in achieving the planned objectives <strong>and</strong> identify these in a<br />

partnership risk register. Key decision making processes should be the subject of a risk<br />

assessment <strong>and</strong> where necessary risk management plans to identify timelines, responsible<br />

individuals, contingency plans <strong>and</strong> financial monitoring arrangements need to be agreed<br />

confirming what action should be taken should the risks be realised.<br />

All directorates are required to formerly identify <strong>and</strong> record their major partnerships in accordance<br />

with the <strong>Trust</strong> Key Objectives <strong>and</strong> Code of Practice for Partnerships<br />

Clinical Directors<br />

The <strong>Trust</strong> has 11 Clinical Directorates:<br />

1. Emergency care<br />

2. Acute Medicine<br />

3. Neurosciences<br />

4. Surgery<br />

5. Specialist Surgery<br />

6. Anaesthetics<br />

7. Specialist medicine<br />

8. Pathology<br />

9. Women<br />

10. Children<br />

11. Support services<br />

The risk management responsibilities of the <strong>Trust</strong> are shared by the Executive Directors<br />

(corporate risks) <strong>and</strong> the Clinical Directors who are responsible for ensuring Clinical Directorates<br />

operational risks are assessed, mitigated as appropriate <strong>and</strong> reported upon when they cannot be<br />

mitigated locally. Each Clinical Directorate has its own Risk Register.<br />

The Clinical Directors are responsible for the implementation of risk management in all areas<br />

within their Clinical Directorate <strong>and</strong> the process to be followed is described in Section 7.1,<br />

Assessment Process.<br />

Clinical Directors are responsible for implementing <strong>and</strong> monitoring any identified risk management<br />

control or assurance measures within their designated area/s <strong>and</strong> scope of responsibility. Any<br />

serious risks to Corporate <strong>and</strong> Directorate objectives must be brought to the immediate attention<br />

of the Clinical Governance Director.<br />

In situations where significant risks have been identified <strong>and</strong> where local control measures are<br />

considered to be potentially inadequate <strong>and</strong> local resolution has not been satisfactorily achieved,<br />

Clinical Directors are responsible for <strong>and</strong> have the authority to;<br />

• Add risks to the local <strong>and</strong> Directorate risk register<br />

• Monitor <strong>and</strong> review the risks<br />

• Bring these risks to the attention of the Clinical Governance Director<br />

General Managers/Line Managers<br />

General Managers/Line Managers must ensure that all staff are aware of the risk management<br />

processes <strong>and</strong> report risks for consideration. There is a requirement, where significant risks have<br />

been identified <strong>and</strong> where local resources/control measures are considered inadequate, that<br />

Managers report such risks to their Clinical Director<br />

They are required to:<br />

• underst<strong>and</strong> <strong>and</strong> implement the <strong>Trust</strong>’s Risk Training Policy, Risk Management<br />

Strategy/Policy <strong>and</strong> other <strong>Trust</strong> policies <strong>and</strong> procedures, all relevant legislation <strong>and</strong> ensure<br />

that they <strong>and</strong> all staff can access appropriate expert advice where required<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 8 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


• ensure that they keep up to date records of staff attendance at all m<strong>and</strong>atory <strong>and</strong> best<br />

practice training as per the <strong>Trust</strong>’s TNA<br />

• ensure that all staff are given the necessary information <strong>and</strong> training together with the<br />

appropriate resources <strong>and</strong> that these are monitored, to enable them to;<br />

o work safely<br />

o raise concerns<br />

o make risk assessments<br />

o take appropriate risk reduction measures<br />

o report risk to their line managers <strong>and</strong> /or Directorate Leads when applicable.<br />

All managers have a key responsibility to ensure that risk assessment is undertaken to minimise:<br />

• Potential harm to patients, staff <strong>and</strong> visitors<br />

• Risks to the achievement of Directorates business plans <strong>and</strong> service<br />

Clinical Governance Team<br />

The Clinical Governance Team will provide leadership, advice <strong>and</strong> support in the implementation<br />

of this policy.<br />

The Clinical Governance Team will ensure that all reporting to <strong>Trust</strong> Committees is co-ordinated<br />

<strong>and</strong> provide reports, training <strong>and</strong> on-going support in relation to Ulysses database <strong>and</strong> risk<br />

registers.<br />

All Staff<br />

All staff have a key role in identifying <strong>and</strong> reporting risks <strong>and</strong> incidents promptly thereby allowing<br />

risks to be managed <strong>and</strong> added to the local risk register if appropriate. In addition, staff have the<br />

responsibility for taking steps to avoid injuries <strong>and</strong> risks to patients, staff, visitors. If in fulfilling this<br />

role, it involves staff in raising concerns about st<strong>and</strong>ards, staff must report this following the<br />

<strong>Trust</strong>’s Speaking Up for a Healthy <strong>Trust</strong> (Whistleblowing) Policy.<br />

It is the responsibility of All Staff (including agency, locums, volunteers <strong>and</strong> contractors) to be<br />

alert to, identify <strong>and</strong> report risks including those relating to patient care, health <strong>and</strong> safety or the<br />

hospital environment. It is also their responsibility to be aware of <strong>and</strong> comply with all risk<br />

management requirements including <strong>Trust</strong> policies. Information <strong>and</strong> training will be provided as<br />

necessary to enable contractors <strong>and</strong> agency/bank staff to fulfil this responsibility.<br />

All <strong>Trust</strong> employees are accountable, through the terms <strong>and</strong> conditions of their employment,<br />

professional regulations, clinical governance <strong>and</strong> statutory health <strong>and</strong> safety regulations.<br />

This responsibility also includes reporting incidents, being aware of any emergency procedures<br />

relevant to their role <strong>and</strong> place of work, e.g. resuscitation, evacuation <strong>and</strong> fire precaution<br />

procedures; being aware of the risk management strategy/policy <strong>and</strong> attendance at training as<br />

specified in the <strong>Trust</strong>’s Risk Management Training Needs Analysis.<br />

All staff have a responsibility to manage risk within their sphere of responsibility. It is a statutory<br />

duty to take reasonable care of their own safety <strong>and</strong> the safety of others who may be affected by<br />

acts or omissions of <strong>Trust</strong> employees.<br />

4.1 TRUST COMMITTEES WITH RESPONSIBILITY FOR RISK MANAGEMENT<br />

There are two committees with delegated responsibility from the <strong>Trust</strong> <strong>Board</strong> for<br />

overseeing the management of risk in the <strong>Trust</strong>, the Quality <strong>and</strong> Safety Committee <strong>and</strong><br />

the Audit Committee. A chart showing the relationship to the <strong>Board</strong> of its delegated Sub<br />

Committees is shown in Appendix 2.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 9 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


4.1.1 Quality <strong>and</strong> Safety Committee<br />

The Committee meets six times per year <strong>and</strong> the core membership comprises two Non<br />

Executives, of whom one acts as Chairman, the Director of Nursing, the Medical Director <strong>and</strong> the<br />

Clinical Governance Director. The purpose of the Committee is to provide assurance to the <strong>Trust</strong><br />

<strong>Board</strong> on all aspects of patient safety, patient outcomes <strong>and</strong> patient experience. Attendance from<br />

finance <strong>and</strong> human resources will be dependent on agenda topics for discussion.<br />

The key risk management responsibilities of the Quality & Safety Committee are as follows:<br />

• To make recommendation on the quality aspects of implementing the <strong>Board</strong>’s objectives<br />

based on consideration of the adequacy of controls, action plans <strong>and</strong> sources of<br />

assurance relating to major risks escalated from the <strong>Trust</strong>’s Risk Register to the <strong>Board</strong><br />

Assurance Framework.<br />

• To review <strong>and</strong> make recommendations relation to the <strong>Trust</strong>’s performance with particular<br />

focus on proposed changes to its strategic directions, i.e. re-structuring of organisational<br />

service <strong>and</strong> care delivery framework. Ensuring that the impact of any organisational<br />

change is risk assessed to ensure delivery of safe, quality patient care <strong>and</strong> effective levels<br />

of performance <strong>and</strong> outcome.<br />

• To develop <strong>and</strong> monitor a Dashboard of key performance indicators that incorporate topics<br />

such as mortality data, incidents/near misses, claims, complaints <strong>and</strong> findings of<br />

investigations into serious incidents/events. Ensuring the monitoring data is measurable<br />

<strong>and</strong> incorporates maternity <strong>and</strong> general acute services <strong>and</strong> enables the Committee to<br />

define priorities <strong>and</strong> make recommendations.<br />

• To provide strategic leadership for ensuring systems <strong>and</strong> processes are in place<br />

throughout the organisation to support risk management, quality assurance <strong>and</strong><br />

governance.<br />

The Committee’s full terms of reference are available on the <strong>Trust</strong> Intranet. The Quality <strong>and</strong><br />

Safety Committee reports to the <strong>Trust</strong> <strong>Board</strong>.<br />

4.1.2 Audit Committee<br />

The Audit Committee has responsibility for assuring that appropriate financial <strong>and</strong> corporate<br />

governance risk management arrangements are in place. The Committee meets not less than<br />

four times per year <strong>and</strong> the membership comprises not less than three Non Executives, of whom<br />

one acts as Chairman. The Director of Finance, the Financial Controller, the Chief Internal<br />

Auditor, <strong>and</strong> a representative of the External Auditors normally attend meetings.<br />

The key risk management responsibilities of the Audit Committee are to review:<br />

• the establishment <strong>and</strong> maintenance of an effective system of internal control <strong>and</strong> risk<br />

management;<br />

• the adequacy of all risk control related disclosure statements, together with any<br />

accompanying Head of Internal Audit Statement, prior to endorsement by the <strong>Board</strong>;<br />

• the structures, processes <strong>and</strong> responsibilities for identifying <strong>and</strong> managing key risks facing<br />

the organisation;<br />

• Policies for ensuring that there is compliance with relevant regulatory, legal <strong>and</strong> code of<br />

conduct requirements as set out in the Department of Health Directions <strong>and</strong> other relevant<br />

guidance.<br />

The Audit Committee receives information on a number of topics primarily on the <strong>Trust</strong>’s financial<br />

position, assurance framework, local development plans, corporate objectives, counter fraud<br />

issues, charitable funds <strong>and</strong> reports from both the internal <strong>and</strong> external auditors.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 10 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


The Statutory Safety Committee, a feeder committee of the Audit Committee, has specific<br />

responsibility for ensuring risks to patients, staff <strong>and</strong> visitors are managed robustly. The Statutory<br />

Safety Committee takes reports on Health, Safety & Fire, Major Incident & Emergency Planning,<br />

Safety Alerts, health & safety key performance indicators, Manual H<strong>and</strong>ing <strong>and</strong> Radiation issues,<br />

<strong>and</strong> approval of risk policies.<br />

Any risks identified by the Audit Committee are reported to the <strong>Trust</strong> <strong>Board</strong> for information /<br />

action. The Committee’s full terms of reference are available on the <strong>Trust</strong> Intranet.<br />

4.2 STRATEGIC OBJECTIVES<br />

BHRUT has St<strong>and</strong>ing Orders, St<strong>and</strong>ing Financial Instructions <strong>and</strong> a Scheme of Delegation, which<br />

include the roles <strong>and</strong> responsibility of its sub-committees. BHRUT’s risk management processes<br />

aim to ensure:<br />

• There is a common framework within which risks are identified <strong>and</strong> assessed via the Risk<br />

Assessment Tool Kit for inclusion in the <strong>Trust</strong> Risk Register.<br />

• Risks to the effective functioning of the <strong>Trust</strong> in its principal objectives are systematically<br />

<strong>and</strong> consistently identified.<br />

• Action plans are in place to prevent or mitigate the adverse effects of identified risks.<br />

• Obstetric risks are managed through the Maternity Risk Management Strategy<br />

• All other risks, including financial risks, are identified, managed <strong>and</strong> audited through the<br />

<strong>Trust</strong>'s risk management procedures<br />

• Action is taken to manage identified risks so that they are kept to an acceptable level.<br />

• There is recognition that innovation <strong>and</strong> improvement within the wider NHS has to include<br />

an element of risk.<br />

• The Risk Management Strategy/Policy is communicated to all staff <strong>and</strong> is embedded in<br />

everyday practice.<br />

• The Risk Management Strategy <strong>and</strong> policy is available to the public <strong>and</strong> other<br />

stakeholders.<br />

4.3 TRUST RISK MANAGEMENT APPROACH<br />

This <strong>Trust</strong> will approach the management of risk from two aspects:<br />

• Strategic Risks<br />

• Operational Risks<br />

Strategic risks are considered as:<br />

Those business risks that if realised, could fundamentally affect the way in which the organisation<br />

conducts its business financially <strong>and</strong> complies with the Health <strong>and</strong> Social Care Act 2008<br />

st<strong>and</strong>ards. Strategic risks will have a detrimental effect on the achievement of the key business<br />

objectives. Strategic risks are detailed in the <strong>Trust</strong> <strong>Board</strong> Assurance Framework <strong>and</strong> are mapped<br />

against the <strong>Trust</strong>s strategic objectives.<br />

Operational risks are considered as:<br />

Those risks associated with the delivery of the key business processes <strong>and</strong> the delivery of patient<br />

care in a safe environment. Issues arising from operational risk assessments will be considered at<br />

Directorate level <strong>and</strong> escalated through the directorate structure before these are reported on the<br />

<strong>Trust</strong> Corporate Risk Register. Operational risks can include:<br />

• Clinical risks: risks associated with the inpatient, day case, outpatient <strong>and</strong> diagnostic<br />

activities of the <strong>Trust</strong>.<br />

• Non-clinical risks: risks associated with the environment of care e.g. use of the building<br />

<strong>and</strong> facilities by staff, patients, contractors <strong>and</strong> other visitors; health <strong>and</strong> safety risks; staff<br />

management; availability <strong>and</strong> use of information.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 11 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


• Financial risks: risks associated with income, expenditure, fulfilment of contracts <strong>and</strong> the<br />

correct application of St<strong>and</strong>ing Orders, St<strong>and</strong>ing Financial Instructions, Scheme of<br />

Delegation <strong>and</strong> other financial obligations.<br />

• Reputational risks: risks associated with public opinion <strong>and</strong> risks which may damage the<br />

credibility or good name of the <strong>Trust</strong>.<br />

It is recognised that the boundaries between these categories are not always clear, <strong>and</strong> that some<br />

risks may fall into more than one category.<br />

Business Planning & Risk Management<br />

Operational risks should link to each Directorate’s Business Plan. The Business Plan is a<br />

document that brings key information together in one place <strong>and</strong> demonstrates the service’s focus<br />

on service <strong>and</strong> <strong>Trust</strong>’s priorities. All major risks impacting the provision of service <strong>and</strong> to other<br />

services <strong>and</strong> partners resulting from the consequences, then a risk assessment <strong>and</strong> action plan<br />

should be recorded with brief mitigation.<br />

4.4 THE RISK MANAGEMENT PROCESS<br />

The <strong>Trust</strong>’s strategy is to apply the following principles to the management of risk:<br />

Establish the context<br />

A strategic, organisational, operational <strong>and</strong> risk management context will be established in<br />

which the process will take place. A criteria against which risk will be evaluated should be<br />

established <strong>and</strong> the structure of the analysis defined.<br />

Identify Risks<br />

Identify what, why, when <strong>and</strong> how risks can arise as the basis for further analysis.<br />

Risk Assessment<br />

Decide who might be harmed <strong>and</strong> how. Using the <strong>Trust</strong>’s generic risk assessment template<br />

<strong>and</strong> transferring the results to a comprehensive risk register. Escalating the findings to line<br />

management <strong>and</strong> all staff.<br />

Analyse risks<br />

Determine the existing controls <strong>and</strong> analyse risks in terms of consequence <strong>and</strong> likelihood in<br />

the context of those controls. The analysis should consider the range of potential<br />

consequences <strong>and</strong> how likely those consequences are to occur. Consequence <strong>and</strong> likelihood<br />

will be combined to produce an estimated level of risk.<br />

Evaluate risks<br />

Evaluate the risks <strong>and</strong> decide on precautions. Compare estimated levels of risk against the<br />

pre-established criteria. This enables risks to be ranked so as to identify management <strong>and</strong><br />

<strong>Board</strong> priorities. It is essential that the evidence used to compare the risk to these criteria is of<br />

known st<strong>and</strong>ards of quality <strong>and</strong> reliability, otherwise the risk may be over or under rated or not<br />

identified at all.<br />

Treat risks<br />

Accept <strong>and</strong> monitor low-priority risks. For other risks, develop <strong>and</strong> implement a specific<br />

Management action plan that includes consideration of the resources required to address the<br />

risk, the impact that treating the risk as well as not treating the risk will have in other service<br />

areas, whether the risk, if realised would be reversible <strong>and</strong> in what context, if any, realising the<br />

risk would be defensible. Record your findings.<br />

Service development planning process<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 12 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Where there are actual or potential risks with high or extreme consequences <strong>and</strong>/or likelihood<br />

that require additional resources, the relevant Directorate will submit Risk assessment <strong>and</strong><br />

action plans for consideration by <strong>Trust</strong> Executive Leads <strong>and</strong> <strong>Trust</strong> <strong>Board</strong>.<br />

Monitor <strong>and</strong> Review<br />

Monitor <strong>and</strong> review the performance of the risk action plan, undertake assessment to identify<br />

gaps <strong>and</strong> improvement. Review your risk assessment <strong>and</strong> update if necessary<br />

Communicate <strong>and</strong> consult<br />

Communicate <strong>and</strong> consult any difficulties with the Clinical Governance Director as appropriate<br />

at each stage of the risk management process <strong>and</strong> concerning the process as a whole.<br />

Shared Learning<br />

Share knowledge <strong>and</strong> learning across other directorates. It is essential to safeguard against<br />

incidents that could have been prevented had lessons learned elsewhere been passed on <strong>and</strong><br />

adopted across the organisation.<br />

4.5 RISK IDENTIFICATION TOOLS<br />

It is the policy of the <strong>Trust</strong> to make systematic use of the risk management tools which are<br />

available for the identification of all risks affecting its activities.<br />

4.5.1 What is a Risk?<br />

Risks will <strong>and</strong> can be identified using the following approaches:<br />

• Risk Assessments using st<strong>and</strong>ard tools e.g. COSHH,<br />

• Legal Risk (mainly risks arising through non-compliance with existing legislation,<br />

national guidance e.g. occupational health & safety legislation)<br />

• Clinical risks (mainly associated with the diagnosis <strong>and</strong> treatment of patients)<br />

• Incidents Management (Near misses, Serious Incidents)<br />

• Complaints/PALS<br />

• CQC<br />

• Expressed concerns by service users ,visitors or stakeholders<br />

• External reviews/ Services user satisfaction surveys<br />

• Audits<br />

• Organisational Risk (mainly risks arising from ineffective implementation of policies<br />

<strong>and</strong> procedures, poor communication, poor staffing <strong>and</strong> management structures).<br />

• Staff survey<br />

• Sickness/Absence information<br />

• Mortality & Morbidity review<br />

• NICE<br />

• NCEPOD<br />

• NHSLA RMS<br />

• Central Alerting system<br />

• Information Risk (mainly risks arising from ineffective management <strong>and</strong> security of<br />

information, including decisions on when <strong>and</strong> when not to share personally<br />

identifiable information)<br />

• Business <strong>and</strong> Financial Risk (mainly concerned with Contracts, revenue, capital<br />

fund)<br />

Proactive Risk Identification<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 13 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Proactive risk assessment enables the <strong>Trust</strong> to identify actual or potential hazards or<br />

threats that may or may not have resulted in actual incidents <strong>and</strong> ensure adequate control<br />

measures are in place to eliminate or reduce the risk of harm occurring. From this<br />

information, the <strong>Trust</strong> can assess whether or not there are sufficient precautions in place<br />

or if more needs to be done to mitigate the risk in order to prevent a particular harm or<br />

threat materialising. Proactive risk assessment also fulfils the <strong>Trust</strong>’s statutory obligations<br />

in terms of Health <strong>and</strong> Safety risk assessments.<br />

Under the management of Health <strong>and</strong> Safety at Work Regulations 1992, employers are<br />

required to make a “suitable <strong>and</strong> sufficient” assessment of the risks to the health <strong>and</strong><br />

safety of employees whilst at work as well as the risks to non employees as a<br />

consequence of work activities.<br />

Ongoing proactive risk assessment will minimise the likelihood of both patient safety <strong>and</strong><br />

non-clinical incidents occurring <strong>and</strong> supports safety improvements across the<br />

organisation.<br />

Range of Internal Inspections<br />

There are a number of internal inspection processes carried out by specialists such as<br />

Infection Control or Fire Safety Officer <strong>and</strong> where risks are pro-actively identified. There is<br />

a requirement for all services to carry out a quarterly Health <strong>and</strong> Safety Inspection <strong>and</strong><br />

ensure improvements are made if indicated.<br />

Nursing <strong>and</strong> Midwifery Audit<br />

There are monthly visible leadership audits undertaken in patient areas. The audits are a<br />

proactive way of measuring compliance with High Impact Actions for Nursing <strong>and</strong><br />

Midwifery <strong>and</strong> Essence of Care. Action plans are developed <strong>and</strong> implementation<br />

monitored by the Nursing <strong>and</strong> Midwifery <strong>Board</strong><br />

Self Assessment of Risk<br />

Upon identification of an individual risk at any time a staff member can complete a generic<br />

risk assessment proforma or one of the specific non clinical assessment proforma’s which<br />

are available on the <strong>Trust</strong>’s intranet site. The risk will be reported to <strong>and</strong> discussed with a<br />

line manager <strong>and</strong> scored using the <strong>Trust</strong> risk scoring matrix. Action plans will be<br />

developed <strong>and</strong> the risk will populate the Risk Register <strong>and</strong> be escalated in line with the<br />

<strong>Trust</strong> risk escalation process. If immediate action is required steps must be taken to<br />

mitigate the risk in the short term whilst longer term plans are implemented. If a staff<br />

member has concerns regarding the practice of another employee of the <strong>Trust</strong>, they<br />

should raise their concerns using the <strong>Trust</strong> Raising Concerns Policy available on intranet<br />

Evaluation of National Reports<br />

As key reports are published appointed members of staff will be directed to review the<br />

content to evaluate the relevance of the report <strong>and</strong> st<strong>and</strong>ards that will be required of the<br />

<strong>Trust</strong>. This includes deficits in compliance with a range of st<strong>and</strong>ards<br />

such as Maternity or any of the National Inquiry reports such as those into Peri-Operative<br />

Care or Maternal <strong>and</strong> Child Deaths. It also includes Independent Inquiries where risks are<br />

identified that apply to services within this <strong>Trust</strong> including those that relate to<br />

Safeguarding Children <strong>and</strong> Vulnerable Adults, clinical services <strong>and</strong> health <strong>and</strong> safety.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 14 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Central Alert System (CAS)<br />

Review <strong>and</strong> response to CAS which is an electronic system developed by the Department<br />

of Health, the National Patient Safety Agency (NPSA), NHS Estates <strong>and</strong> the Medicines<br />

<strong>and</strong> Healthcare products Regulatory Agency (MHRA) that includes medicines, healthcare<br />

products, medical device, National Patient Safety Agency alerts <strong>and</strong> NHS Estate warning<br />

notices. Where alerts are issued <strong>and</strong> the <strong>Trust</strong> is not compliant a risk will be registered<br />

<strong>and</strong> an action plan implemented<br />

Reactive Risk Identification<br />

Incident Reporting / Near Miss Reporting<br />

Incident <strong>and</strong> near miss reporting by staff is an efficient <strong>and</strong> effective system for identifying<br />

risk. Rapid action in resolving how <strong>and</strong> why an incident may have occurred can facilitate<br />

the organisation in learning how to avoid repeat occurrences of similar incidents. The<br />

<strong>Trust</strong> operates within a just <strong>and</strong> fair blame culture, to ensure that staff feel safe in being<br />

open to report events. Incidents <strong>and</strong> near misses are scored using the <strong>Trust</strong>’s risk matrix<br />

Complaint Reporting<br />

Complaint reporting is a very effective way through which an organisation can learn to<br />

manage its services <strong>and</strong> risks. Complaints are responded to by the Clinical Directorates /<br />

Corporate Departments <strong>and</strong> the <strong>Trust</strong> has a systematic approach which attempts a<br />

frontline instant response where possible, followed up <strong>and</strong> escalated through the line<br />

management structure in the Division if necessary. Formal complaint responses are coordinated<br />

in accordance with the <strong>Trust</strong>'s Complaints Policy <strong>and</strong> Procedure<br />

Informal concerns also provide useful information to support the <strong>Trust</strong> to enhance the<br />

patient experience. Concerns are assigned a risk score by the Patient Advice <strong>and</strong> Liaison<br />

Service (PALS)<br />

Claims<br />

The review of claims is also an effective way through which the organisation can learn to<br />

prevent the reoccurrence of incidents, manage its risks <strong>and</strong> improve the quality of care<br />

delivered. The <strong>Trust</strong> response to claims is managed on behalf of the <strong>Trust</strong> by the Legal<br />

Services Team in accordance with the <strong>Trust</strong>’s Claims H<strong>and</strong>ling Policy, Clinical<br />

Directorates are involved in reviews to support the management of risk locally <strong>and</strong> review<br />

closed claims as they arise.<br />

External Assessments <strong>and</strong> Reviews<br />

Care Quality Commission (CQC)<br />

A review is undertaken of st<strong>and</strong>ards across the <strong>Trust</strong> that identify lapses, lapses identified<br />

result in action plans developed which are monitored for implementation via the<br />

Transformation <strong>Board</strong><br />

Risks highlighted during service reviews <strong>and</strong> the audit work that is undertaken by the<br />

<strong>Trust</strong>’s auditors are sources of risk identification. Risks identified are scored using the<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 15 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


<strong>Trust</strong>’s risk matrix <strong>and</strong> will populate the <strong>Trust</strong>’s Risk Register <strong>and</strong> be escalated in line with<br />

the <strong>Trust</strong>’s escalation process.<br />

4.6 RISK GRADING AND ACCEPTABLE / UNACCEPTABLE RISK<br />

4.6.1 Grading<br />

Once risks are identified, it is the policy of the <strong>Trust</strong> that they must be prioritised for full<br />

assessment <strong>and</strong> management by initially grading them, according to their impact <strong>and</strong> the<br />

likelihood that they will occur again in the future.<br />

The <strong>Trust</strong> has adopted a risk assessment matrix for grading all non-financial risks whether<br />

clinical, non-clinical or organisational. The matrix is set out in the <strong>Trust</strong>’s Risk Assessment Tool<br />

Kit, which can be found on the <strong>Trust</strong>’s Intranet. The grading matrix is attached in Appendix 1. It<br />

has four grades of risk - low, moderate, high <strong>and</strong> extreme, which are identified respectively by the<br />

four colours: green, yellow, orange <strong>and</strong> red.<br />

Incidents are also graded using the same matrix in accordance with the <strong>Trust</strong>’s Incident Reporting<br />

& SI Policy which can be accessed on the <strong>Trust</strong>’s intranet.<br />

4.6.2 Acceptable / Unacceptable Risk<br />

It is the policy of the <strong>Trust</strong> that control action is:<br />

• considered for all risks where the initial grading is more than green / low<br />

• implemented to reduce the residual risk after the action to green / low, unless the impact<br />

<strong>and</strong> likelihood of the risk is such that the burden of the available action is disproportionate<br />

to the reduction of risk to be achieved.<br />

Thus, risks graded low / green need to be revisited annually unless further concerns arise.<br />

Yellow <strong>and</strong> low orange (under a risk score of 9) represent increasing levels of risk <strong>and</strong> therefore<br />

require control action <strong>and</strong> review at intervals depending on the impact of the risk <strong>and</strong> the<br />

likelihood of recurrence as identified through risk assessment processes.<br />

Red represents extreme levels of risk which are by definition unacceptable <strong>and</strong> require control<br />

action <strong>and</strong> review at intervals to reduce them as far as reasonably practicable.<br />

4.7 ASSESSMENTS, CONTROL AND ACCEPTANCE OF RISK<br />

4.7.1. Assessment Process<br />

It is the responsibility of each Clinical Directorate Directors, Senior Nurses, Directorates General<br />

Managers/Managers, Clinical Leads, Nurse Consultants <strong>and</strong> Ward / Service Managers to ensure<br />

that the <strong>Trust</strong>’s risk assessment programme is implemented within their areas in accordance with<br />

this policy.<br />

Each Directorate must undertake risk assessments locally in accordance with the <strong>Trust</strong> Risk<br />

Assessment Tool Kit. Directorates have the responsibility to assess their clinical, environmental,<br />

health, safety, financial <strong>and</strong> performance related risks.<br />

The local management of risk will be carried out by various different groups of senior staff<br />

according to the grading of the risk identified but would have an overview in regards to mitigation<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 16 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


y the Directorate Lead <strong>and</strong> or General Manager. The following table describes the type of<br />

evidence that will be used to demonstrate compliance with the aims of this policy.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 17 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Risk Grading Staff Group Evidence<br />

Red/Extreme<br />

Orange/High<br />

Yellow/Moderate<br />

Green/Low<br />

Executive Directors<br />

Clinical Directors<br />

Directorates Manager<br />

Matron<br />

Other relevant senior staff<br />

Clinical Directors<br />

Directorates Managers<br />

Matron<br />

Other relevant senior staff<br />

Matrons<br />

Service Leads<br />

Ward/Departmental Manager<br />

Directorates Risk Registers<br />

Investigation report<br />

Risk Assessment <strong>and</strong> action plan<br />

Committee minutes<br />

External reporting - STEIS, HSE<br />

MHRA etc<br />

IR1 Form<br />

Investigation report<br />

Risk Assessment <strong>and</strong> action plan<br />

Minutes of Directorates directorate<br />

meetings<br />

IR1 Form<br />

Local investigation<br />

IR1 Form<br />

Local investigation<br />

Where risks cannot be effectively managed or responded to locally that is where they require<br />

resources <strong>and</strong>/or authority beyond the remit of the local area, or where the risk is common to<br />

more than one area the risk assessment should be forwarded to:<br />

#riskregister@bhrhospitals.nhs.uk for inclusion in the <strong>Trust</strong> Risk Register<br />

Newly identified risks that are rated high/extreme will be added to the <strong>Trust</strong> corporate risk register<br />

<strong>and</strong> for risks that require immediate action these will be reported via the <strong>Trust</strong> SI process (see SI<br />

policy)<br />

Review of Assessments<br />

A quarterly review will be undertaken by the directorates on their risks to ensure that the<br />

information recorded on their Local risk register is reflective of the <strong>Trust</strong> Corporate Risk Register<br />

(high orange <strong>and</strong> extreme risks). Failure to receive review from Directorates will be noted on the<br />

register <strong>and</strong> this information is cascaded to the Audit Committee <strong>and</strong> <strong>Trust</strong> <strong>Board</strong> via the <strong>Board</strong><br />

Assurance Framework.<br />

Risk Closure Form<br />

This ensures that risks are considered <strong>and</strong> agreed prior to closure. It also prevents unauthorised<br />

closure of Corporate risks by any staff<br />

Risk Review Form<br />

Risk assessments must be reviewed regularly <strong>and</strong> immediately if there is any reason to suspect<br />

the assessment is no longer valid such as there has been significant change to the work of to the<br />

risks of the work<br />

Exception Report<br />

To identity the material deviation between actual risk occurrence <strong>and</strong> controls in a report, which<br />

warrants management investigation<br />

Risk Validation Report<br />

The risk validation report is a very effective way to define <strong>and</strong> determine efficient methods to<br />

reduce emotional risk scoring. It reduces the unnecessary cost <strong>and</strong> where appropriate promotes<br />

a robust process.<br />

Archiving of risk assessments<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 18 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


All risk assessments must be archived by the local area in accordance with the records<br />

management policy. The length of time individual risk assessments will be dependent on the<br />

particular subject of the assessment for instance clinical assessments form part of the patients<br />

medical records <strong>and</strong> therefore should be retained as such. Assessments made in relation to<br />

human resource issues such as workplace assessments should be kept in accordance with the<br />

personnel file. Generic risk assessments or environmental risk assessments should be kept as a<br />

minimum for five years following the last review date.<br />

4.7.4 Other Escalation Processes<br />

Other mechanisms are open to Executive Directors <strong>and</strong>/or Directorates to escalate risks for wider<br />

discussion before they become high level risks; this may be as exception reports to the Quality &<br />

Strategy Committee or presentations/reports as part of the rolling assessment programme of the<br />

Audit Committee. Lower level risks should be discussed <strong>and</strong> risks fully considered at feeder<br />

committees throughout the organisation that are specific to particular topics ie the Drugs <strong>and</strong><br />

Therapeutic Committee or the Clinical Risk Committee. An overview of this process is described<br />

in section 13, Key Performance Indicators.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 19 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


4.8 RISK REGISTER<br />

The Risk Registers set out the existing controls that relate to the risk as most are already subject<br />

to some degree of management. This helps BHRUT to set a more realistic or “real” prioritisation<br />

of the issues by assignment of a residual risk score. This means effort <strong>and</strong> resource can be<br />

targeted to mitigate or manage the risk <strong>and</strong> actions with responsibilities <strong>and</strong> target dates being set<br />

out in the Risk Register. Through this reassessment of priority scores (using the “Residual Risk<br />

Score) further work or “solutions” can be planned to address the risk until it reaches an<br />

acceptable level (i.e. within the risk appetite set).<br />

Managing risk is part of everyday management in the NHS, however due to the time that is<br />

required to implement solutions to risks <strong>and</strong> financial constraints; the concept of Risk Registers<br />

has been developed to provide an on-going log of these risks. Risk Registers are primarily an<br />

internal management tool to support Directorates/corporate departments in managing their risks<br />

whilst there is an opportunity to raise/escalate particular risks for inclusion on to the <strong>Trust</strong>’s<br />

Corporate Risk Register <strong>and</strong> the <strong>Board</strong> Assurance framework for input on mitigation of the risk.<br />

It is the policy of the <strong>Trust</strong> to maintain a Risk Register recording financial <strong>and</strong> non-financial risks<br />

as identified by its processes for continuous risk identification <strong>and</strong> risk assessment. For the<br />

avoidance of doubt, non-financial risks include clinical, non-clinical <strong>and</strong> organisational risks.<br />

The Risk Register is maintained <strong>and</strong> updated by the Risk Management Team <strong>and</strong> provides<br />

quarterly reports to the directorates via the Safeguard Risk Management system to enable them<br />

to scrutinise their risk to ensure that they are adequately described <strong>and</strong> graded <strong>and</strong> that action<br />

plans are formulated the Risk register.<br />

4.8.1 Clinical Directorate risk registers<br />

All risks must be submitted with a risk assessment <strong>and</strong> an action plan which would be updated to<br />

reflect the current Directorate risk profile, Risk action plan with details of key dates <strong>and</strong><br />

individual responsibility for action should be integrated into service plans <strong>and</strong> project<br />

plans. Appropriate review is needed to keep the risk register current. Each risk owner will<br />

need to have a securely retained copy of the register <strong>and</strong> a clear<br />

history of changes made as risk registers may be requested at any time by<br />

decision makers, project boards, the Risk Manager, Internal or External Auditors<br />

or any interested parties in the interest of openness & accountability<br />

Local Monitoring of incidents, complaints <strong>and</strong> claims including serious incidents<br />

Make reference to policies<br />

4.9 BOARD ASSURANCE FRAMEWORK<br />

The <strong>Board</strong> Assurance Framework (BAF) will identify which of BHRUT’s principal objectives are at<br />

risk because of inadequacies in the operation of the organisational controls or areas where the<br />

organisation has insufficient assurance about the effectiveness of the controls in place. At the<br />

same time the <strong>Board</strong> Assurance Framework will provide structured assurances where key risks<br />

are being managed effectively <strong>and</strong> which principal objectives are being delivered.<br />

The <strong>Board</strong> Assurance Framework will form the key document for the <strong>Trust</strong> <strong>Board</strong> in ensuring all<br />

principal risks are controlled, that the effectiveness of these key controls has been assured, <strong>and</strong><br />

that there is sufficient evidence to support the Annual Governance Statement<br />

Review by the <strong>Trust</strong> <strong>Board</strong> of the BAF provides the opportunity for risk to prioritisation <strong>and</strong> ensure<br />

effective performance management. The structure of the BAF allows for the identification of where<br />

the <strong>Trust</strong>’s objectives may not be met because of inadequacies in the operation of controls or<br />

where the organisation has insufficient assurances.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 20 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


The <strong>Trust</strong>’s BAF is audited by the <strong>Trust</strong>’s internal auditors <strong>and</strong> will be the basis for reports to the<br />

Audit Committee. It is the policy of the <strong>Trust</strong> to maintain effective assurance of the risk<br />

management arrangements for its organisational risks, through:<br />

• identification, assessment, review <strong>and</strong> control of the risks associated with its principal<br />

service, staffing, financial <strong>and</strong> governance objectives, at both the corporate <strong>and</strong><br />

departmental / directorate level;<br />

• assessment of both the internal <strong>and</strong> external assurances available of the effectiveness of<br />

the control of those risks;<br />

• action to put in place effective assurance where assessment indicates that to be<br />

necessary;<br />

• recognising gaps in the controls <strong>and</strong><br />

• regular review of organisational risk management <strong>and</strong> its associated assurance<br />

arrangements by the <strong>Trust</strong> <strong>Board</strong>.<br />

The BAF demonstrates the sequential actions taken quarter by quarter to reduce <strong>and</strong> remove<br />

risks facing the organisation.<br />

4.10 EXTERNAL RISK MANAGEMENT STANDARDS<br />

The <strong>Trust</strong> is committed to pursue best practice in its risk control measures by continuously<br />

applying external risk management st<strong>and</strong>ards, advice <strong>and</strong> recommendations relevant to its<br />

activities.<br />

To that end it will maintain continuous comprehensive compliance programmes with relevant<br />

st<strong>and</strong>ards, including the following:<br />

• The Care Quality Commission’s (CQC)<br />

• The NHS Litigation Authority’s (NHSLA) risk management st<strong>and</strong>ards - Clinical Negligence<br />

Scheme for <strong>Trust</strong>s (CNST)<br />

• The st<strong>and</strong>ards of Clinical Pathology Accreditation Ltd (CPA)<br />

• The advice of the National Confidential Enquiries into patient mortality<br />

• The guidance of the National Institute for Health & Clinical Excellence (NICE).<br />

• The guidance within National Service Frameworks <strong>and</strong> High Level Enquiries<br />

• The Health & Safety at Work Act <strong>and</strong> subordinate legislation.<br />

• Patient Environment Action Team<br />

5. THE DEVELOPMENT OF THIS POLICY<br />

This policy was written using the <strong>Trust</strong> Policy Template <strong>and</strong> giving consideration to all the<br />

elements required within the <strong>Trust</strong> Policy for the Development <strong>and</strong> Management of <strong>Trust</strong>-<br />

Wide Procedural Documents.<br />

The individual/group nominated as responsible for this Policy is the <strong>Trust</strong> <strong>Board</strong>.<br />

This Policy was developed through an update to the existing policy, consultation with<br />

stakeholders <strong>and</strong> discussion/agreement at the Quality & Safety Committee, the Audit<br />

Committee <strong>and</strong> the <strong>Trust</strong> <strong>Board</strong>.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 21 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


5.1 Consultation <strong>and</strong> Communication with Stakeholders<br />

Stakeholders identified for this process are<br />

• Clinical Governance Director<br />

• <strong>Trust</strong> <strong>Board</strong><br />

• Clinical Directors<br />

• Managers<br />

• Clinical Governance Staff<br />

• All Staff<br />

They were included in the development of the updated Policy by consultation, either<br />

individual or as part of the approving Committees.<br />

They were included in the approval of the Policy by representation at the Audit Committee<br />

or the Quality & Safety Committee.<br />

All involved stakeholders received a copy of the final approved policy or were notified that<br />

it is available on the Intranet.<br />

5.2 Equality Impact Assessment<br />

This policy has been equality impact assessed to ensure that the guidance provided does<br />

not place at a disadvantage any service, population or workforce over another. A<br />

completed Equality Impact Assessment is shown page 30<br />

5.3 Approval <strong>and</strong> Ratification<br />

A copy of the Checklist for Review <strong>and</strong> Approval of Procedural Documents has been<br />

completed for this Policy <strong>and</strong> submitted with the final draft for approval <strong>and</strong> ratification.<br />

This policy was reviewed <strong>and</strong> approved by the Quality & Safety Committee on<br />

………………….<br />

This policy was reviewed <strong>and</strong> approved by the Audit Committee on ……………………….<br />

This policy was reviewed <strong>and</strong> ratified by the Policy Ratification Committee on<br />

………………………..<br />

6. REVIEW AND REVISION ARRANGEMENTS<br />

6.1 Review<br />

This policy will be reviewed every 2 years or sooner if there are pertinent legislative or<br />

organisational changes.<br />

6.2 Revision<br />

Details of all/any revision to this Policy are documented in Amendments – Section 11.<br />

7. DISSEMINATION AND IMPLEMENTATION<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 22 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


7.1 Dissemination<br />

Once approved, the Strategy will be placed on the <strong>Trust</strong>’s intranet site for ease of access by staff.<br />

Risk <strong>and</strong> patient safety issues will be raised frequently through the weekly electronic newsletter<br />

‘The Link’, ‘MISSES’ maternity newsletter <strong>and</strong> ‘PHAT’ public health midwives newsletter. Key<br />

information from this Strategy will be used to provide guidance <strong>and</strong> advice at the <strong>Trust</strong>’s corporate<br />

<strong>and</strong> specialist induction sessions <strong>and</strong> m<strong>and</strong>atory risk management training to ensure the<br />

maximum coverage of staff at all levels in the organisation.<br />

A Plan for Dissemination of Procedural Documents has been completed <strong>and</strong> submitted<br />

with the final draft for approval <strong>and</strong> ratification.<br />

7.2 Implementation<br />

The <strong>Trust</strong> will ensure that training is provided in order that the objectives of this document are<br />

met.<br />

There is corporate responsibility to ensure a framework of corporate, local <strong>and</strong> specialty<br />

inductions are in place together with m<strong>and</strong>atory <strong>and</strong> risk management training for all permanent<br />

staff at all levels of the organisation. The <strong>Trust</strong> carries out an annual training needs analysis to<br />

assess the training requirements of the organisation to ensure there is sufficient risk management<br />

training provision to enable its workforce to perform their duties safely. Details of the courses<br />

available are contained within the Learning & Development Prospectus.<br />

A copy of the current training needs analysis is incorporated within the Guidance for Accessing<br />

Education & Learning Opportunities.<br />

Examples of training that the <strong>Trust</strong> provides:<br />

Risk management training for <strong>Board</strong> members <strong>and</strong> members of Executive Team by<br />

representative from Clinical Governance Team, Non attendance is followed up by Clinical<br />

Governance Team. Attendance is recorded on a database kept by Clinical Governance centrally<br />

M<strong>and</strong>atory Nurse Training (three day course)<br />

Root cause analysis – (one-day course)<br />

8. MONITORING<br />

It is the policy of the <strong>Trust</strong> to monitor adherence to the relevant st<strong>and</strong>ards by means of<br />

programmes of annual self-assessment <strong>and</strong> audit <strong>and</strong> it is the responsibility of the Clinical<br />

Directors to ensure the <strong>Trust</strong>’s rolling programme of corporate audits is undertaken.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 23 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


The <strong>Trust</strong> recognises the importance of collecting meaningful <strong>and</strong> relevant data in a statistical<br />

format so the analysis <strong>and</strong> trends can be monitored <strong>and</strong> appropriate action taken. Where<br />

possible both qualitative <strong>and</strong> quantitative information is sought to inform decision-making, <strong>and</strong> is<br />

aggregated to provide a holistic interpretation of the risks faced by the organisation via the <strong>Board</strong><br />

Assurance Framework <strong>and</strong> quarterly Aggregated Data reports sent to the Directorates <strong>and</strong><br />

reviewed by the Quality <strong>and</strong> Safety Committee.<br />

Each Directorate has an allocated clinical governance lead that attends the Directorates <strong>Board</strong><br />

meetings <strong>and</strong> can assist with risk issues if required, <strong>and</strong> a named complaints manager that can<br />

offer advice <strong>and</strong> guidance. Audit advice <strong>and</strong> guidance can be provided through the <strong>Trust</strong>’s Audit<br />

Department. Each Directorate also has financial <strong>and</strong> human resource support from named leads.<br />

It is the policy of the <strong>Trust</strong> that the impact of its risk management processes should be monitored<br />

continuously via appropriate, quantified key indicators, capable of indicating progress over time.<br />

The following key performance indicators will be used to monitor implementation at both a<br />

corporate <strong>and</strong> local level.<br />

It is the policy of the <strong>Trust</strong> that comprehensive quarterly monitoring reports on the identified risks<br />

are produced <strong>and</strong> considered at each meeting of the Audit Committee. Copies of the reports are<br />

also made available at the appropriate level of detail to internal stakeholders including all levels of<br />

management with responsibilities for risk management <strong>and</strong> to relevant external stakeholders as<br />

requested.<br />

The matrix below identifies all the monitoring of this policy which will be carried out, how<br />

this will be done (e.g. audit), frequency, who is the lead person responsible for ensuring<br />

that the monitoring is carried out, where reports from monitoring are reported, who<br />

(individual/group/committee) is responsible for ensuring that any gaps or deficiencies are<br />

recorded on an action plan which is followed up <strong>and</strong> who is responsible for ensuring that<br />

implementation of any changes which follow the action plan completion are implemented<br />

<strong>and</strong>, where appropriate, information disseminated within the <strong>Trust</strong> to enable learning from<br />

the experience<br />

What will be<br />

monitored<br />

<strong>and</strong>/or<br />

St<strong>and</strong>ard To Be<br />

Achieved<br />

How/Method Frequency Lead Reported to Deficiencies/gaps<br />

recommendations<br />

<strong>and</strong> action plans<br />

followed up by<br />

Implementation<br />

of any required<br />

change<br />

responsibility<br />

of<br />

In date risk<br />

management<br />

strategy in<br />

place with<br />

risk<br />

management<br />

structures<br />

described<br />

Significant<br />

risk register<br />

reviewed by<br />

Audit<br />

Committee<br />

<strong>Board</strong><br />

Assurance<br />

Framework is<br />

scrutinised<br />

by the Audit<br />

Strategy in place<br />

<strong>and</strong> approved<br />

Assurance that<br />

the <strong>Trust</strong> <strong>Board</strong><br />

are aware of the<br />

organisations<br />

significant risks<br />

Minutes of<br />

meetings<br />

evidence review<br />

Every two<br />

years<br />

Quarterly<br />

Clinical<br />

Governance<br />

Director<br />

Audit<br />

Committee<br />

Audit<br />

Committee<br />

Relevant<br />

Directorates<br />

Quarterly <strong>Trust</strong> <strong>Board</strong> Relevant<br />

Directorates<br />

/ Relevant<br />

Executive<br />

Policy <strong>and</strong><br />

Ratification<br />

Committee<br />

Audit<br />

Committee<br />

Audit<br />

Committee<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 24 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Committee<br />

Review <strong>and</strong><br />

monitoring of<br />

risks<br />

Incident<br />

Reporting<br />

(Patient<br />

Safety)<br />

Reporting to<br />

external<br />

agencies to<br />

support<br />

shared<br />

learning<br />

(NRLS)<br />

Information<br />

on<br />

complaints,<br />

claims <strong>and</strong><br />

incidents is<br />

aggregated,<br />

analysed <strong>and</strong><br />

disseminated<br />

Incidents<br />

graded<br />

according to<br />

severity<br />

Serious<br />

Incident<br />

investigations<br />

compliant<br />

with Incident<br />

<strong>and</strong> SI policy<br />

Safety Alerts<br />

implemented<br />

within<br />

Evidence of<br />

review <strong>and</strong><br />

actions<br />

undertaken -<br />

recorded on<br />

Ulysses database<br />

quarterly reports<br />

Assurance that<br />

delivery <strong>and</strong><br />

performance<br />

against the<br />

<strong>Trust</strong>’s objectives<br />

are being<br />

appropriately<br />

monitored.<br />

Incident reporting<br />

rate > NPSA<br />

average<br />

Evidence of<br />

timely reporting to<br />

NRLS<br />

Aggregated data<br />

reports are<br />

presented to<br />

Committees,<br />

Directorates <strong>and</strong><br />

are published on<br />

the <strong>Trust</strong> Intranet<br />

including<br />

commentary on<br />

organisational<br />

learning<br />

All incidents are<br />

triaged <strong>and</strong> coded<br />

accurately, in line<br />

with severity as<br />

set out in the<br />

Incident <strong>and</strong> SI<br />

policy<br />

Audit of reports<br />

shows<br />

compliance with<br />

Incident <strong>and</strong> SI<br />

policy<br />

CAS alerts are<br />

implemented<br />

within time frames<br />

Quarterly<br />

Risk<br />

Management<br />

Team<br />

Performance<br />

Efficiency<br />

<strong>and</strong> Quality<br />

Committee<br />

Audit<br />

Committee<br />

Quality &<br />

Strategy<br />

Committee<br />

Relevant<br />

Directorates<br />

/ Relevant<br />

Executive<br />

Monthly <strong>Trust</strong> <strong>Board</strong> Relevant<br />

Directorates<br />

On<br />

publication<br />

Quarterly<br />

On-going<br />

On-going<br />

Quarterly<br />

Clinical Risk<br />

Management<br />

Committee<br />

Clinical Risk<br />

management<br />

Committee<br />

Statutory<br />

Safety<br />

Committee<br />

Audit<br />

Committee<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Directorates<br />

Patient<br />

Safety<br />

Adviser<br />

Patient<br />

Safety<br />

Adviser<br />

Clinical<br />

Governance<br />

Director<br />

Clinical Risk<br />

Management<br />

Committee<br />

Relevant<br />

Directorates<br />

Relevant<br />

Directorates<br />

Relevant<br />

Directorates<br />

Relevant<br />

Directorates<br />

Relevant<br />

Directorates<br />

Audit<br />

Committee<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Clinical Risk<br />

Management<br />

Committee<br />

Clinical Risk<br />

Management<br />

Committee<br />

Clinical Risk<br />

management<br />

Committee<br />

Statutory<br />

Safety<br />

Committee<br />

Audit<br />

Committee<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Directorates<br />

Patient Safety<br />

Adviser<br />

Patient Safety<br />

Adviser<br />

Clinical<br />

Governance<br />

Director<br />

Clinical Risk<br />

Management<br />

Committee<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 25 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


timescale<br />

with supporting<br />

evidence<br />

provided<br />

Annual<br />

Health <strong>and</strong><br />

Safety review<br />

Annual report<br />

detailing Health<br />

<strong>and</strong> Safety Issues<br />

within the <strong>Trust</strong><br />

submitted to<br />

Statutory Safety<br />

Committee<br />

Annual<br />

Audit<br />

Committee<br />

Relevant<br />

Directorates<br />

Audit<br />

Committee<br />

Clinical<br />

Governance<br />

Review<br />

Annual report<br />

regarding Clinical<br />

Governance<br />

within the <strong>Trust</strong><br />

submitted to<br />

Quality <strong>and</strong><br />

Strategy<br />

Committee<br />

Annual<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Relevant<br />

Directorates<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Procedural<br />

documents<br />

are reviewed<br />

in line with<br />

review date<br />

Annual report to<br />

Clinical<br />

Governance Risk<br />

Committee<br />

Annual<br />

Relevant<br />

Committees<br />

Quality<br />

Systems<br />

Manager<br />

Quality<br />

Systems<br />

Manager<br />

Service<br />

Users<br />

Annual Patient<br />

Survey<br />

Annual<br />

Clinical Risk<br />

Management<br />

Committee<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Relevant<br />

Directorates<br />

Clinical Risk<br />

Management<br />

Committee<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Complaints<br />

compliant<br />

with national<br />

targets for<br />

responses<br />

<strong>Trust</strong><br />

performance with<br />

acknowledgement<br />

within 2 days <strong>and</strong><br />

30 days targets<br />

Monthly<br />

Quarterly<br />

<strong>Trust</strong> <strong>Board</strong><br />

Relevant<br />

Directorates<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Any deficiencies identified during monitoring will be recorded <strong>and</strong> reported to the Quality<br />

<strong>and</strong> Safety Committee. The nominated persons <strong>and</strong>, ultimately, the Quality <strong>and</strong> Safety<br />

Committee, will be responsible for ensuring that an action plan has been developed, is<br />

followed through, all required actions taken to remedy the deficiency/s identified <strong>and</strong>,<br />

where appropriate, information disseminated within the <strong>Trust</strong> to enable learning from the<br />

experience.<br />

9. REFERENCES<br />

NHSLA Risk Management Strategy Checklist March <strong>2012</strong>/13<br />

The NHS Improvement Plan; 2006: Department of Health www.doh.org<br />

Making it Happen – a Guide for Risk Managers on How to Populate a Risk<br />

Register. Controls Assurance Support<br />

The How to Guide for Leadership for Safety. Patient Safety First Campaign.<br />

2008.www.patientsafetyfirst.nhs.uk<br />

The Healthy NHS <strong>Board</strong> Principles for Good Governance.<br />

The H<strong>and</strong>book to the NHS Constitution. Department of Health<br />

Quality governance in the NHS – a guide for provider boards – National Quality <strong>Board</strong> 2011<br />

Compliance Framework - Monitor<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 26 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


10. ASSOCIATED DOCUMENTATION<br />

Other <strong>Trust</strong> policies <strong>and</strong> procedures with links to this Risk Management Strategy are<br />

listed below:<br />

• Blood Transfusion Policy<br />

• Claims Policy <strong>and</strong> Procedure<br />

• Clinical & Non Clinical Documentation<br />

• Clinical Audit & Effectiveness Strategy<br />

• Clinical Governance Annual report<br />

• Complaints Policy <strong>and</strong> Procedure<br />

• Consent to Examination or Treatment Policy<br />

• Control of Contractors Policy<br />

• Corporate Governance Manual<br />

• COSHH Policy<br />

• Display Screen Equipment (DSE)<br />

• Fire Policy <strong>and</strong> Procedures<br />

• Guidance for Accessing Education & Learning Opportunities<br />

• Incident Reporting & SI Policy<br />

• Induction Policy<br />

• Infection Control Policy<br />

• Latex Policy<br />

• Learning & Development Prospectus<br />

• Lockdown Policy<br />

• Lone Workers Policy<br />

• Major Incident Plan.<br />

• Manual H<strong>and</strong>ling Operations Policy<br />

• Maternity Services Risk Management Strategy 2009-10<br />

• Medical Devices – Policy for the Safe Use of<br />

• Mental Capacity Act 2005 Interim Policy<br />

• NCEPOD at BHR Policy on Compliance<br />

• Evidence Based Practice Policy & Procedure<br />

• PALS Policy<br />

• P<strong>and</strong>emic Flu (H1NI) <strong>and</strong> Winter Resilience Plan<br />

• Patient Identification Policy<br />

• Patient Information Policy<br />

• Policy on Policies<br />

• Radiation Protection Policy<br />

• Risk Assessment Tool Kit<br />

• Aggregated Data reports<br />

• Safety Alert Broadcast System Policy<br />

• Safety Policy<br />

• Service Improvement & Reconfiguration Policy<br />

• Slips Trips <strong>and</strong> Falls Policy<br />

• Transportation of Dangerous Goods Policy<br />

• Violence <strong>and</strong> Aggression Policy<br />

11. AMENDMENTS<br />

To be completed only when the Policy has been reviewed <strong>and</strong> changed.<br />

Page/Section<br />

Strategy <strong>and</strong> Policy<br />

updated to reflect<br />

<strong>2012</strong>/2013 risk<br />

management st<strong>and</strong>ards<br />

Change<br />

Whole document<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 27 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Checklist for the Review <strong>and</strong> Approval of Procedural Documents<br />

To be completed <strong>and</strong> attached to any procedural document when submitted to the appropriate<br />

committee for consideration <strong>and</strong> approval or ratification.<br />

1. Title<br />

Title of document being reviewed:<br />

Is the title clear <strong>and</strong> unambiguous?<br />

Is it clear whether the document is a policy,<br />

protocol or guideline?<br />

2. Rationale<br />

Are reasons for development of the document<br />

stated?<br />

3. Development Process<br />

Is the method described in brief?<br />

Are individuals involved in the development<br />

identified?<br />

Do you feel a reasonable attempt has been made<br />

to ensure relevant expertise has been used?<br />

Is there evidence of consultation with stakeholders<br />

<strong>and</strong> users?<br />

4. Content<br />

Is the objective of the document clear?<br />

Is the target population clear <strong>and</strong> unambiguous?<br />

Are the intended outcomes described?<br />

Are the statements clear <strong>and</strong> unambiguous?<br />

5. Evidence Base<br />

Is the type of evidence to support the document<br />

identified explicitly?<br />

Are key references cited?<br />

Are the references cited in full?<br />

Are local/organisational supporting documents<br />

referenced?<br />

6. Approval<br />

Does the document identify which committee/group<br />

will approve it?<br />

Does the document identify which committee/group<br />

will ratify it?<br />

If appropriate, have the joint staff side committee<br />

(or equivalent) approved the document?<br />

7. Dissemination <strong>and</strong> Implementation<br />

Yes/No/<br />

Unsure<br />

Comments, including where<br />

information is included in the<br />

document<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 28 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Title of document being reviewed:<br />

Is there a completed Plan for Dissemination of<br />

Procedural Documents which identifies how this will<br />

be done?<br />

Does the plan include the necessary<br />

training/support to ensure compliance?<br />

8. Document Control<br />

Does the document identify where it will be held?<br />

Have archiving arrangements for superseded<br />

documents been addressed?<br />

9. Process for Monitoring Compliance<br />

Are there measurable st<strong>and</strong>ards or KPIs to support<br />

monitoring compliance of the document?<br />

Is there a plan to review or audit compliance with<br />

the document?<br />

10. Review Date<br />

Is the review date identified?<br />

Is the frequency of review identified? If so, is it<br />

acceptable?<br />

11. Overall Responsibility for the Document<br />

Is it clear who will be responsible for coordinating<br />

the dissemination, implementation <strong>and</strong> review of<br />

the documentation?<br />

Yes/No/<br />

Unsure<br />

Comments, including where<br />

information is included in the<br />

document<br />

Individual/Group/Committee Approval<br />

If you are happy to approve this document, please sign <strong>and</strong> date below <strong>and</strong> forward to the chair of the<br />

committee where it will receive ratification.<br />

Name<br />

Signature<br />

Date<br />

On behalf of<br />

Committee Ratification<br />

If the committee is happy to ratify this document, please sign <strong>and</strong> date below <strong>and</strong> forward copies to the person<br />

with responsibility for disseminating <strong>and</strong> implementing the document <strong>and</strong> the Quality Systems Manager.<br />

Name<br />

Date<br />

Signature<br />

On behalf of<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 29 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Equality Impact Assessment Tool<br />

To be completed <strong>and</strong> attached to any policy when submitted to the appropriate committee/group for<br />

consideration <strong>and</strong> approval or ratification.<br />

Policy Title<br />

Policy Number<br />

Responsible Individual/Committee<br />

Approving Committee<br />

Ratifying Committee<br />

1. Does the policy affect one group less or more<br />

favourably than another on the basis of:<br />

Age<br />

Disability – learning disabilities, physical disability,<br />

sensory impairment <strong>and</strong> mental health problems.<br />

Race<br />

Nationality<br />

Ethnic origin – including gypsies <strong>and</strong> travellers<br />

Gender / Gender reassignment<br />

Religion<br />

Beliefs<br />

Sexual orientation – including lesbian, gay <strong>and</strong><br />

bisexual people<br />

Domestic circumstances<br />

Social <strong>and</strong> employment status<br />

Marital/partnership status<br />

HIV status<br />

Political affiliation<br />

Trade Union membership<br />

2. What is the overall purpose of this policy area,<br />

function or activity?<br />

3. What approaches are currently used to measure<br />

progress <strong>and</strong> performance in this area?<br />

4. What counts as success in this area?<br />

5. Are there opportunities within this policy to:<br />

Eliminate illegal discrimination<br />

Promote equality of opportunity<br />

Promote good relations between people of different<br />

groups?<br />

Yes/No<br />

Comments<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 30 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


6. Is the impact of the policy likely to be negative<br />

e.g. is their risk of:<br />

Illegal discrimination<br />

Reducing equality of opportunity for some groups?<br />

Harming relations between different people of<br />

different groups?<br />

7. If you have identified potential discrimination,<br />

are any exceptions valid, legal <strong>and</strong>/or<br />

justifiable?<br />

8. If so, what action could be taken to reduce<br />

adverse effects <strong>and</strong> promote or enhance<br />

positive effects?<br />

9. Please describe the options available for<br />

incorporating equality monitoring into routine<br />

arrangements?<br />

Yes/No<br />

Comments<br />

If you have identified a potential discriminatory impact of this policy document, please refer the issue<br />

to the Workforce Equality Lead, together with any suggestions as to the action required to<br />

avoid/reduce this impact.<br />

For advice in respect of answering the above questions, please contact the Workforce Equality Lead,<br />

HR Department, Queen’s Hospital on extension 3294.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 31 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Plan for Dissemination of Procedural Documents<br />

To be completed <strong>and</strong> attached to any procedural document when submitted to the appropriate<br />

committee for consideration <strong>and</strong> approval or ratification.<br />

Title of document:<br />

Dissemination lead (name <strong>and</strong> contact details):<br />

Date finalised:<br />

Previous document<br />

already being used?<br />

Yes / No<br />

(Please delete as<br />

appropriate)<br />

Date due to be reviewed:<br />

If yes, in what format <strong>and</strong> where?<br />

Proposed action to retrieve out of date copies of the document:<br />

Have any training needs been identified <strong>and</strong> addressed (give details):<br />

To be disseminated to:<br />

How will it be disseminated,<br />

who will do it <strong>and</strong> when?<br />

Format (i.e.<br />

paper<br />

or electronic)<br />

Comments:<br />

Quality Systems Manager<br />

Originator to send after<br />

ratification at committee<br />

Electronic<br />

For numbering, logging <strong>and</strong> issue<br />

Web Manager<br />

Sent by Quality Systems<br />

Manager once numbered <strong>and</strong><br />

logged<br />

Electronic<br />

For inclusion on <strong>Trust</strong> Intr@net<br />

<strong>and</strong>, where appropriate, archiving<br />

previous version.<br />

Originator<br />

Sent by Quality Systems<br />

Manager once issued<br />

Electronic<br />

For dissemination<br />

All staff<br />

Placed on Intr@net<br />

(fill in date once issued)<br />

Dissemination Record - to be used once document is approved, ratified <strong>and</strong> issued<br />

Disseminated to: (either<br />

directly or via meetings, etc.)<br />

Format<br />

(i.e. paper or<br />

electronic)<br />

Date<br />

disseminated:<br />

No. of<br />

copies<br />

sent:<br />

Contact details /<br />

comments:<br />

Please add as many extra lines as required to this document to ensure it reflects the dissemination<br />

plan for the Policy.<br />

Issued <strong>November</strong> 2010 Version 1<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 32 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


APPENDIX 1<br />

RISK GRADING MATRIX<br />

Likelihood<br />

Likelihood score 1 2 3 4 5<br />

Rare Unlikely Possible Likely Almost certain<br />

5 Catastrophic 5 10 15 20 25<br />

4 Major 4 8 12 16 20<br />

3 Moderate 3 6 9 12 15<br />

2 Minor 2 4 6 8 10<br />

1 Negligible 1 2 3 4 5<br />

1 - 3 Low risk<br />

4 - 6 Moderate risk<br />

8 - 12 High risk<br />

15-25 Extreme risk<br />

RISK<br />

GRADING<br />

ACTION TO BE TAKEN<br />

EXTREME<br />

Urgent senior management attention needed. For risks graded as extreme the investigation should be led by a Director, General Manager or Matron.<br />

HIGH<br />

Urgent senior management attention needed. A decision about risk acceptability must be made within 4 weeks <strong>and</strong> an action plan for controlling the risk must be devised.<br />

MODERATE<br />

Management responsibility for risk control must be identified (unless a decision is made to accept the risk). Any action requirements must be added to a ward / department action<br />

plan.<br />

LOW<br />

Risks can be / are already being managed by routine procedures – no further action required.<br />

Consequence Scoring table (C)<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 33 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Consequence score (severity levels) <strong>and</strong> examples of descriptors<br />

1 2 3 4 5<br />

Domains Negligible Minor Moderate Major Catastrophic<br />

Impact on the safety of patients, staff<br />

or public (physical/psychological<br />

harm)<br />

Minimal injury requiring<br />

no/minimal intervention or<br />

treatment.<br />

Minor injury or illness,<br />

requiring minor intervention<br />

Moderate injury requiring<br />

professional intervention<br />

Major injury leading to long-term<br />

incapacity/disability<br />

Incident leading to death<br />

No time off work<br />

Requiring time off work for >3<br />

days<br />

Increase in length of hospital<br />

stay by 1-3 days<br />

Requiring time off work for 4-14<br />

days<br />

Increase in length of hospital<br />

stay by 4-15 days<br />

Requiring time off work for >14<br />

days<br />

Increase in length of hospital<br />

stay by >15 days<br />

Multiple permanent injuries or<br />

irreversible health effects<br />

An event which impacts on a<br />

large number of patients<br />

RIDDOR/agency reportable<br />

incident<br />

Mismanagement of patient care<br />

with long-term effects<br />

An event which impacts on a<br />

small number of patients<br />

Quality/complaints/audit<br />

Peripheral element of<br />

treatment or service<br />

suboptimal<br />

Informal complaint/inquiry<br />

Overall treatment or service<br />

suboptimal<br />

Formal complaint (stage 1)<br />

Local resolution<br />

Single failure to meet internal<br />

st<strong>and</strong>ards<br />

Minor implications for patient<br />

safety if unresolved<br />

Treatment or service has<br />

significantly reduced<br />

effectiveness<br />

Formal complaint (stage 2)<br />

complaint<br />

Local resolution (with potential<br />

to go to independent review)<br />

Repeated failure to meet<br />

internal st<strong>and</strong>ards<br />

Non-compliance with national<br />

st<strong>and</strong>ards with significant risk to<br />

patients if unresolved<br />

Multiple complaints/<br />

independent review<br />

Low performance rating<br />

Critical report<br />

Totally unacceptable level or<br />

quality of treatment/service<br />

Gross failure of patient safety if<br />

findings not acted on<br />

Inquest/ombudsman inquiry<br />

Gross failure to meet national<br />

st<strong>and</strong>ards<br />

Human resources/ organisational<br />

development/staffing/ competence<br />

Short-term low staffing<br />

level that temporarily<br />

reduces service quality (<<br />

1 day)<br />

Reduced performance rating if<br />

unresolved<br />

Low staffing level that reduces<br />

the service quality<br />

Major patient safety implications<br />

if findings are not acted on<br />

Late delivery of key objective/<br />

service due to lack of staff<br />

Unsafe staffing level or<br />

competence (>1 day)<br />

Low staff morale<br />

Poor staff attendance for<br />

m<strong>and</strong>atory/key training<br />

Uncertain delivery of key<br />

objective/service due to lack of<br />

staff<br />

Unsafe staffing level or<br />

competence (>5 days)<br />

Loss of key staff<br />

Very low staff morale<br />

No staff attending m<strong>and</strong>atory/<br />

key training<br />

Non-delivery of key<br />

objective/service due to lack of<br />

staff<br />

Ongoing unsafe staffing levels or<br />

competence<br />

Loss of several key staff<br />

No staff attending m<strong>and</strong>atory<br />

training /key training on an<br />

ongoing basis<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 34 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Statutory duty/ inspections<br />

Adverse publicity/ reputation<br />

Business objectives/ projects<br />

Finance including claims<br />

No or minimal impact or<br />

breech of guidance/<br />

statutory duty<br />

Rumours<br />

Potential for public concern<br />

Insignificant cost increase/<br />

schedule slippage<br />

Small loss Risk of claim<br />

remote<br />

Breech of statutory legislation<br />

Reduced performance rating if<br />

unresolved<br />

Local media coverage –<br />

short-term reduction in public<br />

confidence<br />

Elements of public expectation<br />

not being met<br />

25 per cent<br />

over project budget<br />

Schedule slippage<br />

Key objectives not met<br />

Non-delivery of key objective/<br />

Loss of >1 per cent of budget<br />

Failure to meet specification/<br />

slippage<br />

Loss of contract / payment by<br />

results<br />

Service/business interruption<br />

Environmental impact<br />

Loss/interruption of >1<br />

hour<br />

Minimal or no impact on<br />

the environment<br />

Loss/interruption of >8 hours<br />

Minor impact on environment<br />

Loss/interruption of >1 day<br />

Moderate impact on<br />

environment<br />

Loss/interruption of >1 week<br />

Major impact on environment<br />

Claim(s) >£1 million<br />

Permanent loss of service or<br />

facility<br />

Catastrophic impact on<br />

environment<br />

Likelihood Scoring table (L)<br />

Likelihood score 1 2 3 4 5<br />

Descriptor Rare Unlikely Possible Likely Almost certain<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 35 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Frequency<br />

How often might it/does it<br />

happen<br />

This will probably never<br />

happen/recur<br />

Do not expect it to happen/recur<br />

but it is possible it may do so<br />

Might happen or recur<br />

occasionally<br />

Will probably happen/recur but it<br />

is not a persisting issue<br />

Will undoubtedly<br />

happen/recur,possibly frequently<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 36 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


APPENDIX 2<br />

REPORTING STRUCTURE<br />

FOR RISK<br />

TRUST BOARD PUBLIC<br />

Quality <strong>and</strong> Strategy<br />

Committee<br />

Audit Committee<br />

Clinical Risk Management Committee<br />

(CRC)<br />

Statutory Safety Committee<br />

Safeguarding Children Committee<br />

(SCC)<br />

Safeguarding Adults Committee<br />

(SAC)<br />

Evidence Based Practice <strong>Board</strong><br />

(EBPC)<br />

Drugs <strong>and</strong> Therapeutic Committee<br />

(D&TC)<br />

Infection Control Committee<br />

(ICC)<br />

Clinical Audit Committee<br />

(CAC)<br />

Research & Development Committee<br />

(R&DC)<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 37 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Appendix 3<br />

Framework for Risk Management<br />

Self Assessment tool for Directorates/Departments<br />

Key Element Required Action Complaint<br />

Yes<br />

No<br />

N/A<br />

Leadership The Directorate/Department has a local clinical governance or risk<br />

management group which evaluates implementation of risk management<br />

systems <strong>and</strong> strategies <strong>and</strong> aggress service changes as necessary<br />

The Directorate group considers matters pertaining to risk management<br />

including incidents, complaints <strong>and</strong> claims<br />

There is an indentified lead for risk management who is part of the local<br />

clinical governance (or similar) group <strong>and</strong> whose remit includes sharing<br />

information <strong>and</strong> learning on incidents, complaints, claims <strong>and</strong> health <strong>and</strong><br />

safety<br />

The Clinical Directorate team provide the medical director with an annual<br />

governance report outlining their progress against directorate <strong>and</strong> corporate<br />

objectives<br />

Culture<br />

Accountability<br />

The Clinical Director receives copies of all relevant guidance including NICE<br />

guidelines <strong>and</strong> Centralised Alerting Systems (CAS) alerts, national<br />

confidential enquiries <strong>and</strong> ensures that appropriate action is instigated<br />

All leaders behave in a way which is consistent with <strong>and</strong> demonstrates<br />

commitment to being open <strong>and</strong> fair<br />

The Directorate identify areas of required improvement through both<br />

corporate <strong>and</strong> local risk management systems <strong>and</strong> implement appropriately<br />

Incidents, near misses <strong>and</strong> risks are regularly reported using the <strong>Trust</strong> Risk<br />

Management reporting system<br />

Incidents <strong>and</strong> near misses are investigated <strong>and</strong> analysed <strong>and</strong> where specific<br />

areas of learning are identified or changes to practice required appropriate<br />

action is taken<br />

Major Incident<br />

Planning<br />

Incident investigation to the level appropriate for severity (as per policy) <strong>and</strong><br />

final approval is undertaken within the agreed timescales<br />

The Directorate/Department managers are aware of the <strong>Trust</strong> Major Incident<br />

Plan<br />

The Directorate/Department managers are aware of their responsibilities in<br />

relation to the Major Incident Plan<br />

Business<br />

Continuity<br />

Management<br />

Strategy<br />

External<br />

Assessments<br />

Where relevant staff have received briefing/training on the Major Incident<br />

Plan <strong>and</strong> associated policies<br />

Directorate/Department Business Continuity plans are maintained<br />

The Directorate/Department teams participate in Business Continuity<br />

planning<br />

The Directorate/Department is aware of the objectives of the <strong>Trust</strong> Risk<br />

Management Policy <strong>and</strong> Strategy <strong>and</strong> has formulated a plane to enable these<br />

to be achieved locally<br />

The Directorate/Department has an action plan to meet local objectives<br />

related to risk management<br />

The Directorate/Department are aware of the safety <strong>and</strong> risk management<br />

st<strong>and</strong>ards as indentified by external agencies such as Care Quality<br />

Commission <strong>and</strong> NHS Litigation Authority<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 38 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


External Reporting<br />

Responsibility<br />

Induction<br />

Training<br />

Requirements <strong>and</strong> achievements against external assessments are<br />

communicated to all relevant staff<br />

Directorate/Department managers are aware of their responsibilities in<br />

relation to reporting incidents <strong>and</strong> near misses to external agencies<br />

All staff are aware of their responsibility in relation to risk management <strong>and</strong><br />

health <strong>and</strong> safety<br />

All permanent staff have attended the <strong>Trust</strong> corporate induction programme<br />

All staff including temporary staff <strong>and</strong> volunteers have completed the local<br />

induction process<br />

A training needs assessment is undertaken within the<br />

Directorate/Department on an annual basis<br />

There is a system for monitoring attendance at m<strong>and</strong>atory training <strong>and</strong> for<br />

following up those that fail to attend<br />

All permanent staff have completed the required m<strong>and</strong>atory training<br />

programme<br />

The Directorate/Department participates in the system for assessment <strong>and</strong><br />

training for medical equipment <strong>and</strong> devices<br />

Relevant staff have received training in risk management techniques such as<br />

risk assessment <strong>and</strong> root cause analysis<br />

Patient <strong>and</strong> Public<br />

Involvement<br />

Risk Assessment<br />

Relevant staff have received training in incident reporting <strong>and</strong> management<br />

of risk register<br />

There is patient information available to support patients to be guardians of<br />

their own safety<br />

Patients <strong>and</strong> where relevant carers are informed of incidents as per Being<br />

Open Policy<br />

The Directorate/Department have undertaken risk assessments <strong>and</strong> reported<br />

compliance with regards to health <strong>and</strong> safety<br />

Risk assessment of patient falls is undertaken buy nursing staff on<br />

admission, if clinical condition changes or at a minimum weekly<br />

Infection Control<br />

Risk assessment of VTE is undertaken by the doctors on each admission<br />

The <strong>Trust</strong> has a designated representative for infection control<br />

Infection control high risk areas have been identified <strong>and</strong> the<br />

Directorate/Department is working with Infection Control to minimise <strong>and</strong><br />

manage risk<br />

All relevant areas have access to infection control policies<br />

There is evidence that staff received appropriate training <strong>and</strong> updates in<br />

infection control issues<br />

There is a system for reporting, analysing <strong>and</strong> learning from serious incidents<br />

associated with infection control<br />

Each clinical team can demonstrate consistently high levels of compliance<br />

with the H<strong>and</strong> Hygiene Policy<br />

Medical Equipment<br />

<strong>and</strong> Devices<br />

The local cleaning arrangements are informed by <strong>Trust</strong> Infection policies<br />

The Directorate/Department is aware of the training in the use of Medical<br />

Devices Policy<br />

• Ensuring that all equipment used <strong>and</strong> is recorded on <strong>Trust</strong> inventory<br />

• Agreeing with individual members of staff which equipment from the<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 39 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Risk Register<br />

inventory they are expected to use <strong>and</strong> process for training <strong>and</strong><br />

competency assessment, including frequency of updates<br />

• Ensuring that training is made available for all uses of devices where<br />

training is necessary <strong>and</strong> that all equipment users are properly<br />

trained <strong>and</strong> competent<br />

• Ensuring that users complete competency records for appropriate<br />

medical devices<br />

• Reviewing the inventory annually <strong>and</strong>/or when the new<br />

equipment/devices are introduced into their area of responsibility<br />

• Identifying training <strong>and</strong> assessment needs at appointment, local<br />

induction <strong>and</strong> as part of annual reviews<br />

The Directorate/Department has a Risk Register which is compiled <strong>and</strong> kept<br />

up to date by nominated trained staff following risk assessment <strong>and</strong> data<br />

from incidents, complaints <strong>and</strong> claims<br />

The Risk Register is reviewed <strong>and</strong> updated on an ongoing, live basis<br />

Where risks have been indentified, risk reduction measures are developed<br />

<strong>and</strong> included in action plans<br />

Medicines<br />

Management<br />

The Risk Register is linked to local business planning <strong>and</strong> service<br />

development <strong>and</strong> is assessed at each Directorates performance review<br />

All clinical areas are aware of the Procedure for the Prescribing, Recording<br />

<strong>and</strong> Administration of Medicines<br />

All medication errors are reviewed by a senior nurse, pharmacist <strong>and</strong>/or<br />

clinician<br />

All areas of non-compliance should be indentified on the Risk Register with<br />

appropriate controls, risk reduction measures <strong>and</strong> action plan<br />

Completed by …………………………………………<br />

Directorate/Department …………………………….<br />

Date ……………………………………………………<br />

Planned date of next review ……………………<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 40 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


EXECUTIVE SUMMARY<br />

TITLE:<br />

BOARD/GROUP/COMMITTEE:<br />

Quality <strong>and</strong> Patient St<strong>and</strong>ards Performance<br />

Report – September <strong>2012</strong><br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

The Quality <strong>and</strong> Patient St<strong>and</strong>ards Performance Report<br />

provides an analysis of performance against trust-wide<br />

<strong>and</strong> national targets for the following domains:<br />

• Patient Safety <strong>and</strong> Quality<br />

• Performance<br />

• Workforce<br />

• Productivity<br />

• Finance<br />

The following areas where monthly performance is of<br />

concern are discussed within the report:<br />

• Clostridium Difficile<br />

• MRSA<br />

• MRSA Screening – Emergency<br />

• MRSA Screening - Elective<br />

• Complaints not Responded To over 3 months old<br />

• Patients Assessed as Risk Free<br />

• Elective <strong>and</strong> Non-elective Re-admissions


2. DECISION REQUIRED: CATEGORY:<br />

The <strong>Trust</strong> <strong>Board</strong> is asked to note the content of the report<br />

<strong>and</strong> support the actions to bring the performance back in<br />

line with trajectory/target.<br />

NATIONAL TARGET □ CNST<br />

□ CQC REGISTRATION □ HEALTH & SAFETY<br />

□ ASSURANCE FRAMEWORK<br />

CQUIN/TARGET FROM COMMISSIONERS<br />

□ CORPORATE OBJECTIVE ……………………………....<br />

□ OTHER …………………….. (please specify)<br />

AUTHOR: Claire Burns, Head of Planning, Commissioning<br />

<strong>and</strong> Information<br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

Not applicable.<br />

PRESENTER: Neill Moloney, Director of Performance <strong>and</strong><br />

Planning<br />

DATE: Oct <strong>2012</strong><br />

4. DELIVERABLES<br />

The delivery of the <strong>Trust</strong> wide objectives.<br />

5. KEY PERFORMANCE INDICATORS<br />

Please see attached <strong>Trust</strong> Performance Dashboard.<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________<br />

2


Performance Report<br />

September <strong>2012</strong><br />

Performance Indicators - Exception Report<br />

1. Introduction<br />

This report provides the <strong>Board</strong> with an overview of mitigating actions identified by the Business<br />

Units to improve performance such that it brings it back into line with target. Finance <strong>and</strong> Human<br />

Resources performance are subject to separate reports to the <strong>Trust</strong> <strong>Board</strong>.<br />

2. Patient Safety <strong>and</strong> Quality<br />

MRSA bacteraemia –.2 MRSA bacteraemia were reported this month, both of which were found<br />

to be deep seated infections related to septic arthritis. One patient had this in multiple sites <strong>and</strong><br />

for the other patient only in the shoulder. On investigation some clinical practice issues were<br />

identified which are now being addressed.<br />

The New Director of Infection Prevention <strong>and</strong> Control is now in post. There is a change of focus<br />

to infection prevention <strong>and</strong> the current action plan is being reviewed to identify the high impact<br />

actions, one of which is ANTT.<br />

ANTT has been introduced across the <strong>Trust</strong> <strong>and</strong> to date 60% of Matrons <strong>and</strong> 72% of senior<br />

sisters have achieved Train the Trainer competencies. These staff will now roll out the training<br />

across the wards. New h<strong>and</strong> washing campaigns <strong>and</strong> training programmes introduced. Training<br />

for doctors has commenced for FY1/2s, Consultants <strong>and</strong> is being planned for staff grades.<br />

Clostridium difficile infection – There were 7 cases of infection reported during September,<br />

none of the patients acquiring the infection occurred as a result of cross contamination. No<br />

primary cause was identified for the infection on Heather ward but the ward has been required to<br />

produce an action plan to address the issues highlighted by the Infection Control team<br />

investigation of the infection. The Infection Control Committee will monitor the ward’s progress<br />

against this action plan.<br />

MRSA screening – Elective<br />

A number of actions have been identified to improve performance to ensure delivery of this<br />

st<strong>and</strong>ard. These include:<br />

• A review of the pathway for<br />

patients who go straight to a<br />

procedure without attending a preadmission<br />

clinic to ensure that<br />

these patients are swabbed prior to<br />

admission. This pathway will be<br />

implemented from October <strong>and</strong> so<br />

will improve performance during<br />

December <strong>2012</strong> <strong>and</strong> reported to<br />

the <strong>Board</strong> in January 2013.<br />

Page 1 of 8


• A review of data capture to ensure that all swabs are matched correctly to admissions –<br />

this will be completed in September <strong>and</strong> therefore will be shown in the performance at the<br />

<strong>November</strong> <strong>Board</strong> meeting.<br />

• Training of Admissions Team Leader on data accuracy, which will improve data quality<br />

when patients are added to waiting list <strong>and</strong> thereby improve coverage of data for MRSA<br />

elective screening; this will be completed in September <strong>and</strong> therefore will be shown in the<br />

performance at the <strong>November</strong> <strong>Board</strong> meeting.<br />

MRSA screening – Emergency. A number of actions have been identified to improve<br />

performance to ensure delivery of the st<strong>and</strong>ard for September. These include:<br />

• A change of process in the<br />

Emergency Day Unit (EMDU) to<br />

screen patients who currently do<br />

not qualify for screening was<br />

implemented in September <strong>and</strong><br />

will be demonstrated in the data<br />

received at the <strong>November</strong> <strong>Board</strong><br />

Meeting.<br />

• Using the ward board rounds to<br />

check patents have been<br />

screened. The Ward Sponsors<br />

will work with the wards to<br />

ensure that screening takes place.<br />

• Staff to be reminded to write legibly on test requests to ensure that the Lab is able to<br />

identify which patient the swabs have come from. This error will be addressed by the roll<br />

out of order communications for Pathology in December <strong>2012</strong>, <strong>and</strong> will be reflected in the<br />

performance reported to the <strong>Board</strong> in January 2013.<br />

• Review of the data to ensure patients who do not require screening are excluded from the<br />

data. This will be completed in October <strong>and</strong> therefore will be shown in the performance at<br />

the <strong>November</strong> <strong>Board</strong>.<br />

Number of complaints not yet responded to over 3 months old - The number of complaints<br />

over 3 months old has reduced from 55 last month to 53 this month, this figure includes both new<br />

<strong>and</strong> reactivated complaints. The Complaints Team continue to agree a closure timescale for a<br />

formal response with each complainant. Extending an agreed response date can now only be<br />

agreed either by an Executive Director or an Associate Director. In order to ensure there is a<br />

clear line of responsibility for responding to complaints during October the complaints h<strong>and</strong>ling<br />

process will be re-launched via Associate Directors, who will cascade the procedure down to<br />

General <strong>and</strong> Services Managers. In addition the Medicine Directorate is piloting a new tracking<br />

process to identify earlier issues which may prevent the timely resolution of a complaint. If<br />

successful the process will be rolled out across the <strong>Trust</strong>.<br />

Page 2 of 8


% Patients assessed as risk free - This indicator measure the % of patients free from the four<br />

harms of 1.Venous Thromboembolism (VTE),<br />

2.category 3 <strong>and</strong> 4 pressure ulcers, 3.catheter<br />

associated urinary tract infections (CAUTI) <strong>and</strong><br />

4. falls resulting in harm.<br />

The main areas of concern within the trust remain<br />

pressure ulcers <strong>and</strong> falls. These are being<br />

addressed by the relevant action plans <strong>and</strong><br />

significant progress has been made. More<br />

detailed analysis is now being undertaken as six<br />

months data is now available to identify where the<br />

trends for harm are occurring from both a community <strong>and</strong> hospital perspective.<br />

Re-admissions Elective <strong>and</strong> Emergency


Pilot Wards<br />

Division<br />

Discharges<br />

Per<br />

Ward<br />

Surveys<br />

ompleted<br />

%<br />

ompleted<br />

Surveys<br />

NPS Score<br />

Bluebell B Medicine 62 17 27.4 68<br />

Ocean A Surgery 48 35 72.9 23<br />

Coral Ward Maternity 185 137 74.1 47<br />

Cornflower B Women 109 16 14.7 6<br />

Pilot Ward Totals 404 205 50.7% 31<br />

Following evaluation of the pilot the paper based survey will, during October, be rolled out across<br />

all wards areas <strong>and</strong> A&E<br />

Same sex breaches –.There were 13 single sex breaches for the month of September <strong>2012</strong>.<br />

These occurred within the High Dependency Unit (9), Intensive Therapy Unit (3), <strong>and</strong> Coronary<br />

Care Unit (1) at Queen’s Hospital. This is an improvement from August position when 18 single<br />

sex breaches were reported.<br />

All of the breaches occurred due to delays in the<br />

transfer out of patients who had been ‘stepped<br />

down’ to general care. This was due to<br />

constraints on the availability of suitable beds<br />

for ‘step down’ due to patient flow delays across<br />

the organisation. A root cause analysis on all<br />

patients who breach will commence on the 1 st<br />

October <strong>2012</strong>.<br />

The Deputy Director of Nursing has received<br />

feedback from a number of patients who<br />

breached in September who were interviewed following the breach <strong>and</strong> they confirmed that the<br />

reason for the breach was explained to them <strong>and</strong> that their privacy <strong>and</strong> dignity was maintained<br />

during this period of their care.<br />

Page 4 of 8


3. Performance<br />

Referral to treatment – delivery in all specialties Specialties continue to fail on the<br />

admitted RTT pathway. The <strong>Trust</strong> has not been commissioned to deliver RTT by<br />

specialty in <strong>2012</strong>/13 but is required to meet the target as a cumulative performance.<br />

Discussions have commenced with Commissioners regarding the approach in 2013/14.<br />

The <strong>Trust</strong> requires an early decision as to whether specialty performance will be<br />

purchased as this will require an additional investment in 2013/14 over <strong>and</strong> above that<br />

already agreed as specialty backlog will need to be cleared. A scoping exercise is<br />

currently under way.<br />

Cancer - 62 days urgent RTT from hospital specialist – this is an in-month problem due to<br />

the small number of patients who are affected. The year to date performance is 88.6% for<br />

this measure against an 85% target. Three patients breached the st<strong>and</strong>ard in the month<br />

<strong>and</strong> these were complex clinical cases.<br />

Four hour wait in A&E – in September the <strong>Trust</strong> failed to meet the 95% st<strong>and</strong>ard <strong>and</strong> has<br />

deteriorated from the August performance. The <strong>Trust</strong> achieved <strong>Trust</strong> 89.37% with Queens at<br />

85.14 <strong>and</strong> KGH at 95.79%<br />

% of patients referred to specialist team < 2hours of registration - the percentage of patients<br />

waiting more than 2hrs from registration to referral has remained the same. Daily performance<br />

information is shared with Emergency Department senior staff with peer challenge of decision<br />

making to identify alternatives to referrals by using care pathways such as ambulatory care /<br />

virtual ward.<br />

% Patients seen by speciality team within less than 30 minutes of request – the percentage<br />

of patients seen by specialty teams within 30 minutes has deteriorated in September. Any that<br />

occur are fed back daily to the specialties concerned to discuss with their teams with feedback<br />

requested at the daily bed meetings.<br />

Number of ambulance black breaches - there were 14 black breaches in September all of<br />

which occurred during the week beginning 17th September. Full Serious Incident investigations<br />

were undertaken for each patient <strong>and</strong> in the main these breaches were caused by lack of bed<br />

availability. The extended Rapid Assessment <strong>and</strong> Treatment area will be completed by the end of<br />

<strong>November</strong> <strong>and</strong> will improve offload times <strong>and</strong> support a reduction in the number of black<br />

breaches.<br />

Page 5 of 8


Workforce<br />

Appraisals – the actions included in last month’s report have not improved performance – the<br />

performance has deteriorated from last month. Business Units have been asked to provide plans<br />

showing dates for all outst<strong>and</strong>ing appraisals <strong>and</strong> the forward plan for appraisals that will be due in<br />

the coming months.<br />

Basic life support training (BLS) – Resuscitation training compliance for this month is 75.09%.<br />

This is the same overall compliance rate as last month. Uptake on all advertised resuscitation<br />

training sessions has increased slightly since last month’s report. Monthly compliance reports<br />

continue to be sent to the Business Units to highlight those staff that still need to book onto a<br />

training session. Projected overall compliance for the year end (December 31 st <strong>2012</strong>) is estimated<br />

at 80.17%, based on bookings already made. This would be a slight improvement on the same<br />

time last year when compliance stood at 72.15%.<br />

Page 6 of 8


4. Productivity<br />

Length of stay (LOS) – elective <strong>and</strong> non-elective.<br />

Non elective LoS has increased slightly in September <strong>and</strong> Elective had decreased (including<br />

<strong>and</strong> excluding 0 days). The reason for this is considered to be due to the closure of Foxglove<br />

ward resulting in medical wards keeping their patients on the main wards <strong>and</strong> discharging<br />

straight patients from there (Foxglove was a step-down ward). The LoS work-stream<br />

continues to focus on three main areas of delay:<br />

• Therapy input<br />

• Discharge paperwork<br />

• Family disputes<br />

This work has enabled Foxglove to close <strong>and</strong> also gradually reduce the medical outliers.<br />

Other key actions in month were:<br />

• Care of Elderly in-reach senior consultant cover is provided within the Acute<br />

Medicine Unit to further support the Care of Elderly admissions <strong>and</strong> expedite<br />

discharges.<br />

• 7 day Cardiology rota implemented<br />

• 7 day Consultant model agreed to start beginning <strong>November</strong>.<br />

Page 7 of 8


Delayed transfers of care (DTOC) - The closure of Foxglove ward has necessitated greater<br />

focus on complex discharge support <strong>and</strong> to that<br />

end a rotational training programme has been<br />

implemented to improve the timeliness of this<br />

process. As yet there has not been a matching<br />

decrease in LoS due to DTOC patients remaining<br />

on their base wards but as outliers reduce this is<br />

expected to follow. This work has been<br />

implemented as part of the Ernest & Young Cost<br />

Improvement Plan (CIP) work-streams with the<br />

outcomes now business as usual.<br />

The 7 day Consultant ward cover starts at the beginning of <strong>November</strong> <strong>and</strong> this is expected to<br />

support a reduction in DTOC by more timely completion of the medical reports required for<br />

discharge. In order to improve the discharge interface across the whole health economy the <strong>Trust</strong><br />

is working in partnership with the local Boroughs <strong>and</strong> Community Services, facilitated by<br />

McKinsey, to reduce h<strong>and</strong>over delays.<br />

% Patients discharges between 6am <strong>and</strong> 11am - these have reduced slightly from August.<br />

This measure is to ensure availability of beds <strong>and</strong> there has also been work undertaken to reduce<br />

the discharges between 6am <strong>and</strong> 11am.<br />

Goal directed fluid therapy (GDFT) for planned colorectal <strong>and</strong> emergency abdominal<br />

patients –To increase performance the follow actions are being taken:<br />

When reviewing the notes to identify when the GDFT method has been used the Enhanced<br />

Recovery Program (ERP) Facilitator will escalate to the General Manager <strong>and</strong> Lead Anaesthetist<br />

immediately where this is not the case. Performance in emergency has increased from 33% to<br />

57% but the elective pathway has deteriorated. This was raised at the recent audit meeting where<br />

it was agreed that the profile of GDFT needed to be raised further within the <strong>Trust</strong>.<br />

DNA rates for first <strong>and</strong> follow-up appointments –<br />

The trust is carrying out three key projects to reduce DNA rates. They are:<br />

• The text reminder service<br />

• Phoning patients who have DNA’d to underst<strong>and</strong> why they did not attend the appointment.<br />

• Exploring additional approaches for appointment reminders<br />

Page 8 of 8


Patient Safety <strong>and</strong> Quality<br />

July Aug Sept Target red July Aug Sept Target red July Aug Sept Target Red<br />

Reducing hospital mortality<br />

SHMI ‐ quarterly December 11 95.96<br />

93.92 95.00 % untreated waiting less than 18 weeks 92.70% 92.10% 92.60% 92% 87% LOS (Elective) 3.15 3.31 3.01 3.1 3.48<br />

% emergency admitted patients review by<br />

senior clinician within 12 hours ND ND ND 95% 94% RTT admitted in 18 weeks 91.20% 90.50% 90.40% 90% 85% LOS (Non‐Elective) 5.13 5.02 5.22 4.454 5.05<br />

% emergency admitted patients review by<br />

consultant within 12 hours ND ND ND 95% 94% RTT non‐admitted in 18 weeks 99.50% 98.90% 98.50% 95% 90% LOS (Elective‐ excluding 0 LOS) 3.62 3.78 3.53 3.5 3.92<br />

Maternal Death Rate per 100000 ( rolling 12<br />

m) 32.36 21.66 21.73 TBA TBA RTT not delivered in all specialties 9 6 7 0 >20 LOS (Non‐ Elective‐excluding 0 LOS) 6.36 6.27 6.41 5.8 6.53<br />

% Day case rate ‐ All 88% 90% 88% 80% 75%<br />

Serious Untoward Incidents<br />

Cancer<br />

DTOC 4.69 5.54 4.18 3.50% 5.00%<br />

Number 13 23 18 18 19 2 Wk. % seen all urgent refs & ref for breast* 98.8% 95.3% 94.4% 93% 88% admissions on day of surgery 86.04 94.44 93.83 85% 80%<br />

% reported within 48Hours ‐ quarterly 64%<br />

50% 49% 2 Wk. GP RefTo 1st OP for susp cancer* 99.5% 99.5% 98.4% 93% 88% % patients discharged between 6 am <strong>and</strong> 11 am 11% 13.18% 11.12% 50% 30%<br />

2 Wk GP Ref To 1st OP for breast symptoms* 94.3% 98.9% 97.9% 93% 88%<br />

Infection Control<br />

31 Day 2nd Or Subs Treatment ‐ Surgery* 100.0% 100.0% 100.0% 94% 89%<br />

Enhanced Recovery<br />

MRSA Bacteraemia 6 YTD<br />

6 7 31 Day 2nd Or Subs Treatment ‐ Drug* 100.0% 100.0% 100.0% 98% 93%<br />

% patients with an ERP code entered onto the national<br />

database* 86% 74% 99% 95% 95%<br />

C Diff Infection 37YTD<br />

59 60 31 Day DTT for all cancers* 97.5% 100.0% 99.5% 96% 91% % planned colorectal having GDFT* 57% 78% 37% 80% 80%<br />

MRSA Elective Screening 78% 79% 84% 95% 86% 62 Day RTT From Cancer Screening** 100.0% 90.9% 100.0% 90% 85% % emergency abdominal patients having GDFT* 33% 33% 57% 80% 80%<br />

MRSA Emergency Screening 77% 75% 79% 95% 86% 62 Days ‐ treated from referral ** 88.5% 84.1% 91.4% 86% 80% *one month in arrears * JUNE , JULY <strong>and</strong> AUG data reported<br />

62 Day RTT From Hosp Specialist** 100.0% 100.0% 77.8% 85% 80%<br />

Outpatients<br />

Complaints<br />

62 Days Urgent RTT of all cancers** 88.2% 82.0% 91.5% 85% 80% FFU Ratio 2.13 2.08 2.06 2.16 2.20<br />

% complaints responded to in line with<br />

agreement with patients 87.00% 86.00% 95.00% 80% 79% 31 Day Subs Treatment ‐ Radiotherapy* 100.0% 100.0% 100.0% 94% 89% DNA First 9.83% 9.42% 10.12% 5.00% 5.50%<br />

number of complaints not yet responded to<br />

over 3 months old 18 42 53 TBA TBA * fully validated data provided one month in arrears ** JUNE , JULY <strong>and</strong> AUG data reported DNA Follow‐Up 10.58% 10.58% 10.84% 5.00% 5.50%<br />

Dementia<br />

% patients aged over 75% having a mental<br />

test score 55% 60% 78% 50% 49%<br />

Performance<br />

Referral to Treatment<br />

A&E<br />

Productivity<br />

Four‐Hour Maximum Wait In A&E 92.26% 94.59% 89.37% 95% 94%<br />

Finance<br />

Percentage of patients referred to speciality team<br />


EXECUTIVE SUMMARY<br />

TITLE:<br />

Emergency Care Report<br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

• To advise <strong>Trust</strong> <strong>Board</strong> of the<br />

improvements in the Emergency Care<br />

Pathway<br />

• To advise <strong>Trust</strong> <strong>Board</strong> of the Emergency<br />

Access performance<br />

• To advise <strong>Trust</strong> <strong>Board</strong> of the action plan<br />

to sustain improved performance<br />

2. DECISION REQUIRED: CATEGORY:<br />

PEQ……….…...…….<br />

□ STRATEGY……….….…….<br />

□ FINANCE ……..……… □ AUDIT ………….……..….<br />

□ CLINICAL GOVERNANCE …………..………….....……<br />

□ CHARITABLE FUNDS ………………………………...…<br />

□ TRUST BOARD<br />

□ REMUNERATION ………………………………….…...<br />

□ OTHER …………………………..……. (please specify)<br />

None<br />

NATIONAL TARGET<br />

□ CQC REGISTRATION<br />

□ CNST<br />

□ HEALTH & SAFETY<br />

□ ASSURANCE FRAMEWORK<br />

□ CQUIN/TARGET FROM COMMISSIONERS<br />

CORPORATE OBJECTIVE ……………………………....<br />

□ OTHER …………………….. (please specify)<br />

AUTHOR: Shelagh Smith/Claire Dixon<br />

PRESENTER: Dorothy Hosein<br />

DATE: 16 th October <strong>2012</strong><br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

Reduction in temporary staff<br />

4. DELIVERABLES<br />

Improved ED access performance<br />

Improved quality of care<br />

Reduction in the use of temporary staff<br />

5. KEY PERFORMANCE INDICATORS<br />

ED access target<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________


Performance for September<br />

Emergency Care Pathway Report<br />

Four Hour Maximum wait in ED<br />

In September the <strong>Trust</strong> failed to meet the 95% st<strong>and</strong>ard <strong>and</strong> has deteriorated from August. The <strong>Trust</strong> achieved <strong>Trust</strong> 89.37% with Queens at 85.14 <strong>and</strong> KGH at<br />

95.79%<br />

Ambulance Offload Times<br />

There were 14 black breaches in September all of which occurred during the week beginning 17 th September. Full SI investigations have been done for each patient<br />

<strong>and</strong> in the main these were caused by lack of bed availability during that week.<br />

Urgent Care Workstream<br />

A significant amount of work has been undertaken within the UCC <strong>and</strong> the number of breaches in the UCC in August was 4 this is a significant improvement form the<br />

July figure of 174.<br />

Additional actions are being taken <strong>and</strong> monitored with the Director of Transformation as part of the ongoing action plan for the RESET sustainability programme.<br />

These are:<br />

1. Implemented ED Actions<br />

1.1 Daily Performance Management<br />

• ED breaches are discussed daily with the ED doctors involved to review if alternative management plans could have been taken <strong>and</strong> provide educational feedback to<br />

prevent reoccurrence.<br />

• Specialty breaches have reduced <strong>and</strong> any that occur are fed back to the specialties concerned to discuss with their teams.<br />

• Daily performance information is shared with ED seniors both nursing <strong>and</strong> consultants to identify trends <strong>and</strong> agree actions to prevent reoccurrence.<br />

• Daily peer challenge of decision making at board rounds <strong>and</strong> identifying alternatives to referrals by using alternative care pathways such as ambulatory care / virtual<br />

ward is completed.<br />

• Daily productivity monitoring is completed by consultants <strong>and</strong> performance issues are fedback to juniors<br />

1.2 ED Workforce Actions<br />

• Recruitment of doctor’s ongoing, SHOs <strong>and</strong> middle grades appointed last week.<br />

• Paediatric ED consultant post advertised <strong>and</strong> General ED consultant in progress for advertising.<br />

• Review of Senior Medical Cover on the Weekends has been undertaken <strong>and</strong> additional middle grade shift has been implemented as a trial for Saturday <strong>and</strong> Sunday<br />

• Clinical Nurse Director in post in Emergency Care<br />

• Review of KGH nursing workforce has been undertaken by the Clinical Nurse Director<br />

• Review of Paediatric workforce to be commenced<br />

• Review of RAT nursing workforce to be undertaken<br />

• Competency skillset has been completed for OIC role, training to be developed with a plan to implement by mid-<strong>November</strong><br />

1


• Training competencies are being reviewed for all roles in the department to ensure that all staff have clear responsibilities <strong>and</strong> competencies to undertake that role.<br />

This work is being led by the Clinical Nurse Director with support from the Matrons.<br />

2. Implemented Acute Medicine Unit Actions<br />

• Additional senior consultant cover is provided to further support the General Medicine junior on call team in ED <strong>and</strong> to support the team to look at alternatives to<br />

admissions.<br />

• Re-launch to the <strong>Trust</strong> of the Ambulatory Care / Virtual Ward referral route is being completed<br />

• Continued focus on Category B discharges<br />

• GP calls diverted to KGH daily<br />

3. Implemented General Medicine Actions<br />

• Care of Elderly in reach senior consultant cover is provided within the Acute Medicine Unit to further support the Care of Elderly admissions <strong>and</strong> expedite discharges.<br />

• 7 day Cardiology rota implemented<br />

4. ED Quality Improvements:<br />

• Patient information leaflet explaining the process of the ED is being drafted which will include a feedback section. This will enable direct feedback to the staff that<br />

cared for the patient.<br />

• Trend information on complaints is being collated to further support feedback to all staff<br />

• Customer service competency checklist is being developed to provide staff with additional training to support improvements in communication skills<br />

5. Enablers to support fundamental changes:<br />

5.1 Estates at QH<br />

• Improvements in the RAT area at QH to be operational by mid-<strong>November</strong> will improve <strong>and</strong> sustain the ambulance h<strong>and</strong>over performance times <strong>and</strong> provide rapid<br />

assessment <strong>and</strong> treatment for all patients including walk in patients.<br />

• Expediting the redesign of the ‘Majors’ area as per the new designs would facilitate further improvements in the flow in majors in conjunction with the new RAT model<br />

<strong>and</strong> ensure an improved patients experience.<br />

• Expediting the expansion of the Resuscitation Room is crucial to ensure that the ED critical care capacity matches the current dem<strong>and</strong>, therefore enabling the staff to<br />

provide improved quality or care <strong>and</strong> ensure patients receive appropriate care in a timely fashion.<br />

• Expediting the redesign of the UCC / minors area would enhance the current service improvements in patient flow.<br />

5.2 Reconfiguration<br />

• Closure of KGH to acute admissions would enable 7 day working for Acute <strong>and</strong> General Medicine<br />

5.3 Organisation Development<br />

• There has been a high turnover of ED nurse staffing over the last 12 months (45%) a clear recruitment <strong>and</strong> retention plan is underway <strong>and</strong> recruitment has improved.<br />

• It is difficult to recruit medical staff to ED therefore in order to avoid agency staff higher salaries should be available to complete with local organisations.<br />

2


3<br />

5.4 Key actions to be delivered<br />

• Implement redesigned medical rotas<br />

• Bed Management review<br />

• Ward reviews to commence<br />

• 7 day working across the <strong>Trust</strong> including support services<br />

• Reducing Length of Stay by working with partner organisations <strong>and</strong> families to reduce length of stay<br />

• Improve communication with partner organisation to expedite discharges <strong>and</strong> forward planning to meet dem<strong>and</strong>


Appendix A: Trajectory for all type performance for <strong>Trust</strong> <strong>and</strong> by site<br />

Monthly plan Monthly actuals Quarterly plan Quarterly actuals<br />

Month QH KGH <strong>Trust</strong> QH KGH <strong>Trust</strong> QH KGH <strong>Trust</strong> QH KGH <strong>Trust</strong><br />

No. of Black<br />

Breaches<br />

April 77.50% 88.39% 79.50% 77.49% 92.92% 83.90% 55<br />

May 84.63% 93.17% 87.49% 85.71% 94.75% 89.49% 3<br />

June 89.26% 89.26% 89.26% 87.99% 95.77% 91.26% 84.44% 90.42% 85.93% 83.82% 94.51% 88.29% 15<br />

July 89.30% 96.50% 92.90% 88.42% 97.36% 92.26% 0<br />

August 92.50% 97.50% 95.00% 92.96% 97.14% 94.51% 0<br />

September 93.00% 97.00% 95.00% 85.14% 95.79% 89.37% 92.20% 96.33% 94.30% 88.97% 96.76% 92.07% 14<br />

October 95.00% 95.00% 95.00%<br />

<strong>November</strong> 95.00% 95.00% 95.00%<br />

December 95.00% 95.00% 95.00% 95.00% 95.00% 95.00%<br />

January 95.00% 95.00% 95.00%<br />

February 95.00% 95.00% 95.00%<br />

March 95.00% 95.00% 95.00% 95.00% 95.00% 95.00%<br />

4


EXECUTIVE SUMMARY<br />

TITLE:<br />

Maternity Update – September <strong>2012</strong><br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong><br />

DATE:<br />

The purpose of this report is to provide the <strong>Trust</strong><br />

<strong>Board</strong> with an update on the monthly performance<br />

for maternity services <strong>and</strong> other key issues.<br />

The key areas to note are:<br />

• Births continue to be high at 781 <strong>and</strong> are<br />

red on the maternity dashboard.<br />

• The escalation policy was implemented<br />

once in September.<br />

• 88% of women were seen in the triage by<br />

a doctor within 30 minutes, in hours.<br />

• Out of hours triage achieved 57% however<br />

the data collection is not robust. A new<br />

Proforma has been devised <strong>and</strong><br />

implemented. Early results are showing<br />

significant improvements.<br />

• The OAU achieved 95%.<br />

• Women continue to be booked for delivery<br />

at Bart’s Health to reduce activity at<br />

BHRUT. The impact of this will commence<br />

in late <strong>November</strong> <strong>2012</strong>.<br />

• A caseload transfer of women is likely to<br />

occur in <strong>November</strong> <strong>2012</strong>, the impact of this<br />

on the deliveries will be in February 2013.<br />

• A formal consultation on TUPE of staff has<br />

commenced <strong>and</strong> will finish on 24 th October<br />

<strong>2012</strong>. It is anticipated that 11 wte staff will<br />

TUPE to Barts Health<br />

• NELC are undertaking an assurance<br />

review on 22 nd October <strong>2012</strong> to assess<br />

readiness for reduction in capacity,<br />

opening of QBC <strong>and</strong> closure of KGH<br />

• Full recruitment of midwives for Queen’s<br />

Birth Centre has taken place. The staff are<br />

competent <strong>and</strong> trained.<br />

• Discussions with Deanery continue with<br />

regard to timing of closure of KGH<br />

• Births are to be reduced to 8000 2013/14<br />

• There were 2 SI’s reported SI’s in<br />

September Full RCA are being<br />

undertaken.<br />

• Discussions have taken place with NELC<br />

as to the future structure of the<br />

performance report. The assurance<br />

framework, maternity dashboard <strong>and</strong><br />

exemption report will now replace the<br />

monthly reporting template The Directorate<br />

□ TEC …….….. □ STRATEGY…….…….<br />

□ FINANCE …… □ AUDIT ………………<br />

□ QUALITY & STRATEGY ………….....……<br />

□ CHARITABLE FUNDS …………………...…<br />

□ TRUST BOARD ………………….………….<br />

□ REMUNERATION …………………….…...<br />

□ OTHER …………………………..…….<br />

(please specify)


would welcome feedback from the <strong>Trust</strong><br />

<strong>Board</strong> as to whether they would want to<br />

adopt a similar approach. Weekly reporting<br />

continues.<br />

• Maternity Modernisation <strong>Board</strong> inaugural<br />

meeting to be held in October <strong>2012</strong><br />

2. DECISION REQUIRED: CATEGORY:<br />

The <strong>Board</strong> are asked to note the content of the<br />

report <strong>and</strong> feedback comments on replacing the<br />

monthly reporting with assurance framework,<br />

maternity dashboard <strong>and</strong> exemption report.<br />

□ NATIONAL TARGET<br />

□ RMS<br />

□ CQC REGISTRATION □ HEALTH &<br />

SAFETY<br />

□ ASSURANCE FRAMEWORK<br />

□ CQUIN/TARGET FROM<br />

COMMISSIONERS<br />

□ CORPORATE OBJECTIVE ……………....<br />

□ OTHER ……………….. (please specify)<br />

AUTHOR/PRESENTER: W Matthews<br />

Presenter:<br />

DATE: 30 th September <strong>2012</strong><br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

N/A<br />

4. DELIVERABLES<br />

Maternity Dashboard, Monthly meeting with NELC.<br />

5. KEY PERFORMANCE INDICATORS<br />

98% of women seen within 15 minutes of arrival within Triage<br />

98% of women seen within an hour of referral to an obstetrician within the obstetric assessment<br />

unit.<br />

All emergency LSCS performed within the graded time allocated.<br />

AGREED AT ______________________<br />

MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________<br />

2


<strong>Barking</strong>, <strong>Havering</strong> <strong>and</strong> Redbridge University Hospitals NHS <strong>Trust</strong><br />

Source<br />

Responsibility On Target<br />

Target<br />

Of<br />

Concern<br />

Q1 12/13 Q2 12/13<br />

Q3 12/13<br />

Q4 12/13<br />

Action<br />

Required Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13<br />

Maternity Quality <strong>and</strong> Safety Committee attendance<br />

Number of guidelines over due for review<br />

SI's- declared with care service problems <strong>and</strong> contributory factors<br />

S.I panel meeting within 4 days<br />

No of S.I submitted within required time frame<br />

Improved patient satisfaction- 50% of women surveyed<br />

Complaints<br />

CNST JP Quorate<br />

Not<br />

Quorate Quorate Quorate Quorate Quorate Quorate Quorate<br />

CNST CH 5 10 0 25 19 16 10 12<br />

CQUINN JP 0 3 5 5 3 6 2/5 6 / 11 0/2<br />

CQUINN JP 95% 90% 50% 3 7 4/5 11 / 11 2/2<br />

CQUINN JP 75% 60% 55% 0 7 2/5 5 / 13* 9/9<br />

CQUINN WM 50% 40% 30% NA NA NA NA NA 70%<br />

TRUST SL 10 2 5 3 7 8 4<br />

Activity<br />

Workforce<br />

Births Benchmarked to 8,700<br />

KPI SL 710 730 766 667 802 782 823 804 781<br />

Births in acute Queens LW setting<br />

KPI SL 540 560 580 516 605 591 641 636 617<br />

Births taking place at KGH<br />

KPI SL 165 175 185 136 175 166 160 167 147<br />

Midwife led unit (10%) of births<br />

KPI SL 70 75 80 NA NA NA NA NA NA<br />

Homebirths<br />

KPI SL 2% 1% 0.50% 1.00% 1% 1.50% 0.85% 1.30% 1.10%<br />

No of referrals received<br />

KPI SE 741 929(86) 1123(69) 985(66) 1136(59) 869(62) 943(84)<br />

No of referrals received by 10 weeks <strong>and</strong> 6 days<br />

KPI SE 720 769 621 590 726 521<br />

No: of women booked before 12 weeks <strong>and</strong> 6 days<br />

KPI SE 90% 85-90%


Maternity Services Monthly Performance Report<br />

<strong>Trust</strong> Name<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals<br />

NHS <strong>Trust</strong><br />

Reporting month<br />

This report covers the period:<br />

1 st September to 30 th September <strong>2012</strong><br />

Completed by<br />

Mr Dele Olorunshola<br />

Clinical Director of Obstetrics, Gynaecology <strong>and</strong><br />

Sexual Health<br />

Wendy Matthews, Director of Midwifery<br />

Reviewed by<br />

Dorothy Hosein, Director of Transformation<br />

On behalf of<br />

Director of Nursing<br />

Neill Moloney<br />

Director of Planning & Performance<br />

Contact Details<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals<br />

NHS <strong>Trust</strong><br />

1st Floor Green Zone<br />

Maternity Services, Queens Hospital<br />

Rom Valley Way, Romford, RM7 0AG<br />

Tel: 01708 435 000 x 3894<br />

A monthly report will be provided to; monitor the progress made against the maternity services<br />

improvement plan, provide assurance that the safety <strong>and</strong> quality of maternity services are<br />

improving within BHRUT. It will summarise the themes <strong>and</strong> actions that have arisen from the<br />

analysis of activity within the unit.<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 1 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

1


1. Introduction<br />

The purpose of this report is to summarise the progress made in September <strong>2012</strong> against the<br />

maternity service improvement plan <strong>and</strong> the KPIs outlined in the maternity service specification as<br />

agreed with NELC.<br />

2. Total Number of Births at BHRUT for September <strong>2012</strong><br />

KGH Queens BHRUT (%)<br />

Elective CS 14 53 67<br />

Emergency CS 26 113 139<br />

Others 107 451 558<br />

Total 147 617 764<br />

9%<br />

18%<br />

73%<br />

* There were 17 births outside of the unit, registered as BBA <strong>and</strong> homebirths. Total birth rate for<br />

the <strong>Trust</strong> including outside deliveries is 781.<br />

3. Monthly Activity (excluding elective LSCS)<br />

Monthly Hospital Delivery Activity<br />

800<br />

700<br />

600<br />

500<br />

400<br />

300<br />

Queens<br />

Optimum QH<br />

KGH<br />

Optimum KGH<br />

200<br />

100<br />

May Jun Jul Aug Sep<br />

Month<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 2 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

2


4. Capping<br />

The maternity service is no longer subject to capping births as BHRUT have moved towards business<br />

as usual. The service continues to use internal escalation <strong>and</strong> conforms to the pan London escalation<br />

policy.<br />

Discussions are underway with the commissioners to cap maternity bookings to ensure that births<br />

reduce to 8000 by 2013/14<br />

5. Diverts<br />

Diverts occur when the number of labouring women accessing the service is greater than the service<br />

can deal with without compromising care. The <strong>Trust</strong> has moved to the pan London escalation policy<br />

since the lifting of restrictions in early June. In these instances, women are diverted to the nearest<br />

accepting unit unless their clinical presentation indicates that transfer to another provider would pose a<br />

greater risk. Since the lift of the cap, diverts are recorded based on a 24 hour clock (i.e. 0000 – 2400)<br />

<strong>and</strong> not between the hours of 18:00 - 18:00 as was the case previously.<br />

The divert policy was activated once across the <strong>Trust</strong> during the month of September. However, no<br />

women were actually diverted. On that occasion there were no other hospitals that could accept<br />

women from BHRUT which increased the risk at Queen’s Hospital.<br />

6. Triage<br />

The st<strong>and</strong>ard is that 98% of women should be seen by a midwife within 30 minutes of arrival at<br />

triage. In September, 1014 women accessed the Triage service at Queen’s. Of these women 88%<br />

were seen within 30 minutes.<br />

The graph below depicts the monthly average percentage of patients seen within 30 minutes of their arrival in triage,<br />

indicated by a single figure for the month<br />

Triage Attendance - % seen ≤ 30 mins <strong>and</strong> No. of Women Attending<br />

% Seen ≤ 30 minutes<br />

100%<br />

90%<br />

80%<br />

70%<br />

60%<br />

50%<br />

40%<br />

30%<br />

20%<br />

10%<br />

0%<br />

STANDARD 1200<br />

STANDARD (98%)<br />

87%<br />

1163<br />

86% 89%<br />

1149 86%<br />

88%<br />

85%<br />

1150<br />

81%<br />

1140 1146<br />

78%<br />

1110 1110<br />

73%<br />

1100<br />

1085<br />

1050<br />

1014<br />

1000<br />

973<br />

950<br />

900<br />

850<br />

Jan Feb Mar Apr May Jun Jul Aug Sep<br />

% SEEN ≤ 30 MINS STANDARD No of women attending<br />

No of Women Attending (Actual)<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 3 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

3


The graph below depicts the daily actual percentages of patients seen within 30 minutes of their arrival in triage,<br />

indicated by a collection of figures for each month 1<br />

100<br />

Triage - % of Patients Seen within 30 Minutes of Arrival<br />

(JANUARY <strong>2012</strong> - AUGUST <strong>2012</strong> Inclusive weekly capture)<br />

90<br />

Number of Patients<br />

80<br />

70<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

January<br />

<strong>2012</strong><br />

February<br />

<strong>2012</strong><br />

March<br />

<strong>2012</strong><br />

April <strong>2012</strong><br />

May <strong>2012</strong><br />

June <strong>2012</strong><br />

July <strong>2012</strong><br />

August<br />

<strong>2012</strong><br />

September<br />

<strong>2012</strong><br />

Day<br />

% of patients Seen within 30 minutes Target<br />

As part of the continuous improvement programme the Triage pathway has gone through several<br />

iterations including most recently in June <strong>2012</strong>. This explains day to day the variances during the<br />

month of June. This process is continuing through the work of Maternity Clinical Fellows. It is<br />

anticipated the service will settle with much higher percentages of women seen in 15 minutes once<br />

this work is completed. Phase one of the new pathway commenced on 30 th July.<br />

1 Triage figures Jan – July inclusive were 98% st<strong>and</strong>ard against 15 minutes. This has changed in September to 98%<br />

st<strong>and</strong>ard against 30 minutes.<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 4 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

4


7. Obstetric Assessment Unit (OAU)<br />

It has been agreed that 98% of women should be seen by an obstetrician, where this is deemed<br />

clinically appropriate, within 1 hour of their arrival to the Obstetric Assessment Unit (OAU). The<br />

<strong>Trust</strong> average for September <strong>2012</strong> was 95%.<br />

% of Patients seen within 1 hour on OAU by an Obstetrician<br />

85<br />

St<strong>and</strong>ard<br />

90 94<br />

92 91<br />

99 96<br />

98 99<br />

St<strong>and</strong>ard<br />

95<br />

65<br />

45<br />

25<br />

Jan<br />

Feb<br />

Mar<br />

Apr<br />

% of patients seen<br />

May<br />

Jun<br />

Jul<br />

Aug<br />

Sep<br />

Seen


.<br />

% of Patients seen within 1 Hour of Referral<br />

120<br />

100<br />

St<strong>and</strong>ard St<strong>and</strong>ard St<strong>and</strong>ard St<strong>and</strong>ard St<strong>and</strong>ard St<strong>and</strong>ard St<strong>and</strong>ard St<strong>and</strong>ard<br />

80<br />

60<br />

40<br />

59<br />

70<br />

65<br />

72<br />

60<br />

58<br />

60<br />

65<br />

57<br />

20<br />

0<br />

Jan<br />

Feb<br />

Mar<br />

Apr<br />

May<br />

Jun<br />

Jul<br />

Aug<br />

Sep<br />

Seen


10. Serious Incidents Reported<br />

Incidents which meet the NHS London SI reporting criteria are declared as they occur /<br />

are detected. Because they are reported retrospectively, the information below details<br />

incidents that either occurred within September <strong>2012</strong> or were reported in September<br />

<strong>2012</strong>. There will be overlap <strong>and</strong> repetition between information provided each month<br />

for this report.<br />

Full summaries <strong>and</strong> details are to be found on the STEIS system (references numbers<br />

provided).<br />

Summary:<br />

STEIS<br />

number<br />

Site<br />

22405 QH<br />

23880 QH<br />

Issue<br />

controlled<br />

drugs<br />

potentially<br />

missing<br />

NNU<br />

admission /<br />

transfer to<br />

UCLH<br />

Incident<br />

date<br />

Date of<br />

declaration<br />

MDT /<br />

panel<br />

reviews<br />

10/09/12 10/09/12 10/09/12<br />

23/09/12 25/09/12<br />

27/09/<strong>2012</strong><br />

2/10/12<br />

Comment<br />

At routine controlled drug check on<br />

morning of 10/9/12 it was found<br />

that the controlled drug book had<br />

been altered (pages removed) <strong>and</strong><br />

potentially some controlled drugs<br />

were missing<br />

congenital pneumonia / no<br />

contributory care or service<br />

delivery problems identified at<br />

panel<br />

11. Caesarean Deliveries including Elective Activity<br />

When a decision is made to perform an emergency LSCS, the timing for this is dictated by the<br />

acuity of each case which is graded from 1-4.<br />

Grade 1<br />

Caesarean section is considered as urgent <strong>and</strong> has an immediate threat to the life of the<br />

woman <strong>and</strong> foetus. To be performed within 30 minutes.<br />

At BHRUT hospitals, 54% of the audited grade 1 C/S were performed within 30 minutes.<br />

Delays were due to:<br />

• Increased BMI impacting on the procedure<br />

• Difficulty in sitting the spinal<br />

• Delay due to anaesthetic issues.<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 7 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

7


Grade 2<br />

Caesarean section is considered urgent with maternal or foetal compromise which is not<br />

immediately life threatening. To be performed within 60 minutes<br />

At BHRUT hospitals, of 63% the audited grade 2 emergency C/S were performed within 60<br />

minutes.<br />

An audit of the grading of emergency caesarean sections is being carried out to ensure that<br />

emergency caesarean sections are not being misclassified.<br />

Grade 3 & 4<br />

Caesarean section is an emergency with no maternal or foetal compromise, but requires<br />

early delivery. To be performed at a time to suit the mother <strong>and</strong> the department.<br />

At BHRUT, 100% of the audited grade 3/4 emergency C/S were performed within time.<br />

There were no adverse outcomes associated with delayed LSCS.<br />

It should also be noted that the target of 100% achievement is not based on national guidance.<br />

Royal College of Obstetricians <strong>and</strong> Gynaecologists Good Practice No. 11 2 of 4noted that:<br />

To formalise the concept that urgency of caesarean section represents a continuum of risk:<br />

● four broad categories of risk are defined<br />

● all staff should be aware that, within each category, the degree of risk in individual cases can<br />

vary<br />

● a coloured spectrum is used to emphasise that continuum of risk<br />

● this variance in degree of risk requires an individual, case-by-case approach in deciding the<br />

specific<br />

decision-to-delivery interval (DDI).<br />

The ‘Sentinel’ caesarean section audit suggested that in cases such as cord prolapse, a DDI of 15<br />

minutes was feasible. However, in many category-1 cases, delivery within 30 minutes was not<br />

achieved. Delivery within 75 minutes does not appear to increase the risk of compromise, while<br />

delivery within 30 minutes may not<br />

always result in a good neonatal outcome. Once a decision to deliver has been made, therefore,<br />

delivery should be carried out with an urgency appropriate to the risk to the baby <strong>and</strong> the safety<br />

of the mother. Units should strive to design guidelines that result in the shortest safely achievable<br />

DDI. Evidence suggests that any delay is usually associated with the delay in transfer to theatre.<br />

A target DDI for caesarean section for ‘fetal compromise’ of 30 minutes is an audit tool that<br />

allows testing of the efficiency of the whole delivery team <strong>and</strong> has become accepted practice;<br />

however:<br />

• certain clinical situations will require a much quicker DDI than 30 minutes <strong>and</strong> units should<br />

work towards improving their efficiency<br />

• undue haste to achieve a short DDI can introduce its own risk, both surgical <strong>and</strong><br />

anaesthetic, with the potential for maternal <strong>and</strong> neonatal harm.<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 8 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

8


12. Maternity Dashboard<br />

The dashboard <strong>and</strong> exception report for September <strong>2012</strong> is attached seperatly.<br />

Discussions have taken place with NEC as to the future structure of the performance report. The<br />

assurance framework, maternity dashboard <strong>and</strong> exemption report will now replace the monthly<br />

reporting template The Directorate would welcome feedback from the <strong>Trust</strong> <strong>Board</strong> as to whether<br />

they would want to adopt a similar approach.<br />

.<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 9 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

9


Women’s Services<br />

Exception Report for the Maternity Performance Dashboard <strong>and</strong><br />

Assurance Framework<br />

September <strong>2012</strong><br />

Red Areas<br />

Guidelines<br />

There are 12 guidelines which have expired; the reasons being:<br />

An Increase has been noted from the previous month due to a large number of<br />

guidelines expiring in September. Most of these have been updated but are waiting<br />

approval or uploading onto the Intr@net.<br />

Deliveries<br />

There were a high number of deliveries at both units during September. This<br />

continues a trend for the first six months of the year. Births are monitored very<br />

carefully <strong>and</strong> escalation occurred as required. It is anticipated that births should start<br />

to decrease in <strong>November</strong> due to an increase in the bookings in <strong>Barking</strong> being<br />

undertaken by Barts Heath for the last five months. The case load transfer has been<br />

delayed by a month to mid <strong>November</strong>. Discussions are ongoing with the<br />

commissioners; the bookings have reduced over the last month.<br />

Triage<br />

The triage area on the Labour Ward at Queen’s Hospital achieved 88% in seeing women<br />

within 30 minutes. As part of the continuous improvement programme the Triage<br />

pathway has gone through several iterations including most recently in July <strong>2012</strong>. This<br />

process is continuing through the work of Maternity Clinical Fellows. It is anticipated the<br />

service will settle with much higher percentages of women seen in 15 minutes once this<br />

work is completed. Phase one of the new pathway commenced on 30 th July.<br />

LSCS Grading.<br />

This continues to be problematic with data recording <strong>and</strong> appropriate grading of<br />

LSCS with only 54% achievement of grade 1 LSCS. It has been agreed that the clinical<br />

director will identify one of the obstetric team to monitor the doctors to ensure that<br />

they have completed the E3 at the time of LSCS, this will ensure that we have<br />

accurate data. It will also ensure that we are able to accurately record the grading of<br />

the LSCS <strong>and</strong> any inappropriateness will be addressed with individuals. We hope to<br />

see an improvement in the next month’s figures. There were no poor outcomes<br />

noted from the notes audited.


It should also be noted that the target of 100% achievement is not based on national<br />

guidance. Royal College of Obstetricians <strong>and</strong> Gynaecologists Good Practice No. 11 2<br />

of 4noted that:<br />

To formalise the concept that urgency of caesarean section represents a continuum<br />

of risk:<br />

● four broad categories of risk are defined<br />

● all staff should be aware that, within each category, the degree of risk in<br />

individual cases can vary<br />

● a coloured spectrum is used to emphasise that continuum of risk<br />

● this variance in degree of risk requires an individual, case‐by‐case approach in<br />

deciding the specific<br />

decision‐to‐delivery interval (DDI).<br />

The ‘Sentinel’ caesarean section audit suggested that in cases such as cord prolapse,<br />

a DDI of 15 minutes was feasible. However, in many category‐1 cases, delivery within<br />

30 minutes was not achieved. Delivery within 75 minutes does not appear to<br />

increase the risk of compromise, while delivery within 30 minutes may not<br />

always result in a good neonatal outcome. Once a decision to deliver has been made,<br />

therefore, delivery should be carried out with an urgency appropriate to the risk to<br />

the baby <strong>and</strong> the safety of the mother. Units should strive to design guidelines that<br />

result in the shortest safely achievable DDI. Evidence suggests that any delay is<br />

usually associated with the delay in transfer to theatre.<br />

A target DDI for caesarean section for ‘fetal compromise’ of 30 minutes is an audit<br />

tool that allows testing of the efficiency of the whole delivery team <strong>and</strong> has become<br />

accepted practice; however:<br />

• certain clinical situations will require a much quicker DDI than 30 minutes<br />

<strong>and</strong> units should work towards improving their efficiency<br />

• undue haste to achieve a short DDI can introduce its own risk, both surgical<br />

<strong>and</strong> anaesthetic, with the potential for maternal <strong>and</strong> neonatal harm.<br />

PPH’s<br />

There were 6 PPH’s the governance department has reviewed the care of all these<br />

deliveries <strong>and</strong> has not noted any specific care issue.


Maternity Services Assurance Framework <strong>2012</strong>-13<br />

September <strong>2012</strong><br />

Introduction<br />

This report sets out an assurance framework for patient safety <strong>and</strong> minimum quality st<strong>and</strong>ards at BHRUT. This framework compliments a range of<br />

other assurances both commissioners <strong>and</strong> the trust boards already have in place.<br />

From 1 st April <strong>2012</strong> Maternity Services is moving back to ward business as normal. However BHRUT will need to continue to provide assurance to<br />

external organisations such as NELC, that the services remain safe.<br />

Following discussions at the monthly NELC Cluster & BHRUT Maternity Sub Group Meeting it was agreed that BHRUT would devise a Maternity<br />

Services Assurance Framework based on several indicators including:<br />

• Key Performance Indicators<br />

• Workforce<br />

• Governance<br />

• Dem<strong>and</strong> <strong>and</strong> Activity<br />

• Patient experience<br />

Governance Arrangements<br />

Both the trust <strong>and</strong> the PCT boards have established committees which focus on safety <strong>and</strong> clinical governance. However, the assurance<br />

framework below outlines how the priority areas will be scrutinised <strong>and</strong> monitored.<br />

Interim Chairman: George Wood<br />

Chief Executive: Averil Dongworth


Priority Action Lead Monitoring Tool Current Risk<br />

Rating<br />

Risk rating<br />

previous<br />

month<br />

Antenatal<br />

Access to maternity<br />

services<br />

Intrapartum<br />

Ensure that Labour Ward<br />

remains safe <strong>and</strong><br />

appropriate escalation<br />

occurs<br />

Women where the referral received by<br />

10+6weeks to be booked by 12+6 weeks for<br />

90% of maternities<br />

90% of women to be triaged within 30<br />

minutes of arrival<br />

Number of bookings must not exceed cap<br />

C:\Data\matthews w\<br />

Bookings\New Templa<br />

Escalation policy in place<br />

NELC informed of diverts as per PAN London<br />

divert policy<br />

W<br />

Matthews<br />

Monthly reporting to <strong>Trust</strong> <strong>Board</strong> <strong>and</strong><br />

on maternity dashboard<br />

92% 92%<br />

A Archibald Monthly performance report 88% 89%<br />

W<br />

Matthews<br />

Avril<br />

Archibald<br />

Weekly teleconference, weekly<br />

submission of booking data<br />

*Evidence of BHRUT escalation<br />

implemented.<br />

NELC informed of escalation in line<br />

with agreed process.<br />

Evidence of LSA database updated<br />

with escalation details.<br />

Awaiting cap<br />

implementation<br />

date<br />

1 3<br />

Ensuring woman receive<br />

1:1 care by a midwife in<br />

established labour<br />

Staffing levels on Labour Ward to allow for<br />

1:1 care in labour.<br />

Clinical pathways facilitator to have an<br />

overview of staffing levels across maternity in<br />

hours, out of hours this is undertaken by<br />

Labour Ward co-ordinator<br />

Avril<br />

Archibald<br />

BHRUT to maintain a minimum<br />

midwife ratio of 1:29.<br />

Weekly audit of one to one care<br />

Review of patient feedback.<br />

Dashboard entry monthly<br />

100% 100%<br />

All women presenting to the<br />

unit are assessed in a<br />

timely way.<br />

High risk women identified<br />

*BHRUT to ensure that 90% of women seen<br />

within 30mins of arrival to triage.<br />

*Daily percentage of high risk women seen<br />

within target time (98% within 1hour).<br />

2<br />

Monthly reporting. 88% 89%


Priority Action Lead Monitoring Tool Current Risk<br />

Rating<br />

<strong>and</strong> treated in a timely way.<br />

Risk rating<br />

previous<br />

month<br />

100%Grade 1 LSCS are<br />

performed within 30<br />

minutes<br />

Maintain high st<strong>and</strong>ard of<br />

care for women. Women<br />

cared for in appropriate<br />

location.<br />

Audit appropriateness of grading LSCS<br />

Identify reasons why grade 1LSCS not<br />

undertaken within 30 minutes<br />

Once Birthing Centre is open ensure that low<br />

risk women are encouraged to birth there.<br />

Agree trajectory with NELC<br />

D<br />

Olorunshola<br />

J<br />

Richardson<br />

Monthly monitoring report 54% 65%<br />

% Births in Birthing Centre<br />

Monthly Dashboard entry<br />

Decision still<br />

awaited on<br />

opening of QBC<br />

To ensure that maternal<br />

<strong>and</strong> neonatal morbidity <strong>and</strong><br />

mortality is in line with<br />

national targets<br />

Revise maternity dashboard to include<br />

national benchmarks.<br />

S Lovell<br />

Monthly Dashboard<br />

Exemption reporting on outliers<br />

3 2<br />

Postnatal<br />

Ensure that neonatal<br />

readmissions is not an<br />

outlyer<br />

Audit pathway for neonatal readmissions<br />

Revise pathway to ensure that neonates are<br />

readmitted in the most appropriate<br />

environment<br />

M O’Leary<br />

D Jones<br />

Dashboard entry monthly.<br />

Exemption reporting if outlying<br />

1 2<br />

To review discharge<br />

pathway <strong>and</strong> reduce LOS<br />

NPAN midwife rota 100% coverage<br />

Pathway review through Clinical fellow<br />

programme<br />

Clinical<br />

Fellows<br />

Helen<br />

Mansfield<br />

Dashboard entry<br />

Monthly performance report<br />

87% coverage 87% coverage<br />

Workforce<br />

Strengthen the levels of<br />

statutory supervision of<br />

midwives within the <strong>Trust</strong><br />

Ratio of SOM to Midwives improves. Current<br />

position 1:20.<br />

D Jones<br />

J Read<br />

Shift in ratio towards 1:15 1:18 1:19<br />

Review midwifery numbers Agree baseline based on Birthrate Plus D Jones 1:29 midwife to birth ratio 1:29 1:29<br />

3


Priority Action Lead Monitoring Tool Current Risk<br />

Rating<br />

as births decrease<br />

findings.<br />

Review WTE on a quarterly basis depending<br />

on birth numbers<br />

W<br />

Matthews<br />

Reduction in bank <strong>and</strong> move towards<br />

removing agency midwives<br />

Risk rating<br />

previous<br />

month<br />

Governance<br />

Information <strong>and</strong><br />

Governance Arrangements<br />

*Ensure that BHRUT are recording <strong>and</strong><br />

reviewing all serious untoward incidents<br />

Compliance with CQUIN requirements.<br />

D Jones<br />

J Piper<br />

Monthly performance report.<br />

SI’s notified to NHS London<br />

CQUIN performance<br />

2 11<br />

Patient Experience<br />

Ensure that women receive<br />

a positive experience<br />

Monitor complaints <strong>and</strong> ensure timely<br />

response.<br />

Appoint patient experience midwife<br />

50% of delivered women to use patient<br />

tracker device<br />

Action Plan developed to improve patient<br />

experience.<br />

Collate positive feedback from women<br />

W<br />

Matthews<br />

D Jones<br />

Monthly reporting of complaints<br />

Milestone of CQUIN<br />

70% compliance<br />

on pilot ward<br />

N/A<br />

C:\Data\matthews w\<br />

Patient experience\03<br />

September <strong>2012</strong><br />

4


Complaints Annual Report<br />

2011 - <strong>2012</strong>


Contents<br />

Section No: Description Page No:<br />

1. Introduction 3<br />

2. Overview of the Service 3<br />

3. Complaints Activity 4<br />

4. Actions taken in Response to Complaints 10<br />

5. Service Developments 11<br />

6. The Year Ahead - Future Plans 12<br />

2


1. Introduction<br />

Under the Local Authority Social Services <strong>and</strong> NHS Complaints (Engl<strong>and</strong>) Regulations<br />

2009, all NHS bodies are required to prepare an annual report on complaints received. The<br />

report should include the number <strong>and</strong> subject matter of all complaints received during the<br />

year, the number upheld, the number known to have been referred to the Parliamentary<br />

<strong>and</strong> Health Service Ombudsman (PHSO) <strong>and</strong> any actions taken to improve services as a<br />

result of complaints.<br />

This report provides a summary of complaints received by <strong>Barking</strong>, <strong>Havering</strong> & Redbridge<br />

University Hospitals NHS <strong>Trust</strong> (BHRUT) in relation to its own services during the period 1 st<br />

April 2011 - 31 st March <strong>2012</strong>.<br />

2. Overview of the Complaints Service<br />

2.1 <strong>Barking</strong> <strong>Havering</strong> & Redbridge University Hospital NHS <strong>Trust</strong> (BHRUT) complaints service<br />

is accessible to all patients who have used the services provided by the <strong>Trust</strong>.<br />

Specifically these services are delivered on the two main hospital sites - King George<br />

Hospital (KGH) <strong>and</strong> Queen’s Hospital, but also include any outreach services provided.<br />

Every effort is made to ensure that complainants are able to access the service in a way<br />

which meets their needs. The service operates Monday to Friday, 9am - 5pm.<br />

The Complaints Team can be contacted in the following ways:<br />

<br />

<br />

<br />

Telephone - there is a dedicated complaints telephone number which is supported by<br />

an answer phone facility at busy times <strong>and</strong> outside of core working hours.<br />

Email - there is one dedicated complaints email address where enquirers can send<br />

their complaint.<br />

Letter - enquirers can write to the Complaints Team at either of the two main hospital<br />

sites.<br />

The complaints process in the <strong>Trust</strong> is for all formal complaints to be received, logged <strong>and</strong><br />

acknowledged by the core Complaints Team. They are then sent to the Directorates who<br />

are responsible for liaising with the complainant, agreeing the complaint plan, agreeing<br />

appropriate response times, undertaking a full investigation <strong>and</strong> providing a draft response.<br />

The core Complaints Team then resume responsibility for the complaint, checking the<br />

investigation <strong>and</strong> response before it is reviewed <strong>and</strong> signed by the Accountable Officer.<br />

During 2011 - <strong>2012</strong>, the core Complaints Team was resourced by:<br />

1 WTE B<strong>and</strong> 7 Complaint Manager<br />

1 WTE B<strong>and</strong> 6 Complaint Manager<br />

2.92 WTE B<strong>and</strong> 4 Complaints Administrators<br />

The service is also supported by four B<strong>and</strong> 3 Directorate Complaint Co-ordinators <strong>and</strong> adhoc<br />

Directorate administrative support as needed.<br />

During 2011 - <strong>2012</strong>, the budget for complaints was £305,131.<br />

3


3. Complaints Activity<br />

3.1 Total Complaints Received<br />

During the year, the <strong>Trust</strong> received 1096 formal complaints. There was a significant rise in<br />

the number of complaints received this year compared with the previous year of 671.<br />

During the year, the <strong>Trust</strong> was the subject of a Care Quality Commission (CQC)<br />

investigation which highlighted a number of areas of concern across the <strong>Trust</strong>, <strong>and</strong> the<br />

increase in the number of complaints received reflects this.<br />

The chart below shows the total activity received on a monthly basis:<br />

140<br />

120<br />

100<br />

80<br />

60<br />

40<br />

20<br />

0<br />

April<br />

May<br />

June<br />

July<br />

August<br />

September<br />

October<br />

<strong>November</strong><br />

December<br />

January<br />

February<br />

March<br />

Each complaint is assigned to the relevant Directorate it is regarding <strong>and</strong> the chart below<br />

demonstrates the percentage of total complaints received for each Directorate.<br />

21%<br />

10%<br />

2%<br />

33%<br />

C.D.T<br />

Corporate Non Clinical<br />

Medical<br />

Surgical<br />

Women And Children<br />

34%<br />

4


3.2 Acknowledgement Time<br />

The Complaints Regulations (2009), state that all complainants should receive an<br />

acknowledgement from the <strong>Trust</strong> within 3 working days.<br />

During the year, 99.6% of complainants received an acknowledgement within 3 working<br />

days.<br />

3.3 Response Time<br />

During the year the <strong>Trust</strong>’s target for percentage of complainants receiving a response<br />

within the agreed timescale was 80%. Unfortunately, the <strong>Trust</strong> did not meet this target.<br />

The chart below outlines the actual monthly percentages achieved:<br />

100%<br />

90%<br />

80%<br />

70%<br />

60%<br />

50%<br />

40%<br />

30%<br />

20%<br />

10%<br />

0%<br />

April<br />

May<br />

June<br />

July<br />

August<br />

September<br />

October<br />

<strong>November</strong><br />

December<br />

January<br />

February<br />

March<br />

3.4 Outcome<br />

Of the 1096 complaints received <strong>and</strong> investigated by the <strong>Trust</strong>, 604 were upheld.<br />

The table below reflects the status of all complaints received during this period. 85% of<br />

complaints received were resolved after a first written response or a first response meeting<br />

with the complainant, even though this may not have been within the agreed timeframe.<br />

Stage<br />

No of Complaints<br />

Open 44<br />

Open - reactivated complaint 32<br />

Closed - no consent 15<br />

Closed after first response/first meeting 930<br />

Closed after additional response/ local resolution<br />

75<br />

meeting<br />

Total 1096<br />

5


3.5 Themes<br />

General care issues <strong>and</strong> communication were the two main themes of complaints received<br />

during the year accounting for 92% of complaints received, <strong>and</strong> as outlined above, this is in<br />

line with the outcome of the CQC investigation. These two main themes are common<br />

across all Directorates.<br />

General Care Issues<br />

General care issues received during the past year related to:<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

Delay in diagnosis<br />

Wrong diagnosis<br />

Failure to respond to patients’ buzzers in a timely manner <strong>and</strong>/or leaving buzzers<br />

out of reach of patient<br />

Failure to respond to a patient needing help with getting to the toilet/personal<br />

hygiene<br />

Failure to provide assistance to patients needing help to eat<br />

Food <strong>and</strong> water being left out of the reach of patients<br />

Failure to supervise the taking of medication<br />

Communication Issues<br />

Communication issues received during this period included:<br />

<br />

<br />

<br />

<br />

<br />

Staff interaction with patients <strong>and</strong> families - a lack of basic courtesy to visitors or<br />

telephone callers<br />

Patients <strong>and</strong> visitors being spoken to in an abrupt manner on the ward or in the<br />

clinic environment<br />

Failure to keep patients <strong>and</strong> visitors informed as to developments whilst they are in<br />

hospital<br />

Failure to document fully in medical <strong>and</strong> nursing records, which then leads to<br />

problems for other staff to determine the up-to-date position.<br />

Difficulties in being able to contact the Appointments Call Centre, particularly as<br />

there was no queuing facility resulting in patients often hearing an engaged tone<br />

Overall, the <strong>Trust</strong> received complaints about the following:<br />

Category<br />

No. of<br />

Complaints<br />

Category<br />

No. of<br />

Complaints<br />

Care general -<br />

316 Wait - in out-patient<br />

4<br />

nurse/midwife<br />

department<br />

Care general - treatment 290 Care process - in<br />

3<br />

department<br />

Communication 160 Safety - other, accident 3<br />

Care general - diagnosis 145 Safety - other, assault etc 3<br />

Communication - staff<br />

54 Security - general 3<br />

attitude<br />

Care process - cross<br />

department<br />

19 Wait - for tests/scans etc<br />

out-patient<br />

2<br />

6


Category<br />

Communication -<br />

privacy/dignity/<br />

discrimination<br />

Care process -<br />

transfer/discharge<br />

Wait - for out-patient<br />

appointment<br />

No. of<br />

Category<br />

Complaints<br />

17 Facilities/equipment - hotel<br />

services<br />

No. of<br />

Complaints<br />

2<br />

13 Care process - attendance 2<br />

etc<br />

13 Care procedure - other 1<br />

Wait- in A&E 12 Communication - patient 1<br />

property/ expenses<br />

Care general - patient<br />

10 Facilities/equipment -<br />

1<br />

event<br />

availability<br />

Care procedure -<br />

7 Facilities/equipment -<br />

1<br />

medication<br />

maintenance<br />

Care procedure -<br />

7 Safety - patient, accident 1<br />

documentation<br />

Wait - for in-patient<br />

5 Safety – patient, accident 1<br />

admission<br />

fall from height<br />

Total 1096<br />

The categories for each Directorate are outlined in the tables below.<br />

Specialist Medicine<br />

Category<br />

Number of Complaints<br />

Communication 46<br />

Care general - treatment 23<br />

Communication - staff attitude 10<br />

Care general - diagnosis 6<br />

Care process - cross department 5<br />

Care general - nurse/midwife 4<br />

Communication - privacy/dignity/discrimination 3<br />

Wait - in out-patient department 3<br />

Care procedure - medication 2<br />

Care process - transfer/discharge 2<br />

Wait - for tests/scans etc (out-patient) 2<br />

Care procedure - documentation 1<br />

Facilities/Equipment - hotel services 1<br />

Wait - for out-patient appointment 1<br />

Total 109<br />

7


Corporate Non Clinical<br />

Category<br />

Number of Complaints<br />

Communication 6<br />

Communication - staff attitude 3<br />

Care process - cross department 1<br />

Care general - nurse/midwife 1<br />

Facilities/equipment - availability 1<br />

Safety - other, accident 1<br />

Safety - other, assault etc 1<br />

Security - general 3<br />

Total 17<br />

Medical<br />

Surgical<br />

Category<br />

Number of Complaints<br />

Communication 58<br />

Care general - treatment 121<br />

Communication - staff attitude 19<br />

Care general - diagnosis 43<br />

Care process - cross department 3<br />

Care general - nurse/midwife 100<br />

Communication - privacy/dignity/discrimination 2<br />

Care procedure - medication 1<br />

Care process - transfer/discharge 6<br />

Care procedure - documentation 2<br />

Wait - for out-patient appointment 1<br />

Communication - patient property/expenses 1<br />

Safety - other, assault etc 2<br />

Safety - patient, accident 1<br />

Safety - patient, accident fall from height 1<br />

Wait - in A&E 12<br />

Total 373<br />

Category<br />

Number of Complaints<br />

Communication 36<br />

Care general - treatment 120<br />

Communication - staff attitude 10<br />

Care general - diagnosis 70<br />

Care process - cross department 9<br />

Care general - nurse/midwife 75<br />

Communication - privacy/dignity/discrimination 7<br />

Wait - in out-patient department 1<br />

Care procedure - medication 3<br />

Care process - transfer/discharge 5<br />

Care procedure - documentation 1<br />

Facilities/equipment - hotel services 1<br />

8


Category<br />

Number of Complaints<br />

Wait - for out-patient appointment 11<br />

Care general - patient event 8<br />

Care procedure - other 1<br />

Care process - attendance etc 2<br />

Care process - in department 2<br />

Facilities/equipment - maintenance 1<br />

Safety - other, accident 1<br />

Wait - for in-patient admission 5<br />

Total 369<br />

Women & Children<br />

Category<br />

Number of Complaints<br />

Communication 14<br />

Care general - treatment 26<br />

Communication - staff attitude 12<br />

Care general - diagnosis 26<br />

Care process - cross department 1<br />

Care general - nurse/midwife 136<br />

Communication - privacy/dignity/discrimination 5<br />

Care procedure - medication 1<br />

Care procedure - documentation 3<br />

Care general - patient event 2<br />

Care process - in department 1<br />

Safety - other, accident 1<br />

Total 228<br />

3.6 Reactivated Complaints<br />

During the year the <strong>Trust</strong> received 75 new requests from complainants to re-open their<br />

complaint.<br />

By Directorates these were:<br />

Directorates<br />

Specialist Medicine 9<br />

Medical 36<br />

Surgical 13<br />

Women <strong>and</strong> Children 15<br />

Corporate non-clinical 2<br />

No of Reactivated<br />

The majority of reactivated complaints related to complex medical cases where the<br />

complainant was seeking further clarification of the response or where they did not agree<br />

with the <strong>Trust</strong>’s response. A number of complaints were reactivated as following a written<br />

response the complainant had requested financial recompense.<br />

Where complaints were reactivated, complainants were offered a further written response<br />

or the opportunity to have a local resolution meeting with relevant <strong>Trust</strong> representatives in<br />

9


order to resolve concerns. Particularly where there are complex medical issues which<br />

require explanation, it is often more helpful for the complainant if this is achieved through a<br />

face-to-face meeting as it allows the complainant to ask questions <strong>and</strong> to raise any<br />

outst<strong>and</strong>ing concerns.<br />

3.7 Parliamentary <strong>and</strong> Health Service Ombudsman (PHSO)<br />

Once the local resolution process has been concluded between the <strong>Trust</strong> <strong>and</strong> the<br />

complainant, if they are dissatisfied with the way in which the complaint has been h<strong>and</strong>led<br />

or if it is not possible to resolve the complaint, they can ask the PHSO to review the case.<br />

Sometimes, complainants do not wait until the local resolution process has concluded<br />

before approaching the PHSO <strong>and</strong> the case is then returned to the <strong>Trust</strong> to continue with<br />

local resolution. Where local resolution has concluded, the PHSO reviews the case <strong>and</strong><br />

either upholds the complaint, often suggesting the resolution that needs to take place, or<br />

rejecting the complaint <strong>and</strong> no further action is required.<br />

During the last year the <strong>Trust</strong> were advised of 38 complaints which were referred by<br />

complainants to the PHSO.<br />

Of this number, the status of the cases were:<br />

Still being considered 5<br />

Local resolution 17<br />

Upheld 3<br />

Rejected 13<br />

Although a number of cases were referred to the PHSO, it is encouraging to note that only<br />

8% of these cases were upheld. The remainder were either rejected, returned to the <strong>Trust</strong><br />

to conclude local resolution or are still awaiting PHSO consideration.<br />

The PHSO are unable to provide the <strong>Trust</strong> with details as to why a complaint has been<br />

referred to them without the consent of the complainant. It is therefore sometimes difficult<br />

to determine the specific reasons why complainants refer their complaint to the PHSO.<br />

However, during this period, delays in the <strong>Trust</strong> complaint h<strong>and</strong>ling process has led to<br />

some referrals being made to the PHSO prior to conclusion of local resolution.<br />

According to the PHSO findings <strong>and</strong> recommendations, the large majority of cases referred<br />

to them during 2011-12 were as a result of failures <strong>and</strong>/or delays in care <strong>and</strong> treatment <strong>and</strong><br />

this is in line with the overall themes from complaints.<br />

Of the 38 cases referred to the PHSO during 2011-12, 3 referred to Specialist Medicine, 1<br />

to Corporate Non-clinical, 20 to Medical, 10 to Surgical, 4 to Women & Children.<br />

Of the cases that the PHSO upheld against the <strong>Trust</strong>, 2 related to Surgical Division <strong>and</strong> 1<br />

related to Medical Division.<br />

4. Actions Taken in Response to Complaints<br />

BHRUT is keen to learn from all patient feedback including complaints. Any complaint<br />

which identifies shortcomings in services provided to patients is supported by an individual<br />

action plan which details learning <strong>and</strong> actions required to prevent a recurrence of the<br />

events which led to the complaint.<br />

10


The following improvements / actions were implemented during the year:<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

Additional pain management capacity identified to ensure patients are seen as<br />

quickly as possible<br />

Every patient admitted to a ward is seen within 24 hours by a consultant even if their<br />

own consultant is not available<br />

Introduction of 1 - 2 hourly comfort ward rounds ensure patients needs are regularly<br />

identified<br />

A communication book is now available on all wards to assist patients with<br />

communication difficulties. This is a pictorial book <strong>and</strong> allows patients who cannot<br />

verbalise to point out their needs<br />

The <strong>Trust</strong> senior nursing team undertake a rolling programme of weekly audits that<br />

concentrate on a topic of the week. The process of audit allows the senior nursing<br />

team to monitor documentation <strong>and</strong> feedback to staff any issues with inappropriate<br />

or inadequate documentation. This then identifies the gaps <strong>and</strong> support if given to<br />

that ward area. During these audits the senior nursing team speak to patients about<br />

their experience, particularly around issues of privacy <strong>and</strong> dignity, access to nurse<br />

call buzzers, nutrition, quality of food, use of ‘red tray’ <strong>and</strong> water jug system that is<br />

in place for patients who require assistance<br />

Within the Care of the Elderly Unit, the Matrons are introducing a twice weekly<br />

Matron’s surgery. This will be publicised to families <strong>and</strong> patients in the ward areas.<br />

This will allow patients <strong>and</strong> next-of-kin to have direct access to a Matron to discuss<br />

any concerns they may have. This will promote <strong>and</strong> improve communication. It is<br />

anticipated that following a review period, if successful, it will be rolled out across<br />

the <strong>Trust</strong><br />

Introduction of a parents advice leaflet within paediatrics<br />

Redesign of emergency department to include a dedicated room for mothers to use<br />

to breast-feed their babies<br />

Introduction of enhanced telephony system for Appointment Call Centre<br />

Medical Director led communication forums for junior medical staff<br />

Complaints discussed in consultant governance meetings, learning identified <strong>and</strong><br />

shared<br />

5. Service Developments<br />

Review of Complaints H<strong>and</strong>ling<br />

Following the publication of the CQC investigation report into issues at the <strong>Trust</strong>, in January<br />

<strong>2012</strong>, NHS London provided a resource to the <strong>Trust</strong> to undertake a review into the reasons<br />

for the decline in the <strong>Trust</strong> meeting its own targets for providing responses to complainants.<br />

The review took place throughout January <strong>2012</strong> <strong>and</strong> all aspects of the complaints h<strong>and</strong>ling<br />

process were considered.<br />

11


The findings of the review were that there were two main areas of concern relating to<br />

process issues <strong>and</strong> systems issues. Along with the review report, the project lead also<br />

submitted a proposed action plan to address the issues raised.<br />

At the time of this report progress on delivering the actions in the plan are being regularly<br />

reviewed at the <strong>Trust</strong>’s Quality & Safety Committee.<br />

H<strong>and</strong>ling Complaints Policy & Procedure<br />

During the later part of the year, the <strong>Trust</strong>’s H<strong>and</strong>ling Complaints Policy <strong>and</strong> Procedure was<br />

reviewed to bring the <strong>Trust</strong> in line with the Complaint Regulations 2009. The draft policy<br />

includes all aspects of the 2009 regulations <strong>and</strong> places greater emphasis on getting it right<br />

for the complainant. It aims to ensure a flexible, proportionate approach is implemented in<br />

order that the process be as easy to underst<strong>and</strong> <strong>and</strong> as un-bureaucratic as possible.<br />

The draft policy <strong>and</strong> procedure has been widely circulated to internal <strong>and</strong> external<br />

stakeholders for comment, prior to being presented at the <strong>Trust</strong>’s Policy Ratification<br />

Committee.<br />

New Complaints Leaflets<br />

A new <strong>Trust</strong> complaints leaflet has been designed <strong>and</strong> is currently in the process of being<br />

printed. The new leaflet is completely different to the old version <strong>and</strong> provides much more<br />

information for patients <strong>and</strong> relatives on making a complaint <strong>and</strong> other services <strong>and</strong><br />

organisations who can help. Once printed, the new leaflet will be available in all patient<br />

areas across the two main hospital sites.<br />

The leaflet is available for download on the <strong>Trust</strong>’s website.<br />

6. The Year Ahead - Future Plans<br />

Development/Goal<br />

Date Due<br />

Implementation of a complaints annual workplan <strong>2012</strong>-2013 Summer <strong>2012</strong><br />

Distribution of a new complaints leaflet Summer <strong>2012</strong><br />

Production of easy-read complaints leaflet Summer <strong>2012</strong><br />

Develop complaints induction material Summer <strong>2012</strong><br />

Moving core complaints team onto one site Summer <strong>2012</strong><br />

Service review of processes <strong>and</strong> procedures Autumn 2013<br />

Gary Etheridge<br />

Deputy Director of Nursing<br />

Victoria Wallen<br />

Interim Head of Complaints & PALS<br />

12


TITLE:<br />

EXECUTIVE SUMMARY<br />

BOARD/GROUP/COMMITTEE:<br />

Single Operating Model – Self certification template<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

Delivering the NHS Foundation <strong>Trust</strong> Pipeline: Single<br />

Operating Model (SOM) sets out the requirement for<br />

□ PEQ……….…...……. □ STRATEGY……….….…….<br />

<strong>Trust</strong>s to complete a self-assessment.<br />

□ FINANCE ……..……… □ AUDIT ………….……..….<br />

The SOM requires NHS <strong>Trust</strong>s to regularly self-certify<br />

governance <strong>and</strong> financial risk ratings on a monthly basis.<br />

They are also required to submit a template of quality <strong>and</strong><br />

contractual information <strong>and</strong> provide an accurate selfassessment<br />

against a series of <strong>Board</strong> statements drawn<br />

from the Monitor Compliance Framework.<br />

□ CLINICAL GOVERNANCE …………..………….....……<br />

□ CHARITABLE FUNDS ………………………………...…<br />

TRUST BOARD – Oct <strong>2012</strong><br />

□ REMUNERATION ………………………………….…...<br />

□ OTHER …………………………..……. (please specify)<br />

All declarations <strong>and</strong> self-certification should have been<br />

robustly discussed <strong>and</strong> approved by the <strong>Trust</strong> <strong>Board</strong> with<br />

the discussion minuted. Where an issue of non-compliance<br />

is identified the <strong>Trust</strong> should submit the relevant <strong>Board</strong><br />

approved action plan to rectify the issue. In line with the<br />

principle of avoiding duplication this would normally be the<br />

same level of detail that has been presented to the <strong>Board</strong><br />

to provide them with assurance that an issue can be<br />

rectified.<br />

2. DECISION REQUIRED: CATEGORY:<br />

The <strong>Trust</strong> <strong>Board</strong> is asked to discuss <strong>and</strong> approve the<br />

contents of the <strong>Trust</strong> Self-Assessment<br />

NATIONAL TARGET<br />

□ CQC REGISTRATION<br />

□ CNST<br />

□ HEALTH & SAFETY<br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

Not applicable.<br />

4. DELIVERABLES<br />

□ ASSURANCE FRAMEWORK<br />

□ CQUIN/TARGET FROM COMMISSIONERS<br />

□ CORPORATE OBJECTIVE ……………………………....<br />

□ OTHER …NHS Operating Framework<br />

AUTHOR: Claire Burns, Head of Planning, Commissioning<br />

<strong>and</strong> Information<br />

PRESENTER: Neill Moloney, Director of Delivery<br />

DATE: Oct <strong>2012</strong><br />

Meeting the Delivering the NHS Foundation <strong>Trust</strong> Pipeline: Single Operating Model (SOM) requirement for <strong>Trust</strong>s to<br />

complete a self-assessment<br />

5. KEY PERFORMANCE INDICATORS<br />

Please see attached self-assessment which includes indicators<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________


SELF-CERTIFICATION RETURNS<br />

Organisation Name:<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

Monitoring Period:<br />

September 12<br />

NHS <strong>Trust</strong> Over-sight self certification template


TFA Progress<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

Sep‐12<br />

Select the Performance from the drop‐down list<br />

TFA Milestone (All including those delivered)<br />

Milestone<br />

Date<br />

Performance<br />

Comments where milestones are not delivered or where a risk to<br />

delivery has been identified<br />

Mar<br />

1 AA - TFA governance agreed by <strong>Trust</strong> / Cluster / SHA Aug-12 On track to deliver<br />

2 AA - <strong>Trust</strong> Transformation Programme Plan developed Sep-12<br />

3 AA - Transformation plan approved by <strong>Board</strong> Oct-12<br />

High risk to delivery<br />

within timescale<br />

High risk to delivery<br />

within timescale<br />

4 AA - All <strong>Trust</strong> <strong>Board</strong> <strong>and</strong> Executive Director positions filled Oct-12 On track to deliver<br />

complete<br />

plan developed to go to Joint Transformation board in October <strong>and</strong><br />

board in <strong>November</strong><br />

Transformation plan to be developed by Dec 12 following approval of the<br />

LTFM<br />

Chairman <strong>and</strong> Director of Nursing commenced post. Chief Information<br />

Office appointed , due to commence in Nov 12<br />

Fully On track<br />

achieved to deliver<br />

in time<br />

ll h High k risk d l h l<br />

to<br />

delivery<br />

Not fully<br />

achieved<br />

5 AA - OD plan agreed with deliverables/milestones Dec-12 On track to deliver<br />

OD plans were submitted to gain funding ‐ awaiting feedback from DoH<br />

6 AA - Quality Governance self assessment agreed by <strong>Trust</strong> <strong>Board</strong> Jan-13 On track to deliver<br />

7 AA - BGAF self assessment agreed by <strong>Trust</strong> <strong>Board</strong> Jan-13 On track to deliver<br />

Recruited Director of Governance who is taking the lead on this<br />

requirement<br />

Recruited Director of Governance who is taking the lead on this<br />

requirement<br />

8 AA - Formal review of Transformation Programme Jan-13 On track to deliver `12/13 review in Oct 12 , 13/14 plan being developed<br />

9 AA - Workforce strategy/education/training plan approved May-13 On track to deliver New Head of HR recruited <strong>and</strong> taking the lead on this development<br />

10 AA - A&E target achieved at KGH Aug-12 On track to deliver KGH meeting 95% target since June 12<br />

11 AA - A&E target achieved at Queen’s Oct-12<br />

High risk to delivery<br />

within timescale<br />

To meet this st<strong>and</strong>ard the following actions are being put in place<br />

Implement redesigned medical rotas – pilot on 7 day a week consultant<br />

cover commencing in <strong>November</strong><br />

Bed Management review ensuring defined roles <strong>and</strong> responsibilities that<br />

support <strong>and</strong> focus on flow from ED to Assessment <strong>and</strong> then with focus<br />

on the delivery of bed availability from the inpatient areas to deliver<br />

seamless use of the bed capacity to meet dem<strong>and</strong> <strong>and</strong> ensure timely<br />

patient flow.<br />

Ward reviews to commence<br />

7 day working across the <strong>Trust</strong> including support services<br />

Reducing Length of Stay by working with partner organisations <strong>and</strong><br />

families to reduce length of stay<br />

Improved communication with partner organisation to expedite<br />

discharges <strong>and</strong> forward planning to meet dem<strong>and</strong>


12 AA - Quality Improvement Strategy approved by <strong>Trust</strong> <strong>Board</strong> Jan-13 On track to deliver<br />

13 AA - March <strong>2012</strong> CQC compliance actions addressed Dec-12 On track to deliver<br />

<strong>Trust</strong> wide areas agreed in July 12. Each of the 11 Directorates to come<br />

up with up to 3 Directorate Quality indicators to be reported regularly in<br />

their performance meetings alongside progress with the <strong>Trust</strong> wide<br />

areas. These will be confirmed <strong>and</strong> discussed when each Directorate<br />

presents plans to the Quality <strong>and</strong> Safety Committee (sub committee of<br />

the <strong>Board</strong> chaired by Non‐ execs).<br />

the stratgic actions have now been incorporporated as business as usual.<br />

Mock CQC inspections are being undertaken ahead of the CQC<br />

inspections.<br />

14 AA - 12/13 monthly CIP plan re-profiled Sep-12 On track to deliver completed in August <strong>2012</strong><br />

15 AA - Plan to deliver £23m Recurrent CIP by Mar 13 agreed by <strong>Trust</strong><br />

<strong>Board</strong><br />

Oct-12<br />

High risk to delivery<br />

within timescale<br />

full year effects of current plan £17.7M<br />

16<br />

AA - Plan to deliver additional in year non recurrent CIP to deliver 12/13<br />

control total agreed by <strong>Trust</strong> <strong>Board</strong><br />

Oct-12<br />

High risk to delivery<br />

within timescale<br />

Plans in place for 17m , to go to Joint Transformation board in October<br />

<strong>and</strong> board in <strong>November</strong><br />

17 AA - <strong>2012</strong>/13 £23.2m CIP target delivered Oct-12<br />

18 AA - <strong>2012</strong>/13 Plan deficit no greater than £39.2m Apr-13<br />

High risk to delivery<br />

within timescale<br />

High risk to delivery<br />

within timescale<br />

Current forecast to deliver £17.7M CIPs. In additon to this the detail is<br />

included in the <strong>Trust</strong> FIMS return<br />

as of month 6 FOT is £46.8M<br />

19 AA - 5 year <strong>Trust</strong> productivity programme developed Sep-12 On track to deliver<br />

baseline LTFM with 5 yr productivity programme complete with report to<br />

<strong>Trust</strong> <strong>Board</strong><br />

20<br />

AA - LTFM base case assumptions <strong>and</strong> options to bridge gap agreed by<br />

commissioners<br />

Oct-12<br />

On track to deliver<br />

baseline LTFM complete <strong>and</strong> activity assumptions agreed with<br />

commissioners<br />

21<br />

AA - SHA review 5 year <strong>Trust</strong> productivity programme <strong>and</strong> LTFM<br />

baseline <strong>and</strong> options to bridge gap<br />

Oct-12<br />

On track to deliver<br />

amendments being made to final report following trust board <strong>and</strong> on<br />

track to deliver against timeframe<br />

22 AA - Clinical & Financial Viability Plan approved by <strong>Trust</strong> <strong>Board</strong> Dec-12 On track to deliver baseline LTFM complete. Awaiting completion of out of hospital LTFM<br />

23 AA - OBC (inc commissioner support) approved by <strong>Trust</strong> <strong>Board</strong> Date for OBC to be confirmed<br />

24 AA - SHA approval of OBC at CIC Date for OBC to be confirmed<br />

25 AA - FBC approved by <strong>Trust</strong> <strong>Board</strong> Date for FBC to be confirmed<br />

26 AA - SHA approval of FBC Date for FBC to be confirmed<br />

27 AA - BHR transition plan for closure KGH maternity (intrapartum care) Oct-12 On track to deliver approved at the October <strong>Trust</strong> <strong>Board</strong> MeetingMeeting<br />

28 AA - BHR system readiness assurance gateway Dec-12 On track to deliver this is a commissioner led process on track to deliver<br />

29 AA - BHR birth numbers < 8000 per annum (@660 pcm) Feb-13 On track to deliver<br />

arrangements now agreed with commissioners on how birth numbers<br />

will be reduced <strong>and</strong> escaltion policy in place for varriation in activity


30 AA - KGH maternity closed Mar-13 On track to deliver progress being monitored by Maternity Strategy <strong>Board</strong><br />

31<br />

32


TFA Progress<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

Sep‐12<br />

Select the Performance from the drop‐down list<br />

TFA Milestone (All including those delivered)<br />

Milestone<br />

Date<br />

Performance<br />

Comments where milestones are not delivered or where a risk to<br />

delivery has been identified<br />

1<br />

TFA - Agreement reached on BHRUT assuming reasonability for<br />

integrated elderly pathway with transfer of staffing <strong>and</strong> assets during<br />

2011/12 (RED)<br />

Jun-11<br />

Not fully achieved<br />

No agreement reached with commissioners on the transfer of these<br />

services. Out of Hospital review currently being undertaken <strong>and</strong> due to<br />

report by December<br />

2<br />

TFA - BHRUT achieving 95th percentile st<strong>and</strong>ard for all A&E departmentsthen<br />

sustained to year end. (RED)<br />

Jun-11<br />

Not fully achieved<br />

A&E target not sustained<br />

3<br />

TFA - BHRUT achieving all Cancer targets- then sustained to year end<br />

(GREEN)<br />

Jun-11<br />

Fully achieved in time<br />

In 2011/12 this milestone was achieved although performance has<br />

deteriorated in the first quarter of <strong>2012</strong>/13<br />

4<br />

TFA - Agreement of volumes <strong>and</strong> value of transfer of elective work from<br />

Whipps Cross <strong>and</strong> tertiary providers during 2011/12 <strong>and</strong> <strong>2012</strong>/13 (RED)<br />

Jun-11<br />

Not fully achieved<br />

No agreement on the transfer of these services has been agreed.<br />

5<br />

TFA - Financial return at month 2 on target against plan YTD <strong>and</strong> yearend<br />

projection in control (RED)<br />

Jun-11<br />

Not fully achieved<br />

Financial commitments in 2011/12 not achieved.<br />

6 TFA - SHA financial challenges <strong>and</strong> productivity opportunities<br />

assessment (RED)<br />

Jun-11 Fully achieved in time complete<br />

7 TFA - Q1 review of finance, CIPs <strong>and</strong> quality <strong>and</strong> performance (including<br />

achievement <strong>and</strong> trajectory of CIPs)<br />

Jun-11 Fully achieved in time complete<br />

8<br />

TFA - <strong>Board</strong> to <strong>Board</strong> (20 Sept) on financial challenge <strong>and</strong> productivity<br />

opportunity<br />

Sep-11 Fully achieved in time complete<br />

9<br />

TFA - Financial return at month 5 on target to meet £28.8m (including<br />

IFRS) control total(RED)<br />

Sep-11 Not fully achieved Financial commitments in 2011/12 not achieved<br />

10 TFA - <strong>Board</strong> to <strong>Board</strong> 18 October 2011 Oct-11 Fully achieved in time complete


11 TFA - Q3 review of finance, quality <strong>and</strong> performance (including<br />

achievement <strong>and</strong> trajectory of CIPs) (RED)<br />

Oct-11<br />

Not fully achieved<br />

12<br />

TFA - Financial return at month 7 on target to meet £35.6m (including<br />

IFRS) control total(RED)<br />

Oct-11 Not fully achieved Financial commitments in 2011/12 not achieved<br />

13<br />

TFA - Establishment of Clinical Productivity Programme - year 1 of full<br />

delivery <strong>2012</strong>/13<br />

Nov-11<br />

Fully achieved but late<br />

Business Plans were constructed such that first draft plans were available<br />

in January <strong>2012</strong>.<br />

14 TFA - Application to CQC for removal of conditions (RED) Nov-11 Fully achieved but late Final removal of conditions achieved in Q1 of <strong>2012</strong>/13<br />

15<br />

TFA - Financial return at month 8 on target to meet £28.8m (including<br />

IFRS) control total (RED)<br />

Nov-11 Not fully achieved Financial commitments in 2011/12 not achieved.<br />

16 TFA - Q3 review of finance, quality <strong>and</strong> performance (including<br />

achievement <strong>and</strong> trajectory of CIPs) (RED)<br />

Jan-12<br />

Not fully achieved<br />

17 TFA - £41.0m deficit control total for 2011/12 projected to be met (RED) Feb-12 Not fully achieved Financial commitments in 2011/12 not achieved.<br />

18 TFA - No CQC conditions (RED) Mar-12 Fully achieved but late Final removal of conditions achieved in Q1 of <strong>2012</strong>/13<br />

19<br />

TFA - Q4 review of finance, quality & performance (including<br />

achievement <strong>and</strong> trajectory of CIPs) (RED)<br />

Apr-12<br />

Not fully achieved<br />

20 TFA - Submit IBP & LTFM (RED) Jun-12 Not fully achieved<br />

Baseline LTFM completed in June <strong>2012</strong> which is being updated using 4<br />

options for clinical productivity <strong>and</strong> reconfiguration by October <strong>2012</strong><br />

21 TFA - Q1 review of finance, CIPs <strong>and</strong> quality <strong>and</strong> performance (including<br />

achievement <strong>and</strong> trajectory of CIPs)<br />

Jul-12 Fully achieved in time complete<br />

22 TFA - Undertake public consultation (RED) Jul-12 Not fully achieved Revised tracjectory to be agreed.<br />

23 TFA - Safety & Quality Assurance Gateway Review Aug-12<br />

Will not be delivered on<br />

time<br />

Revised trajectory to be agreed<br />

24<br />

TFA - Q2 review of finance. CIPs <strong>and</strong> Quality & performance (including<br />

achievement <strong>and</strong> trajectory of CIPs)<br />

Oct-12<br />

On track to deliver


25 TFA - Final IBP /; LTFM Dec-12<br />

High risk to delivery<br />

within timescale<br />

Revised trajectory for IBP to be agreed<br />

26<br />

TFA - Q3 review of finance, CIPs <strong>and</strong> Quality & Performance (including<br />

achievement <strong>and</strong> trajectory of CIPs)<br />

Jan-13<br />

High risk to delivery<br />

within timescale<br />

27 TFA - <strong>Board</strong> to <strong>Board</strong> Meeting Jan-13<br />

28 TFA - <strong>Trust</strong> <strong>Board</strong> formal approval of FT Application Feb-13<br />

29 TFA - SHA <strong>Board</strong> Approval of FT Application Mar-13<br />

30 TFA - Submission of FT Application to DH Apr-13<br />

Will not be delivered on<br />

time<br />

Will not be delivered on<br />

time<br />

Will not be delivered on<br />

time<br />

Will not be delivered on<br />

time<br />

Revised trajectory to be agreed<br />

Revised trajectory to be agreed<br />

Revised trajectory to be agreed<br />

31<br />

32


NHS <strong>Trust</strong> Governance Declarations : <strong>2012</strong>/13 In-Year Reporting<br />

Name of Organisation: BHR University Hospitals NHS <strong>Trust</strong> Period: August <strong>2012</strong><br />

Organisational risk rating<br />

Each organisation is required to calculate their risk score <strong>and</strong> RAG rate their current performance, in addition to providing comment with regard to any contractual issues<br />

<strong>and</strong> compliance with CQC essential st<strong>and</strong>ards:<br />

Key Area for rating / comment by Provider<br />

Governance Risk Rating (RAG as per SOM guidance)<br />

Financial Risk Rating (Assign number as per SOM guidance)<br />

Contractual Position (RAG as per SOM guidance)<br />

Score / RAG rating*<br />

R<br />

R<br />

g<br />

* Please type in R, A or G<br />

Governance Declarations<br />

NHS <strong>Trust</strong>s must ensure that plans in place are sufficient to ensure compliance in relation to all national targets <strong>and</strong> including ongoing compliance with the Code of<br />

Practice for the Prevention <strong>and</strong> Control of Healthcare Associated Infections, CQC Essential st<strong>and</strong>ards <strong>and</strong> declare any contractual issues.<br />

Supporting detail is required where compliance cannot be confirmed.<br />

Please complete sign one of the two declarations below. If you sign declaration 2, provide supporting detail using the form below. Signature may be either h<strong>and</strong> written<br />

or electronic, you are required to print your name.<br />

Governance declaration 1<br />

The <strong>Board</strong> is satisfied that plans in place are sufficient to ensure continuing compliance with all existing targets (after the application of thresholds), <strong>and</strong> with all known<br />

targets going forward. The board is satisfied that plans in place are sufficient to ensure ongoing compliance with the Code of Practice for the Prevention <strong>and</strong> Control of<br />

Healthcare Associated Infections (including the Hygiene Code) <strong>and</strong> CQC Essential st<strong>and</strong>ards. The board also confirms that there are no material contractual disputes.<br />

Signed by:<br />

Print Name:<br />

on behalf of the <strong>Trust</strong> <strong>Board</strong><br />

Acting in capacity as:<br />

Signed by:<br />

Print Name:<br />

on behalf of the <strong>Trust</strong> <strong>Board</strong><br />

Acting in capacity as:<br />

Governance declaration 2<br />

For one or some of the following declarations Governance, Finance, Service Provision, Quality <strong>and</strong> Safety, CQC essential st<strong>and</strong>ards or the Code of Practice for the<br />

Prevention <strong>and</strong> Control of Healthcare Associated Infections the <strong>Board</strong> cannot make Declaration 1 <strong>and</strong> has provided relevant details below.<br />

The board is suggesting that at the current time there is insufficient assurance available to ensure continuing compliance with all existing targets (after the application<br />

of thresholds) <strong>and</strong>/or that it may have material contractual disputes.<br />

Signed by : Print Name :<br />

Sir Peter Dixon<br />

on behalf of the <strong>Trust</strong> <strong>Board</strong><br />

Acting in capacity as:<br />

Chairman<br />

Signed by : Print Name :<br />

Averil Dongworth<br />

on behalf of the <strong>Trust</strong> <strong>Board</strong><br />

Acting in capacity as:<br />

Chief Executive<br />

If Declaration 2 has been signed:<br />

Please identify which targets have led to the <strong>Board</strong> being unable to sign declaration 1. For each area such as Governance, Finance, Contractual, CQC Essential<br />

St<strong>and</strong>ards, where the board is declaring insufficient assurance please state the reason for being unable to sign the declaration, <strong>and</strong> explain briefly what steps are being<br />

taken to resolve the issue. Please provide an appropriate level of detail.<br />

Target/St<strong>and</strong>ard:<br />

The Issue :<br />

Goverance<br />

A&E performance, MRSA & Cdiff performance, CQC warning notices non compliance<br />

MRSA & Cdiff:<br />

New Director of Infection Prevention <strong>and</strong> Control is now in post. There is a change of focus to Infection prevention<br />

<strong>and</strong> the current action plan is being reviewed to identify the high impact actions, one of which is ANTT. ANTT has<br />

been introduced across the <strong>Trust</strong> <strong>and</strong> to date 60% of Matrons <strong>and</strong> 72% of senior sisters have achieved Train the<br />

Trainer competencies. These staff will now roll out the training across the wards. New h<strong>and</strong> washing campaigns <strong>and</strong><br />

training programmes have been introduced. Training for doctors has commenced for FY1/2s Consultants <strong>and</strong> is<br />

being planned for staff grades.<br />

Action :<br />

CQC:<br />

<strong>Trust</strong>-wide action plan in place that captures all outst<strong>and</strong>ing CQC requirements that has been comprehensively<br />

shared with the SHA <strong>and</strong> local Commissioners, is being implemented with <strong>Trust</strong> <strong>Board</strong> <strong>and</strong> is subjected to external<br />

monitoring.<br />

A&E target<br />

Implement redesigned medical rotas – pilot on 7 day a week consultant cover commencing in <strong>November</strong><br />

Bed Management review ensuring defined roles <strong>and</strong> responsibilities that support <strong>and</strong> focus on flow from ED to<br />

Assessment <strong>and</strong> then with focus on the delivery of bed availability from the inpatient areas to deliver seamless use of th<br />

Ward reviews to commence<br />

7 day working across the <strong>Trust</strong> including support services<br />

Reducing Length of Stay by working with partner organisations <strong>and</strong> families to reduce length of stay<br />

Improved communication with partner organisation to expedite discharges <strong>and</strong> forward planning to meet dem<strong>and</strong><br />

Target/St<strong>and</strong>ard:<br />

The Issue :<br />

Action :<br />

Finance<br />

Financial risk rating of 1<br />

In-year savings programme developed with support from external consultancy. Programme Management Office established<br />

to support delivery of cost improvement plans. Long term financial model developed along with 5 year productivity <strong>and</strong><br />

efficiency programme for review at October <strong>2012</strong> <strong>Trust</strong> <strong>Board</strong>


Effectiveness<br />

GOVERNANCE RISK RATINGS<br />

BHR University Hospitals NHS<br />

<strong>Trust</strong><br />

See 'Notes' for further detail of each of the below indicators<br />

Area Ref Indicator Sub Sections<br />

Threshold<br />

Referral to treatment information 50%<br />

1a<br />

Data completeness: Community services<br />

comprising:<br />

Referral information 50%<br />

Treatment activity information 50%<br />

Weighting<br />

Historic Data<br />

Qtr to Dec- Qtr to<br />

11 Mar-12<br />

1.0 N/a<br />

Insert YES (target met in month), NO (not met in month) or N/A (as<br />

appropriate)<br />

See separate rule for A&E<br />

Qtr to<br />

Jun-12<br />

N/a N/a N/a<br />

Current Data<br />

Jul 12 Aug-12 Sep-12<br />

Patient identifier information 50% N/a N/a N/a N/a N/a N/a Yes<br />

Data completeness, community services:<br />

1b<br />

(may be introduced later)<br />

Patients dying at home / care<br />

50% N/a N/a N/a N/a N/a N/a Yes<br />

home<br />

1c Data completeness: identifiers MHMDS 97% 0.5 N/a N/a N/a N/a N/a N/a Yes<br />

N/a<br />

N/a<br />

Qtr to<br />

Sep-12<br />

Yes<br />

Comments where target<br />

not achieved<br />

1c<br />

2a<br />

Data completeness: outcomes for patients<br />

on CPA<br />

From point of referral to treatment in<br />

aggregate (RTT) – admitted<br />

50% 0.5 N/a N/a N/a N/a N/a N/a Yes<br />

Maximum time of 18 weeks 90% 1.0 N/a N/a Yes Yes Yes yes Yes<br />

Patient Experience<br />

2b<br />

2c<br />

2d<br />

3a<br />

From point of referral to treatment in<br />

aggregate (RTT) – non-admitted<br />

From point of referral to treatment in<br />

aggregate (RTT) – patients on an<br />

incomplete pathway<br />

Certification against compliance with<br />

requirements regarding access to<br />

healthcare for people with a learning<br />

disability<br />

All cancers: 31-day wait for second or<br />

subsequent treatment, comprising :<br />

Maximum time of 18 weeks 95% 1.0 Yes Yes Yes Yes yes yes Yes<br />

Maximum time of 18 weeks 92% 1.0 Yes Yes Yes Yes yes yes Yes<br />

Surgery 94%<br />

Anti cancer drug treatments 98%<br />

Radiotherapy 94%<br />

From urgent GP referral for<br />

suspected cancer<br />

85%<br />

3b All cancers: 62-day wait for first treatment: 1.0 yes<br />

From NHS Cancer Screening<br />

90%<br />

Service referral<br />

N/A 0.5 no no no no no no No<br />

1.0 yes<br />

yes yes yes yes yes<br />

yes<br />

no<br />

Yes<br />

No yes yes No<br />

the <strong>Trust</strong> is meeting meeting 5 of the 6<br />

requirements . The area not yet fully<br />

compliant 'audit of practice' against policy.<br />

Business Units will review casenote for<br />

patients with LD treated in the service during<br />

October to meet this requirement<br />

This measure was not met in July. The<br />

underachievement was due to complex<br />

pathways, endoscopy capacity <strong>and</strong> lack of<br />

escalation across the pathways. The annual<br />

trajectory was approved by the <strong>Trust</strong><br />

Executive Committee (TEC) with action plans<br />

being provided by each specialty. In addition<br />

the NHS Intensive Support Team provided<br />

the Service with advice. Weekly specialtylevel<br />

patient target list (PTL) meetings with<br />

each Service Manager have been<br />

introduced; a more robust escalation process<br />

for delays in radiological <strong>and</strong> pathology<br />

reporting has been implemented together<br />

with a review of endoscopy capacity. The<br />

Service is also recruiting additional MDT coordinators<br />

a senior MDT coordinator <strong>and</strong> a<br />

float MDT coordinator to provide cover for<br />

leave. The target has been achieved since<br />

August <strong>2012</strong>.


3c<br />

3d<br />

All Cancers: 31-day wait from diagnosis to<br />

first treatment<br />

Cancer: 2 week wait from referral to date<br />

first seen, comprising:<br />

all urgent referrals 93%<br />

for symptomatic breast patients<br />

(cancer not initially suspected)<br />

93%<br />

96% 0.5 yes yes yes yes yes yes Yes<br />

0.5 yes yes yes yes yes yes Yes<br />

Quality<br />

3e<br />

3f<br />

3g<br />

3h<br />

A&E: From arrival to<br />

admission/transfer/discharge<br />

Care Programme Approach (CPA) patients,<br />

comprising:<br />

Minimising mental health delayed transfers<br />

of care<br />

Admissions to inpatients services had<br />

access to Crisis Resolution/Home<br />

Treatment teams<br />

Maximum waiting time of four<br />

hours<br />

Receiving follow-up contact within<br />

7 days of discharge<br />

Having formal review<br />

within 12 months<br />

95% 1.0 No No No No no no No<br />

95%<br />

1.0 N/a N/a N/a N/a n/a n/a Yes<br />

95%<br />

≤7.5% 1.0 yes yes Yes Yes yes yes Yes<br />

95% 1.0 N/a N/a N/a n/a n/a n/a Yes<br />

Implement redesigned medical rotas – pilot<br />

on 7 day a week consultant cover<br />

commencing in <strong>November</strong><br />

Bed Management review ensuring defined<br />

roles <strong>and</strong> responsibilities that support <strong>and</strong><br />

focus on flow from ED to Assessment <strong>and</strong><br />

then with focus on the delivery of bed<br />

availability from the inpatient areas to deliver<br />

seamless use of the bed capacity to meet<br />

dem<strong>and</strong> <strong>and</strong> ensure timely patient flow.<br />

Ward reviews to commence<br />

7 day working across the <strong>Trust</strong> including<br />

support services<br />

Reducing Length of Stay by working with<br />

partner organisations <strong>and</strong> families to reduce<br />

length of stay<br />

Improved communication with partner<br />

organisation to expedite discharges <strong>and</strong><br />

forward planning to meet dem<strong>and</strong><br />

3i<br />

Meeting commitment to serve new<br />

psychosis cases by early intervention<br />

teams<br />

95% 0.5 N/a N/a N/a N/a n/a n/a Yes<br />

3j<br />

Category A call – emergency response<br />

within 8 minutes<br />

75% 1.0 N/a N/a N/a N/a n/a n/a Yes<br />

3k<br />

Category A call – ambulance vehicle<br />

arrives within 19 minutes<br />

95% 1.0 N/a N/a N/a N/a n/a n/a Yes<br />

There were 7 cases of infection reported<br />

during September, none of the patients<br />

acquiring the infection was as the result of<br />

cross contamination.<br />

4a<br />

Clostridium Difficile<br />

Enter<br />

Are you below the ceiling for your<br />

contractual<br />

monthly trajectory<br />

ceiling<br />

1.0 yes yes no no no no No<br />

Exception reporting occurred in all 7 cases<br />

against the st<strong>and</strong>ardised 17 criteria. 6 wards<br />

scored 100%, one ward (heather) scored<br />

less than 100% <strong>and</strong> has been required to<br />

produce an action plan to address the issues<br />

highlighted by the infection control exception<br />

report. No primary cause was identified for<br />

this case. The issues identified were practice<br />

related. The Infection Control Committee<br />

monitors the wards progress against their<br />

action plans


Safety<br />

4b<br />

MRSA<br />

Enter<br />

Are you below the ceiling for your<br />

contractual<br />

monthly trajectory<br />

ceiling<br />

1.0 yes yes no no No No No<br />

2 cases Q1 , 2 cases in September. 6 YTD<br />

against ceiling 7 per year New Director of<br />

Infection Prevention <strong>and</strong> Control is now in<br />

post.There is a change of focus to Infection<br />

prevention <strong>and</strong> the current action plan is<br />

being reviewed to identify the high impact<br />

actions, one of which is ANTT. ANTT has<br />

been introduced across the <strong>Trust</strong> <strong>and</strong> to date<br />

60% of Matrons <strong>and</strong> 72% of senior sisters<br />

have achieved Train the Trainer<br />

competencies. These staff will now roll out<br />

the training across the wards. New h<strong>and</strong><br />

washing campaigns <strong>and</strong> training<br />

programmes introduced. Training for doctors<br />

has commenced for FY1/2s Consultants <strong>and</strong><br />

is being planned for staff grades.<br />

A<br />

CQC Registration<br />

Non-Compliance with CQC Essential<br />

St<strong>and</strong>ards resulting in a Major Impact on<br />

Patients<br />

0 2.0 yes yes Yes No No No No<br />

B<br />

Non-Compliance with CQC Essential<br />

St<strong>and</strong>ards resulting in Enforcement Action<br />

0 4.0 yes yes Yes Yes Yes Yes<br />

<strong>Trust</strong>-wide action plan in place that captures<br />

all outst<strong>and</strong>ing CQC requirements that has<br />

been comprehensively shared with the SHA<br />

<strong>and</strong> local Commissioners, is being<br />

implemented with <strong>Trust</strong> <strong>Board</strong> <strong>and</strong> is<br />

subjected to external monitoring.<br />

C<br />

NHS Litigation Authority – Failure to<br />

maintain, or certify a minimum published<br />

CNST level of 1.0 or have in place<br />

appropriate alternative arrangements<br />

0 2.0 no no No No No No No<br />

RAG RATING :<br />

GREEN = Score of 1 or under<br />

TOTAL 5.5 5.5 8.5 8.5 7.5 3.5 8.5<br />

AMBER/GREEN = Score between 1 <strong>and</strong> 1.9<br />

AMBER / RED = Score between 2 <strong>and</strong> 3.9<br />

RED = Score of 4 or above<br />

Overriding Rules - Nature <strong>and</strong> Duration of Override at SHA's Discretion<br />

Greater than six cases in the year to date, <strong>and</strong> either:<br />

i) Meeting the MRSA Objective<br />

Breaches the cumulative year-to-date trajectory for three<br />

successive quarters<br />

no no no No No no No<br />

Breaches its full year objective<br />

Greater than 12 cases in the year to date, <strong>and</strong> either:<br />

Breaches the cumulative year-to-date trajectory for three<br />

ii) Meeting the C-Diff Objective<br />

successive quarters<br />

Breaches its full year objective<br />

no no no no No No No<br />

Reports important or signficant outbreaks of C.difficile, as<br />

defined by the Health Protection Agency.<br />

Breaches:<br />

The admitted patients 18 weeks waiting time measure for a<br />

third successive quarter


iii) RTT Waiting Times The non-admitted patients 18 weeks waiting time measure<br />

for a third successive quarter<br />

The incomplete pathway 18 weeks waiting time measure for<br />

a third successive quarter<br />

no<br />

no<br />

no no No<br />

No<br />

No<br />

Fails to meet the A&E target twice in any two quarters over<br />

iv) A&E Clinical Quality Indicator a 12-month period <strong>and</strong> fails the indicator in a quarter during yes yes yes yes Yes Yes Yes<br />

the subsequent nine-month period or the full year.<br />

v) Cancer Wait Times<br />

Breaches either:<br />

the 31-day cancer waiting time target for a third successive<br />

quarter<br />

the 62-day cancer waiting time target for a third successive<br />

quarter<br />

no no no no No<br />

No<br />

No<br />

vi)<br />

Ambulance Response Times<br />

Breaches either:<br />

the category A 8-minute response time target for a third<br />

successive quarter<br />

the category A 19-minute response time target for a third<br />

successive quarter<br />

N/a<br />

n/a n/a n/a N/a N/a<br />

Yes<br />

vii)<br />

Community Services data completeness<br />

Fails to maintain the threshold for data completeness for:<br />

referral to treatment information for a third successive<br />

quarter;<br />

service referral information for a third successive quarter,<br />

or;<br />

treatment activity information for a third successive quarter<br />

n/a<br />

n/a<br />

n/a n/a N/a<br />

N/a<br />

Yes<br />

viii) Any Indicator weighted 1.0 Breaches the indicator for three successive quarters.<br />

yes yes yes yes Yes<br />

Number of Overrides Triggered 2.0 2.0 2.0 2.0 1.0 1.0 4.0<br />

A&E target


FINANCIAL RISK RATING<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

Insert the Score (1-5) Achieved for each<br />

Criteria Per Month<br />

Risk Ratings<br />

Reported<br />

Position<br />

Normalised<br />

Position*<br />

Criteria Indicator Weight 5 4 3 2 1<br />

Year to<br />

Date<br />

Forecast<br />

Outturn<br />

Year to<br />

Date<br />

Forecast<br />

Outturn<br />

Underlying<br />

performance<br />

EBITDA margin % 25% 11 9 5 1


FINANCIAL RISK TRIGGERS<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

Insert "Yes" / "No" Assessment for the Month<br />

Historic Data<br />

Current Data<br />

Criteria<br />

Qtr to<br />

Dec-11<br />

Qtr to<br />

Mar-12<br />

Qtr to<br />

Jun-12<br />

Jul 12 Aug-12 Sep-12<br />

Qtr to<br />

Sep-12<br />

Comments where risks are triggered<br />

1<br />

Unplanned decrease in EBITDA margin in two<br />

consecutive quarters<br />

yes yes yes no No Yes Yes<br />

11/12 figures influenced by position against Plan where<br />

agreed Control total with SHA adjusted £10m. Ytd at Sep<br />

<strong>2012</strong>/13 EBITDA -2.2% against plan of -1.6%<br />

2<br />

Quarterly self-certification by trust that the financial risk<br />

rating (FRR) may be less than 3 in the next 12 months<br />

yes yes yes yes Yes Yes Yes<br />

Driven by deficit position both planned <strong>and</strong> actual<br />

3<br />

Working capital facility (WCF) agreement includes default<br />

clause<br />

4<br />

Debtors > 90 days past due account for more than 5% of<br />

total debtor balances<br />

yes yes yes yes Yes Yes Yes<br />

Taken from AR ledger, after application of bad debt provision.<br />

Debtors > 90 days account for 9% of total debt. Overseas<br />

patients forms a particular risk. Some debt written off in<br />

September<br />

5<br />

Creditors > 90 days past due account for more than 5% of<br />

total creditor balances<br />

yes yes yes yes Yes Yes Yes<br />

Taken from AP ledger, creditors over 90 days form 14% of<br />

total creditors. Heavily influenced by cash-flow consequences<br />

of running a deficit, plus planning for October's PFI payment.<br />

6<br />

7<br />

8<br />

Two or more changes in Finance Director in a twelve<br />

month period<br />

Interim Finance Director in place over more than one<br />

quarter end<br />

Quarter end cash balance


CONTRACTUAL DATA<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

Insert "Yes" / "No" Assessment for the Month<br />

Historic Data<br />

Current Data<br />

Criteria #REF! #REF! #REF! #REF! #REF! #REF! #REF! Comments where reds are triggered<br />

Are the prior year contracts* closed? yes yes yes yes yes yes Yes<br />

Are all current year contracts* agreed <strong>and</strong><br />

signed?<br />

Are both the NHS <strong>Trust</strong> <strong>and</strong> commissioner<br />

fulfilling the terms of the contract?<br />

yes yes yes yes yes yes Yes<br />

yes yes no no no no No<br />

CDIFF Targets, A&E admissions, Activity<br />

reductions <strong>and</strong> Readmissions reinvestment<br />

are currently all under review<br />

on a weekly basis to ensure acheivement<br />

by the end of the Financial year.<br />

Are there any disputes over the terms of the<br />

contract?<br />

Might the dispute require SHA intervention or<br />

arbitration?<br />

no no no no no no No<br />

no no no no No no No<br />

no<br />

Are the parties already in arbitration? no no no no no no No<br />

no<br />

Have any performance notices been issued? yes yes no no no no No<br />

Sexual health notice was issued in 2011/12<br />

<strong>and</strong> has now been resolved <strong>and</strong> removed.<br />

Have any penalties been applied? no no no no no no No


QUALITY<br />

#REF!<br />

Insert Performance in Month<br />

Criteria<br />

Unit Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12<br />

Septemb<br />

er 12<br />

Comments on Performance in Month<br />

1 SHMI - latest data Ratio 95.6<br />

2<br />

Venous Thromboembolism (VTE)<br />

Screening<br />

% 92 92 90 90 91 91 94 94 93 94 94 95<br />

To improve performance to ensure delivery of this<br />

st<strong>and</strong>ard the following actions have been taken<br />

A review of the pathway for patients who go straight to a<br />

procedure without attending a pre‐admission clinic to<br />

ensure that these patients are swabbed prior to admission.<br />

This pathway will be implemented from October<br />

3a Elective MRSA Screening % no data 71 61 67 81 78 78 78 74 78 79 84<br />

A review of data capture to ensure that all swabs are<br />

matched correctly to admissions – this will be completed in<br />

September<br />

Training of Admissions Team Leader on data accuracy,<br />

which will improve data quality when patients are added to<br />

waiting list <strong>and</strong> thereby improve coverage of data for MRSA<br />

elective screening; this will be completed in September<br />

To improve performance to ensure delivery of this<br />

st<strong>and</strong>ard the following actions have been taken<br />

3b Non Elective MRSA Screening % no data 76 72 71 70 69 69 74 83 77 75 79<br />

• A change of process in emergency day unit (EMDU) to<br />

screen patients who currently do not qualify for screening<br />

has been implemented in September<br />

• Using the ward board rounds to check if patents have<br />

been screened. The Ward Sponsors will work with the<br />

wards to ensure that screening takes place.<br />

• Staff to be reminded to write legibly on test requests to<br />

ensure that the Lab is able to identify which patient the<br />

swabs have come from. This error will be addressed by the<br />

roll out of order communications for Pathology in<br />

December <strong>2012</strong>,<br />

• Review of the data to ensure patients who do not require<br />

screening are excluded from the data this will be<br />

completed in September


4<br />

Single Sex Accommodation<br />

Breaches<br />

Number 39 34 14 17 21 30 30 21 10 12 19 13<br />

These occurred within the High Dependency Unit (9),<br />

Intensive Therapy Unit (3), <strong>and</strong> Coronary Care Unit (1) at<br />

Queen’s Hospital. All of the breaches occurred due to<br />

delays in the transfer out of patients who had been<br />

‘stepped down’ to general care. This was due to constraints<br />

on the availability of suitable beds for ‘step down’ due to<br />

patient flow delays across the organisation. A root cause<br />

analysis on all patients who breach will commence on the<br />

1st October <strong>2012</strong>.The Deputy Director of Nursing during<br />

September r<strong>and</strong>omly spoke to a number of patients who<br />

breached during September <strong>and</strong> they confirmed that the<br />

reason for the breach was explained to them <strong>and</strong> that their<br />

privacy <strong>and</strong> dignity was maintained during this period of<br />

their care.<br />

5<br />

Open Serious Incidents Requiring<br />

Investigation (SIRI)<br />

Number 320 318 274 274 274 270 216 105 91 68 46 35<br />

6 "Never Events" in month Number 0 1 0 0 0 0 0 0 0 0 0 0<br />

7 CQC Conditions or Warning Notices Number 3 3 3 3 2 2 2 2 2 2 2 2<br />

8<br />

Open Central Alert System (CAS)<br />

Alerts<br />

Number 0 0 0 0 0 0 0 0 0 0 0 0<br />

<strong>Trust</strong>‐wide action plan in place that captures all<br />

outst<strong>and</strong>ing CQC requirements that has been<br />

comprehensively shared with the SHA <strong>and</strong> local<br />

Commissioners, is being implemented with <strong>Trust</strong> <strong>Board</strong> <strong>and</strong><br />

is subjected to external monitoring.<br />

9<br />

10<br />

RED rated areas on your maternity<br />

dashboard?<br />

Falls resulting in severe injury or<br />

death<br />

Number 16 13 10 6 7 5 8 10 9 7 5<br />

Number 4 1 1 1 3 3 3 2 8 2 3 0<br />

11 Grade 3 or 4 pressure ulcers Number 12 5 8 11 6 5 5 4 6 5 2 1<br />

one grade 3 pressure ulcer occurred in Sept 12. The trust is<br />

now focussing on reducing the number of grade 2 PU by<br />

50%<br />

12<br />

100% compliance with WHO<br />

surgical checklist<br />

Y/N n y y n y y<br />

13 Formal complaints received Number 85 111 78 121 120 128 101 98 85 100 85 67<br />

14<br />

Agency as a % of Employee Benefit<br />

Expenditure<br />

% 5.3 6.5 4.7 5.3 4.8 4.65<br />

15 Sickness absence rate % 5.46 5.13 6 5.15 5.81 4.41 4.29 4.51 4 4.59 4.68 4.88<br />

16<br />

Consultants which, at their last<br />

appraisal, had fully completed their<br />

previous years PDP<br />

% this data is not collected


<strong>Board</strong> Statements<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

September 12<br />

For each statement, the <strong>Board</strong> is asked to confirm the following:<br />

For CLINICAL QUALITY, that: Response Comments<br />

The <strong>Board</strong> is satisfied that, to the best of its knowledge <strong>and</strong> using its own processes <strong>and</strong> having had regard to the<br />

SHA's Provider Management Regime (supported by Care Quality Commission information, its own information on<br />

1 serious incidents, patterns of complaints, <strong>and</strong> including any further metrics it chooses to adopt), the trust has, <strong>and</strong> will Yes<br />

keep in place, effective arrangements for the purpose of monitoring <strong>and</strong> continually improving the quality of healthcare<br />

provided to its patients.<br />

2<br />

The board is satisfied that plans in place are sufficient to ensure ongoing compliance with the Care Quality<br />

Commission’s registration requirements.<br />

Yes<br />

3<br />

The board is satisfied that processes <strong>and</strong> procedures are in place to ensure all medical practitioners providing care on<br />

behalf of the trust have met the relevant registration <strong>and</strong> revalidation requirements.<br />

Yes<br />

For FINANCE, that: Response Comments<br />

4 The board anticipates that the trust will continue to maintain a financial risk rating of at least 3 over the next 12 months. No<br />

The board is satisfied that the trust shall at all times remain a going concern, as defined by relevant accounting<br />

5 Yes<br />

st<strong>and</strong>ards in force from time to time.<br />

For GOVERNANCE, that: Response Comments<br />

6 The board will ensure that the trust remains at all times compliant with has regard to the NHS Constitution.<br />

Yes<br />

All current key risks have been identified (raised either internally or by external audit <strong>and</strong> assessment bodies) <strong>and</strong><br />

7 Yes<br />

addressed – or there are appropriate action plans in place to address the issues – in a timely manner.<br />

8<br />

The board has considered all likely future risks <strong>and</strong> has reviewed appropriate evidence regarding the level of severity,<br />

likelihood of it occurring <strong>and</strong> the plans for mitigation of these risks.<br />

Yes<br />

The necessary planning, performance management <strong>and</strong> corporate <strong>and</strong> clinical risk management processes <strong>and</strong><br />

9 mitigation plans are in place to deliver the annual operating plan, including that all audit committee recommendations Yes<br />

accepted by the board are implemented satisfactorily.<br />

An Annual Governance Statement is in place, <strong>and</strong> the trust is compliant with the risk management <strong>and</strong> assurance<br />

10 framework requirements that support the Statement pursuant to the most up to date guidance from HM Treasury<br />

Yes<br />

(www.hm-treasury.gov.uk).<br />

The board is satisfied that plans in place are sufficient to ensure ongoing compliance with all existing targets (after the<br />

11 application of thresholds) as set out in the relevant GRR; <strong>and</strong> a commitment to comply with all known targets going No<br />

forwards.<br />

12<br />

The trust has achieved a minimum of Level 2 performance against the requirements of the Information Governance<br />

Toolkit.<br />

No<br />

Details are included in previous on the GRR commentary<br />

Last year 10/45 requirements at level 1<br />

Action plans agreed to ensure level 2 reached for all<br />

st<strong>and</strong>ards<br />

Majority of actions will be complete by Dec 12 although<br />

evidence will not be available for a small number until<br />

Feb 13<br />

The board will ensure that the trust will at all times operate effectively. This includes maintaining its register of interests,<br />

13 ensuring that there are no material conflicts of interest in the board of directors; <strong>and</strong> that all board positions are filled, or Yes<br />

plans are in place to fill any vacancies.<br />

The board is satisfied that all executive <strong>and</strong> non-executive directors have the appropriate qualifications, experience <strong>and</strong><br />

14 skills to discharge their functions effectively, including setting strategy, monitoring <strong>and</strong> managing performance <strong>and</strong> risks, Yes<br />

<strong>and</strong> ensuring management capacity <strong>and</strong> capability.<br />

15<br />

The board is satisfied that: the management team has the capacity, capability <strong>and</strong> experience necessary to deliver the<br />

annual operating plan; <strong>and</strong> the management structure in place is adequate to deliver the annual operating plan.<br />

Yes<br />

Signed on behalf of the <strong>Trust</strong>: Print name Date<br />

CEO Averil Dongworth 18/09/<strong>2012</strong><br />

Chair Sir Peter Dixon 18/09/<strong>2012</strong>


TITLE:<br />

EXECUTIVE SUMMARY<br />

BOARD/GROUP/COMMITTEE:<br />

Workforce Key Performance Indicators<br />

<strong>Trust</strong> <strong>Board</strong> & TEC<br />

1. KEY ISSUES: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

• For the month of September <strong>2012</strong> the overall<br />

number of FTE's in post across the <strong>Trust</strong><br />

decreased by 2.52 FTE's on the August position<br />

but has increased overall by 67.18 FTE's across<br />

the 12 month period.<br />

• The number of starters in month was 53.78<br />

FTE's compared to 47.92 FTE's in the previous<br />

month, September saw an increase in the<br />

number of leavers with 71.42 fte leavers<br />

compared to 57.75 fte's in August. Following a<br />

period of focussed recruitment activity, a total of<br />

582.93 FTE's have started in the <strong>Trust</strong> since<br />

October 11 whilst 556.14 fte's have left.<br />

• Starters & leavers data analysis over the same<br />

period differs from the staff in post growth for the<br />

same 3 reasons as in previous reports.<br />

1. If new starters commence employment or leave<br />

after the payroll cut off date (midmonth) they will not<br />

be entered or removed onto/off ESR until month end<br />

– therefore they will not appear on the staff in post<br />

report generated from ESR until the following month.<br />

2. Staff who increase or decrease their hours will<br />

affect the reported FTE’s in post but not the starters<br />

<strong>and</strong> leavers<br />

3. Timliness of managers completing <strong>and</strong> submitting<br />

the appropriate forms to HR - for entering onto ESR.<br />

• Overall <strong>Trust</strong> Bank & Agency spend decreased<br />

by £32,847 in month. The bank <strong>and</strong> agency<br />

spend continues to account for 11.9% of the pay<br />

bill despite a 2.68% decrease over the 12 month<br />

period. Bank & Agency spend is provided by the<br />

Finance department <strong>and</strong> relates to paid invoices<br />

in month. The YTD figure reported on the<br />

dashboard relates to the rolling 12 month period<br />

spend ( Oct 11 to Sept 12) rather than the fiscal<br />

year measurement which may be reported<br />

elsewhere.<br />

• Overall <strong>Trust</strong> bookings of Bank & Agency<br />

decreased on the August position with a<br />

reduction of 31.65 FTE. The number of agency<br />

bookings decreased by 16.96 FTE's in month -<br />

bank bookings decreased by 14.70 FTE's in the<br />

same period.<br />

1. Midwifery bank <strong>and</strong> agency FTE bookings<br />

decreased in September by 0.14 FTE's on<br />

the August position<br />

2. Registered nursing temporary staff bookings<br />

increased in September by 0.59 FTE's on<br />

the August position.<br />

• For the month of September, <strong>Trust</strong> annualised DATE:<br />

√ TEC October<br />

□ FINANCE ……………<br />

□ EPB ………..…….<br />

□ AUDIT ………..….<br />

□ CLINICAL GOVERNANCE …………..…...……<br />

□ CHARITABLE FUNDS ………………………...…<br />

√ TRUST BOARD <strong>November</strong> <strong>2012</strong><br />

□ REMUNERATION ………………………….…...<br />

□ OTHER ………………………. (please specify)<br />

CATEGORY:<br />

□ NATIONAL TARGET<br />

□ CNST<br />

□ STANDARDS FOR BETTER HEALTH<br />

□ HEALTH & SAFETY<br />

□ ASSURANCE FRAMEWORK<br />

□ TARGET FROM COMMISSIONERS<br />

□ CORPORATE OBJECTIVE …………………..<br />

……………………………………………………..<br />

□ OTHER …………………….. (please specify)<br />

AUTHOR/PRESENTER:<br />

Author – Linda Baker – Head of workforce<br />

Planning<br />

Presenter – Dorothy Hosein – Director of<br />

Transformation<br />

1


turnover increased by 0.34% to 11.57% -<br />

despite the increase this remains 0.43% below<br />

the current average of other large Acute <strong>Trust</strong>s.<br />

• The reported sickness absence rate for the<br />

month of September has decreased slightly by<br />

0.13% on the August position, reducing from<br />

4.68% to 4.55% across the month. The sickness<br />

absence rate has decreased by 0.25% when<br />

compared to the same period last year.<br />

• The pan London benchmarking exercise against<br />

other acute Large London <strong>Trust</strong>s has been<br />

repeated which shows that the combined<br />

average sickness absence rate for this group is<br />

3.59% - as such the graph has been revised to<br />

reflect this. Based upon this revised information<br />

BHRUT's benchmarked position shows us as<br />

currently sitting 0.94% above the 3.59% average<br />

of all other large acute London <strong>Trust</strong>s. The<br />

<strong>Trust</strong>'s target remains at 3.6%<br />

• Part of the increase in reported sickness<br />

absence rates is related to improve recording<br />

through the roll out of electronic systems such as<br />

e-rostering. This has minimised the effort in<br />

recording <strong>and</strong> reporting of all types of staff<br />

absence, including sickness through<br />

managers/supervisors especially in the clinical<br />

areas no longer having to complete <strong>and</strong> submit<br />

weekly absence returns.<br />

• It is acknowledged that key to achieving a<br />

significant reduction in rates is: reviewing &<br />

updating our existing sickness absence policy,<br />

sickness absence management training <strong>and</strong><br />

working with proactively managers to underst<strong>and</strong><br />

the support they require to manage sickness<br />

absence.<br />

• These actions have been initiated <strong>and</strong> additional<br />

schemes such as staff MOT days continue in<br />

order to encourage staff to proactively manage<br />

their own health & wellbeing at work.<br />

• Occupational Health have implemented monthly<br />

case meetings with Directorates to discuss the<br />

management <strong>and</strong> progress of individual cases<br />

• The estimated costs associated with sickness<br />

absence have increased this month. It is<br />

estimated that the cost to the <strong>Trust</strong> for<br />

September was £878,995. This figure has risen<br />

by an estimated £259,997 on the same period<br />

last year despite the sickness rate reducing by<br />

0.25%. The rise in the estimated costs of<br />

sickness absence is attributed to the b<strong>and</strong>ing<br />

<strong>and</strong> roles of those staff taking sick absence<br />

compared to the same period last year, the<br />

higher the b<strong>and</strong> or more senior the role the<br />

higher the associated cost.<br />

• When the number of FTE's lost due to sickness<br />

absence is analysed by reason for absence, the<br />

highest loss remains 'Unknown causes - not<br />

specified' with 39.40 fte lost.<br />

• To counteract this as previously presented to the<br />

<strong>Trust</strong> <strong>Board</strong>, the <strong>Trust</strong> as part of their contract<br />

review <strong>and</strong> renewal process with McKesson<br />

have requested that this reason be removed<br />

from the reporting options. Therefore 'unknown<br />

2


causes/ Not specified' will be removed from the<br />

option list from <strong>November</strong> providing greater<br />

clarity on the reasons for absence allowing for a<br />

review of potential proactive measures to be<br />

taken in reducing sickness absence.<br />

• Compliance to Statutory & M<strong>and</strong>atory training<br />

programmes has been included within the KPI<br />

report for the first time. Currently this information<br />

will continue to be reported to the <strong>Board</strong> on a<br />

quarterly basis, however, a new system, WIRED<br />

which has been successful within other NHS<br />

Organisations for reporting m<strong>and</strong>atory training is<br />

in the process of being commissioned to provide<br />

clear, real time information in regards to<br />

Statutory & M<strong>and</strong>atory training.<br />

2. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

3. ALTERNATIVES CONSIDERED/REASONS FOR REJECTION:<br />

N/A<br />

4. DELIVERABLES:<br />

Continuous measurement <strong>and</strong> monitoring of workforce performance against NHS <strong>and</strong> local agreed<br />

targets<br />

5. EVIDENCE :<br />

ESR data<br />

IView Data<br />

NHSIE data<br />

6. RECOMMENDATION/ACTION REQUIRED:<br />

No action for information only<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE ___________________________<br />

(if applicable)<br />

3


TRUST - WORKFORCE KEY PERFORMANCE INDICATORS - SEPTEMBER <strong>2012</strong><br />

Indicator Target Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 YTD<br />

Staff In Post 5263.48 5313.23 5363.19 5353.99 5355.45 5350.71 5366.64 5366.82 5397.95 5397.08 5392.02 5382.93 5380.41 5368.37<br />

Starters *¹ 70.57 78.23 55.37 31.24 44.46 38.74 58.25 50.44 50.53 29.00 44.97 47.92 53.78 582.93<br />

Leavers *¹ 49.75 38.32 40.87 42.38 39.15 41.19 52.31 46.83 32.93 34.59 58.39 57.75 71.42 556.14<br />

Turnover (Annualised)<br />

*¹<br />

12.0% 10.69% 10.60% 10.70% 10.78% 10.82% 11.0% 10.9% 10.9% 10.9% 10.8% 10.9% 11.2% 11.57%<br />

<strong>Trust</strong> Sickness<br />

Absence % for month<br />

4.5% 4.80 5.46 5.13 6.00 5.15 5.81 4.41 4.29 4.51 4.00 4.59 4.68 4.55<br />

<strong>Trust</strong> Sickness<br />

Absence Rolling 12<br />

Month Period<br />

<strong>Trust</strong> Estimated Cost<br />

of Sickness Absence<br />

(Month)<br />

3.6% 4.49 4.63 4.31 4.77 4.76 4.87 4.92 4.99 5.09 5.00 4.96 4.90 4.88<br />

£618,998 £760,710 £707,395 £903,771 £756,866 £764,730 £594,960 £582,757 £645,566 £511,345 £750,024 £824,139 £878,995 £8,681,258<br />

Appraisals 80.0% 76.03% 76.42% 72.25% 73.74% 77.80% 79.3% 74.3% 77.9% 78.49% 76.40% 72.69% 68.49% 67.96%<br />

Resus 80.0% 69.04% 68.22% 68.26% 72.15% 75.69% 77.8% 78.6% 76.3% 77.86% 77.89% 77.50% 75.09% 75.09%<br />

Paybill Budget £21,393,649 £21,806,873 £22,000,988 £21,907,263 £22,422,582 £22,276,976 £25,028,069 £23,895,905 £23,701,154 £23,492,904 £23,179,203 £25,711,256 £24,350,165 £279,773,338<br />

Paybill £24,012,335 £24,085,519 £24,357,038 £24,267,150 £24,857,841 £24,430,745 £24,518,224 £24,282,126 £24,950,935 £24,441,456 £24,764,208 £24,607,757 £24,508,722 £294,071,722<br />

Bank/Agency Spend £3,259,189 £3,179,473 £3,176,222 £3,079,296 £3,527,427 £3,053,265 £3,584,109 £3,155,363 £3,326,525 £2,988,710 £3,011,923 £2,929,439 £2,896,592 £37,908,344<br />

% Paybill Budget spent<br />

on bank & Agency staff<br />

15.23% 14.58% 14.44% 14.06% 15.73% 13.71% 14.32% 13.20% 14.04% 12.72% 12.99% 11.39% 11.90% 13.55%<br />

Overtime Spend (£) £116,637 £67,772 £65,940 £58,911 £69,768 £70,658 £62,666 £53,941 £61,881 £57,877 £54,076 £56,638 £49,581 £729,709<br />

IHB FTE Bookings 646.05 663.25 661.31 600.15 667.76 672.17 714.77 587.37 586.98 592.32 578.73 565.82 534.17 7424.80<br />

IHB FTE Booked as a<br />

% of Substantive SIP<br />

12.27% 12.48% 12.33% 11.21% 12.47% 12.56% 13.32% 10.94% 10.87% 10.97% 10.73% 10.51% 9.93% 11.53%<br />

*¹ Starters, Leavers & Turnover figures excludes junior doctors on rotation<br />

Financial value in month of February <strong>2012</strong> for Bank/Agency spend has been adjusted by a £353,356 reduction relating to prior period accruals. This has come about from: an improved system between IHB <strong>and</strong> Finance creating a more accurate base<br />

resulting in an downward adjustment of £182,354 for agency; a further reduction to the agency accrual due to writing off of old year agency accruals from the system of £51,186 as part of an aged analysis; <strong>and</strong> as a reduction for ageing to the Bank<br />

Accrual of £119,816.<br />

1


Staff In Post<br />

Starters & Leavers<br />

FTE's<br />

5500.00<br />

5400.00<br />

5300.00<br />

5200.00<br />

5100.00<br />

Sep-11<br />

Oct-11<br />

Nov-11<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Mar-12<br />

Apr-12<br />

Month<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

FTE's<br />

90.00<br />

80.00<br />

70.00<br />

60.00<br />

50.00<br />

40.00<br />

30.00<br />

20.00<br />

10.00<br />

0.00<br />

Sep-11<br />

Oct-11<br />

Nov-11<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Month<br />

Mar-12<br />

Apr-12<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

Staff In Post<br />

Starters *¹ Leavers *¹<br />

Staff in Post ( SIP )<br />

For the month of September <strong>2012</strong> the overall number of FTE's in post across the <strong>Trust</strong> decreased by 2.52 FTE's on the August position but has increased overall by 67.18 FTE's<br />

across the 12 month period.<br />

Starters & leavers<br />

The number of starters in month was 53.78 FTE's compared to 47.92 FTE's in the previous month, September saw an increase in the number of leavers with 71.42 fte leavers<br />

compared to 57.75 fte's in August. Following a period of focussed recruitment activity , a total of 582.93 FTE's have started in the <strong>Trust</strong> since October 11 whilst 556.14 fte's have left<br />

Supported by the HR Advisors, Divisions have been tasked to actively promote Exit interviews so that 'reasons for leaving' can be truly understood.<br />

Starters & leavers data analysis over the same period differs from the staff in post growth for the same 3 reasons as in previous reports.<br />

1. If new starters commence employment or leave after the payroll cut off date (mid month) they will not be entered or removed onto/off ESR until month end – therefore they will not<br />

appear on the staff in post report generated from ESR until the following month. Starters <strong>and</strong> leavers numbers are refreshed each month to capture any late input to ESR.<br />

2. Staff who increase or decrease their hours will affect the reported FTE’s in post but not the starters <strong>and</strong> leavers<br />

3.Timliness of managers completing <strong>and</strong> submitting the appropriate forms to HR - for entering onto ESR.<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


Temporary staff Use <strong>and</strong> Spend<br />

4500000<br />

Bank/Agency Spend ( Provided by Finance)<br />

800<br />

IHB Bookings - FTE<br />

3750000<br />

700<br />

Spend (£'s)<br />

3000000<br />

2250000<br />

1500000<br />

750000<br />

FTE<br />

600<br />

500<br />

400<br />

300<br />

200<br />

100<br />

Agency<br />

Bank<br />

0<br />

Sep-11<br />

Oct-11<br />

Nov-11<br />

Bank/Agency Spend<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Mar-12<br />

Apr-12<br />

Month<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

0<br />

Oct-11<br />

Nov-11<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Mar-12<br />

Date<br />

Apr-12<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

Bank & Agency Spend<br />

Overall <strong>Trust</strong> Bank & Agency spend decreased by £32,847 in month. The bank <strong>and</strong> agency spend continues to account for 11.9% of the pay bill despite a 2.68% decrease over the 12<br />

month period. Data relating to Bank & Agency spend is provided by the Finance department <strong>and</strong> relates to paid invoices in month. The YTD figure reported on the dashboard relates to<br />

the rolling 12 month period spend ( Oct 11 to Sept 12) rather than the fiscal year measurement which may be reported elsewhere.<br />

Bank & Agency Usage<br />

Overall <strong>Trust</strong> bookings of Bank & Agency decreased on the August position with a reduction of 31.65 FTE. The number of agency bookings decreased by 16.96 FTE's in month - bank<br />

bookings decreased by 14.70 FTE's in the same period.<br />

Midwifery bank <strong>and</strong> agency FTE bookings decreased in September by 0.14 FTE's on the August position.<br />

Registered Nursing temporary staff bookings increased in September by 0.59 FTE's on the August position.<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


TURNOVER<br />

Actual Versus Target Annualised Turnover<br />

14.0<br />

Turnover %<br />

12.0<br />

10.0<br />

Turnover<br />

For the month of September, <strong>Trust</strong> annualised turnover increased by 0.34% to<br />

11.57% - despite the increase this remains 0.43% below the current average of<br />

other large Acute <strong>Trust</strong>s.<br />

8.0<br />

Sep-11<br />

Oct-11<br />

Nov-11<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Mar-12<br />

Apr-12<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

Actual Turnover<br />

SICKNESS ABSENCE<br />

Percentage (%)<br />

6.50<br />

6.00<br />

5.50<br />

5.00<br />

4.50<br />

4.00<br />

3.50<br />

3.00<br />

2.50<br />

2.00<br />

1.50<br />

1.00<br />

0.50<br />

0.00<br />

Sep-11<br />

Oct-11<br />

Nov-11<br />

Month<br />

Target Turnover<br />

Real - Time Sickness Absence<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Mar-12<br />

Apr-12<br />

Month<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

Sickness Absence<br />

Reported sickness absence rates for the month of September has decreased<br />

slightly by 0.13% on the August position, reducing from 4.68% to 4.55% across<br />

the month. The sickness absence rate has decreased by 0.25% when<br />

compared to the same period last year. The pan London benchmarking<br />

exercise against other acute Large London <strong>Trust</strong>s has been repeated which<br />

shows that the combined average sickness absence rate for this group is<br />

3.59% - as such the graph has been revised to reflect this. Based upon this<br />

revised information BHRUT's benchmarked position shows us as currently<br />

sitting 0.94% above the 3.59% average of all other large acute London <strong>Trust</strong>s.<br />

The <strong>Trust</strong>'s target remains at 3.6%<br />

Driving down our sickness absence rates is a key focus for the trust for 12/13<br />

Part of the increase in reported sickness absence rates is related to improve<br />

recording through the introduction of electronic systems such as e-rostering.<br />

This has minimised the effort in recording <strong>and</strong> reporting of all types of staff<br />

absence, including sickness through managers/supervisors especially in the<br />

clinical areas no longer having to complete <strong>and</strong> submit weekly absence returns.<br />

It is acknowledged that key to achieving a significant reduction in rates is:<br />

reviewing & updating our existing sickness absence policy, sickness absence<br />

management training <strong>and</strong> working with proactively managers to underst<strong>and</strong> the<br />

support they require to manage sickness absence. These actions have been<br />

initiated <strong>and</strong> additional schemes such as staff MOT days continue in order to<br />

encourage staff to proactively manage their own health & wellbeing at work.<br />

BHRUT Target Other Large Acute London<br />

Occupational Health have implemented monthly case meetings with<br />

Directorates to discuss the management <strong>and</strong> progress of individual cases<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


<strong>Trust</strong> Estimated Cost of Sickness Absence (Month)<br />

£1,000,000<br />

Estimated Cost (£'s)<br />

£900,000<br />

£800,000<br />

£700,000<br />

£600,000<br />

£500,000<br />

£400,000<br />

£300,000<br />

£200,000<br />

Estimated costs of sickness absence<br />

The estimated costs associated with sickness absence has increased this<br />

month. It is estimated that the cost to the <strong>Trust</strong> for September was £878,995.<br />

This figure has risen by an estimated £259,997 on the same period last year<br />

despite the sickness rate reducing by 0.25%. The rise in the estimated costs of<br />

sickness absence is attributed to the b<strong>and</strong>ing <strong>and</strong> roles of those staff taking sick<br />

absence compared to the same period last year, the higher the b<strong>and</strong> or more<br />

senior the role the higher the associated cost.<br />

£100,000<br />

£0<br />

Sep-11<br />

Oct-11<br />

Nov-11<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Mar-12<br />

Apr-12<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

Month<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


FTE Lost due to Sickness Absence by Absence Reason<br />

S10 Anxiety/stress/depression/other psychiatric illnesses<br />

S11 Back Problems<br />

Absence Reason<br />

S12 Other musculoskeletal problems<br />

S13 Cold, Cough, Flu - Influenza<br />

S14 Asthma<br />

S15 Chest & respiratory problems<br />

S16 Headache / migraine<br />

S17 Benign <strong>and</strong> malignant tumours, cancers<br />

S19 Heart, cardiac & circulatory problems<br />

S20 Burns, poisoning, frostbite, hypothermia<br />

S21 Ear, nose, throat (ENT)<br />

S22 Dental <strong>and</strong> oral problems<br />

S23 Eye problems<br />

S24 Endocrine / gl<strong>and</strong>ular problems<br />

S25 Gastrointestinal problems<br />

S26 Genitourinary & gynaecological disorders<br />

S27 Infectious diseases<br />

S28 Injury, fracture<br />

S29 Nervous system disorders<br />

S30 Pregnancy related disorders<br />

S31 Skin disorders<br />

S98 Other known causes - not elsewhere classified<br />

S99 Unknown causes / Not specified<br />

0 5 10 15 20 25 30 35 40 45<br />

FTE Lost<br />

Reasons for Sickness Absence v FTE's<br />

lost<br />

When the number of FTE's lost due to<br />

sickness absence is analysed by reason for<br />

absence, the highest loss remains 'Unknown<br />

causes - not specified' with 39.40 fte lost. HR<br />

acknowledge this creates concern as it<br />

means that staff are not providing their<br />

absence reason or it isn't being recorded by<br />

their manager / supervisor. • To counteract<br />

this as previously presented to the <strong>Trust</strong><br />

<strong>Board</strong>, the <strong>Trust</strong> as part of their contract<br />

review <strong>and</strong> renewal process with McKesson<br />

have requested that this reason be removed<br />

from the reporting options. Therefore<br />

'unknown •causes/ Not specified' will be<br />

removed from the option list from <strong>November</strong><br />

providing greater clarity on the reasons for<br />

absence allowing for a review of potential<br />

proactive measures to be taken in reducing<br />

sickness absence.<br />

In order to further improve the accuracy of<br />

sickness absence reporting <strong>and</strong> recording, HR<br />

have incorporated 'effective recording<br />

processes' in their ' Essential Skills for<br />

Managers ' training programme. The effects<br />

of this training on the actual reported data may<br />

take time to show a demonstrable change.<br />

Directorates must not only ensure that<br />

managers record absence correctly within the<br />

weekly absence returns but also that returns<br />

are submitted in a timely way.<br />

STATUTORY & MANDATORY TRAINING COMPLIANCE<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


The table below provides a quarterly <strong>Trust</strong>-wide perspective of compliance to identified statutory & m<strong>and</strong>atory training programmes for monitoring purposes . This data is run <strong>and</strong><br />

analysed by the workforce information department on a quarterly basis via ESR for the Education <strong>Board</strong>, with the education department providing the commentary to the data (located<br />

on the following page). At the current time due to the method of recording <strong>and</strong> inputting attendance to training data onto ESR analysis by the workforce information team takes 3 days<br />

per course, as such this data can only be provided quarterly. However, a national solution called WIRED will revolutionise recording <strong>and</strong> reporting allowing the <strong>Trust</strong> to increase its<br />

frequency <strong>and</strong> complexity of reporting in the medium term <strong>and</strong> participate in an employee 'passport' scheme where compliance to training requirements moves with the employee as<br />

they change jobs . A Business case is currently being developed with funding identified, for presentation to TEC, in the meanwhile the workforce information <strong>and</strong> education departments<br />

will continue to report to the <strong>Board</strong> quarterly.<br />

Statutory <strong>and</strong> M<strong>and</strong>atatory Training Monitoring as at 30th September <strong>2012</strong><br />

Reporting Period - Compliance Rate<br />

Course Name Frequency 31-Dec-10 28-Feb-11 30-Jun-11 30-Sep-11 31-Dec-11 31-Mar-12 30-Jun-12 30-Sep-12<br />

Conflict Resolution 3 yearly 11.61%<br />

Equality, Diversity & Human Rights 3 yearly 55.92%<br />

Fire Training Annual 52.46% 39.49% 36.33% 28.63% 33.57% 21.63% 35.10% 45.46%<br />

Health & Safety Annual 41.31%<br />

Infection Control Annual 41.61%<br />

Information Governance Annual 37.42% 36.22% 36.92% 37.98% 17.43% 21.45% 21.35% 28.23%<br />

Manual H<strong>and</strong>ling (Loads) 2 yearly 12.77% 18.76% 20.37% 22.77% 33.00% 39.54% 33.53% 38.28%<br />

Manual H<strong>and</strong>ling (People - Refresher) 2 yearly 55.97% 63.50% 68.83% 69.22% 85.12% 73.84% 76.19% 71.16%<br />

Manual H<strong>and</strong>ling (People + Loads) Once 14.23% 46.60% 41.62% 40.90% 40.55% 40.77% 65.95% 63.80%<br />

Resuscitation Yearly 93.32% 89.72% 78.42% 69.04% 72.15% 78.61% 77.89% 75.09%<br />

Safeguarding Adults 3 Yearly 65.84%<br />

Safeguarding Children Level 1 3 yearly 67.86% 62.61% 70.50% 56.61% 67.79% 69.72% 71.15% 71.12%<br />

Safeguarding Children Level 2 3 yearly 32.37% 26.87% 37.50% 10.76% 53.25% 58.29% 30.08% 42.93%<br />

Safeguarding Children Level 3 3 Yearly 54.98% 54.49% 50.97% 34.78% 67.68% 80.82% 72.14% 71.29%<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


The data on the previous page has been presented by training subject, to reflect the Skills for Health National Training Framework. This sets minimum training st<strong>and</strong>ards <strong>and</strong><br />

frequency <strong>and</strong> promotes consistency <strong>and</strong> avoids duplication between organisations. Therefore Conflict Resolution, Equality, Diversity <strong>and</strong> Human Rights are now included.<br />

This format also reflects previous discussion <strong>and</strong> agreement to not report by programme but to report by subject.<br />

Detailed reports for Resuscitation, RN, HCA <strong>and</strong> ODP M<strong>and</strong>atory are still provided.<br />

Subject Matter Experts (SME) are aware of their responsibilities to drive up compliance in their area, this is dependent on them being provided with robust data<br />

Fire <strong>and</strong> Health <strong>and</strong> Safety have now been separated into specific Subject Matter to reflect the national requirements.<br />

Infection Control figures now include the Risk Management St<strong>and</strong>ard (RMS) requirements for H<strong>and</strong> Hygiene training which is now included on <strong>Trust</strong> Induction <strong>and</strong> on<br />

M<strong>and</strong>atory programmes.<br />

Conflict Resolution training has not been regarded as a m<strong>and</strong>atory priority. However in view of the CQC findings this will need to be mapped into the ongoing work on cultural<br />

change which will improve compliance. to complete this successfully there will need to be a resource review.<br />

Did Not Attend (DNA) data is shown on the next page to reflect requirements of internal audit, <strong>and</strong> this is followed up by the SME.<br />

The data demonstrates that release <strong>and</strong> uptake remains the biggest challenge as the amount of places offered for most subjects exceeds the amount required. Low compliance<br />

rates for Information Governance are reflective of the change of frequency from 3yearly to annual. Safeguarding children level 2 uptake saw a drop as nursing staff are now<br />

required to do this <strong>and</strong> not level 1 as was previously the case.<br />

In April <strong>2012</strong> the <strong>Trust</strong> launched new M<strong>and</strong>atory programmes specifically designed to improve compliance for other clinical staff groups <strong>and</strong> for admin <strong>and</strong> clerical staff.<br />

It is anticipated that should the <strong>Board</strong> endorse the proposal to implement the WIRED system, compliance will rise across subjects as data will be timely, transparent, accurate<br />

<strong>and</strong> align to the Training Needs Analysis <strong>and</strong> available to all Managers.<br />

CONFLICT RESOLUTION<br />

HEALTH & SAFETY<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Requiring Training 447 470 472<br />

Number of Staff<br />

Requiring Training 1408<br />

Actual Number Trained 131 135 147 Actual Number Trained 915<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


Places Offered 184 163 196 Places Offered 2051<br />

DNAs 31 30 28 DNAs 173<br />

EQUALITY, DIVERSITY & HUMAN RIGHTS<br />

INFECTION CONTROL<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Requiring Training 469<br />

Number of Staff<br />

Requiring Training 1408<br />

Actual Number Trained 517 Actual Number Trained 908<br />

Places Offered 1316 Places Offered 2051<br />

DNAs 89 DNAs 173<br />

FIRE<br />

INFORMATION GOVERNANCE<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Requiring Training 1408<br />

Number of Staff<br />

Requiring Training 1400 1408 1408<br />

Actual Number Trained 728 Actual Number Trained 286 307 713<br />

Places Offered 728 Places Offered 1550 1912 <strong>2012</strong><br />

DNAs 0 DNAs 25 53 52<br />

MANUAL HANDLING - LOADS<br />

MANUAL HANDLING - PEOPLE & LOADS 1 DAY<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Requiring Training 200 293 317<br />

Number of Staff<br />

Requiring Training 163 92 83<br />

Actual Number Trained 160 182 96 Actual Number Trained 49 67 52<br />

Places Offered 664 852 647 Places Offered 127 185 156<br />

DNAs 44 62 13 DNAs 6 1 6<br />

MANUAL HANDLING - PEOPLE REFRESHER SAFEGUARDING LEVEL 1<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Requiring Training 480 319 327<br />

Number of Staff<br />

Requiring Training 364 214 211<br />

Actual Number Trained 216 381 355 Actual Number Trained 283 393 186<br />

Places Offered 772 775 704 Places Offered 1059 815 950<br />

DNAs 31 8 77 DNAs 38 26 34<br />

RESUS SAFEGUARDING LEVEL 2<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Requiring Training 996 1000 995<br />

Number of Staff<br />

Requiring Training 53 208 207<br />

Actual Number Trained 613 574 895 Actual Number Trained 0 333 366<br />

Places Offered 1661 1791 1711 Places Offered 240 318 923<br />

DNAs 154 186 166 DNAs 11 38 156<br />

SAFEGUARDING ADULTS SAFEGUARDING LEVEL 3<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Number of Staff<br />

Requiring Training 467 469 472<br />

Requiring Training 51 52 51<br />

Actual Number Trained 277 517 831 Actual Number Trained 26 20 19<br />

Places Offered 956 1394 2031 Places Offered 189 318 328<br />

DNAs 31 77 164 DNAs 27 15 28<br />

DIRECTORATE WORKFORCE KPI REPORTS<br />

DIAGNOSTICS & SPECIAL MEDICINE DIRECTORATE -<br />

WORKFORCE KEY PERFORMANCE INDICATORS - SEPTEMBER <strong>2012</strong><br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


Indicator Target Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 YTD<br />

Staff In Post 1094.28 1104.66 1104.97 1104.66 1101.17 1102.35 1102.02<br />

Starters *¹ 9.43 12.66 6.00 10.91 8.43 11.15 58.58<br />

Leavers *¹ 6.12 4.46 12.20 12.00 7.70 10.77 53.25<br />

Turnover (Annualised) *¹ 12.0% 9.1% 8.6% 9.1% 9.1% 9.4% 9.6%<br />

<strong>Trust</strong> Sickness Absence %<br />

for month<br />

3.6% 4.29% 4.51% 4.00% 4.59% 4.68% 4.55%<br />

Directorate Sickness<br />

Absence For Month<br />

Directorate Sickness<br />

Absence Rolling 12 Month<br />

Period<br />

Directorate Estimated Cost<br />

of Sickness Absence<br />

(Month) *²<br />

3.6% 5.11% 5.03% 4.50% 5.36% 5.64% 5.43%<br />

3.6% 5.11% 5.07% 4.88% 5.00% 5.13% 5.18%<br />

£151,450 £162,189 £116,008 £151,225 £164,939 £194,557 £940,368<br />

Appraisals Compliance 80.0% 71.95% 71.96% 69.55% 61.65% 57.28% 61.49%<br />

Resus Compliance 80.0% 77.57% 77.13% 77.83% 78.15% 78.77% 75.09%<br />

Paybill Budget<br />

£4,719,045 £4,655,044 £4,745,751 £4,659,061 £4,669,833 £4,582,046 £28,030,779<br />

Paybill £4,763,991 £4,859,576 £4,799,919 £4,957,346 £4,879,298 £4,778,114 £29,038,245<br />

Bank/Agency Spend £496,296 £517,013 £461,899 £569,332 £562,077 £477,070 £3,083,687<br />

% Paybill Budget spent on<br />

bank & Agency staff<br />

10.52% 11.11% 9.73% 12.22% 12.04% 10.41% 11.00%<br />

Overtime Spend (£) £15,913 £22,366 £21,338 £29,976 £21,885 £16,800 £128,278<br />

IHB FTE Bookings 77.34 75.64 73.15 85.37 83.02 72.12 466.64<br />

IHB FTE Booked as a % of<br />

Substantive SIP<br />

7.07% 6.85% 6.62% 7.73% 7.54% 6.54% 7.06%<br />

*¹ Starters, Leavers & Turnover figures excludes junior doctors on rotation<br />

EMERGENCY, GEN. MEDICINE & NEUROSCIENCES DIRECTORATE -<br />

WORKFORCE KEY PERFORMANCE INDICATORS - SEPTEMBER <strong>2012</strong><br />

Indicator Target Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 YTD<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


Staff In Post 1497.50 1488.89 1537.40 1532.03 1480.44 1481.43 1502.95<br />

Starters *¹ 24.47 16.73 8.40 15.40 20.43 12.80 98.23<br />

Leavers *¹ 17.71 5.00 10.99 19.20 23.27 20.97 97.14<br />

Turnover (Annualised)<br />

*¹<br />

12.0% 12.3% 12.4% 12.6% 12.7% 13.6% 14.2%<br />

<strong>Trust</strong> Sickness<br />

Absence % for month<br />

3.6% 4.29% 4.51% 4.00% 4.59% 4.68% 4.55%<br />

Directorate Sickness<br />

Absence For Month<br />

3.6% 3.71% 3.88% 3.46% 3.58% 3.85% 3.75%<br />

Directorate Sickness<br />

Absence Rolling 12<br />

Month Period<br />

3.6% 3.71% 3.80% 3.68% 3.66% 3.70% 3.71%<br />

Directorate Estimated<br />

Cost of Sickness<br />

Absence (Month) *²<br />

Appraisals<br />

Compliance<br />

£128,632 £143,589 £119,511 £169,367 £202,747 £214,494 £978,340<br />

80.0% 74.07% 75.21% 75.82% 73.91% 68.83% 66.33%<br />

Resus Compliance 80.0% 76.26% 78.64% 79.23% 77.88% 72.52% 73.68%<br />

Paybill Budget<br />

£6,897,802 £6,887,836 £6,900,253 £6,626,925 £7,353,490 £6,655,213 £41,321,519<br />

Paybill £6,945,598 £7,283,477 £7,305,661 £7,090,481 £6,856,072 £6,752,570 £42,233,860<br />

Bank/Agency Spend £1,351,514 £1,514,580 £1,455,228 £1,412,147 £1,171,550 £1,063,376 £7,968,395<br />

% Paybill Budget<br />

spent on bank &<br />

Agency staff<br />

19.59% 21.99% 21.09% 21.31% 15.93% 15.98% 19.28%<br />

Overtime Spend (£) £4,331 £6,229 £6,057 £3,546 £6,139 £5,823 £32,125<br />

IHB FTE Bookings 247.95 261.02 256.04 247.01 224.43 210.39 1446.84<br />

IHB FTE Booked as a<br />

% of Substantive SIP<br />

16.56% 17.53% 16.65% 16.12% 15.16% 14.20% 16.04%<br />

SURGICAL DIRECTORATE - WORKFORCE KEY PERFORMANCE INDICATORS - SEPTEMBER <strong>2012</strong><br />

Indicator Target Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 YTD<br />

Staff In Post 1122.50 1151.10 1094.11 1094.93 1100.01 1099.09 1110.29<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


Starters *¹ 7.00 3.60 5.00 7.43 6.21 7.00 36.24<br />

Leavers *¹ 10.67 7.43 6.20 7.00 7.31 10.61 49.22<br />

Turnover (Annualised)<br />

*¹<br />

12.0% 8.5% 8.9% 8.7% 8.9% 9.3% 10.0%<br />

<strong>Trust</strong> Sickness<br />

Absence % for month<br />

3.6% 4.29% 4.51% 4.00% 4.59% 4.68% 4.55%<br />

Directorate Sickness<br />

Absence For Month<br />

3.6% 3.44% 3.90% 3.65% 4.45% 3.58% 3.98%<br />

Directorate Sickness<br />

Absence Rolling 12<br />

Month Period<br />

3.6% 3.44% 3.67% 3.66% 3.86% 3.80% 3.83%<br />

Directorate Estimated<br />

Cost of Sickness<br />

Absence (Month) *²<br />

£99,908 £120,250 £109,709 £178,309 £151,067 £171,684 £830,927<br />

Appraisals Compliance 80.0% 85.65% 86.14% 83.32% 82.55% 79.02% 77.86%<br />

Resus Compliance 80.0% 76.42% 78.59% 78.65% 77.18% 74.18% 73.87%<br />

Paybill Budget<br />

£5,182,485 £5,288,767 £5,177,341 £5,149,402 £5,857,824 £5,332,322 £31,988,141<br />

Paybill £5,501,762 £5,495,357 £5,380,580 £5,434,785 £5,471,086 £5,497,975 £32,781,545<br />

Bank/Agency Spend £753,584 £655,882 £629,230 £647,069 £659,381 £711,319 £4,056,465<br />

% Paybill Budget spent<br />

on bank & Agency staff<br />

14.54% 12.40% 12.15% 12.57% 11.26% 13.34% 12.68%<br />

Overtime Spend (£) £25,315 £22,791 £20,505 £11,955 £19,845 £17,212 £117,623<br />

IHB FTE Bookings 137.79 112.35 121.92 111.77 116.02 116.41 716.26<br />

IHB FTE Booked as a %<br />

of Substantive SIP<br />

12.28% 9.76% 11.14% 10.21% 10.55% 10.59% 10.75%<br />

*¹ Starters, Leavers & Turnover figures excludes junior doctors on rotation<br />

WOMEN, CHILDREN & SUPPORT SERVICES DIRECTORATE -<br />

WORKFORCE KEY PERFORMANCE INDICATORS - SEPTEMBER <strong>2012</strong><br />

Indicator Target Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 YTD<br />

Staff In Post 1181.94 1180.51 1181.31 1181.78 1171.20 1163.20 1176.66<br />

Starters *¹ 3.40 10.80 7.60 5.01 7.00 6.83 40.64<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


Leavers *¹ 13.33 12.60 5.20 12.59 16.87 12.54 73.13<br />

Turnover (Annualised)<br />

*¹<br />

12.0% 11.4% 11.7% 11.4% 10.9% 11.7% 12.0%<br />

<strong>Trust</strong> Sickness<br />

Absence % for month<br />

3.6% 4.29% 4.51% 4.00% 4.59% 4.68% 4.55%<br />

Directorate Sickness<br />

Absence For Month<br />

3.6% 5.24% 5.57% 4.83% 5.04% 5.41% 5.02%<br />

Directorate Sickness<br />

Absence Rolling 12<br />

Month Period<br />

3.6% 5.24% 5.41% 5.21% 5.17% 5.22% 5.19%<br />

Directorate Estimated<br />

Cost of Sickness<br />

Absence (Month) *²<br />

£140,926 £149,545 £125,186 £183,603 £206,326 £193,995 £999,581<br />

Appraisals Compliance 80.0% 85.03% 86.20% 82.43% 77.28% 75.18% 72.89%<br />

Resus Compliance 80.0% 76.40% 77.79% 76.66% 78.35% 79.04% 78.43%<br />

Paybill Budget<br />

£4,559,907 £4,562,188 £4,567,601 £4,542,598 £4,537,970 £4,600,939 £27,371,203<br />

Paybill £4,627,315 £4,640,770 £4,569,944 £4,597,102 £4,585,629 £4,576,345 £27,597,106<br />

Bank/Agency Spend £444,148 £422,884 £420,487 £385,261 £401,752 £423,014 £2,497,546<br />

% Paybill Budget spent<br />

on bank & Agency staff<br />

9.74% 9.27% 9.21% 8.48% 8.85% 9.19% 9.12%<br />

Overtime Spend (£) £2,542 £3,422 £3,818 £2,275 £2,864 £2,266 £17,187<br />

IHB FTE Bookings 103.68 108.89 110.33 98.74 101.42 100.52 623.58<br />

IHB FTE Booked as a %<br />

of Substantive SIP<br />

8.77% 9.22% 9.34% 8.36% 8.66% 8.64% 8.83%<br />

*¹ Starters, Leavers & Turnover figures excludes junior doctors on rotation<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


EXECUTIVE SUMMARY<br />

TITLE:<br />

COST IMPROVEMENT UPDATE<br />

BOARD/GROUP/COMMITTEE:<br />

TRUST BOARD<br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

TO UPDATE THE TRUST BOARD ON PROGRESS AND<br />

CURRENT STATUS OF THE COST IMPROVEMENT<br />

PROGRAMME – MONTH 6 (SEPT <strong>2012</strong>)<br />

□ TEC ……………..….. □ STRATEGY……….….…….<br />

□ FINANCE ……..……… □ AUDIT ………….……..….<br />

□ QUALITY & SAFETY …………..………….....……<br />

□ WORKFORCE<br />

□ CHARITABLE FUNDS ………………………………...…<br />

X TRUST BOARD ……………………………….………….<br />

□ REMUNERATION ………………………………….…...<br />

□ OTHER …………………………..……. (please specify)<br />

2. DECISION REQUIRED: CATEGORY:<br />

TO NOTE PROGRESS, RISKS AND MITIGATIONS<br />

□ NATIONAL TARGET □ CNST<br />

□ CQC REGISTRATION □ HEALTH & SAFETY<br />

□ ASSURANCE FRAMEWORK<br />

X CQUIN/TARGET FROM COMMISSIONERS<br />

□ CORPORATE OBJECTIVE ……………………………....<br />

□ OTHER …………………….. (please specify)<br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

AUTHOR/PRESENTER: Dorothy Hosein<br />

DATE: 29/10/<strong>2012</strong><br />

The CIP position shows year to date delivery of £4.3m against a period target of £6.5m. This is a shortfall of £2.2m.<br />

The forecast delivery is £17.7m of which £8.4m is considered to be at high risk, this is however <strong>and</strong> improvement on the<br />

£6.2m of high risk schemes reported at Month 5 (August <strong>2012</strong>)<br />

4. DELIVERABLES<br />

5. KEY PERFORMANCE INDICATORS<br />

Cost Improvement Tracker<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________


Cost Improvement Programme Update September <strong>2012</strong><br />

Summary<br />

The CIP position shows year to date delivery of £4.3m against a target for the period of<br />

£6.5m, a shortfall of £2.2m. The forecast delivery is £17.7m of which £4.8m is<br />

considered to be at high risk as compared to £6.2m of schemes identified in Month 6;<br />

CIP mitigation plans to achieve the £17.7m forecast are now as follows:<br />

Blue Green Amber Red Total<br />

£000 £000 £000 £000 £000<br />

Draft Forecast Outturn Workstream 7,090 2,270 2,190 2,998 14,548<br />

Add/(Deduct):<br />

Repatriation JAK 2 tests ‐ Path; Non recurrent Diagnostics 10 10<br />

Further opportunities identified post ‐ M6 Diagnostics 66 66<br />

Medicines Management ‐ various Medicines Management ‐121 182 166 227<br />

Lucentis ‐ pass back 65% of income to commissioners Medicines Management ‐152 ‐152<br />

VAT on Utilities ‐ b/f start by 1 month to December Estates 30 30<br />

Rates assessment Estates 100 100<br />

Emergency Care Non‐pay 24 100 124<br />

Outpatients ‐ 140k deducted in Tracker; replaced by Outpatients 36 300 16 352<br />

Outpatients ‐ FURTHER POSTS Outpatients 37 37<br />

Theatres ‐ ITU skill mix Theatres 62 62<br />

AHP's Workforce ‐ AHP ‐26 100 74<br />

Neurosciences Workforce ‐ Medical 16 94 20 130<br />

Nursing ‐ Bed & Site team Workforce ‐nursing 8 8<br />

Annual Leave accrual Corporate 750 750<br />

Medicines Management Medicines Management 400 400<br />

Stroke Consultant release 5 PA's Workforce ‐ Medical 20 20<br />

Medical locums ‐ VAT Corporate 600 600<br />

Other ‐ Salary sacrifice (Car parking), Pharmacy VAT Corporate 66 ‐49 297 314<br />

Final M6 Forecast Outturn 7,090 2,365 3,453 4,792 17,700<br />

Key areas to focus to maximise run rate <strong>and</strong> in year delivery <strong>and</strong> turn red schemes<br />

green:<br />

• Continue to implement mechanisms for monitoring, <strong>and</strong> challenging budget<br />

holders against agreed plans<br />

• Provide strong project management <strong>and</strong> delivery support to Directorates <strong>and</strong><br />

Work streams<br />

• Validate Bank <strong>and</strong> Agency reductions as real cost containment, supporting the<br />

achievements of the control total<br />

• Ensure rapid escalation of risks <strong>and</strong> issues relating to CIP delivery.<br />

• Embed recently developed Executive SRO roles<br />

1


Month 6 CIP Performance<br />

Workstream progress<br />

Admin& Clerical: Approximately 30% of the A&C workforce spend relates to bank <strong>and</strong><br />

agency. There has been an improvement of £<br />

Medical Efficiency: The Job planning process has commenced with CDs arranging<br />

formal meetings with Consultants <strong>and</strong> Managers. Completion of 1st level sign off<br />

<strong>November</strong> <strong>2012</strong> with final JPA sign off December <strong>2012</strong>. Directorates agreeing bank <strong>and</strong><br />

agency spend in line with budgets. Benchmarking with pan-London Bank rates being<br />

undertaken.<br />

Allied Health Professionals: There is a cost pressure of circa £300k relating to length<br />

of Stay. On-call payment analysis is underway. Further investigation of opportunities for<br />

CIPs in pharmacy production.<br />

Workforce Reduction: In terms of established vacancies throughout the <strong>Trust</strong>, a<br />

reduction of 30 vacancies has attracted savings. A further 14 vacancies identified <strong>and</strong><br />

associated savings are anticipated by December <strong>2012</strong>. The Head of Workforce<br />

Transformation has established a project plan for further potential vacancies where<br />

savings are anticipated at the end of this financial year. Agreement was reached at the<br />

Transformation <strong>Board</strong> to take forward a 3 year pay protection policy to the Joint Staff<br />

Committee for ratification. PAUL<br />

Beds & Length of Stay – Bed Reduction: A further saving of equivalent costs for 30<br />

beds in year is required to achieve the CIP. Plans are currently being worked up with<br />

options to provide ‘winter’ contingency beds.<br />

2


Diagnostics – Introduction of ‘Hot’ Reporting of CT & MRI Scans: To support the<br />

A&E four hour target <strong>and</strong> to ensure maximum efficient use of <strong>Trust</strong> ward beds ‘hot’<br />

reporting on a five day week with a view to extend to seven day week has commenced.<br />

Continued progress is being monitored. Additional schemes are under review.<br />

Diagnostics - Interventional Radiology (non clinical): To date a review of current<br />

activity is being undertaken by Radiology <strong>and</strong> will be completed in three main phases;<br />

1. A review of recorded <strong>and</strong> reported activity with cross referencing to income,<br />

audit data <strong>and</strong> PAS/RIS information<br />

2. A cross referencing of this analysis with the current Contractual (Device)<br />

exclusions<br />

3. A cross referencing with Procurement colleagues to assess cost saving<br />

opportunities.<br />

This work is in progress. Data from the <strong>Trust</strong> Information department has now been<br />

received <strong>and</strong> analysis has commenced.<br />

Outpatients - Reduction in DNA <strong>and</strong> Cancellations: Key metrics have been<br />

developed <strong>and</strong> are being monitored <strong>and</strong> action taken as required with the General<br />

Managers. All specialties have developed action plans to reduce the need for additional<br />

activity <strong>and</strong> capacity, <strong>and</strong> ensure that efficient use of resources is optimised.<br />

Outpatients – e.Choose <strong>and</strong> Book <strong>and</strong> administration: Efficiency <strong>and</strong> Clinical<br />

governance assurance has now been achieved with E Choose & Book now compliant<br />

(71%). Turnaround times for referral validation have reduced further. The review of PAS<br />

clinic letter volumes reducing from 7000 to 900.<br />

Outpatients – Dem<strong>and</strong> & Capacity: Action plan for the delivery of a reduction in New to<br />

Follow Up attendances is now at the implementation stage. All specialities have<br />

developed action plans to reduce the need for additional activity <strong>and</strong> capacity.<br />

Outpatients – Printing & Postage Services (non-clinical): Work is about to<br />

commence on the outsourcing of printing <strong>and</strong> postage services <strong>and</strong> resultant potential<br />

savings. Implementation is likely to commence in Q4.<br />

Theatres – Theatre Utilisation: Theatre utilisation has been reviewed to encompass<br />

start times <strong>and</strong> rescheduling of theatre lists. Workstream programmes have been ratified.<br />

Audits are underway which have <strong>and</strong> will inform the work programme for the next month.<br />

Theatre – Consumables (non-clinical): Procurement analysis on key consumables<br />

have been completed outcomes to be implemented.<br />

Facilities & Estates: Work is on going to identify new opportunities.<br />

Medicine Management – Drugs: Full uptake of homecare services has taken place.<br />

PbR exclusion drug reimbursement <strong>and</strong> the reduction in FP10 issues still to be<br />

addressed.<br />

3


Governance<br />

The Cost Improvement Programme Governance Framework has now been ratified by<br />

The Transformation <strong>Board</strong> (October <strong>2012</strong>). A specific change to the framework is the<br />

inclusion of the Executive Workstream Sponsor who will provide executive level<br />

oversight, support <strong>and</strong> direction to the individual CIP workstream, ensuring an<br />

appropriate escalation route for risks <strong>and</strong> non delivery of schemes.<br />

Weekly Workstream Accountability meetings are held to ensure the ongoing delivery <strong>and</strong><br />

progress of existing directorate schemes. Identified Executive SROs are identified below.<br />

Quality Assurance<br />

A Clinical Quality assurance panel has been set up <strong>and</strong> has reviewed the process <strong>and</strong><br />

documentation to assess <strong>and</strong> monitor the risks associated with each work stream within<br />

the Cost Improvement Programme. The group is chaired by Dr Maureen Dalziel the Non<br />

Executive Director <strong>and</strong> supported by a number of executive <strong>and</strong> clinical staff.<br />

The framework includes impact assessments on clinical outcomes, safety <strong>and</strong> patient<br />

experience in addition to parameters measured by the Quality <strong>and</strong> Safety board. The<br />

Quality Assurance panel meets monthly <strong>and</strong> will provide assurance to both the<br />

Transformation <strong>and</strong> Quality <strong>and</strong> Safety <strong>Board</strong>s. Focused work using this framework is<br />

now taking place to carry out quality impact assessments on any schemes previously<br />

assessed as high or moderate risk.<br />

4


CIP Project Governance – Approval Flowchart<br />

New CIP scheme generated<br />

Work stream steering group<br />

Operational/ directorate<br />

Agree work stream<br />

Complete a Quality Impact Assessment<br />

Directorates add to their risk register<br />

Director/ divisional<br />

review meetings<br />

All schemes‐<br />

Complete a Risk Assessment<br />

CD review of risk assessment<br />

Does the risk assessment contain any<br />

Moderate (M) or High (H) risks after mitigation?<br />

CIP delivery ( as per tracker)<br />

Clinical risk assessment<br />

Blue Green Amber Red<br />

1 2 3 4<br />

Low 1 1 2 3 4<br />

Medium 2 2 4 6 8<br />

High 3 3 6 9 12<br />

PMO add to CIP risk register<br />

Service<br />

Transformation<br />

Office<br />

Complete a Project M<strong>and</strong>ate<br />

for schemes over £50,000<br />

Transformation<br />

<strong>Board</strong><br />

(Monthly)<br />

Ongoing monitoring of operational <strong>and</strong> clinical indictors via directorates dash boards<br />

Patient satisfaction, Length of stay<br />

HCAI’s, Hospital readmission rates, Staff satisfaction<br />

Clinical Quality Assurance<br />

Panel (Monthly)<br />

Quality <strong>and</strong> Safety<br />

<strong>Board</strong> (Bi‐monthly)<br />

Version 3- JM 19/10/12<br />

Status to be tracked in both CIP <strong>and</strong> departmental risk register <strong>and</strong> the Q&S board<br />

5


1<br />

REPORT TO:<br />

REPORT FROM:<br />

<strong>Trust</strong> <strong>Board</strong><br />

Chief Executive<br />

DATE: 11 October <strong>2012</strong><br />

SUBJECT:<br />

FOR:<br />

CHAIRMAN & CHIEF EXECUTIVE’S REPORT<br />

Information<br />

______________________________________________________________<br />

1. INTRODUCTION<br />

This report contains a summary of:<br />

• Actions taken under emergency powers<br />

• Executive decisions<br />

• National Issues/News<br />

• Local Issues/News<br />

2. RECOMMENDATION<br />

The <strong>Board</strong> is asked to note this report.<br />

3. ACTIONS TAKEN UNDER EMERGENCY POWERS<br />

No actions have been taken by the Chairman, or Chief Executive acting under<br />

emergency powers.<br />

4. EXECUTIVE DECISIONS<br />

The <strong>Trust</strong> Executive Committee has been meeting on a monthly basis <strong>and</strong> have<br />

reviewed <strong>and</strong> inputted into several reports prior to their submission to the <strong>Trust</strong><br />

<strong>Board</strong>, such as the <strong>Board</strong> Assurance Framework, Information Governance<br />

Strategy <strong>2012</strong>/13, Complaints Annual Report 2011/12 <strong>and</strong> the Single Operating<br />

Model. .<br />

1.<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


2<br />

NATIONAL ISSUES/NEWS:<br />

New health ministerial team:<br />

Jeremy Hunt has been appointed Secretary of State for Health following the<br />

Government’s reshuffle. He is MP for South West Surrey <strong>and</strong> was previously<br />

Secretary of State for Culture, Olympics, Media <strong>and</strong> Sport. His team consists of<br />

three new health ministers, joining Lord Howe who remains as Health Minister in<br />

the Lords. They are Norman Lamb, Minister of State, Dr Daniel Poulter,<br />

Parliamentary Under Secretary of State <strong>and</strong> Anna Soubry, also Parliamentary<br />

Under Secretary of State.<br />

For further information, go to: http://www.dh.gov.uk/health/aboutus/people/ministers<br />

Fund will boost digital innovation:<br />

The Department has announced that local NHS organisations could now be<br />

awarded funding to develop new digital services that improve patient care <strong>and</strong><br />

can be used to share information more easily across the NHS. Funded projects<br />

are expected to lead to a successful deployment <strong>and</strong> use, in an NHS<br />

environment, of solutions based on the NHS Interoperability Toolkit.<br />

For further information, go to:<br />

http://www.connectingforhealth.nhs.uk/systems<strong>and</strong>services/interop<br />

Join the conversation on how to strengthen the NHS Constitution:<br />

The NHS Future Forum, which is advising the Government on how the NHS<br />

Constitution might be strengthened, is talking about what the NHS Constitution<br />

means to them <strong>and</strong> is keen to hear your views. On a newly-launched blog,<br />

members of the NHS Future Forum will explain what the NHS Constitution<br />

means to them <strong>and</strong> discuss ways of strengthening it.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/09/constitutionblog<br />

Cancer drugs fund – National Cancer Action Team bulletin:<br />

The National Cancer Action Team has published a bulletin providing an update<br />

on drugs that were funded through the cancer drugs fund (CDF) in 2011/12,<br />

highlighting the current systems <strong>and</strong> processes in place <strong>and</strong> focusing on the work<br />

that is underway for the second <strong>and</strong> third year of the fund’s operation.<br />

Link:<br />

http://ncat.nhs.uk/sites/default/files/uploaded/CDF%20National%20Bulletin%20S<br />

ummer%20<strong>2012</strong>.pdf<br />

The Foundation <strong>Trust</strong> Non-Executive role - meeting the challenges:<br />

On 15 <strong>November</strong> <strong>2012</strong>, Monitor, in partnership with the King’s Fund, is holding a<br />

one-day conference in London to support FT Non-Executive Directors. It will<br />

provide a forum for learning, discussion <strong>and</strong> debate on how Non-Executives can<br />

best meet specific challenges facing Foundation <strong>Trust</strong>s <strong>and</strong> those of the<br />

changing health l<strong>and</strong>scape, including regulation.<br />

Link: http://www.kingsfund.org.uk/events/ft_nonexecutive_rol.html#tab_2<br />

Preventing suicide in Engl<strong>and</strong> – a cross-government outcomes strategy:<br />

A new suicide prevention strategy has been launched, with the objectives of<br />

reducing the suicide rate <strong>and</strong> providing better support for those bereaved, or<br />

affected by suicide. Much of the work to prevent suicides is carried out locally<br />

<strong>and</strong> the strategy outlines evidence-based approaches to inform this work. NHS<br />

<strong>and</strong> Local Authority Chief Executives will consider the strategy in preparing joint<br />

strategic needs assessments <strong>and</strong> joint health <strong>and</strong> wellbeing strategies.<br />

For further information, go to: www.dh.gov.uk/health/<strong>2012</strong>/09/suicide-prevention<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


3<br />

Preparations for winter planning <strong>and</strong> reporting:<br />

A letter from David Flory, Deputy NHS Chief Executive <strong>and</strong> Shaun Gallagher,<br />

Acting Director General, Social Care, Local Government <strong>and</strong> Care Partnerships,<br />

sets out preparations for winter planning <strong>and</strong> reporting, which will run from 6<br />

<strong>November</strong> <strong>2012</strong> to the end of February 2013. SHA Cluster Chief Executives<br />

have been asked to ensure preparations are in place <strong>and</strong> encourage local NHS<br />

organisations to review local winter plans <strong>and</strong> observe the timetable for daily<br />

SITREP reporting.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/09/winterreporting-<strong>2012</strong>-13<br />

Commissioning specialised services nationally – new proposals:<br />

The Clinical Advisory Group for prescribed services (CAG) has made<br />

recommendations about which specialised services for people with rare<br />

conditions should be commissioned in Engl<strong>and</strong>. The services listed on its latest<br />

report will be commissioned by the NHS Commissioning <strong>Board</strong> from April 2013,<br />

rather than by Clinical Commissioning Groups. The list will be agreed by<br />

Ministers <strong>and</strong> the Commissioning <strong>Board</strong> in the Autumn.<br />

For further information, go to: http://www.dg.gov.uk/health/<strong>2012</strong>/09/cagreport<br />

New National Equalities Lead for NHS:<br />

The NHS Commissioning <strong>Board</strong> Authority has appointed Paula Vasco-Knight as<br />

National Equality Lead. Reporting to Jim Easton, National Director<br />

Transformation, Paula will lead the equalities work at the <strong>Board</strong>, whilst continuing<br />

her full time role as CEO at the South Devon Healthcare NHS Foundation <strong>Trust</strong><br />

<strong>and</strong> Senior Responsible Officer for the equality delivery system.<br />

Link: http://www.commissioningboard.nhs.uk/<strong>2012</strong>/09/07/national-equalities-leadappointed-to-the-nhs-commissioning-board<br />

Safeguarding children <strong>and</strong> adults in the future NHS – interim advice:<br />

The NHS Commissioning <strong>Board</strong> Authority has published interim advice on<br />

arrangements to secure children’s <strong>and</strong> adult safeguarding, which provides<br />

additional information, in particular to emerging Clinical Commissioning Groups.<br />

A covering letter from Jane Cummings, Chief Nursing Officer, <strong>and</strong> Shaun<br />

Gallagher, Acting Director General, Social Care, Local Government <strong>and</strong> Care<br />

Partnerships, reminds PCTs <strong>and</strong> SHAs of the vital importance of maintaining<br />

appropriate arrangements, as the health system goes through transition.<br />

Link: http://www.commissioningboard.nhs.uk/<strong>2012</strong>/09/12/safeguarding<br />

Publication of organisation patient safety incident data:<br />

The NHS Commissioning <strong>Board</strong> Authority has released the latest organisation<br />

patient safety incident data. High levels of incident reporting provide an<br />

indication of an increased safety culture within the organisation.<br />

Link: http://www.nrls.npsa.nhs.uk/patient-safety-data/organisation-patient-safetyincident-reports<br />

Doctors urged to encourage staff immunisation against flu:<br />

In an open letter to Doctors, Professor Dame Sally Davies, the Chief Medical<br />

Officer <strong>and</strong> Dr Mark Porter, Chair of Council at the British Medical Association,<br />

have stressed the vital role that Doctors can play in ensuring that as many<br />

frontline staff are vaccinated against flu as possible. The letter also includes<br />

supporting evidence on the importance of the influenza vaccine. NHS<br />

organisations are urged to use this letter locally to encourage Doctors to have<br />

their flu jabs.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/09/get-flu-jab<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


4<br />

Nurses <strong>and</strong> midwives have vital role in flu vaccination:<br />

In an open letter to nurses <strong>and</strong> midwives, Professor Viv Bennett, Director of<br />

Nursing, Department of Health, <strong>and</strong> the Government’s principal advisor on public<br />

health nursing, has stressed the vital role that nurses <strong>and</strong> midwives play in<br />

making sure frontline staff are vaccinated against flu <strong>and</strong> patients are protected.<br />

This drive is supported by the Royal College of Nursing (RCN) <strong>and</strong> the Royal<br />

College of Midwives (RCM).<br />

Frontline healthcare workers are more likely to be exposed to the influenza virus,<br />

particularly during winter months, when some of the people in their care will be<br />

infected. It has been estimated that up to 1 in 4 healthcare workers may catch<br />

flu during a mild influenza season, a much higher incidence than expected in the<br />

general population.<br />

For further information, go to:<br />

http://www.nhsemployers,org/HealthyWorkplaces/SeasonalFluCampaign/Latestnews/pages/DepatmentOfHealthIssueLetterToNursesAndMidwivesFluVaccinatio<br />

n.aspx<br />

Hospital patients need high quality food <strong>and</strong> drink:<br />

Principles outlining what patients should expect from hospital food were<br />

announced recently by Health Secretary, Jeremy Hunt. These include the<br />

provision of high quality <strong>and</strong> healthy hospital food <strong>and</strong> drink, <strong>and</strong> patients being<br />

given a choice from a varied menu. A particular focus will be on the most<br />

vulnerable, such as older people, which is a top priority for the Secretary of State.<br />

These principles will be a feature of new patient-led assessments covering areas<br />

such as hospital food, cleanliness, privacy <strong>and</strong> dignity.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/10/hospital-food<br />

Equality duty to make reasonable adjustments:<br />

Although the duty to make reasonable adjustments for disabled service users is<br />

not new, the Department of Health wants to make sure all service providers are<br />

aware of their responsibilities. Where a provider does not comply with the duty<br />

to make reasonable adjustments in the provision of services of a public nature, it<br />

will be committing an act of unlawful discrimination. Further guidance is<br />

available in chapter 7 of the Equality <strong>and</strong> Human Rights Commission’s Statutory<br />

Code of Practice for Services, Public Functions <strong>and</strong> Associations.<br />

Link: http://www.equalityhumanrights.com/uploaded_files/EqualityAct/services<br />

code.pdf<br />

NHS Leadership Recognition Awards <strong>2012</strong> finalists:<br />

The NHS Leadership Academy’s short-listed finalists for these awards represent<br />

outst<strong>and</strong>ing leadership across nine categories <strong>and</strong> exemplify the quality,<br />

dedication <strong>and</strong> innovation of staff working in the system today. The winners will<br />

be announced at the awards ceremony at Barts Great Hall on 10 December<br />

<strong>2012</strong>.<br />

Link: http://www.nhsleadershipawards.nhs.uk/about-the-awards/awards-<br />

<strong>2012</strong>.aspx<br />

Managing nursing performance <strong>and</strong> supporting nurses in difficulty:<br />

With an opening presentation from Professor Juliet Beal, Director of Nursing<br />

Quality, Improvement <strong>and</strong> Care at the NHS Commissioning <strong>Board</strong> Authority, this<br />

Conference in London on 6 December <strong>2012</strong> is for all nurse managers <strong>and</strong><br />

leaders. It offers practical guidance for managing nursing performance <strong>and</strong><br />

supporting nurses in difficulty to ensure safe, high quality patient care.<br />

Link: http://www.healthcareconferencesuk.co.uk/managing-poor-performancesupporting-nurses<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


5<br />

Preparing the Payment by Results package for <strong>2012</strong>/13:<br />

A letter from David Flory updates the NHS on work to prepare the payment by<br />

results (PbR) package for <strong>2012</strong>/13 <strong>and</strong> outlines a provisional timetable for the<br />

rest of the process. NHS Chief Executives will discuss planning for the road test<br />

of the PbR package with relevant colleagues <strong>and</strong> subsequent implementation<br />

from 1 April 2013.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/09/pbr-<strong>2012</strong>-14<br />

Views sought on vision for nursing:<br />

A proposed new vision for nursing, midwifery <strong>and</strong> care given sets out the values<br />

of compassionate care <strong>and</strong> asks how they can be developed further across<br />

health <strong>and</strong> social care. Over recent months, Viv Bennett, Director of Nursing,<br />

Department of Health <strong>and</strong> Jane Cummings, Chief Nursing Officer for Engl<strong>and</strong>,<br />

have been talking to care givers across the Country to start to develop what the<br />

new vision looks like <strong>and</strong> what values unite the profession. They now want to<br />

hear your views on the ideas contained in the draft vision.<br />

For more information, go to: www.dh.gov.uk/health/<strong>2012</strong>/09/views-vision-nursing<br />

Equality, diversity <strong>and</strong> inclusion in the NHS <strong>Board</strong> recruitment process:<br />

Two guides have been developed to build equality, diversity <strong>and</strong> inclusion into<br />

the NHS <strong>Board</strong> recruitment process for both Executives <strong>and</strong> Non-Executives.<br />

These practical resources help ensure selection panels <strong>and</strong> appointed board<br />

members demonstrate confidence, commitment <strong>and</strong> competency in these areas<br />

<strong>and</strong> are able to apply these to core board level business.<br />

Link: www.leadershipacademy.nhs.uk/board-recruitment-guides<br />

NICE Fellowships:<br />

Chief Executives <strong>and</strong> other senior professionals can now apply for Fellowships<br />

provided by NICE. These are unique opportunities to engage in the Institute’s<br />

work more strategically, participate in high level discussions <strong>and</strong> support NICE in<br />

the implementation of its guidance. Appointments start in April 2013 <strong>and</strong> run for<br />

three years.<br />

Link: www.nice.org.uk/fellows<strong>and</strong>scholars<br />

Healthwatch Engl<strong>and</strong> launched:<br />

Healthwatch Engl<strong>and</strong>, the new independent consumer champion for health <strong>and</strong><br />

social care in Engl<strong>and</strong>, has been launched. A key milestone in achieving the<br />

Government’s vision set out in the White paper ‘Equity <strong>and</strong> Excellence:<br />

Liberating the NHS’, Healthwatch Engl<strong>and</strong>’s role is to give a national voice to the<br />

key issues affecting people who use health <strong>and</strong> care services.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/10/healthwatchengl<strong>and</strong>-launched<br />

NHS friends <strong>and</strong> family test – National implementation guidance:<br />

This guidance is now available <strong>and</strong> aims to support those who will be<br />

implementing this work, initially providers of NHS funded acute services for<br />

inpatients, <strong>and</strong> patients discharged from A&E, from April 2013.<br />

Link: http://www.dh.gov.uk/health/<strong>2012</strong>/10/guidance-nhs-fft<br />

Information flows <strong>and</strong> personal information in the new commissioning<br />

l<strong>and</strong>scape:<br />

Robust information governance enables us to safeguard the privacy <strong>and</strong><br />

confidentiality of personal confidential information. In the new commissioning<br />

environment, information governance remains vitally important. Liability for<br />

information governance rests with the legal entity responsible for the processing<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


6<br />

of data, even where this is contracted out, <strong>and</strong> organisations need to ensure they<br />

comply with their legal obligations.<br />

Link: http://www.nigb.nhs.uk/igplgflows<br />

Consensus statement supporting the Liverpool Care Pathway:<br />

Over 200 organisations have signed a consensus statement in support of the<br />

Liverpool Care Pathway for the dying patient, including professional bodies, third<br />

sector organisations, disease specific charities <strong>and</strong> organisations representing<br />

care homes, hospices, social services <strong>and</strong> palliative care specialists.<br />

Link: http://www.endoflifecareforadults.nhs.uk/tools/core-tools/liverpool-carepathway<br />

Radiotherapy treatment to be rolled out across the NHS:<br />

Almost 8,000 more cancer patients a year could benefit from the roll-out of an<br />

advanced radiotherapy technique with fewer side effects, thanks to a £15m<br />

investment announced by the Department of Health. The Cancer Radiotherapy<br />

Innovation Fund will exp<strong>and</strong> NHS capacity to deliver life-saving advanced<br />

radiotherapy techniques by April 2013. The money will be used to speed up the<br />

use of Intensity Modulated Radiotherapy (IMRT) building on the success of the<br />

Cancer Drugs Fund, which has already benefited over 21,000 patients. The<br />

£15m Radiotherapy Innovation Fund will cover the remainder of <strong>2012</strong>/13.<br />

For further information, go to: http://mediacentre.dh.gov.uk/<strong>2012</strong>/10/08/eightthous<strong>and</strong>-patients-to-benefit-from-advanced-cancer-treatment<br />

The Quarter shows continued strong NHS Performance:<br />

David Flory’s quarterly report for Quarter 1 (April to June) <strong>2012</strong>/13, published<br />

recently, provides a summary of the NHS financial position <strong>and</strong> performance<br />

against National priorities set out in the NHS Operating Framework <strong>2012</strong>/13. It<br />

shows the NHS has continued to perform strongly against key performance<br />

measures in the first quarter of this important year for the NHS. The NHS also<br />

continues to make progress with system transformation <strong>and</strong> the financial savings<br />

required to deliver the quality, innovation, productivity <strong>and</strong> prevention (QIPP) <strong>and</strong><br />

reform challenge.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/10/quarter-1-<br />

<strong>2012</strong>-13<br />

Medical revalidation of doctors to start in December:<br />

Medical revalidation, the process by which all doctors who are licensed with<br />

the General Medical Council (GMC) regularly demonstrate they are up-todate<br />

<strong>and</strong> fit to practice, will start in December <strong>2012</strong>.<br />

The new system will help doctors maintain the st<strong>and</strong>ard expected of them by<br />

making sure they keep pace with the latest techniques, technologies <strong>and</strong><br />

research. Revalidation will also require a doctor to tackle any concerns about<br />

skills such as communication <strong>and</strong> maintaining trust with patients.<br />

A joint letter from Sir David Nicholson <strong>and</strong> Sir Bruce Keogh provides more<br />

detail.<br />

To read the letter go to: http://www.dh.gov.uk/health/<strong>2012</strong>/10/medicalrevalidation-uk/<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


7<br />

People with dementia to receive more support:<br />

The Department of Health is providing dedicated funding to create care<br />

environments for people with dementia that help reduce anxiety <strong>and</strong> distress,<br />

<strong>and</strong> make them feel safer.<br />

Up to £50 million will be available to NHS trusts <strong>and</strong> local authorities, working<br />

in partnership with care providers, to help tailor hospitals <strong>and</strong> care homes to<br />

the needs of people with dementia. The care providers involved will need to<br />

sign up to the Dementia Care <strong>and</strong> Support Compact, which commits them to<br />

providing first-rate care <strong>and</strong> support for people with dementia <strong>and</strong> their<br />

families.<br />

For further information go to :<br />

http://www.dh.gov.uk/health/<strong>2012</strong>/10/dementiaenvironments<br />

National Self Care week 12-18 <strong>November</strong> <strong>2012</strong>:<br />

(Gateway reference number: 18251)<br />

This campaign to be launched by Health Minister Norman Lamb, raises<br />

awareness of the support available to help people, especially those with longterm<br />

conditions, to grow older healthily. This year's theme, which builds on<br />

the European Healthy Ageing Initiative, focuses on supporting people to take<br />

control of their own health <strong>and</strong> wellbeing, <strong>and</strong> play a more active role in<br />

decisions about their care.<br />

Link: http://www.dh.gov.uk/health/<strong>2012</strong>/10/self-care-week-<strong>2012</strong>/<br />

Pricing of NHS services:<br />

(Gateway reference number: 18128)<br />

From April 2014, Monitor <strong>and</strong> the NHS Commissioning <strong>Board</strong> will take over<br />

responsibility for pricing NHS services from the Department of Health. They<br />

will do this through the national tariff. The consultation seeks views on which<br />

providers can formally object to Monitor’s way of calculating prices, <strong>and</strong> what<br />

level of objection from commissioners <strong>and</strong>/or providers would require Monitor<br />

to reconsider how it calculates prices.<br />

Link: http://health<strong>and</strong>care.dh.gov.uk/pricing-consultation/<br />

Latest wave of NHS staff survey launched:<br />

(Gateway reference number: 18280)<br />

The Department of Health has commissioned GFK NOP, an independent<br />

research agency, to conduct a survey among NHS staff of their awareness of<br />

a range of important issues, including major NHS policy initiatives <strong>and</strong><br />

attitudes towards them. Fieldwork will begin on 2 <strong>November</strong> <strong>2012</strong> <strong>and</strong> will<br />

run through December <strong>and</strong> possibly into early January 2013. The survey will<br />

be conducted across all SHA clusters, to make sure staff views are<br />

represented across the country. The link below takes you to the results of last<br />

year's NHS staff attitudes survey.<br />

Link: http://www.dh.gov.uk/health/<strong>2012</strong>/06/public-perception/<br />

Finance transition planning arrangements:<br />

(Gateway reference number: 18269)<br />

The Department of Health, in collaboration with PCT <strong>and</strong> SHA finance<br />

colleagues, has developed a draft document covering the main year-end<br />

finance transition areas that SHAs <strong>and</strong> PCTs will need to plan for in <strong>2012</strong>/13.<br />

The final document will be issued by the end of <strong>November</strong> <strong>2012</strong>.<br />

Link: http://www.dh.gov.uk/health/<strong>2012</strong>/10/finance-transition/<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


8<br />

H<strong>and</strong>over <strong>and</strong> closedown: planning for a secure transition:<br />

(Gateway reference number: 18231 <strong>and</strong> 18228)<br />

The Department of Health Integrated Programme Office is working with<br />

transition leads in SHAs to support <strong>and</strong> assure h<strong>and</strong>over <strong>and</strong> closedown<br />

activity. Guidance is being produced by experts in the field, <strong>and</strong> policy <strong>and</strong><br />

business leads, to make sure best practice is followed <strong>and</strong> there is a<br />

consistent approach across all organisations. The first set of guidance is now<br />

available, covering 'transfer documentation' <strong>and</strong> 'intellectual property rights'.<br />

Link: http://www.dh.gov.uk/health/<strong>2012</strong>/10/h<strong>and</strong>over-guidance-transition/<br />

LOCAL NEWS:<br />

Executive Director Appointments:<br />

Recent Executive Director appointments include Flo Panel-Coates, Director of<br />

Nursing, Dr Mike Gill, Medical Director, Steve Huddleston, Chief Information<br />

Officer <strong>and</strong> Dr Ian Hosein, Director of Infection Prevention <strong>and</strong> Control.<br />

Staff Engagement Sessions:<br />

A recent initiative has commenced with staff being invited to attend face to<br />

face briefings from the Chief Executive <strong>and</strong> the Senior Team on<br />

developments around the <strong>Trust</strong>. This is an opportunity for staff to put their<br />

questions <strong>and</strong> suggestions forward <strong>and</strong> to get involved in the <strong>Trust</strong>’s plans for<br />

the future.<br />

HSJ Award Nomination:<br />

The Chief Executive, Director of Estates <strong>and</strong> several other representatives<br />

from the <strong>Trust</strong> recently attended an award ceremony sponsored by the Health<br />

Service Journal, where BHRUT had been nominated in the Category of<br />

Efficiency in Clinical Support Services. Although the <strong>Trust</strong> was not successful<br />

in winning the Award, the Directorate should be congratulated for reaching<br />

the shortlist <strong>and</strong> being nominated for this prestigious Award.<br />

World Health Organisation H<strong>and</strong> Hygiene Compliance Education<br />

Programme:<br />

Through the Infection Control Committee, BHRUT has agreed to a fantastic<br />

opportunity to become only the third NHS <strong>Trust</strong> in the UK to participate in the<br />

World Health Organisation H<strong>and</strong> Hygiene Compliance Education Programme.<br />

Representatives who have been trained by the World Health Organisation will<br />

undertake this Programme.<br />

This is a one year Programme, which will involve four wards at Queen’s <strong>and</strong><br />

three wards at King George Hospital (a cross section of specialties have been<br />

selected). Preliminary Audits will be carried out on the seven wards <strong>and</strong><br />

customised Education Programme Tools will be designed for the specific<br />

needs of each ward. Mid-year Audits will also be undertaken to provide an<br />

interim measure of the effectiveness of the Programme. It will cover all<br />

groups of staff <strong>and</strong> a concise KPI Dashboard will be designed, in order to<br />

track <strong>and</strong> monitor progress.<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


9<br />

Clinical Patient Management <strong>and</strong> H<strong>and</strong>over System (eH<strong>and</strong>over):<br />

The e-H<strong>and</strong>over system developed by Dr Aklak Choudhury, Respiratory<br />

Consultant <strong>and</strong> Mr John White, Consultant Orthopaedic Surgeon/Clinical IT<br />

Director is an award winning business critical SharePoint Hospital solution<br />

that improves patient safety <strong>and</strong> staff productivity. It has been running in the<br />

<strong>Trust</strong> for the past two years <strong>and</strong> is used by many disciplines, including<br />

Doctors, Nurses, Managers <strong>and</strong> Performance Teams.<br />

Dr Choudhury <strong>and</strong> Mr White have been invited by Microsoft to be the first<br />

case study produced as part of the business critical SharePoint Programme<br />

<strong>and</strong> will attend a Microsoft Conference in Las Vegas in <strong>November</strong>.<br />

The eH<strong>and</strong>over solution is the first to identify <strong>and</strong> successfully manage the<br />

shift gap issue, which results in significant communication failure <strong>and</strong> patient<br />

risk during nights <strong>and</strong> weekends. It provides the user with the functionality to<br />

complete their h<strong>and</strong>over tasks safely, efficiently <strong>and</strong> without duplication <strong>and</strong><br />

has the backing of the London Deanery <strong>and</strong> NHS Innovations. It won the<br />

EHI 2011 Award for “Best use of IT to promote patient safety” <strong>and</strong> the<br />

Microsoft Partner of the Year for Health Award. It has also been adopted by<br />

three other organisations <strong>and</strong> they are working with one of the Medical<br />

Education Teams to potentially set the processes as a ‘st<strong>and</strong>ard’ for all health<br />

organisations in the UK.<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


QUALITY & SAFETY COMMITTEE<br />

PART II - OPEN<br />

Minutes of the meeting held on Tuesday 14 th August <strong>2012</strong> at 15.45 hrs in <strong>Board</strong> Rooms 1&2,<br />

<strong>Trust</strong> Headquarters, Queen’s Hospital, Romford.<br />

Present:<br />

Prof. Anthony Warrens, Non Executive Director (AW) (Chair)<br />

Caroline Wright, Non Executive Director (CW)<br />

Maureen Dalziel, Non Executive Director (MD)<br />

George Wood, Chairman (GW)<br />

Averil Dongworth, Chief Executive (AD)<br />

Mike Gill, Medical Director (MG)<br />

Magda Smith, Associate Medical Director MS)<br />

Stephen Burgess, Director of Clinical Strategy (SB)<br />

Pam Strange, Clinical Governance Director (PS)<br />

Alison Crombie, Director of Education (AC)<br />

John Alcolado, Director of Medical Education (JA)<br />

Gary Etheridge, Deputy Director of Nursing (GE)<br />

Portia Omo-Bare, Chief Pharmacist (POB)<br />

Andrew Deaner, Clinical Director – Acute Medicine (ADe)<br />

Dele Olorunshola, Clinical Director – Women’s Services (DO)<br />

Derek Hicks, Clinical Director – Emergency Care (DH)<br />

Gabriel Sayer, Clinical Director – Specialist Surgery (GSa)<br />

Dip Mukherjee, Clinical Director – Surgery (DM)<br />

Geraldine Soosay, Clinical Director – Pathology (GS)<br />

Jane Stevens, Clinical Director – Specialist Medicine (JS)<br />

Zoltan Narg, Clinical Director – Radiology (ZN)<br />

Imogen Shillito, Director of Communications (IS)<br />

Cris Robinson, Committee Coordinator (Minutes) (CR)<br />

Rachel Brady, NHS North East London <strong>and</strong> City (RB)<br />

Elaine Clark, Chair of Improving Patient Experience Group (EC)<br />

In Attendance: Lucy Etheridge, Medical Education<br />

Dr Rull, Emergency Care<br />

Dr Umo-Etuk, Clinical Lead, Anaesthetics deputising for Remi Odejinmi<br />

Dr Andole, Clinical Lead, Neurosciences deputising for Jonathan Pollock<br />

1


102/<strong>2012</strong> Apologies<br />

Apologies were received from:<br />

Ambalika Das, Clinical Director – Children’s Services (ADa)<br />

Remi Odejinmi, Clinical Director – Anaesthetics (RO)<br />

Jonathan Pollock, Clinical Director – Neurosciences (JP)<br />

Cathy Geddes, Chief Operating Officer (CG)<br />

Vanessa Lodge, Deputy Director of Quality & Clinical Governance, NHS<br />

North East London & City<br />

103/<strong>2012</strong> Minutes of the Meeting held on the 12 th June <strong>2012</strong><br />

The minutes from the previous meeting were agreed to be a true record.<br />

104/<strong>2012</strong> Matters Arising<br />

Action Log<br />

18/<strong>2012</strong> - SB advised there had been further discussions with Health UK about<br />

the ISTC that has resulted in the <strong>Trust</strong> agreeing to support cardiac arrests in<br />

the centre. However, the <strong>Trust</strong> declined to provide advice to ISTC clinicians,<br />

although a pathway for referring the patient to A&E was agreed.<br />

36/<strong>2012</strong> – Information Governance Committee reports would in future be<br />

independent items <strong>and</strong> not part of the Feeder Committee update.<br />

42/<strong>2012</strong> – The infection control items were included as agenda items.<br />

45/<strong>2012</strong> – DO advised that the range used for Emergency LSCS performed<br />

within graded times was 30 for grade 1, <strong>and</strong> 60 for grade 2. The national<br />

figure for grade 2 was 75, but the <strong>Trust</strong> had agreed an internal ‘stretch’ target.<br />

45/<strong>2012</strong> – DO <strong>and</strong> IS agreed to jointly review the potential for a positive journal<br />

article on the <strong>Trust</strong>’s experience of meeting NHSL performance indicators for<br />

Emergency LSCS.<br />

54/<strong>2012</strong> – The item on patient stories to be deferred to the October meeting.<br />

70/<strong>2012</strong> – The update from each CD on NICE compliance was deferred to the<br />

October meeting.<br />

70/<strong>2012</strong> – The Deanery/GMC visit was included an agenda item.<br />

72/<strong>2012</strong> – POB reported that the missing methadone had been found, so the<br />

issue was due to a lag in reporting <strong>and</strong> it was not therefore an SI.<br />

74/<strong>2012</strong> – The Dr Foster reports had been re-circulated to members.<br />

74/<strong>2012</strong> – PS advised the <strong>Trust</strong> was in the process of introducing CHKS<br />

mortality data <strong>and</strong> had discontinued the contract with Dr Foster. Further<br />

information would be made available to the next meeting <strong>and</strong> once the<br />

changeover is complete the presentation will be scheduled into the<br />

Committee’s agenda.<br />

MS explained in relation to the update required on weekend mortality data<br />

relating to elective weekend deaths that she had been reviewing the notes of<br />

these patients <strong>and</strong> had identified that some were miscoded; some were<br />

attributable to the way cancer was coded. Of the notes reviewed only 8 relate<br />

to true elective surgical deaths, which she needed to discuss further with<br />

neurosurgery to fully underst<strong>and</strong>. There were 3 actions following the review<br />

i.e. 1) work with the coders to review the miscoding of emergency admissions<br />

as planned deaths, 2) further investigate how cancer day unit cases are coded<br />

<strong>and</strong> 3) review with neuro that the deaths were not inappropriately coded.<br />

IS confirmed that appropriate publicity would be given to ensure mortality data<br />

was transparent.<br />

Action<br />

DO / IS<br />

GE<br />

CDs<br />

PS<br />

2


77/<strong>2012</strong> – GE confirmed invitations to the MenCap Charter launch had been<br />

completed.<br />

78/<strong>2012</strong> – GE confirmed the letter to the Safeguarding team was completed.<br />

79/<strong>2012</strong> – GE confirmed the letter to the Chaplains was completed<br />

81/<strong>2012</strong> – SB confirmed the issue from the PALS Annual Report had been<br />

escalated to the <strong>Trust</strong> <strong>Board</strong>. However, 50% of the total PALS contacts<br />

continue to be in relation to cancellation of Outpatient appointments <strong>and</strong> the<br />

often extensive delays in rebooking some patients. SB felt this was an<br />

ongoing problem that was generating high levels of complaints, but was also a<br />

significant cause of concern for clinicians as patient’s individual risks factors<br />

needed closer scrutiny. It was agreed this item should be referred to the<br />

Directorate Manager for Outpatients for urgent resolution <strong>and</strong> feedback.<br />

GE confirmed that the letter to the PALS team was completed.<br />

Rolling Programme<br />

Members were advised that following discussions aimed at ensuring the<br />

Committee focused on clinical governance outputs, over the next few meetings<br />

the Directorates would be required to provide updates on their progress with<br />

embedding clinical governance. This would by necessity mean some items on<br />

the rolling programme were deferred. It was agreed that MG, SB <strong>and</strong> PS<br />

would revise the rolling programme <strong>and</strong> advise Directorates when they would<br />

be required to make their reports. It was also proposed that the presentations<br />

should focus on the 3 top corporate <strong>and</strong> 3 local priorities.<br />

105/<strong>2012</strong> Quality Dashboard<br />

STRATEGY<br />

PS explained the new dashboard was still being developed <strong>and</strong> future<br />

iterations would include more detail e.g. corporate indicators. The expectation<br />

is that CDs will add to the overall dashboard’s effectiveness by providing<br />

exception reports in future.<br />

AW said the dashboard was moving in the right direction. He asked that the<br />

RAG rating be shown in words as well as in colour.<br />

106/<strong>2012</strong> Items for Escalation from Feeder Committees<br />

This report was presented for information.<br />

107/<strong>2012</strong> Deanery / GMC Visit Report <strong>and</strong> Action Plan<br />

JA reported on the annual Deanery visit in May that required the <strong>Trust</strong> to take<br />

immediate remedial actions in relation to OPD cover, gynae continuity of care,<br />

gynae outpatients, consultant attendance out of hours, triage of patients <strong>and</strong><br />

FY2 responsibilities on HDU. JA explained that all m<strong>and</strong>atory actions had<br />

been completed but further work was needed to address consultant reticence<br />

to attend the <strong>Trust</strong> when they are called at home.<br />

The GMC Survey of trainees identified there was good core training, but<br />

GPVTS in emergency <strong>and</strong> obs. <strong>and</strong> gynae. was poor; paediatrics was<br />

satisfactory. The issues identified are not within the gift of the Education<br />

Department to resolve as they are trustwide issues not specifically educational<br />

ones.<br />

JA also advised there were ongoing patient safety concerns relating to<br />

supervision of junior doctors, the pressure in very busy areas such as obs. <strong>and</strong><br />

gynae. <strong>and</strong> emergency medicine <strong>and</strong> the poor quality of locums.<br />

Action<br />

AK<br />

MG / SB<br />

/ PS<br />

3


Action<br />

Members were advised that acute services <strong>and</strong> maternity should expect<br />

similar visits soon. JA summarised the ongoing challenges to be:<br />

• The need for a clinical governance bulletin<br />

• Hospital at Night<br />

• Bleep free time for junior doctors that would also assist in getting the<br />

11am discharge target met.<br />

• Phlebotomy cover at KGH<br />

• Daily Consultant Ward Rounds<br />

• Study Leave<br />

• Obs. <strong>and</strong> gynae. Middle grade numbers<br />

Most importantly JA felt the issue of clinical supervision of junior doctors must<br />

be focused on.<br />

AD also highlighted the Deanery’s requirement for obs. <strong>and</strong> gynae. junior<br />

doctors to be withdrawn from King George Hospital <strong>and</strong> repatriated to Queen’s<br />

within 72 hours of the MLU opening. MG said he would clarify expectations<br />

around this at his meeting with Andy Mitchell next week.<br />

AW felt that the Clinical Directors needed to tackle the issue of clinical<br />

supervision. JA confirmed that the <strong>Trust</strong>’s Medical & Education Policy for<br />

Supervision was updated in February this year <strong>and</strong> key performance indicators<br />

are in place. It was agreed that JA would write to the Clinical Directors<br />

requesting that each area should have a written policy that clearly states the<br />

level of clinical supervision expected; it should also clarify the <strong>Trust</strong>’s<br />

expectation that a Consultant will always attend to support a trainee if<br />

specifically requested to do so by the trainee.<br />

CW suggested that copies of the presentation would have been useful as<br />

would a broader executive summary that included the salient points. Both CW<br />

<strong>and</strong> AD were concerned that the action plans were not in the <strong>Trust</strong>’s format.<br />

JA explained the action plan was originally generated by the Deanery.<br />

However, GW felt there were too many action plans <strong>and</strong> there should be more<br />

consolidation; the action plans should be developed <strong>and</strong> owned by the <strong>Trust</strong><br />

with segments presented to the various audiences that request it.<br />

There was discussion around potential financial costs resulting from these<br />

visits/surveys that the <strong>Trust</strong> <strong>Board</strong> will be considering, but they will need to be<br />

added to the deficit.<br />

MG concluded the discussion by stating that other <strong>Trust</strong>s do provide better<br />

supervision of their juniors <strong>and</strong> that this leads to safer care. There will be<br />

some challenges but the emergency pathway will be an area to prioritise.<br />

PATIENT SAFETY<br />

108/<strong>2012</strong> Care Quality Commission Update<br />

PS explained that the report was for information but did highlight the action<br />

plan was being updated <strong>and</strong> there was a big drive to sign off as much as<br />

possible.<br />

AW was pleased to note the last Condition had been lifted.<br />

MG<br />

JA<br />

4


109/<strong>2012</strong> Infection Control Annual Report<br />

MS reported that the Infection Control Annual Report includes, at Appendix 3,<br />

the Infection Control Annual Plan that has been reviewed by the Infection<br />

Control Committee. The Plan shows there has been a significant rise in the<br />

first 4 months in both MRSA <strong>and</strong> C.difficile. The Infection Control Committee<br />

is solely focusing on these issues <strong>and</strong> incidence of MSSA. More positively,<br />

urinary catheter infections are decreasing this year. MS felt there needs to be<br />

a different approach with staff to ensuring that the basic principles of patient<br />

care are implemented.<br />

There have also been significant changes in the Infection Control Team with<br />

the Matron retiring recently <strong>and</strong> the Infection Control Doctor due to retire<br />

imminently. There are plans for a new Matron <strong>and</strong> Director of Infection<br />

Prevention <strong>and</strong> Control (DIPC) to be appointed. It was also important that<br />

aseptic touch technique is focused on.<br />

AW questioned whether there was enough support; MS felt that generally<br />

there was, although more Directorate representation at the Infection Control<br />

Committee was needed. She also felt colleagues had a role in being more<br />

challenging with issues such as h<strong>and</strong> hygiene <strong>and</strong> bare below the elbow. An<br />

invitation to Sodexo was being extended to improve environmental control<br />

scrutiny via the Infection Control Committee.<br />

DM commented that in general surgery Matrons <strong>and</strong> Nurses are empowered<br />

to challenge clinicians; this had resulted from a previous poor h<strong>and</strong> hygiene<br />

audit. He felt that there had been a view some time ago that infection control<br />

was a ‘nursing’ issue; this attitude is changing.<br />

MS advised that once the Infection Control Committee had completed its<br />

revision of the Annual Plan, it would be brought back to the Committee by the<br />

new DIPC.<br />

PATIENT OUTCOMES<br />

111/<strong>2012</strong> Surgical Site Infection Surveillance Update<br />

It was noted that a preliminary report had been reviewed by the Infection<br />

Control Committee relating to infections on fractured neck of femur patients. It<br />

was agreed this would be discussed with the CD <strong>and</strong> a decision taken on<br />

when <strong>and</strong> where this data should be presented.<br />

112/<strong>2012</strong> Implementing Patient Stories<br />

PATIENT EXPERIENCE<br />

This item to be deferred to the October meeting.<br />

113/<strong>2012</strong> Energise for Excellence<br />

This report was submitted for information <strong>and</strong> was duly noted. MD was<br />

concerned that dirty utensils in ward areas was affecting patient care. MS<br />

confirmed this was a cultural issue that was being monitored through the<br />

Infection Control Committee.<br />

114/<strong>2012</strong> Complaints Policy<br />

GE explained that the Complaints Policy required approval. It had been<br />

completely revised to take account of the 2009 Regulations <strong>and</strong> current best<br />

evidence. It has received wide circulation <strong>and</strong> comment. Members were<br />

asked to provide any comments to GE within 1 week of this meeting, subject to<br />

which the policy was duly approved.<br />

Action<br />

GSa /<br />

MS<br />

All<br />

5


Action<br />

115/<strong>2012</strong> Any Other Business<br />

The Complaints Annual Report for 2011/12 was tabled. The report was based<br />

on the requirements within the NHS Complaints (Engl<strong>and</strong>) Regulations 2009<br />

providing a summary of complaints received by the <strong>Trust</strong> in relation to its own<br />

services. Since the Annual Report was required for the September <strong>Trust</strong><br />

<strong>Board</strong> meeting, members were asked to pass any comments to GE within 2<br />

weeks from the date of this meeting.<br />

116/<strong>2012</strong> Summary of Issues for Escalation to <strong>Trust</strong> <strong>Board</strong><br />

• Continuing risks to patient care from high levels of cancelled outpatient<br />

appointments <strong>and</strong> delays with rebooking patients.<br />

117/<strong>2012</strong> Date of Next Meeting<br />

The next scheduled meeting will be held in <strong>Board</strong> Rooms 1&2 at 14.00 hours<br />

on the 16 th October <strong>2012</strong><br />

The dates for 2013 will be circulated.<br />

All<br />

MG<br />

CR<br />

6


ACTION LOG – PART I<br />

104/<strong>2012</strong> MATTERS ARISING<br />

45/<strong>2012</strong> - Joint review of potential for a positive journal article on the <strong>Trust</strong>’s<br />

experience of meeting NHSL performance indicators for emergency LSCS.<br />

Responsibility<br />

IS / DO<br />

70/<strong>2012</strong> – NICE compliance updates from CDs to be agenda item in October. CDs<br />

74/<strong>2012</strong> – Mortality update to the next meeting PS<br />

81/<strong>2012</strong> – Continuing risks to patient care from high levels of cancelled outpatient<br />

appointments <strong>and</strong> delays with rebooking patients to be escalated to the Directorate<br />

General Manager for Outpatients for early resolution <strong>and</strong> feedback.<br />

104/<strong>2012</strong> – Schedule of Directorate presentations on progress with embedding<br />

clinical governance to be developed, circulated <strong>and</strong> included in Rolling<br />

Programme.<br />

107/<strong>2012</strong> DEANERY / GMC VISIT REPORT AND ACTION PLAN<br />

Clarification to be sought concerning repatriation of junior doctors from KGH to<br />

Queen’s within 72 hours of MLU opening.<br />

It was agreed that JA would write to the Clinical Directors requesting that each<br />

area should have a written policy that clearly states the level of clinical supervision<br />

expected<br />

111/<strong>2012</strong> SURGICAL SITE INFECTION SURVEILLANCE<br />

Fractured neck of femur infections to be reviewed.<br />

112/<strong>2012</strong> IMPLEMENTING PATIENT STORIES<br />

This item to be included in the October meeting agenda.<br />

114/<strong>2012</strong> COMPLAINTS POLICY<br />

Any comments on the policy to be submitted to Gary Etheridge within 1 week<br />

115/<strong>2012</strong> ANY OTHER BUSINESS<br />

Any comments on the Complaints Annual Report to be submitted to Gary<br />

Etheridge within 2 weeks.<br />

116/<strong>2012</strong> ISSUES FOR ESCALATION TO TRUST BOARD<br />

The continuing risks to patient care from high levels of cancelled outpatient<br />

appointments <strong>and</strong> delays with rebooking patients to be escalated.<br />

117/<strong>2012</strong> DATE OF NEXT MEETING<br />

Dates for 2013 to be circulated to members<br />

AK<br />

MG / SB / PS<br />

MG<br />

JA<br />

GS / MS<br />

GE<br />

All<br />

All<br />

CR<br />

CR<br />

7


EXECUTIVE SUMMARY<br />

TITLE:<br />

Finance Report – Month Six (September)<br />

<strong>2012</strong>/13<br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. KEY ISSUES: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong><br />

DATE:<br />

• In the six month period to the end of September the<br />

trust recorded a year to date deficit of £26.0m<br />

(adjusted for impairments & IFRS reversals), which is<br />

£2.0m worse than plan for the period. This adverse<br />

variance is primarily explained by a £2.2m shortfall<br />

against the CIP target to date.<br />

• The in-month deficit of (£3.5m) was in line with plan.<br />

This represents an improvement on the average monthly<br />

run rate deficit to Month 5 of £4.5m <strong>and</strong> the deficit in<br />

Month 5 of £5.5m.<br />

• The income position to date is £2.1m ahead of plan.<br />

Some payment for over-performance with ONEL has<br />

now been agreed <strong>and</strong> £2.7m of this additional income is<br />

reflected in the year to date income position. Underperformance<br />

on non-ONEL SLAs (primarily Essex) has<br />

reduced income during the period by £0.4m.<br />

• The projected income position at the year-end is for<br />

an over-performance of £19.6m on the ONEL contract,<br />

less £0.9m under-performance for non-ONEL. This<br />

represents a significant risk as the commissioners have<br />

not yet agreed to fund £5.0m of these treatments.<br />

• Aside from the CIP shortfall, the expenditure position<br />

shows a £1.7m overspending year to date. This<br />

overspending is largely associated with the activity overperformance.<br />

An appropriate proportion of the income<br />

over-performance is being devolved to business units, to<br />

mitigate the marginal cost of over-performance.<br />

• The CIP position shows year to date delivery of £4.3m<br />

against a target for the period of £6.5m, a shortfall of<br />

£2.2m. The forecast delivery is £17.7m of which<br />

£4.8m is considered to be at high risk, which is an<br />

improvement on the £6.2m of high risk schemes<br />

reported last month. The <strong>Trust</strong> aims to have plans in<br />

place by the end of the month to deliver all of the £17.7m<br />

forecast.<br />

• This compares to a CIP target of £23.1m for the year.<br />

The PMO/E&Y are leading further work to mitigate the<br />

risks, maximise the savings opportunities <strong>and</strong> is aiming<br />

to deliver at least £20m CIPs.<br />

□ S&SIB ………………□ EPB…...…………..<br />

□ FINANCE ……………□ AUDIT ….……..….<br />

□ CLINICAL GOVERNANCE …………..…......<br />

□ CHARITABLE FUNDS ……………………….<br />

TRUST BOARD ………………………………<br />

□ REMUNERATION ……………………………<br />

□ OTHER ………………………(please specify)<br />

CATEGORY:<br />

□ NATIONAL TARGET □ CNST<br />

□ STANDARDS FOR BETTER HEALTH<br />

□ ASSURANCE FRAMEWORK<br />

□ TARGET FROM COMMISSIONERS<br />

CORPORATE OBJECTIVE To achieve financial<br />

security for the <strong>Trust</strong>, with reduced costs, improved<br />

productivity <strong>and</strong> collecting income due<br />

□ OTHER …………………….. (please specify)<br />

AUTHOR/PRESENTER:<br />

Alan Davies, Deputy Director of Finance / David<br />

Gilburt, Director of Finance<br />

DATE:<br />

• The <strong>Trust</strong> has significant risks to both income <strong>and</strong><br />

CIP delivery. With this level of risk our ability to<br />

deliver the £39.7m year-end control total must be in<br />

doubt.<br />

• We need Commissioners to fund the projected activity<br />

<strong>and</strong> the <strong>Trust</strong> has to deliver the CIP savings.<br />

• Discussions continue with the commissions <strong>and</strong> a<br />

detailed review of the forecast outturn will be<br />

completed <strong>and</strong> reported to the <strong>November</strong> Finance<br />

Committee<br />

2. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

Set out under key issues<br />

3. ALTERNATIVES CONSIDERED/REASONS FOR REJECTION:<br />

1


N/A<br />

4. DELIVERABLES:<br />

N/A<br />

5. EVIDENCE :<br />

N/A<br />

6. RECOMMENDATION/ACTION REQUIRED:<br />

The <strong>Trust</strong> <strong>Board</strong> is request to approve the report <strong>and</strong> note the actions to mitigate risk in achieving<br />

the control total deficit of £39.7m<br />

AGREED AT ______________________<br />

MEETING, OR<br />

REFERRED TO: ______________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE _________________________<br />

(if applicable)<br />

2


1. EXECUTIVE SUMMARY<br />

Monthly I&E Run rate<br />

m<br />

£<br />

43.0<br />

41.0<br />

39.0<br />

37.0<br />

35.0<br />

33.0<br />

31.0<br />

29.0<br />

Month 6 ‐ Monthly Run Rate Trend<br />

1 2 3 4 5 6 7 8 9 10 11 12<br />

Incom e Exp net of Blue/Green/Amber CIP Expenditure Further red CIPs required to m eet forecast<br />

<strong>Trust</strong> I&E Summary (+ve variances = favourable, -ve = adverse)<br />

<strong>2012</strong>/13 In Month (£'000) <strong>2012</strong>/13 Year to date (£'000)<br />

<strong>2012</strong>/13 <strong>2012</strong>/13 Foreast (£'000)<br />

2011/12<br />

2011/12 YTD Annual<br />

Actual £'000 Var £'000 Var % Actual £'000 Var £'000 Var % Actual £'000 Budget £'000 Actual £'000 Var £'000 Var % Actual<br />

(35,508) 1,296 3.79% Income (209,703) 2,138 1.03% (198,584) (413,055) (420,630) 7,575 -1.83% (419,121)<br />

Expenditure<br />

24,509 (159) -0.65% - Pay 147,555 (571) -0.39% 144,367 292,971 297,334 (4,363) -1.49% 291,010<br />

11,068 (207) -1.90% - Non-pay 67,348 (527) -0.79% 66,700 132,269 133,954 (1,685) -1.27% 138,248<br />

(656) -100.00% - QIPP/Cost Reduction (2,782) (13,710) (8,446) (5,264) 38.40%<br />

(78) -100.00% - Contract adjmt. & reserves (189) (122) 3,088 (3,210) 2635.09%<br />

68 198 74.33% EBITDA 5,200 (1,931) -59.07% 12,482 (1,646) 5,300 (6,946) 10,137<br />

ITDA<br />

1,171 37 3.08% - Depreciation 7,104 143 1.97% 7,003 14,494 14,162 332 2.29% 14,033<br />

355 0.00% - Capital Dividends 2,132 0.00% 1,943 4,263 4,263 0.00% 3,613<br />

1,823 21 1.11% - Net Interest 11,904 22 0.19% 11,488 23,822 23,756 66 0.28% 23,011<br />

3,417 255 6.95% Net position 26,339 (1,766) -7.18% 32,917 40,933 47,481 (6,548) -16.00% 50,794<br />

Impairments (2,005) (5,318) (2,005) (2,005) (1,133)<br />

3,417 255 6.95% Net position 24,334 (1,766) -7.82% 27,599 38,928 45,476 (6,548) -16.82% 49,661<br />

In Month <strong>and</strong> YTD Performance<br />

Income<br />

• Income of £35.5m in Month Six was £1.3m over the plan <strong>and</strong> is £2.1m ahead of<br />

plan YTD. The ONEL contract is £4.8m ahead of contract YTD, less transitional<br />

funding not agreed of £2.1m, with a forecast over-performance of £13.0m, less<br />

£4.3m transitional funding. Over-performance has continued to increase,<br />

particularly for non-elective activity, which is only funded at 30% marginal tariff<br />

above 2011/12 baseline, against which the commissioners are applying a 65%<br />

marginal tariff (i.e. net 20% tariff). The forecast expenditure position now<br />

includes £1.8m of non-elective costs not covered by the marginal tariff.<br />

Pay expenditure<br />

• Pay is £159k overspent in the Month, mainly related to Medical staffing £129k<br />

(Radiology £71k <strong>and</strong> Specialist Surgery £93k) <strong>and</strong> £78k (Acute Medicine<br />

£128k).<br />

• The YTD position is £571k overspent, mainly related to Medical staff £508k<br />

(Radiology £497k) <strong>and</strong> Nursing staff £595k (mainly Acute Medicine £640k <strong>and</strong><br />

Midwifery £243k, partly offset by under spending in Corporate Nursing<br />

budgets), both partly offset by under spending on Management/Admin staff of<br />

£679k.<br />

Non-pay expenditure<br />

• Non-pay is £207k overspent in the Month, mainly related to Pathology £109k<br />

<strong>and</strong> Pharmacy £136k<br />

• YTD the overspending is £527k, mainly related to Pathology £355k <strong>and</strong><br />

Specialist Medicine (£224k – Oncology <strong>and</strong> Pharmacy)<br />

EBITDA<br />

• Earnings before Interest, Tax, Depreciation <strong>and</strong> amortisation (EBITDA) were<br />

£0.1m negative in the Month <strong>and</strong> £5.2m negative YTD. The improved in month<br />

position was primarily driven by income. The YTD EBITDA of £5.2m negative is<br />

£1.9m adverse against plan YTD but has improved by £7.3m compared with<br />

the same period last year. The forecast is £5.3m negative, £4.8m better than<br />

last year’s outturn..<br />

Net deficit<br />

• The net deficit is £25.7m to date, which is £1.8m worse than plan. The forecast<br />

deficit is £46.8m, primarily related to:<br />

o £4.3m transitional income support not agreed by commissioners<br />

o £1.0m increased income over-performance not agreed by<br />

commissioners<br />

o £1.8m unfunded cost of Non-elective activity<br />

• The forecast assumes full delivery of £4.8m red-rated CIPs (in addition to the<br />

£12.9m CIP rated as blue/green/amber, making a total of £17.7m)<br />

Add back - Impairment 2,005 2,005 2,005 1,133<br />

121 (221) IFRS reversed (380) (221) (1,202) (759) (443) (882)<br />

3,538 34 Net against control 25,960 (1,987) 39,731 46,722 (6,991) 49,912<br />

3


CIP<br />

CIP<br />

• Overall CIP delivery in month <strong>and</strong> YTD is £1.4m <strong>and</strong> £4.3m respectively. The forecast outturn is £12.9m for blue/green/amber rated schemes, with a further £4.8m of red-rated schemes,<br />

which are in the process of being validated, with the aim of confirming the full £17.7m before the end of October.<br />

Financial risk rating (per Monitor criteria) KPIs<br />

Criteria Indicator Weight 5 4 3 2 1<br />

Underlying<br />

performance<br />

Achievement of<br />

plan<br />

Financial<br />

efficiency<br />

Risk Ratings<br />

Reported<br />

Position<br />

Year to<br />

Date<br />

Forecas<br />

t<br />

Outturn<br />

Normalised<br />

Position*<br />

Year to<br />

Date<br />

Forecast<br />

Outturn<br />

EBITDA margin % 25% 11 9 5 1


<strong>Trust</strong> I&E summary by Division/Directorate:<br />

<strong>2012</strong>/13 In Month <strong>2012</strong>/13 In Month <strong>2012</strong>/13 Year to date (£'000) 2011/12 <strong>2012</strong>/13 <strong>2012</strong>/13 Foreast (£'000)<br />

Actual £'000 Var £'000 Var %<br />

Adj Actual<br />

WTE<br />

Variance<br />

WTE Actual £'000 Var £'000 Var %<br />

Adj Average<br />

Actual WTE<br />

Average<br />

Actual £'000<br />

YTD Actual<br />

£'000<br />

Annual<br />

Budget £'000 Actual £'000 Var £'000<br />

(32,691) 888 2.79% Central Income (193,737) 1,924 1.00% (32,119) (182,812) (381,659) (388,538) 6,879<br />

Surgical Services Division<br />

3,692 (109) -3.04% 662.14 -0.81 Anaesthetics 22,296 (672) -3.11% 613.40 3,507 19,928 42,137 44,268 (2,130)<br />

1,370 (140) -11.38% 224.94 -0.93 Specialist Surgery 8,271 (242) -3.01% 250.26 1,340 7,900 15,600 16,271 (671)<br />

1,475 (73) -5.19% 327.24 -5.18 Surgery 8,678 (203) -2.40% 384.78 1,624 9,614 16,625 17,178 (553)<br />

6,538 (322) -5.17% 1,214.32 -6.92 Total 39,245 (1,117) -2.93% 1,248.44 6,472 37,443 74,363 77,717 (3,354)<br />

Emergency Care, Gen Med & Neurosciences<br />

3,774 (245) -6.95% 957.31 -63.82 Medicine 22,747 (909) -4.16% 1,033.10 3,829 22,837 42,811 44,476 (1,666)<br />

2,371 47 1.95% 523.96 13.12 Emergency Care 15,012 (191) -1.29% 583.37 2,573 14,499 28,732 29,933 (1,201)<br />

1,096 32 2.83% 237.60 -3.74 Neurosciences 6,916 11 0.16% 230.86 1,136 6,927 13,536 13,703 (166)<br />

7,240 (166) -2.35% 1,718.87 -54.44 Total 44,675 (1,089) -2.50% 1,847.33 7,538 44,262 85,079 88,112 (3,032)<br />

Women's, Children & Support Services<br />

1,148 28 2.34% 269.75 -17.84 Children 6,922 117 1.66% 263.71 1,188 7,162 14,093 13,958 135<br />

882 1 0.08% 377.20 -7.52 Support Services 5,380 (119) -2.27% 382.87 887 5,319 10,212 10,685 (473)<br />

2,937 (26) -0.89% 634.61 35.36 Women 17,960 (401) -2.28% 678.97 3,124 18,846 34,907 35,659 (752)<br />

4,967 2 0.05% 1,281.56 10.00 Total 30,262 (403) -1.35% 1,325.55 5,200 31,327 59,212 60,302 (1,090)<br />

Diagnostics & Specialist Medicine<br />

1,884 (158) -9.13% 279.47 7.71 Pathology 11,125 (631) -6.01% 284.06 1,777 10,854 20,519 22,003 (1,484)<br />

1,730 (158) -10.08% 313.05 -21.16 Radiology 10,357 (629) -6.47% 287.38 1,543 9,081 18,869 20,445 (1,576)<br />

3,226 105 3.15% 575.57 7.30 Specialist Medicine 20,354 (349) -1.74% 605.48 3,441 20,440 38,961 40,058 (1,097)<br />

6,840 (211) -3.18% 1,168.09 -6.15 Total 41,836 (1,609) -4.00% 1,176.92 6,762 40,375 78,349 82,506 (4,157)<br />

7,082 504 6.65% 840.00 34.75 Corporate 43,441 1,107 2.49% 728.52 6,777 41,169 87,962 87,437 524<br />

(23) 695 103.46% 6,222.84 -22.76 - Sub-total 5,721 (1,187) -26.18% 6,326.76 630 11,763 3,307 7,536 (4,229)<br />

91 (57) -167.77%<br />

Central adjustment including<br />

provisions & red CIP (520) 725 353.73% 134 764 410 (7,113) 7,523<br />

(440) Contract QIPP adjmt. & reserves (1,465) (5,353) 4,888 (10,241)<br />

1,171 37 3.08% Depreciation 7,104 143 1.97% 1,169 6,958 14,494 14,162 332<br />

2,178 20 0.90% PDC & Net Interest 14,034 18 0.13% 2,209 13,431 28,075 28,008 67<br />

3,417 255 6.95% Total 26,339 (1,766) -7.18% 6,326.76 4,142 32,917 40,933 47,481 (6,548)<br />

Impairments (2,005) (5,318) (2,005) (2,005)<br />

3,417 255 6.95% Net position 24,334 (1,766) -7.82% 6,326.76 4,142 27,599 38,928 45,476 (6,548)<br />

• Central income over-performance primarily driven by over-performance on out-patients (£3.9m), less shortfall of £2.2m transitional funding to be agreed.<br />

• Surgical Services YTD overspending primarily driven by £0.4m CIP shortfall, Medical staffing £0.5m <strong>and</strong> Theatres non-pay £0.2m.<br />

• Emergency/Medicine/Neuro YTD overspending primarily related to CIP shortfall £0.3m <strong>and</strong> Nursing in Acute Medicine £0.6m<br />

• Women/Children/Support YTD, primarily in Women, related to Midwifery £0.2m <strong>and</strong> HIV drugs £0.2m, although run rate has improved in M5.<br />

• Diagnostics & Specialist Medicine primarily related to Pathology consumables £0.4m, pay of £0.8m (mainly Radiology medical staff £0.6m) <strong>and</strong> CIP shortfall £0.5m<br />

• Corporate under-spending primarily from non-recurrent charitable funds contribution £0.4m <strong>and</strong> Estates £0.5m<br />

5


2. CLINICAL INCOME<br />

Key points:<br />

• In line with guidance from the SHA, the <strong>Trust</strong> <strong>and</strong> Commissioners’<br />

have agreed a monthly profile plan based on Commissioners’ QIPP<br />

schemes; as such the Budget has been re-profiled to reflect this<br />

change.<br />

• Income for Month 6 has been forecast using first cut activity for the<br />

Month. Activity for A&E, OP <strong>and</strong> IP were all taken at day 31. This<br />

has ensured that activity is more accurate <strong>and</strong> gives greater<br />

assurance around Income for the current month.<br />

• There was an under- performance of £1.8m in the month, with a year<br />

to date over-performance of £4m, on an ‘activity times price’ basis.<br />

Final Month 5 actual income came in at £30.9m, £1.2m more than<br />

was accrued, <strong>and</strong> as such, the YTD position reflects the actual activity<br />

for Months 1 – 5 <strong>and</strong> the current month forecast.<br />

Business Unit<br />

Performance<br />

In Month Year to date Forecast<br />

Actual Var Actual Var Actual Var<br />

(7,223) 919 Acute Medicine (44,732) 3,240 (89,557) 7,894<br />

(1,950) 223 Anaethetics (11,101) (47) (22,180) (197)<br />

(1,781) (127) Children (11,430) (736) (22,709) (1,347)<br />

(2,318) 192 Emergency Care (14,437) (219) (28,853) 331<br />

(2,257) (56) Neurosciences (13,991) (461) (28,034) (817)<br />

(784) 42 Pathology (4,912) 25 (9,945) 27<br />

(1,062) 61 Radiology (6,191) 493 (12,484) 1,088<br />

(2,734) 538<br />

Specialist<br />

Medicine (16,017) 1,825 (32,324) 3,758<br />

(3,546) 457<br />

Specialist<br />

Surgery (21,402) 1,248 (43,127) 2,569<br />

(3,484) 222 Surgery (21,756) 293 (43,835) 965<br />

(4,393) 494 Women (26,601) 1,107 (53,424) 2,693<br />

547 (1,129) Corp (1,168) (2,695) (2,042) (10,108)<br />

(30,984) 1,837 Total (193,737) 4,074 (388,514) 6,855<br />

• The forecast reflects an £8.7m FOT over- performance on the ONEL<br />

contract, with an FOT under-performance of £1.8m on other ‘non-<br />

ONEL’ contracts. The over-performance for the ONEL contract is now<br />

being renegotiated as the likely outturn has increased by c.£2m due<br />

to increased activity. The £8.7m is net of £4.3m shortfall on<br />

transitional funding (i.e. £13m gross over-performance)<br />

• The <strong>Trust</strong> is currently negotiating for additional income with ONEL for<br />

Best Practice Tariff, Breast Screening <strong>and</strong> Commissioners’ failure to<br />

move births to other providers. Discussions with the cluster are still<br />

on-going.<br />

• On the East of Engl<strong>and</strong> Contract, there has been a reduction in the<br />

Non Elective Activity partially offset by an increase in the use of<br />

Devices; the net effect is an FOT under performance of £1.5m.<br />

• A&E activity has grown by 7% year on year, but this is primarily due to<br />

the full-year effect of the Queen’s UCC, which was taken on by<br />

BHRUT in August <strong>2012</strong>.<br />

• There is a growth of 4% in Day cases year on year as a result of the<br />

achievement of the 18 weeks targets, coupled with the <strong>Trust</strong><br />

undertaking work that went to the ISTC last year.<br />

• Non Elective admissions activity has declined by 3% year on year.<br />

6


Income by POD<br />

In Month Year to date Forecast<br />

Actual Var Actual Var Actual Var<br />

(1,708) 199 A<strong>and</strong>E (10,595) (9) (21,173) 628<br />

(64) (3) Ambulatory Care (451) 6 (912) 10<br />

(216) 50 Breast Screening (1,026) (77) (2,077) (165)<br />

(217) 0 Challenge <strong>Trust</strong> <strong>Board</strong> (1,300) 0 (2,600) 0<br />

(378) 0 CQUIN (2,268) 0 (4,536) 0<br />

(2,419) 295 Critical Care (13,598) 191 (26,971) 117<br />

(2,617) 234 Daycases (16,480) 749 (33,366) 1,380<br />

(945) (11) Devices & Drugs (5,876) 545 (11,880) 1,249<br />

(1,292) 170 Direct Access (7,859) 448 (15,913) 865<br />

(1,798) 36 Elective (11,690) 147 (23,667) 198<br />

(355) 0 HIV Contract (2,132) 0 (4,264) 0<br />

(33) (12) ISTC Contract (211) (59) (412) (128)<br />

(10,931) 767 Non Elective (67,412) 707 (134,441) 3,984<br />

(2,720) 494 OP First Attendances (16,353) 1,557 (33,109) 3,103<br />

(2,875) 528 OP Follow Ups (17,555) 1,989 (35,543) 3,967<br />

(513) 118 OP Procedures (3,040) 428 (6,154) 844<br />

(480) (993) Other (6,972) (1,867) (14,041) (3,637)<br />

Patient Transport<br />

(308) 27 Services (1,762) 78 (3,523) 157<br />

(342) 53 Radiotherapy (2,060) 158 (4,109) 249<br />

496 0 Readmissions 2,976 0 5,953 0<br />

(519) 97 Regular Day Attenders (2,911) 135 (5,806) 173<br />

(92) (147) Road Traffic Accidents (1,168) (264) (2,000) (864)<br />

0 0 Transitional Funding 0 0 0 (4,300)<br />

(659) (65) XBD (3,993) (790) (7,969) (976)<br />

(30,984) 1,837 Total (193,737) 4,074 (388,514) 6,855<br />

Note: Other includes the 65% marginal rate adjustment in respect of ONEL performance (£7.1m)<br />

Activity<br />

POD Group 2011-12 <strong>2012</strong>-13 Var % Change<br />

A<strong>and</strong>E 95,652 110,117 14,465 7%<br />

Ambulatory Care 1,458 1,527 69 2%<br />

Breast Screening 10,482 10,360 (122) -1%<br />

Critical Care 13,383 13,857 474 2%<br />

Daycases 20,254 22,110 1,856 4%<br />

Direct Access 2,447,662 2,401,471 (46,191) -1%<br />

Elective 3,827 3,848 21 0%<br />

Non Elective 39,972 37,897 (2,075) -3%<br />

OP First Attendan 85,277 89,951 4,674 3%<br />

OP Follow Ups 201,644 200,710 (934) 0%<br />

OP Procedures 16,201 18,147 1,946 6%<br />

Other 41,071 43,931 2,860 3%<br />

Radiotherapy 8,931 10,806 1,875 9%<br />

Regular Day Atten 6,912 7,221 309 2%<br />

XBD 20,319 15,084 (5,235) -15%<br />

Total 3,013,045 2,987,037 (26,008)<br />

7


Cluster Performance<br />

In Month Year to date Forecast<br />

Actual Var Actual Var Actual Var<br />

(25,605) 2,011 Outer North East London (161,828) 4,832 (324,928) 8,700<br />

(559) 82 Inner North East London (2,881) 9 (5,776) 5<br />

(1,016) 67 London Specialist Commissioning (5,891) 199 (11,610) 227<br />

East Of Engl<strong>and</strong> Specialist<br />

(3,027) (134) Commissioning (18,288) (787) (36,843) (1,516)<br />

(427) (63) Non Contract Activity (2,297) 127 (4,596) 397<br />

(95) 32 North Central London (383) 3 (768) 5<br />

(255) (158) <strong>Trust</strong> (2,169) (308) (3,992) (963)<br />

(30,984) 1,837 (193,737) 4,074 (388,514) 6,855<br />

8


Devolved income<br />

Annual<br />

Budget<br />

Forecast<br />

Variance<br />

Forecast<br />

Income overperformance<br />

against plan<br />

Income<br />

attibuted to<br />

Directorate<br />

Net variance<br />

after income<br />

attribution<br />

9<br />

Difference<br />

between<br />

forecast<br />

income overperformance<br />

<strong>and</strong> income<br />

attributed<br />

Comment<br />

Surgical Services<br />

Anaesthetics 44,614 (2,476) (197) 479 (1,997) 676<br />

Includes allocation from Surgical Business Units for<br />

over/(under) performance<br />

Specialist Surgery 16,166 (566) 2,569 439 (127) (2,130) Over‐performance primarily related to Out‐patient<br />

Surgery 16,977 (351) 965 29 (322) (936) QiPP non‐delivery<br />

Surgical Services Total 77,757 (3,393) 3,337 948 (2,445) (2,389)<br />

Emergency Care, Gen Med & Neurosciences<br />

Emergency Care 30,208 (1,476) 331 (162) (1,638) (493)<br />

Neurosciences 13,724 (188) (817) (62) (250) 755 Adjustment for Drugs/devices & NEL activity<br />

Medicine 44,561 (1,751) 7,894 1,438 (313)<br />

Most of over‐performance associated with nondelivery<br />

of QiPP as opposed to increase in activity<br />

(6,456) from 2011/12<br />

Emergency Care, Gen Med & Neuroscie 88,493 (3,415) 7,408 1,214 (2,201) (6,194)<br />

Women's, Children & Support Services<br />

Most of under‐performance associated with reclassification<br />

of PAU activity from NEL to Outpatients,<br />

Children 13,858 236 (1,347) 134 370 1,481<br />

not reflected in contract<br />

Support Services 10,779 (567) 172 (395) 172<br />

Most of over‐performance associated with lower<br />

Women 35,567 (660) 2,963 (170) (830) (3,133) reductions in births than planned<br />

Women's, Children & Support Services 60,204 (991) 1,616 136 (855) (1,480)<br />

Diagnostics & Specialist Medicine<br />

Pathology 21,974 (1,455) 27 179 (1,276) 152<br />

Radiology 19,509 (640) 1,088 832 192 (256) Includes allocation from other Business Units for<br />

Specialist Medicine 41,488 (2,527) 3,758 1,259 (1,268) (2,499) support services<br />

Diagnostics & Specialist Medicine Tota 82,971 (4,622) 4,873 2,270 (2,352) (2,603)<br />

Total of above 309,425 (12,421) 17,234 4,569 (7,852)<br />

Most of difference associated with non‐delivery of<br />

(12,665) circa £10m QiPP reductions in contract<br />

• The table above, gives a summary of the forecast outturn position for each business unit, <strong>and</strong> then builds in an appropriate share of over-performance income, as mitigation against the<br />

increased marginal cost of the over-performance for each area.<br />

• Business Unit budgets are funded to 2011/12 outturn levels (as forecast at Month 8), so the principle applied is as follows:<br />

o Take the increase (or decrease) in activity from the 2011/12 outturn (as at Month 8 forecast) to the <strong>2012</strong>/13 forecast outturn (as at Month 6)<br />

o Apply 65% of the full tariff, as a proxy for marginal costs (this is also the level that commissioners are paying for over-performance <strong>and</strong> is commensurate with the average level<br />

of direct & indirect costs, as calculated through SLR)<br />

o Apply 50% of the 65% to Business Units in respect of direct costs, with the other 15% apportioned to clinical support services (e.g. Pathology, Radiology)<br />

o Of the 50%, a proportion is then allocated to Operating Theatres, in respect of the surgical specialties.<br />

o<br />

• It is proposed to allocate budgets through the ledger on this basis for Month 7 <strong>and</strong> to review the allocation again at Q3 (Month 9) <strong>and</strong> Month 12.


3. COST IMPROVEMENT PROGRAMME<br />

Commentary<br />

Forecast outturn<br />

The Month 6 forecast is £17.7m - at the same level as at Month 5. A new “Blue” rating is used to denote schemes that have been fully implemented, e.g. a post has been removed.<br />

£1.5m has moved in the RAG profile from Red to Blue, Green <strong>and</strong> Amber which are forecast at £12.9m.<br />

This includes:<br />

Reversal of Annual Leave Provision 750<br />

Outpatients schemes 330<br />

Emergency Care 120<br />

Neurosciences 110<br />

Rates Assessment 100<br />

Other 90<br />

Total new BAG schemes £1,500k<br />

CIP mitigation schemes (Red rated currently) include:<br />

Short Term Controls 2,350<br />

VAT on Medical Locum spend 600<br />

Medicines Management 560<br />

VAT on Pharmacy 250<br />

Length of Stay 200<br />

Workforce – AHP’s 200<br />

Salary sacrifice 50<br />

Other 580<br />

Total CIP mitigation £4,790k<br />

YTD position<br />

The <strong>Trust</strong> has achieved savings of £4.3m against a target of £6.5m, a shortfall of £2.2m (34%). This is mainly due to the Unidentified CIP gap of £1.4m. In addition there are<br />

material adverse variances in Diagnostics - £200k - <strong>and</strong> Nursing - £400k - relating to workforce <strong>and</strong> temporary pay reduction schemes.<br />

10


4. BALANCE SHEET<br />

Balance Sheet Current Previous Last<br />

(£m) Period Period Yr End<br />

Aug-12 Jul-12 Mar-11<br />

Non-current assets £390.4 £390.3 £389.1<br />

Current assets<br />

Inventories £5.8 £5.8 £7.0<br />

Trade <strong>and</strong> other receivables £35.1 £40.2 £29.5<br />

Cash <strong>and</strong> cash equivalents £1.4 £5.4 £2.8<br />

£42.4 £51.4 £39.3<br />

Current liabilities<br />

Trade <strong>and</strong> other payables (£67.2) (£69.1) (£48.2)<br />

PFI \ Borrow ings (£6.3) (£6.3) (£5.5)<br />

Provisions (£1.9) (£2.1) (£1.8)<br />

Net current assets/(liabilities) (£33.1) (£26.1) (£16.2)<br />

Non-current liabilities:<br />

PFI \ Borrow ings (£255.8) (£255.8) (£259.9)<br />

Trade <strong>and</strong> other payables (£4.9) (£4.9) (£4.9)<br />

Provisions (£4.2) (£5.6) (£5.0)<br />

Total assets employed £92.4 £98.1 £103.0<br />

Financed by taxpayers' equity:<br />

Public dividend capital £365.7 £365.7 £307.3<br />

Retained Earnings - P&L (£284.7) (£279.1) (£216.4)<br />

Retained Earnings - Donated Assets - - -<br />

Revaluation reserve £11.5 £11.5 £11.3<br />

Donated asset reserve £0.0 £0.0 £0.8<br />

Total taxpayers' equity £92.4 £98.1 £103.0<br />

Current Prior Last<br />

KPIs Period Period Yr End<br />

Aug-12 Jul-12 Mar-12<br />

Average Debtors days 16 17 21<br />

Debtors >90 days (£'000s) £1,240 £1,261 £592<br />

Debtors >180 days (£'000s) £466 £495 £1,536<br />

Debtors >365 days (£'000s) £2,089 £2,034 £2,825<br />

Total Bad Debt Provision (£'000s) £2,412 £2,413 £1,926<br />

>365 days provided (£'000s) £1,822 £1,782 £1,293<br />

Average creditor days 50 53 58<br />

Current ratio 53% 62% 71%<br />

Better payment practice code performance:<br />

- Non-NHS<br />

- Volume - paid on time 1,569 1,781 2,773<br />

- Volume - % paid on time 52.35% 52.41% 27.96%<br />

- Value - paid on time (£'000s) £5,874 £20,475.00 £5,150<br />

- Value - % paid on time 68.33% 78.85% 35.85%<br />

- NHS<br />

- Volume - paid on time 39 185 316<br />

- Volume - % paid on time 33.91% 58.36% 34.39%<br />

- Value - paid on time (£'000s) £169 £904 £1,630<br />

- Value - % paid on time 10.82% 26.25% 30.52%<br />

Key points:<br />

• Overall balance sheet position shows a reduction of £5.7m,<br />

related to the in month I&E deficit The cash position shows a<br />

reduction of £4.0m, compared with July.<br />

Key points:<br />

• Average creditor days reduced from 53 in June to 50 in August whilst<br />

average debtor days reduced from 17 to 16. Value of Non-NHS invoices<br />

paid on time reduced from £20.4m to £5.9m in August this was due to PFI<br />

unitary payment in July of £13.3m.<br />

13


5. CAPITAL AND CASHFLOW<br />

Summary Cashflow - Year to date<br />

£000's<br />

Operating Deficit (9,601)<br />

Interest Paid (12,266)<br />

PDC Dividend Paid 0<br />

Interest received 204<br />

Impairments (1,728)<br />

Transfers -<br />

Net I&E deficit (cash impact) (23,390)<br />

Depreciation <strong>and</strong> Amortisation 5,933<br />

Movements in w orking balances:<br />

Decrease in Inventories (5)<br />

Increase in Trade <strong>and</strong> Other Receivables 2,126<br />

Increase in Trade <strong>and</strong> Other Payables 23,159<br />

Decrease in Provisions (1,622)<br />

- sub-total 6,201<br />

Capital expenditure (6,646)<br />

Revenue Rental Income 546<br />

Net cashflow before financing 101<br />

Capital Element of Finance Leases <strong>and</strong> PFI (3,002)<br />

Loans repaid -<br />

Public Dividend Capital Received -<br />

Net Increase/(Decrease) in Cash <strong>and</strong><br />

Cash Equivalents<br />

(2,901)<br />

Opening cash balance 4,343<br />

Closing cash balance 1,442<br />

Capital Programme Summary Aug-12<br />

Total<br />

Approved<br />

Total<br />

Proposed<br />

Total<br />

Funding<br />

YTD<br />

Expenditure<br />

<strong>2012</strong>-13 <strong>2012</strong>-13 <strong>2012</strong>-13<br />

Internally Funded Assets<br />

Medical Equipment 1,926 1,848 3,774 1,609<br />

IT - Hardware 1,429 299 1,728 737<br />

IT - Software 482 0 482 88<br />

Other Plant & Machinery 500 0 500 0<br />

Estates 3,372 382 3,754 962<br />

sub-Total 7,709 2,529 10,238 3,395<br />

Externally Funded Assets<br />

Pathology 4,342 900 5,242 525<br />

SAN 967 0 967 711<br />

MLU 2,396 0 2,396 217<br />

Access Funded Assets 117 0 117 49<br />

sub-Total 7,822 900 8,722 1,503<br />

<strong>Trust</strong> Variation Enquiries 3,380 0 3,380 225<br />

Total <strong>Trust</strong> - Funded 18,911 3,429 22,340 5,123<br />

Subject to External Approval & Funding<br />

Cardiac Cath Lab 0 1,700 1,700 0<br />

CT Scanners 0 2,000 2,000 0<br />

A&E Reconfiguration 0 3,000 3,000 0<br />

Digital Mammography 0 1,548 1,548 0<br />

PAS Replacement 0 10,000 10,000 0<br />

sub-Total 0 18,248 18,248 0<br />

Total Capital Plan to Date 18,911 21,677 40,588 5,123<br />

Total <strong>Trust</strong> Submitted Plan 40,011<br />

Balance to Submitted Plan (577)<br />

Assets to be Considered via Charitable Funds<br />

Da Vinci Robot 0 2,400 2,400<br />

Cashflow - Key points:<br />

• The net cash position decreased from £5.4 to £1.4<br />

in August.<br />

Capital - Key points:<br />

• Against the total <strong>Trust</strong> Capital Plan of £40.9m, £18.3m of externally<br />

funded schemes have yet to be fully approved (including PAS). Of<br />

the remaining £22.6m, £19.2m of projects have been approved, with<br />

a further £3.4m awaiting business case approval.<br />

• Against this position, year to date capital expenditure is £5.1m, an increase<br />

of £1.3m compared with July.<br />

• The <strong>Trust</strong> has frozen all non-essential capital schemes, pending mitigation<br />

of risk in achieving the £40m revenue control total<br />

14


6. Business Unit Summaries<br />

Attached are the summary financial reports for each of the Clinical Business Units. These show:<br />

1. A graphical dashboard summary of the key financial indicators<br />

2. Key financial variances with mitigating actions, including leads <strong>and</strong> timescales<br />

3. CIP report for the Business Unit<br />

4. Income <strong>and</strong> Expenditure statement for each Business Unit. This shows each Business Unit’s share of the Central Income position <strong>and</strong> their local Income <strong>and</strong><br />

Expenditure position, giving an overall Net Deficit (+) / Surplus (‐) position. All Income is shown as a credit (‐) <strong>and</strong> all variances are expressed as Adverse (‐) or<br />

Favourable (+). It should be noted is not a true SLR report, as none of the central income has been apportioned out to the services that are supporting it (e.g.<br />

Diagnostics, Therapies), rather it represents where the income is coded to. They do show, however, the movement in the relationship between coded<br />

income <strong>and</strong> expenditure between current year to date <strong>and</strong> prior year average for expenditure <strong>and</strong> actual reported income.<br />

5. Forecast outturn, with a reconciliation to the previous month’s forecast.<br />

15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!